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Abstract  
 
Organofluorine compounds have found increasing applications in medicinal, agrochemical 
and materials sciences. Due to its singularity, fluorine is able to induce significant alterations on key 
physicochemical properties, such as lipophilicity, electron-density distribution, acid-base properties, 
hydrogen-bonding capability, and even on conformational equilibria. Nevertheless, fluorine is scarcely 
found in naturally occurring organic molecules, and the vast majority of fluorine-containing molecules 
are synthetic. Therefore, the development of new practical methodologies for the generation of 
fluorine-containing organic frameworks, either by site selective fluorination reactions or yielding them 
from simple fluorinated building blocks, is of great interest to the synthetic community. On this basis, 
the present thesis discloses a novel series of synthetic methodologies based on transition metal 
catalysis, ultimately establishing organofluorine chemistry as their top benchmark application. Herein, 
we disclose the discovery of the beneficial effect of 1,7-octadiene on assisting enyne metathesis 
reactions, the generation of a new family of fluorinated α-amino acid derivatives by means of gold-
catalysis and the development of two new methodologies for the enantioselective palladium-catalyzed 
1,1-difunctionalization of terminal alkenes, including a selective electrophilic fluorination reaction.  
 
 
 
 
 
 
	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
 
 
 
 
Resumen  
 
A lo largo de las últimas décadas, los compuestos organofluorados han encontrado numerosas 
aplicaciones dentro del campo de las industrias farmacéutica y agroquímica, así como en ciencias de 
los materiales. Dadas las singulares propiedades del átomo de flúor, éste es capaz de inducir 
alteraciones significativas en propiedades físico-químicas de las moléculas como lipofilia, distribución 
de cargas, acidez-basicidad, capacidad de formar enlaces de hidrógeno e incluso, equilibrios 
conformacionales. Sin embargo, la presencia de flúor en productos naturales es escasa. De hecho, la 
gran mayoría de las moléculas orgánicas que contienen flúor son sintéticas. De ahí el gran interés por 
parte de la comunidad sintética en el desarrollo de nuevas metodologías para la introducción de flúor 
en moléculas orgánicas, bien sea mediante reacciones de fluoración selectivas sobre posiciones 
específicas de la molécula, o bien mediante el empleo de building blocks fluorados, y así construir la 
nueva molécula alrededor de estos sillares. En este contexto, en la presente tesis doctoral se describe el 
desarrollo de nuevas metodologías sintéticas catalizadas por complejos de metales de transición, 
estableciendo la química de flúor como el principal marco de aplicación de dichas metodologías. El 
descubrimiento del efecto beneficioso del empleo de 1,7-octadieno en reacciones de metátesis de 
eninos, la generación de una nueva familia de derivados fluorados de α-aminoácidos mediante 
catálisis con complejos de oro, así como el desarrollo de dos nuevas metodologías sintéticas para la 
1,1-difuncionalización enantioselectiva de alquenos terminales, incluyendo una nueva reacción de 
fluoración electrofílica selectiva, serán objeto de discusión en la presente memoria.  
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General introduction, overview and objectives  
 
 
 
 
The generation of new chemical entities, NCEs, (i.e. original structural skeletons capable of 
interacting with a therapeutic target) is currently one of the most important bottlenecks along the drug 
discovery process. Indeed, within the field of the pharmaceutical industry, the development of new 
drugs has been steadily declining over the last 15-20 years mainly due to the lack of NCEs. 
Consequently, the design and development of new synthetic methodologies leading to diverse 
molecular structures represents a significant goal within the area of Organic Chemistry.  
In this context, it is well known that 20% of the marketed drugs contain fluorine atoms in their 
structures and around 50% possess at least one stereocenter.  
The paramount role displayed by fluorine in the growth and development of medicinal 
chemistry is firmly established (Figure 0.1),1 providing remarkable breakthroughs in this arena. Lot of 
commonly used drugs contain fluorine atoms in their skeleton. For instance, 2nd Fluticasone (Seretide) 
by GSK, 4th Rosuvastatin (Crestor) by AstraZeneca, 17th Sitagliptin (Januvia) by MSD, 20th Tenofovir 
(Atripla) by Gilead, 25th Celecoxib (Celebrex) by Pfizer or 28th Ezetimibe (Zetia) by MSD, were 
placed up in the worldwide ranking of top-selling drugs in 2013.  
 
                                                       
1 (a) Ojima, I. J. Org. Chem. 2013, 78, 6358. (b) Fluorine in Medicinal Chemistry and Chemical Biology; Ojima, I., Ed.; 
Wiley-Blackwell: Chichester, 2009. (c) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37, 
320.  
Figure 0.1. Organofluorine chemistry in medicinal chemistry.
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The combination of a high electronegative character, along with a moderate size, ascribed a 
highly polarized character to the C–F bond. As a result, acid-base properties, electron-density 
distribution, or hydrogen-bonding capability, among other physicochemical properties, might be 
modulated, resulting in improved pharmacological profiles, such as increased lipophilicity, 
bioavailability or metabolic stability.2 Arguably, these particular effects imparted by fluorine explain 
why it becomes so attractive in drug design, achieving a significant impact in a wide range of medical 
applications, including anaesthetics, anti-inflammatory drugs, anti-tumour, anti-viral and anti-bacterial 
agents, or cholesterol inhibitors. But popularity of fluorine is not just tied to medicinal chemistry, as it 
has reached as well other industrial areas such as agrochemicals,3 material science4 or tracers for 
positron emission tomography (PET).5  
Nevertheless, despite its widespread distribution in nature (fluorine is the 13th most abundant 
element in the Earth’s crust), the presence of fluorine in natural organic molecules is scarce,6 and most 
of the fluorine-containing organic molecules are man-made. Therefore, the development of new 
methodologies that gain access into new fluorinated derivatives are always in great demand.  
In this respect, two main strategies have been followed in order to access to fluorinated organic 
molecules. One is the use of either nucleophilic or electrophilic fluorinating reagents.7 Even though 
research for the development of new selective fluorinating reagents able to form C–F bonds from 
either C–H bonds or functional groups are currently ongoing, selective fluorination on specific 
positions of an organic framework is often challenging. Hence, a more flexible synthetic strategy 
                                                       
2 (a) O’Hagan, D. Chem. Soc. Rev. 2008, 37, 308. (b) Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.; Meanwell, N. 
A. J. Med. Chem. 2015, 58, 8315. (c) Huchet, Q. A.; Kuhn, B.; Wagner, B.; Kratochwil, N. A.; Fischer, H.; Kansy, M.; 
Zimmerli, D.; Carreira, E. M.; Müller, K. J. Med. Chem. 2015, 58, 9041.  
3 (a) Fujiwara, T.; O’Hagan, D. J. Fluorine Chem. 2014, 167, 16. (b) Giornal, F.; Pazenok, S.; Rodefeld, L.; Lui, N.; Vors, J.-
P.; Leroux, F. R. J. Fluorine Chem. 2013, 152, 2. (c) Jeschke, P. Pest Manag. Sci. 2010, 66, 10. (d) Jeschke, P. 
ChemBioChem 2004, 5, 570. (e) Banks, R. E.; Smart, B. E.; Tatlow, J. C. Organofluorine Chemistry: Principles and 
Commercial Applications; Plenum Press: New York, 1994.  
4 Berger, R.; Resnati, G.; Metrangolo, P.; Weber, E.; Hulliger, J. Chem. Soc. Rev. 2011, 40, 3496.  
5 (a) Preshlock, S.; Tredwell, M.; Gouverneur, V. Chem. Rev. 2016, 116, 719. (b) Chansaenpak, K.; Vabre, B.; Gabbai, F. P. 
Chem. Soc. Rev. 2016, 45, 954. (c) Buckingham, F.; Gouverneur, V. Chem. Sci. 2016, 7, 1645. 
6 (a) Chan, K. K. J.; O’Hagan, D. Methods Enzymol. 2012, 516, 219. (b) O’Hagan, D.; Harper, D. B. J. Fluorine Chem. 1999, 
100, 127. (c) Paul, E. A.; Huang, P. M. Chemical aspects of soil. In Handbook of Environmental Chemistry; Hutzinger, O., 
Ed.; Springer-Verlag: Berlin, 1980; pp 69−86. Selected examples: (d) Jaivel, N.; Uvarani, C.; Rajesh, R.; Velmurugan, D.; 
Marimuthu, P. J. Nat. Prod. 2014, 77, 2. (e) Xu, X.-H.; Yao, G.-M.; Li, Y.-M.; Lu, J.-H.; Lin, C.-J.; Wang, X.; Kong, C.-H. 
J. Nat. Prod. 2003, 66, 285.  
7 (a) Champagne, P. A.; Desroches, J.; Hamel, J.-D.; Vandamme, M.; Paquin, J.-F. Chem. Rev. 2015, 115, 9073. (b) Yang, 
X.; Wu, T.; Phipps, R. J.; Toste, F. D. Chem. Rev. 2015, 115, 826. (c) Campbell, M. G.; Ritter, T. Chem. Rev. 2015, 115, 612. 
(d) Ma, J.-A.; Li, S. Org. Chem. Front. 2014, 1, 712. (e) Bizet, V.; Besset, T.; Ma, J.-A.; Cahard, D. Curr. Top. Med. Chem. 
2014, 14, 901. (f) Wu, J. Tetrahedron Lett. 2014, 55, 4289. (g) Liann, T.; Neumann, C. N.; Ritter, T. Angew. Chem., Int. Ed. 
2013, 52, 8214. (h) Zhao, Y.; Pan, Y.; Sim, S.-B. D.; Tan, C. H. Org. Biomol. Chem. 2012, 10, 479. (i) Hollingworth, C.; 
Gouverneur, V. Chem. Commun. 2012, 48, 2929. (j) Furuya, T.; Kamlet, A. S.; Ritter, T. Nature 2011, 473, 470. (k) Valero, 
G.; Companyó, X.; Rios, R. Chem. Eur. J. 2011, 17, 2018. (l) Cahard, D.; Xu, X.; Couve-Bonnaire, S.; Pannecoucke, X. 
Chem. Soc. Rev. 2010, 39, 558. (m) Lectard, S.; Hamashima, Y.; Sodeoka, M. Adv. Synth. Catal. 2010, 352, 2708. (n) Kirk, 
K. L. Org. Process Res. Dev. 2008, 12, 305. (o) Bobbio, C.; Gouverneur, V. Org. Biomol. Chem. 2006, 4, 2065. (p) Ma, J.-
A.; Cahard, D. Chem. Rev. 2004, 104, 6119. (q) Singh, R. P.; Shreeve, J. M. Acc. Chem. Res. 2004, 37, 31. (r) Singh, R. P.; 
Shreeve, J. M. Synthesis 2002, 2561.  
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3 
based on the use of simple and readily available fluorine-containing compounds as building blocks,8 
building the new molecule around these scaffolds, plays an important role as a powerful supplement to 
direct fluorination methods. 
On the other hand, the significance of enantiomerically pure compounds in the pharmaceutical 
industry has motivated vast scientific efforts towards the development of stereoselective 
methodologies for their preparation, especially after the FDA’s policy statement for the development 
of new stereoisomeric drugs in 1992.9 This paradigmatic shift from racemates to single-enantiomer 
drugs (Figure 0.2)10 brought asymmetric synthesis into the mainstream in the drug discovery process. 
In general, the additional cost of producing one enantiomer of a chiral molecule makes up for the 
development work needed to elucidate the toxicological and pharmacokinetic profile of the undesired 
enantiomer (distomer).  
 
 
 
The synthetic efforts towards the development of new asymmetric synthetic methodologies 
was recognized in 2001 with the Chemistry Nobel Prize awarded to W. S. Knowles, R. Noyori, and K. 
B. Sharpless, for the design and development of catalytic methods for the construction of chiral 
molecules based on the utilization of transition metal catalysis.11 Alternatively, enzymes have been 
successfully employed as catalysts of certain reactions in a highly specific and efficient manner 
(biocatalysis or enzymatic catalysis).12 In the past decade, organocatalysis, i.e. use of small organic 
                                                       
8 (a) Kuehnel, M. F.; Lentz, D.; Braun, T. Angew. Chem. Int. Ed. 2013, 52, 3328. (b) Dmowski, W. J. Fluorine Chem. 2012, 
142, 6. (c) David, E.; Milanole, G.; Ivashkin, P.; Couve-Bonnaire, S.; Jubault, P.; Pannecoucke, X. Chem. Eur. J. 2012, 18, 
14904. (d) Dmowski, W. J. Fluorine Chem. 2011, 132, 504. (e) Qing, F.-L.; Zheng, F. Synlett 2011, 1052. (f) Fustero, S.; 
Sanz-Cervera, J.-F.; Aceña, J. L.; Sánchez-Roselló, M. Synlett 2009, 525. (g) Wu, J.; Cao, S. Curr. Org. Chem. 2009, 13, 
1791. (h) Pacheco, M. C.; Purser, S.; Gouverneur, V. Chem. Rev. 2008, 108, 1943. (i) Fustero, S.; Sanz-Cervera, J.-F.; Piera, 
J.; Sánchez-Roselló, M.; Chiva, G.; Simón-Fuentes, A. J. Fluorine Chem. 2004, 125, 621. (j) Percy, J. M. Top. Curr. Chem. 
1997, 193, 131.  
9 Tomaszewski, J.; Rumore, M. M. Drug Dev. Ind. Pharm. 1994, 20, 119. 	  
10 Farina, V.; Reeves, J. T.; Senanayake, C. H.; Song, J. J. Chem. Rev. 2006, 106, 2734.  	  
11 (a) Knowles, W. S. Angew. Chem. Int. Ed. 2002, 41, 1998. (b) Noyori, R. Angew. Chem. Int. Ed. 2002, 41, 2008. (c) 
Sharpless, K. B. Angew. Chem. Int. Ed. 2002, 41, 2024. 	  
12 (a) Kielbasinski, P.; Ostaszewski, R.; Szymanski, W. In In Enzymatic Catalysis Today and Tomorrow; Wiley-Blackwell: 
2010; pp 95-120. (b) Lozano, P.; de Teresa, D.; Iborra, J. L. In In Enzymatic Catalysis; Wiley-VCH Verlag GmbH & Co. 
Figure 0.2. Evolution of single enantiomers vs racemates as NCEs.
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molecules to catalyze organic transformations, emerged as a versatile and useful tool for addressing 
contemporary challenges in asymmetric synthesis.13  
Beyond its application in asymmetric catalysis, the use of transition metals in organic 
synthesis has been immense over the past decades, being under continuous innovation and finding 
increasing applications. Likewise, transition metals have been successfully incorporated into the ever-
growing field of organofluorine chemistry with remarkable and often unexpected results.14  
On the other hand, one of the main interests of academia and industry is the enhancement of 
synthetic efficiency. In this sense, tandem catalysis, which can be defined as a set of reactions 
catalyzed independently by one or more catalysts in a consecutive manner, is becoming increasingly 
important in several areas of organic chemistry, including natural products’ synthesis, drug discovery, 
and process chemistry.15 Likewise, it is one of the strategies used by nature in the preparation of 
biomolecules.16 In this manner, using single starting materials, molecular complexity can be increased 
in a single operation, thus allowing the synthesis of complex molecules and avoiding the loss of time 
and product associated with the isolation and purification of intermediates in multistep sequences. 
This approach provides environmental and economic benefits, besides fulfilling the principles of green 
chemistry. However, the difficulty in the optimization of the separated processes independently has 
made these methods very challenging.  
Given this perspective, the overarching goal of this research thesis was to implement, but also 
design new transition metal-catalyzed methods that complement the modern organic chemistry 
toolbox, establishing organofluorine chemistry as the top benchmark application. The employed feed 
back research strategy, from transition metal catalysis to organofluorine chemistry, and vice versa, 
proved as a highly fruitful approach (Figure 0.3), allowing us to reach the below described 
achievements.  
 
                                                                                                                                                                            
KGaA: 2010; Vol. 4, pp 281-302. (c) Drauz, K.; Waldmann, H. Enzyme Catalysis in Organic Synthesis, 2nd ed., Wiley-
VCH: Weinheim 2002.  
13 For selected reviews on asymmetric organocatalysis, see: (a) Scheffler, U.; Mahrwald, R. Chem. Eur. J. 2013, 19, 14346. 
(b) Alemán, J.; Cabrera, S. Chem. Soc. Rev. 2013, 42, 774. (c) Giacalone, F.; Gruttadauria, M.; Agrigento, P.; Noto, R. Chem. 
Soc. Rev. 2012, 41, 2406. (d) Jacobsen, E. N.; MacMillan, D. W. C. Proceed. Nat. Acad. Sci. 2010, 107, 20618. (e) Bertelsen, 
S.; Jorgensen, K. A. Chem. Soc. Rev. 2009, 38, 2178. (f) Dondoni, A.; Massi, A. Angew. Chem. Int. Ed. 2008, 47, 4638. (g) 
List, B. Chem. Rev. 2007, 107, 5413.  
14 Catalán, S.; Muñoz, S. B.; Fustero, S. Chimia, 2014, 68, 382.  
15 Shindoh, N.; Takemoto, Y.; Takasu, K. Chem. Eur. J. 2009, 15, 12168.  
16 (a) Hornsby, C. E.; Paton, R. S. Nat. Chem. 2014, 6, 88. (b) Davis, B. G. Nat. Chem. 2010, 2, 85. 	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Chapter 1 discloses the discovery of the beneficial effect of 1,7-octadiene as an in situ source 
of ethylene gas in cross enyne metathesis processes. This finding was illustrated in a novel tandem 
cross enyne metathesis-Diels Alder reaction, which was further extended to difluoropropargyl amides, 
allowing us to validate this method versus previously reported Mori’s conditions.  
 
 
 
In Chapter 2, diversity oriented synthesis (DOS) principle was applied in order to access to 
new families of fluorine-containing heterocyclic scaffolds by means of gold-catalyzed tandem 
sequences and starting from a common skeleton, fluorinated homopropargyl α-amino esters. 
Remarkably, all the accessed new entities contained a quaternary α-amino acid unit, and most of the 
developed strategies could be further extended to their non-fluorinated counterparts.  
 
 
 
Last two chapters disclose two new methodologies for the enantioselective palladium-
catalyzed 1,1-difunctionalization of terminal alkenes.  
 
Figure 0.3. Research approach.
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chemistry
transition metal 
catalysis
NCEs
R
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H
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Chapter 3 was developed along an internship at the University of California, Berkeley, under 
the supervision of Prof. F. Dean Toste and in collaboration with Dr. Hosea M. Nelson and Dr. Brett. 
D. Williams. This chapter describes a modular and step-economical palladium-catalyzed method for 
the direct preparation of chiral benzyl boronates from terminal alkenes via a three-component Heck-
Matsuda arylation-Miyaura borylation cascade reaction. The process was rendered enantioselective 
through the use of chiral anion phase-transfer (CAPT) technology, establishing the first illustration of 
cooperative CAPT and transition metal catalysis.  
Finally, inspired by the 1,1-difunctionalization reaction manifold applied in Chapter 3, we 
developed the palladium-catalyzed β,β-fluoroarylation of α,β-unsaturated carbonyl-derived systems 
via a single-step three-component Heck arylation-oxidative fluorination cascade reaction (Chapter 4). 
This chapter was developed in collaboration with Prof. F. Dean Toste.  
 
R RPd
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Chapter 1  
1,7-Octadiene-assisted tandem multicomponent cross enyne metathesis-
Diels Alder reaction. A useful alternative to Mori’s conditions  
 
 
1.1. Introduction and current state-of-the-art.  
 
The metathesis reaction has become one of the most powerful synthetic tools for the creation 
of C–C bonds.17 Even though the first metathesis reaction was described in 1955, it was not until the 
90s, with the advent of stable metal-carbene catalysts developed by Schrock, Grubbs and Hoveyda, 
mostly based on molybdenum or ruthenium (Figure 1.1),18 that metathesis processes became a useful 
method in synthetic organic chemistry.19 In general, these catalysts showed wide functional group 
tolerance and stability to air and moisture, whilst enabling metathesis under mild reaction conditions.  
 
                                                       
17 (a) Fürstner, A. Science, 2013, 341, 1357. (b) Kotha, S.; Dipak, M. K. Tetrahedron, 2012, 68, 397. (c) Kress, S.; Blechert, 
S. Chem. Soc. Rev. 2012, 41, 4389. (d) Nolan, S. P.; Clavier, H. Chem. Soc. Rev. 2010, 39, 3305. (e) Vougioukalakis, G. C.; 
Grubbs, R. H. Chem. Rev. 2010, 110, 1746. (f) Hoveyda, A. H.; Malcolmson, S. J.; Meek, S. J.; Zhugralin, A. R. Angew. 
Chem. Int. Ed. 2010, 49, 34.  
18 (a) Poulsen, S. C.; Madsen, R. Synthesis, 2003, 1. (b) Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H. Angew. 
Chem. Int. Ed. 1995, 34, 2039. (c) Nguyen, S. T.; Johnson, L. K.; Grubbs, R. G. Ziller, J. W. J. Am. Chem. Soc. 1992, 114, 
3974. (d) Schrock, R. R.; Murdzek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; O’Regan, M. J. Am. Chem. Soc. 1990, 112, 
3875.  
19 The relevance of this transformation was recognized in 2005 with the Nobel Prize for three of its main contributors, Yves 
Chauvin, Robbert H. Grubbs and Richard R. Schrock: (a) Grubbs, R. H. Angew. Chem. Int. Ed. 2006, 45, 3760. (b) Schrock, 
R. R. Angew. Chem. Int. Ed. 2006, 45, 3748.  
Schrock, 1990 Grubbs 1 st, 1995 Grubbs 2nd, 1999
Figure 1.1. Selected carbene-type catalysts employed in metathesis.
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The term “metathesis”, taken from Greek and meaning “change of position”, describes the 
exchange of carbon atoms between a pair of π-C–C bonds. Among the different variants of metathesis 
reactions (Figure 1.2), enyne metathesis20 has emerged as a singular process since a new functionality 
in the product, different from those of the starting materials, is generated in the product. Moreover, in 
comparison with olefin metathesis or alkyne metathesis (formal substitution reactions), enyne 
metathesis is an atom economical process, since no byproducts are formed (it resembles an addition 
event).  
 
 
 
This reorganization of an alkene and an alkyne to produce a 1,3-diene was first reported by 
Katz in 1985, using stoichiometric amounts of a tungsten Fischer-type carbene (Scheme 1.1).21  
 
 
 
Though the mechanism by which enyne metathesis occurs is not yet clear, the formation of the 
diene can be explained as follows (Scheme 1.2). The reaction would be initiated by a [2+2] 
                                                       
20 (a) Hansen, E. C.; Lee, D. Acc. Chem. Res. 2006, 39, 509. (b) Diver, S. T.; Geissert, A. J. Chem. Rev. 2004, 104, 1317.  
21 (a) Katz, T. J.; Sivavec, T. M. J. Am. Chem. Soc. 1985, 107, 737. (b) Katz, T. J.; Sivavec, T. M. Tetrahedron Lett. 1985, 
26, 2159.  
ring closing diene metathesis ring closing enyne metathesis ring closing diyne metathesis
Figure 1.2. Metathesis reactions.
cross diene metathesis cross enyne metathesis cross diyne metathesis
R2
R1
R2
R1 R1
R2 R2
R1
R1
R2
R3
R4
R1
R3
R2
R4
Scheme 1.1. Katz's seminal report (1985).
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Me                             (1.0 equiv) 
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cycloaddition of the benzylidene metal carbene A to the alkene counterpart, rendering 
metallacyclobutane B. Then, cycloelimination would release a styrene derivative, which generally 
does not interfere in cross metathesis reactions. Resulting vinyl carbene C, the active catalytic species, 
would then react with the alkyne moiety, yielding metallacyclobutene D.  A new [2+2] retro-
cycloaddition step would give rise to dienic metal carbene E, which would react with another alkene 
molecule, thus releasing final diene and the catalytically active species C, completing the catalytic 
cycle.  
 
 
 
Enyne metathesis has found both intra- (ring-closing enyne metathesis, RCEYM) and 
intermolecular (cross enyne metathesis, CEYM) applications. While examples of RCEYM are well 
documented in the literature, the intermolecular CEYM reaction has found fewer applications, mainly 
due to the difficulties associated in controlling the stereoselectivity of the newly formed double bond, 
leading to mixtures of E/Z-isomers. Indeed, these problems arose in the first reported example of 
CEYM (Scheme 1.3).22  
 
                                                       
22 Stagies, R.; Schuster, M.; Blechert, S. Angew. Chem. Int. Ed. 1997, 36, 2518. 	  
Scheme 1.2. EYM mechanism.
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Typically, this problem has been circumvented by bubbling ethylene gas into the reaction 
mixture as the olefinic coupling partner, since ethylene’s symmetry avoids these selectivity issues.23 
For instance, CEYM was a key step in the Mori’s synthesis of reverse transcriptase inhibitors of HIV-
1 anolignan A and anolignan B (Scheme 1.4).24  
 
 
 
Likewise, the development of enyne metathesis has lagged behind its diene counterpart, 
probably due to its less predictable nature as regards to regioselectivity. Cross diene metathesis and 
cross diyne metathesis arise as potential competitive processes when dealing with an alkene and an 
alkyne at the same time.  
                                                       
23 Kinoshita, A.; Sakakibara, N.; Mori, M. J. Am. Chem. Soc. 1997, 119, 12388.  
24 Mori, M.; Tonogaki, K.; Nishiguchi, N. J. Org. Chem. 2002, 67, 224.  
Scheme 1.3. First intermolecular EYM (Blechert, 1997).
5-7 mol% Grubbs 1st  
DCM, rt, 12-48 h R
TMSTMSR +
Scheme 1.4. Previous work by Mori (2002).
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The discovery of the beneficial effect of ethylene by Mori et al. changed this tendency.25 They 
observed a significant improvement in the efficiency of the RCEYM reaction leading to dienes 1.8 
when the reaction was carried out under an atmosphere of ethylene, i.e. the so-coined Mori’s 
conditions (Scheme 1.5).  
 
 
 
In our own lab, in collaboration with the Hammond group, we confirmed the beneficial effect 
of an ethylene atmosphere in the RCEYM of 1,7-enynes 1.9.26 Yields of fluorolactams 1.10 increased 
from ~20% up to ~70% under Mori’s conditions (Scheme 1.6).  
 
 
 
In these cases, ethylene does not act as a coupling partner, i.e. it is not integrated into the 
product, but instead acts as a promoting agent, triggering the metathesis reaction. Though it is not 
clear how it interferes to increase the efficiency of the whole process, some authors have stated the 
intermediacy of species A, with an additional coordinative interaction between the ruthenium metal 
center and the vinyl moiety (Scheme 1.7).27 On the basis of the stability imparted by this chelate effect, 
such type of ruthenium-carbene species A would hinder the regeneration of catalytically active 
ruthenium species D. Nevertheless, under an ethylene atmosphere, the high concentration of this olefin 
presumably favours the transference of the methylene group via intermediate B, rendering the 
                                                       
25 Mori, M.; Sakakibara, N.; Kinoshita, A. J. Org. Chem. 1998, 63, 6082.  
26 Arimitsu, S.; Fernández, B.; del Pozo, C.; Fustero, S.; Hammond, G. B. J. Org. Chem. 2008, 73, 2656.  
27 Trnka, T. M.; Day, M. W.; Grubbs, R. H. Organometallics, 2001, 20, 3845.  
Scheme 1.5. Mori's conditions (Mori, 1998).
1-3 mol% Grubbs 1st  
DCM, rt, 5-22 hXR XR
X = NTs, O, CH2(CO2Et)2 
n = 0, 1, 2 
R = H, Ph
argon atmosphere, 15-76% yield (8-76% recovered SM) 
ethylene atmosphere, 65-99% yield (0-18% recovered SM)
1.8
(  )n (  )n
1.7
Scheme 1.6. Previous work by Fustero and Hammond (2008).
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corresponding 1,3-diene C, and regenerating the catalytically active species D. Thus, ethylene 
improves the turnover of the ruthenium alkylidene A.28  
 
 
 
As mentioned above, enyne metathesis processes have an added value in comparison to other 
metathesis variants, since the generated 1,3-dienes are highly valuable synthetic intermediates suitable 
to participate in further metathetic and non-metathetic transformations,29  such as cycloaddition, 
cyclopropanation, or hydrovinylation reactions, either in a stepwise or a tandem manner. Arguably, 
this metathesis cascade chemistry has emerged as a powerful tool for the synthesis of skeletally 
diverse small molecules, converting the resulting diene intermediate into other useful functionalities.  
The inherent tandem nature of enyne metathesis is particularly appealing in its combination 
with the Diels Alder reaction, enabling the easy generation of diverse poly(hetero)cyclic and 
benzannulated products, thus increasing molecular complexity in a quite simple manner.30 This 
strategy has allowed the synthesis of a wide variety of natural and non-natural products. For instance, 
Savignac and Genêt developed the one-pot synthesis of polycyclic β-lactams 1.13 based on a tandem 
RCEYM-Diels Alder reaction (Scheme 1.8).31  
 
 
 
                                                       
28 For another example on the beneficial effect of ethylene, see: Layton, M. E.; Morales, C. A.; Shair, M. D. J. Am. Chem. 
Soc. 2002, 124, 773.  
29 Li, J.; Lee, D. Eur. J. Org. Chem. 2011, 4269.  
30 Kotha, S.; Chavan, A. S.; Goyal, D. ACS Comb. Sci. 2015, 17, 253.  
31 Desroy, N.; Robert-Peillard, F.; Toueg, J.; Hénaut, C.; Duboc, R.; Rager, M.-N.; Savignac, M.; Genêt, J.-P. Synthesis, 
2004, 2665.  
Scheme 1.7. Key intermediate species in CEYM.
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[Ru] CH2+
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Scheme 1.8. Previous work by Savignac and Genêt (2004).
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On the other hand, Lee and coworkers employed 1,6- and 1,7-enynes in a triple tandem 
RCEYM-cross metathesis-Diels Alder cascade reaction, yielding final cycloadducts 1.14 in good 
yields (Scheme 1.9).32  
 
 
 
Similarly, Plumet and coworkers reported another triple tandem ring opening metathesis-
RCEYM-Diels Alder reaction for the preparation of heteropolycycles 1.16, starting from norbornene 
derivatives 1.15 (Scheme 1.10).33  
 
 
 
The carbotetracyclic skeleton 1.19, featured in several antibiotics, can be afforded by means of 
a stepwise RCEYM-Diels Alder sequence (Scheme 1.11).34  
 
                                                       
32 Lee, H. Y.; Kim, H.-Y.; Tae, H.; Kim, B. G.; Lee, J. Org. Lett. 2003, 5, 3439.  
33 (a) Ljarilla, A.; Murcia, A.; Csákÿ, A. G.; Plumet, J. Eur. J. Org. Chem. 2009, 822. For previous similar reaction 
sequences, see: (b) Banti, D.; North, M. Adv. Synth. Catal. 2002, 344, 694. (c) Banti, D.; North, M. Tetrahedron Lett. 2002, 
43, 1561.  
34 Vanga, D. G.; Kaliappan, K. P. Eur. J. Org. Chem. 2012, 2250.  
Scheme 1.9. Previous work by Lee (2003).
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Scheme 1.10. Previous work by Plumet (2009).
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In 2010, Choi and coworkers reported a tandem RCEYM-RCM reaction over dieneyne 1.20, 
which rendered macrocyclic diene 1.21. This was prone to participate in a [4+2] cycloaddition with 
maleic anhydride, although only when adopting an s-cis conformation (Scheme 1.12).35  
 
 
 
Sometimes, the ruthenium species employed to catalyze the metathesis transformation can 
impart a beneficial effect in the subsequent cycloaddition. This effect was reported by Pérez-Castells 
and coworkers in the preparation of steroid-like compounds 1.25 (Scheme 1.13).36 While yields 
                                                       
35 Park, H.; Hong, Y.-L.; Kim, Y.-B.; Choi, T.-L. Org. Lett. 2010, 12, 3442.  
36 Rosillo, M.; Domínguez, G.; Casarrubios, L.; Amador, U.; Pérez-Castells, J. J. Org. Chem. 2004, 69, 2084.  
Scheme 1.11. Previous work by Kaliappan (2012).
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Scheme 1.12. Previous work by Choi (2010).
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reached up to 85% when carrying out the process in a tandem fashion, the Diels Alder cycloaddition 
from isolated 1,3-diene 1.24, in the absence of the [Ru] catalyst, occurred in lower 60% yield.  
 
 
 
Although they are more challenging, intermolecular enyne metathesis reactions have also been 
successfully applied in tandem sequences with [4+2] cycloadditions. For instance, Schürer and 
Blechert reported the preparation of highly substituted tetrahydropyridines 1.26 by means of a one-pot 
CEYM-hetero-Diels Alder sequence (Scheme 1.14).37 The same sequence was further applied to 
prepare pseudo-oligosaccharides.38  
 
 
 
More recently, a CEYM-Diels Alder sequence was utilized in the synthesis of phenylalanine-
based di- and tri-peptides 1.29, but in a stepwise fashion (Scheme 1.15).39  
 
                                                       
37 Schürer, S. C.; Blechert, S. Tetrahedron Lett. 1999, 40, 1877.  
38 Schürer, S. C.; Blechert, S. Chem. Commun. 1999, 1203.  
39 Kotha, S.; Goyal, D.; Thota, N.; Srinivas, V. Eur. J. Org. Chem. 2012, 1843.  
Scheme 1.13. Previous work by Pérez-Castells (2004).
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Scheme 1.14. Previous work by Schürer and Blechert (1999).
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Previously, the Diver group disclosed a CEYM reaction between terminal alkynes and 
polybutadiene, giving rise to cyclic 1,3-hexadienes, suitable to be trapped later by dienophiles such as 
N-phenylmaleimide, in a one-pot procedure (Scheme 1.16).40  
 
 
 
Additionally, a multicomponent CEYM-intermolecular hetero-Diels Alder reaction involving 
alkynes, ethyl glyoxalate and ethyl vinyl ether was reported for the preparation of 2,3-dihydropyrans 
1.31 (Scheme 1.17).41  
 
 
 
                                                       
40 Kulkarni, A. A.; Diver, S. T. J. Am. Chem. Soc. 2004, 126, 8110.  
41 (a) Castagnolo, D.; Botta, L.; Botta, M. Carbohydr. Res. 2009, 344, 1285. (b) Castagnolo, D.; Botta, L.; Botta, M. 
Tetrahedron Lett. 2009, 50, 1526.  
Scheme 1.15. Previous work by Kotha (2012).
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Scheme 1.16. Previous work by Diver (2004).
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Scheme 1.17. Previous work by Botta (2009).
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In 2005, the Blechert group published a CEYM-intramolecular Diels Alder reaction by 
combining Baylis-Hillman adducts 1.32 with terminal alkynes in the presence of second generation 
Hoveyda-Grubbs catalyst (Scheme 1.18).42 After the initial formation of the triene 1.33, avoiding 
RCM of diene 1.32, a spontaneous intramolecular Diels Alder reaction rendered highly functionalized 
bicyclic derivatives 1.34 in a very efficient manner.  
 
 
 
Similarly, we have recently published a tandem CEYM-intramolecular Diels Alder reaction 
involving aromatic terminal alkynes and conjugated carbonyl-derived systems 1.35 with a remote 
double bond (Scheme 1.19).43 The overall process enables the preparation of different-sized linear 
bicyclic scaffolds 1.36 in a very simple manner.  
 
 
 
Furthermore, several authors have applied the enyne metathesis-Diels Alder sequence to the 
synthesis of common skeletons featuring in various natural products. For instance, the bridged bicycle 
                                                       
42 Mix, S.; Blechert, S. Org. Lett. 2005, 7, 2015.  
43 Miró, J.; Sánchez-Roselló, M.; Sanz, A.; Rabasa, F.; del Pozo, C.; Fustero, S. Beilstein J. Org. Chem. 2015, 11, 1486.  
Scheme 1.18. Previous work by Blechert (2005).
5-7.5 mol% Hoveyda-Grubbs 2nd 
DCM, rt to 45 ºC, 24 h 
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Scheme 1.19. Further work by Fustero (2015).
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skeleton embedded in natural alkaloids like taxol, could be prepared by means of a tandem CEYM-
intramolecular Diels Alder reaction (Scheme 1.20).44  
 
 
 
On the other hand, despite the increasing interest in organofluorine chemistry, the use of 
fluorinated building blocks in such enyne metathesis-Diels Alder sequences has scarcely been 
explored.45 To the best of our knowledge, just one example from Grée’s and Kaliappan’s laboratories 
was reported (Scheme 1.21). They designed a CEYM-Diels Alder sequence from propargyl fluorides 
1.40, followed by a final oxidation step, as a novel strategy for the preparation of benzyl fluorides 
1.42.46  
 
 
 
 
 
 
 
                                                       
44 Kaliappan, K.; Ravikumar, V.; Pujari, S. A. Tetrahedron Lett. 2006, 47, 981.  
45 For a recent revision on metathesis reactions with fluorinated substrates, see: Fustero, S.; Simón-Fuentes, A.; Barrio, P.; 
Haufe, G. Chem. Rev. 2015, 115, 871.  
46 Pujari, S. A.; Kaliappan, K. P.; Valleix, A.; Grée, D.; Grée, R. Synlett, 2008, 2503.  
Scheme 1.20. Previous work by Kaliappan (2006).
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Scheme 1.21. Previous work by Grée and Kaliappan (2008).
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1.2. 1,7-Octadiene-assisted tandem multicomponent cross enyne metathesis-Diels Alder 
reaction.  
 
Given this perspective, during the course of an on-going project in our laboratory aimed at the 
development of new tandem protocols, we envisioned a procedure to carry out a CEYM-CM-Diels 
Alder reaction: a triple tandem protocol (Scheme 1.22). In this context, the CEYM of an alkyne and an 
1,n-diene would render a new 1,3-diene functionality bearing a pendant double bond suitable for a 
subsequent CM reaction that would convert this olefin into a good dienophile for an intramolecular 
Diels Alder reaction (IMDAR).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.22. Our original idea.
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1.3. Results and discussion.  
 
Within this pursuit, phenyl acetylene was subjected to the tandem protocol by treatment with 5 
mol% second generation Hoveyda-Grubbs catalyst in the presence of 1,7-octadiene (4.0 equiv) and 
ethyl acrylate (3.0 equiv). However, when this mixture was heated in toluene at 90 ºC for 6 hours, 
instead of the expected bicyclic derivative, a mixture of regioisomers 1.43a and 1.43b was isolated in 
an excellent 90% yield and 82:18 ratio (Scheme 1.23).47  
 
 
 
This result indicated that ring-closing metathesis (RCM) reaction of 1,7-octadiene is more 
favourable than the attempted cross-metathesis protocol (Scheme 1.24). As a result, cyclohexadiene 
and ethylene are released. The ruthenium carbene is then prone to carry out CEYM reaction between 
phenyl acetylene and in situ generated ethylene to afford intermediate diene 1.44. Under the reaction 
conditions, in the presence of ethyl acrylate, diene 1.44 is trapped in a Diels Alder fashion affording 
regioisomers 1.43a and 1.43b. The overall process constitutes a novel tandem multicomponent 
CEYM-Diels Alder reaction.  
 
 
 
                                                       
47 Conditions were taken from a previously evaluated CEYM-Diels Alder protocol under Mori’s conditions: Fustero, S.; 
Bello, P.; Miró, J.; Sánchez-Roselló, M.; Haufe, G.; del Pozo, C. Beilstein J. Org. Chem. 2013, 9, 2688. Reducing the 
equivalents of either dienophile or 1,7-octadiene resulted in lower yields.  
Scheme 1.23. Preliminary result.
1,7-octadiene (4.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
toluene 0.05 M, 90 ºC, 20 h 
sealed tube
Ph
CO2EtPh
+
Ph CO2Et
CO2Et
+
1.43a + 1.43b, 90% yield (82:18)
Scheme 1.24. Proposed mechanism.
PhCO2Et
Ph
(  )4
+
Ph CO2Et
CO2Et
+ [Ru] CH2
Ph
[Ru]
Ph
[Ru] CH2
RCM
CEYM
DAR
1.43
A B 1.44
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With these data in hand, we firstly evaluated the formation of proposed 1,3-diene in the 
presence of 1,7-octadiene (Scheme 1.25). Thus, when phenylacetylene was heated with 1,7-octadiene 
as the internal source of ethylene in the presence of 5 mol% second generation Hoveyda-Grubbs 
catalyst in toluene at 90 ºC, complete formation of the diene 1.44 was observed after two hours. Under 
these conditions, diene 1.44 was isolated in 98% yield after flash chromatography, confirming the 
above proposed mechanistic outcome (Scheme 1.24).  
 
 
 
These conditions were further extended to different starting alkynes and dienophiles. Several 
dienophiles were tested, as depicted in Table 1.1.  
 
 
 
Other than ethyl acrylate, ethyl fumarate and 1,4-benzoquinone gave the desired products 1.45 
and 1.48, respectively, in quantitative yield. Diethyl acetylene dicarboxylate gave rise to final product 
1.46 in a 70% yield and no aromatization was observed after purification. N-phenyl maleimide was 
also a good partner for the tandem protocol, affording cycloadduct 1.47 in 62% yield.  
 
Scheme 1.25. Formation of diene 1.44.
1,7-octadiene (4.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
toluene 0.05 M, 90 ºC, 2 h 
sealed tube
PhPh
1.44, 98% yield
Table 1.1. Dienophile scope.a
1,7-octadiene (4.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
dienophile (3.0 equiv) 
toluene 0.05 M, 90 ºC, 20 h 
sealed tube
PhPh
Ph
CO2Et
CO2Et
1.45, 98% yield
Ph
CO2Et
CO2Et
1.46, 70% yield
Ph
1.47, 62% yield
NPh
H
H
O
O
Ph
1.48, 99% yield
O
O
H
H
a Isolated yields.
0.5 mmol
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Thereafter, we explored the efficiency of the process with different terminal alkynes (Table 
1.2), using ethyl fumarate as the dienophile to avoid regioselectivity issues.  
 
 
 
Regarding the alkyne scope, the tandem protocol proceeded with excellent efficiency with 
aromatic terminal alkynes, affording the final adducts in excellent yields (1.49-1.55). Aromatic 
alkynes with either electron-donating (1.49-1.50) or electron-withdrawing (1.54-1.55) substituents 
reacted with ethyl fumarate in almost quantitative yield in most cases. Likewise, steric effects on the 
aryl ring did not have a detrimental effect on the efficiency of the process (1.50, 1.52-1.53). However, 
with heteroaromatic alkynes (1.56), aliphatic alkynes (1.57), or deactivated alkynes (1.58), the overall 
process was less effective, yielding the final products in moderate yields. The reaction also took place 
with the very sterically demanding triisopropyl silyl acetylene, albeit in a modest 31% yield after 72 
hours (1.59).  
Table 1.2. Alkyne scope.a
1,7-octadiene (4.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
ethyl fumarate (3.0 equiv) 
toluene 0.05 M, 90 ºC 
sealed tube
RR
a Isolated yields.
0.5 mmol
CO2Et
CO2Et
CO2Et
CO2Et
1.49, 99% yield (20 h)
CO2Et
CO2Et
1.50, 99% yield (20 h)
CO2Et
CO2Et
1.51, 99% yield (20 h)
MeO
OMe
F
CO2Et
CO2Et
1.52, 99% yield (20 h)
CO2Et
CO2Et
1.53, 86% yield (20 h)
CO2Et
CO2Et
1.54, 99% yield (20 h)
CO2Et
CO2Et
1.55, 95% yield (30 h)
F
F
F
F
F3C
F3C
CF3
CO2Et
CO2Et
1.56, 50% yield (22 h)
N
AcO
CO2Et
CO2Et
1.57, 42% yield (28 h)
MeO2C
CO2Et
CO2Et
1.58, 46% yield (20 h)
TIPS
CO2Et
CO2Et
1.59, 31% yield (72 h)
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When methyl propiolate was used as the starting alkyne, besides the desired product 1.58 
(46% yield), compound 1.60 was isolated in 30% yield (Scheme 1.26a). This product arises from the 
highly regioselective Diels Alder reaction between two molecules of the intermediate diene, one of 
them acting as the diene counterpart and the other one as the dienophile through the most electron 
deficient double bond.48 In the presence of ethyl fumarate, this dimerization event competes with the 
Diels Alder reaction with ethyl fumarate. In fact, when we carried out the process in the absence of 
ethyl fumarate, compound 1.60 was isolated in 70% yield in a regioselective fashion after 22 hours 
(Scheme 1.26b).  
 
 
 
Finally, we decided to validate our strategy versus Mori’s conditions. To this end, several 
difluoropropargyl carbonyl derivatives were subjected to the developed reaction conditions, in the 
presence of 1,7-octadiene as an in situ ethylene source (Table 1.3). The obtained carbo- and hetero-
cycles were previously prepared in our laboratory in a one-pot procedure under Mori’s conditions, i.e. 
under ethylene’s atmosphere.47  
 
                                                       
48 For a related RCEYM-Diels Alder dimerization process, see: Hoye, T. R.; Donaldson, S. M.; Vos, T. J. Org. Lett. 1999, 1, 
277.  
Scheme 1.26. Multicomponent reaction with methyl propiolate.
1,7-octadiene (4.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
ethyl fumarate (3.0 equiv) 
toluene 0.05 M, 90 ºC, 20 h 
sealed tube
MeO2C
MeO2C
1.58, 46% yield
CO2Et
CO2Et
MeO2C
1.60, 30% yield
CO2Me
+
1,7-octadiene (4.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
 
toluene 0.05 M, 90 ºC, 22 h 
sealed tube
MeO2C MeO2C
1.60, 70% yield
CO2Me
(a)
(b)
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Benzyl difluoropropargyl amide reacted with ethyl fumarate to give adduct 1.61 in improved 
70% yield when comparing to Mori’s conditions (55% yield). Diethyl acetylene dicarboxylate 
afforded diene 1.62 in comparable 55% yield (versus 51% yield). N-phenyl maleimide and para-
benzoquinone were also good partners for the tandem process, affording cycloadducts 1.63 and 1.64 in 
slightly better 63% and 50% yields, compared to previous results (50% and 47% yield, respectively). 
Table 1.3. Validation versus Mori's conditions.a
1,7-octadiene (4.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
dienophile (3.0 equiv) 
toluene 0.05 M, 90 ºC 
sealed tube
a Isolated yields.
0.12 mmol
CO2Et
CO2Et
1.61
(A) 70% yield (20 h)
(B) 55% yield (8 h)
CO2Et
CO2Et
F
F
OR
F
F
R O
F
F
OR
ethylene (1 atm) 
5 mol% Hoveyda-Grubbs 2nd 
toluene 0.05 M, 90 ºC 
sealed tube
dienophile (3.0 equiv)
method A 
our conditions
method B 
Mori's conditions
F
F
OBnHN
F
F
OBnHN
1.62
(A) 55% yield (6 h)
(B) 51% yield (6 h)
F
F
OBnHN
1.63
(A) 63% yield (24 h)
(B) 50% yield (4 h)
NPh
O
O
H
H
F
F
OBnHN
1.64
(A) 50% yield (24 h)
(B) 47% yield (24 h)
H
H
O
O
CO2Et
CO2Et
1.65
(A) 73% yield, 1:1 dr (24 h)
(B) 87% yield, 1:1 dr (4 h)
F
F
ON
H
Ph
Me
CO2Et
CO2Et
F
F
ON
H
Ph
Me
1.66
(A) 70% yield, 1:1 dr (10 h)
(B) 74% yield, 1:1 dr (20 h)
F
F
ON
H
Ph
Me
F
F
ON
H
Ph
Me
NPh NPh
H
H
O
O
OH
H O
CO2Et
CO2Et
F
F
ON
H
1.67
(A) 60% yield (24 h)
(B) 63% yield (10 h)
Ph
Me
CO2Et
CO2Et
F
F
O
1.68
(A) 55% yield (15 h)
(B) 48% yield (4 h)
Ph
CO2Et
CO2Et
F
F
O
1.69
(A) 70% yield (17 h)
(B) 58% yield (12 h)
Ph
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With chiral starting materials, an inseparable 1:1 mixture of diastereoisomers was obtained (1.65-
1.66), which indicates that the chiral information is too far from the reacting center. On the other hand, 
fluorinated ketones were also adequate substrates, providing better yields than the one-pot procedure 
(1.68-1.69).  
These results indicate that afforded yields under the newly developed conditions (method A) 
were comparable to those previously obtained under Mori’s conditions (method B).  
The developed methodology has been further successfully employed in our research group in 
different projects within diversity-oriented synthesis,49 providing better results in comparison to 
Mori’s conditions (Scheme 1.27).  
 
 
 
                                                       
49 (a) Rodríguez, E.; Grayson, M. N.; Asensio, A.; Barrio, P.; Houk, K. N.; Fustero, S. ACS Catal. 2016, 6, 2506. (b) Herrera, 
L.; Barrio, P.; Ibáñez, I.; Román, R.; Mateu, N.; Fustero, S. Org. Lett. 2016, 18, 4722. (c) Lázaro, R.; Barrio, P.; Finamore, 
C.; Román, R.; Fustero, S. Struct. Chem. 2016, DOI: 10.1007/s11224-016-0849-z.  
Scheme 1.27. Further work by Fustero (2016).
additive 
10 mol% Hoveyda-Grubbs 2nd 
DCM, sealed tube
OH
Ph
OH
Ph
additive: none 
additive: ethylene (1 atm) 
additive: 1,7-octadiene (4.0 equiv)
20% yield (40ºC, 12 h) 
47% yield (45ºC, 24 h) 
76% yield (45 ºC, 16 h)
1.70 1.71
1,7-octadiene (5.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
DCM, 40 ºC, sealed tube 
90% yield1.72 1.73
Ph
NHSOtBu
Ph
NHSOtBu
1,7-octadiene (2 x 4.0 equiv) 
2 x 5 mol% Grubbs 2nd 
DCM, 45 ºC, sealed tube 
50-99% yield
1.74 1.75
R
HN HN
R
S S
tBu
O
tBu
O
Ar Ar
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Likewise, Sutherland and coworkers have reported the synthesis of amino-substituted indanes 
and tetralins based on a one-pot RCEYM-Diels Alder cascade reaction under our developed 
conditions.50 The use of 1,7-octadiene as an in situ source of ethylene allowed complete conversion of 
enynes 1.76 to the corresponding exo-dienes 1.77, greatly increasing the efficiency of the overall 
sequence in most cases (Scheme 1.28).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                       
50 (a) Grafton, M. W.; Farrugia, L. J.; Sutherland, A. J. Org. Chem. 2013, 78, 7199. (b) Grafton, M. W.; Johnson, S. A.; 
Farrugia, L. J.; Sutherland, A. Tetrahedron, 2014, 70, 7133. (c) Calder, E. D. D.; Grafton, M. W.; Sutherland, A. Synlett, 
2014, 25, 1068. (d) Mostafa, M. A. B.; Grafton, M. W.; Wilson, C.; Sutherland, A. Org. Biomol. Chem. 2016, 14, 3284.  
Scheme 1.28. Further work by Sutherland (2013-2016).
[Ru] catalyst
1,7-octadiene  
dienophile
n = 0, 1 
X = CH2, O, NTs1.76 1.77
X
HN O
R
CCl3
n(  )
X
NH
n(  )
R
CCl3
O
H
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1.4. Conclusions.  
 
We found that liquid 1,7-octadiene can act as a useful ethylene surrogate by RCM, 
establishing a complementary method to Mori’s conditions in EYM-type processes, thus avoiding the 
use of flammable ethylene gas. The utility of this finding was illustrated in a novel multicomponent 
tandem CEYM-Diels Alder reaction (Scheme 1.29).51 Aliphatic, aromatic and fluorinated alkynes, 
along with several dienophiles, were compatible substrates under the developed conditions, being 
particularly efficient with aromatic alkynes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                       
51 Fustero, S.; Bello, P.; Miró, J.; Simón, A.; del Pozo, C. Chem. Eur. J. 2012, 18, 10991.  
Scheme 1.29. Multicomponent CEYM-Diels Alder reaction.
dienophile R
R
(  )4
multicomponent CEYM-Diels Alder reaction
Ru
terminal 
alkyne
Diels Alder 
cycloadduct
1,7-octadiene 
as an in situ
ethylene 
source 
by RCM
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1.5. Experimental section.  
 
General remarks: Unless otherwise noted, reactions were carried out under argon atmosphere and all 
reagents were purchased from commercial suppliers and used without further purification. The 
solvents were purified prior to use: THF, diethyl ether and toluene were distilled from 
sodium/benzophenone, dichloromethane and acetonitrile were distilled from calcium hydride. The 
reactions were monitored with the aid of thin-layer chromatography (TLC) on 0.25 mm precoated 
silica gel plates. Visualization was carried out with UV light and aqueous potassium permanganate 
stain. Flash column chromatography was performed with the indicated solvents on silica gel 60 
(particle size 0.040-0.063 mm). Melting points were measured on Büchi B-540 apparatus. 1H, 13C and 
19F spectra were recorded on 300 MHz and 500 MHz Bruker spectrometers. Chemical shifts (δ) are 
given in ppm relative to the residual solvent signals (chloroform, 7.26 ppm for 1H NMR and 77.00 
ppm for 13C NMR). Coupling constants (J) are given in Hertz (Hz). Letters m, s, d, t and q stand for 
multiplet, singlet, doublet, triplet and quartet, respectively. Letters br indicate that the signal is broad. 
High-resolution mass spectra were carried out on an AB SCIEX TripleTOF™ 5600 LC/MS/MS 
system in ESI mode [Conditions: Ion source gas 1 (GC1): 35 psi; Ion source gas 2 (GC2): 35 psi; 
Curtain gas 1: 25 psi; Temperature: 450 ºC; Ion Spray Voltage (ISVF): 5500; Infusion positive mode] 
by the University of Valencia Mass Spectrometry Service.  
 
 
1.5.1. General procedure for the multicomponent tandem protocol.  
	  
	  
A solution of Hoveyda-Grubbs catalyst second generation (5 mol%), 1,7-octadiene (4.0 equiv), alkyne 
(1.0 equiv, 0.5 mmol), and the corresponding dienophile (3.0 equiv) in dry toluene (0.05 M, 10.0 mL) 
was heated at 90 ºC in a sealed tube. The reaction mixture was stirred at this temperature until TLC 
showed total consumption of the starting material. Then, solvents were removed under reduced 
pressure and the crude mixture was purified by flash column chromatography.  
 
1,7-octadiene (4.0 equiv) 
5 mol% Hoveyda-Grubbs 2nd 
dienophile (3.0 equiv) 
toluene 0.05 M, 90 ºC 
sealed tube
RR
0.5 mmol
Hoveyda-Grubbs 
catalyst 2nd generation
Ru
Cl
Cl
NN MesMes
iPrO
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2-Phenyl-1,3-butadiene. Following the general procedure described above and before adding the 
dienophile, the crude mixture was subjected to flash chromatography affording 65 mg of 1.44 (98% 
yield) as a colourless oil starting from 51 mg of phenyl acetylene. Spectra matches previously reported 
data.52  
 
 
Ethyl 3-phenyl-3-cyclohexene carboxylate + ethyl 4-phenyl-3-cyclohexene carboxylate. Following 
the general procedure described above, 115 mg of an inseparable mixture of regioisomers 1.43a + 
1.43b (82:18, 99% yield) were obtained as a yellowish oil starting from 51 mg of phenyl acetylene. 
Spectra matches previously reported data.53  
 
 
Trans-diethyl 4-phenyl-4-cyclohexene-1,2-dicarboxylate. Following the general procedure 
described above, 148 mg of 1.45 (98% yield) were obtained as a yellowish oil starting from 51 mg of 
phenyl acetylene. Spectra matches previously reported data.53  
 
 
Diethyl 4-phenyl-1,4-cyclohexadiene dicarboxylate. Following the general procedure described 
above, 105 mg of 1.46 (70% yield) were obtained as a yellowish oil starting from 51 mg of phenyl 
acetylene. 1H-NMR (CDCl3, 300 MHz): δ 1.24 (t, J = 6 Hz, 3H), 1.25 (t, J = 6 Hz, 3H), 3.11-3.19 (m, 
2H), 3.29-3.35 (m, 2H), 4.19 (q, J = 6 Hz, 2H), 4.20 (q, J = 6 Hz, 2H), 6.00-6.03 (m, 1H), 7.16-7.34 
(m, 5H). 13C-NMR (CDCl3, 300 MHz): δ 14.0, 29.1, 29.7, 61.1, 61.2, 119.2, 125.0, 127.5, 128.4, 
131.8, 132.5, 132.6, 139.9, 167.8, 167.9. HRMS (ES) calc. for (M+-2) C18H19O4: 209.1278, found: 
209.1287.  
 
                                                       
52 Lindh, J.; Sävmarker, J.; Nilsson, P.; Sjöber, P. J. R.; Larhed, M. Chem. Eur. J. 2009, 15, 4630.  
53 Pidaparthi, R. R.; Junker, C. S.; Welker, M. E.; Day, C. S.; Wright, M. W. J. Org. Chem. 2009, 74, 8290.  
Ph
Ph Ph CO2Et
CO2Et
+
Ph
CO2Et
CO2Et
Ph
CO2Et
CO2Et
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2,5-Diphenyl-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione. Following the general procedure 
described above, 94 mg of 1.47 (62% yield) were obtained as a yellowish oil starting from 51 mg of 
phenyl acetylene. Spectra matches previously reported data.53  
 
 
2-Phenyl-1,4,4a,9a-tetrahydroanthracene-9,10-dione. Following the general procedure described 
above, 143 mg of 1.48 (99% yield) were obtained as a yellowish oil starting from 51 mg of phenyl 
acetylene. 1H-NMR (CDCl3, 300 MHz): δ 2.36 (d, J = 18 Hz, 1H), 2.53 (d, J = 17 Hz, 1H), 2.64 (d, J 
= 18 Hz, 1H), 2.85 (d, J = 17 Hz, 1H), 3.35 (dd, J1 = 11 Hz; J2 = 6 Hz, 1H), 3.46 (dd, J1 = 11 Hz; J2 = 
6 Hz, 1H), 5.98 (s, 1H), 7.11-7.28 (m, 4H), 7.65 (dd, J1 = 5 Hz; J2 = 3 Hz, 2H), 7.96 (d, J = 3 Hz, 2H). 
13C-NMR (CDCl3, 300 MHz): δ 25.3, 26.7, 46.1, 47.0, 121.5, 125.2, 126.8, 126.9, 127.1, 128.2, 133.9, 
134.3, 134.7, 141.0, 197.7, 198.0. HRMS (ES) calc. for (M++1) C20H17O2: 289.1223, found: 289.1232.  
 
 
Trans-diethyl 4-(4-methoxyphenyl)-4-cyclohexene-1,2-dicarboxylate. Following the general 
procedure described above, 164 mg of 1.49 (99% yield) were obtained as a yellowish oil starting from 
66 mg of 1-ethynyl-4-methoxybenzene. 1H-NMR (CDCl3, 300 MHz): δ 1.26 (t, J = 7.1 Hz, 3H), 1.27 
(t, J = 7.1 Hz, 3H), 2.29-2.41 (m, 1H), 2.47-2.66 (m, 2H), 2.76-2.84 (m, 1H), 2.85-3.04 (m, 2H), 3.79 
(s, 3H), 4.16 (q, J = 7.1 Hz, 2H), 4.17 (q, J = 7.1 Hz, 2H), 5.97 (t, J = 2.4 Hz, 1H), 6.85 (d, J = 8.4 Hz, 
2H), 7.29 (d, J = 8.7 Hz, 2H). 13C-NMR (CDCl3, 300 MHz): δ 14.1, 28.6, 30.2, 41.1, 42.0, 55.2, 60.6, 
60.6, 113.7, 120.3, 126.2, 133.5, 134.5, 158.9, 174.6, 174.7. HRMS (ES) calc. for (M++1) C19H24O5: 
333.1697; found: 333.1700.  
 
Ph
NPh
H
H
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O
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H
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Trans-diethyl 4-(2-methoxyphenyl)-4-cyclohexene-1,2-dicarboxylate. Following the general 
procedure described above, 165 mg of 1.50 (99% yield) were obtained as a yellowish oil starting from 
66 mg of 1-ethynyl-2-methoxybenzene. 1H-NMR (CDCl3, 300 MHz): δ 1.24 (t, J = 7.2 Hz, 3H), 1.26 
(t, J = 7.1 Hz, 3H), 2.29-2.39 (m, 1H), 2.53-2.75 (m, 3H), 2.90-3.03 (m, 2H), 3.78 (s, 3H), 4.09-4.21 
(m, 4H), 5.72-5.74 (m, 1H), 6.83-6.91 (m, 2H), 7.09 (dd, J1 = 7.4 Hz, J2 = 1.9 Hz, 1H), 7.19-7.25 (m, 
1H). 13C-NMR (CDCl3, 300 MHz): δ 14.0, 28.5, 31.4, 41.0, 41.9, 55.2, 60.3, 60.4, 110.5, 120.4, 123.4, 
128.3, 129.4, 131.6, 135.7, 156.5, 174.7, 174.8. HRMS (ES) calc. for (M++1) C19H24O5: 333.1697, 
found: 333.1703.  
 
 
Trans-diethyl 4-(4-fluorophenyl)-4-cyclohexene-1,2-dicarboxylate. Following the general 
procedure described above, 159 mg of 1.51 (99% yield) were obtained as a yellowish oil starting from 
60 mg of 1-ethynyl-4-fluorobenzene. 1H-NMR (CDCl3, 300 MHz): δ 1.27 (t, J = 7.1 Hz, 3H), 1.27 (t, 
J = 7.1 Hz, 3H), 2.32-2.42 (m, 1H), 2.49-2.67 (m, 2H), 2.73-2.81 (m, 1H), 2.86-3.05 (m, 2H), 4.17 (q, 
J = 7.1 Hz, 2H), 4.18 (q, J = 7.1 Hz, 2H), 6.00 (t, J = 2.4 Hz, 1H), 6.99 (dd, J1 = J2 = 8.7 Hz, 2H), 7.31 
(dd, J1 = 8.7 Hz, J2 = 5.4 Hz, 2H). 13C-NMR (CDCl3, 300 MHz): δ 14.0, 28.4, 30.1, 40.9, 41.8, 60.8, 
60.6, 115.0 (d, 2JCF = 21.3 Hz), 121.8, 126.6 (d, 3JCF = 7.9 Hz), 134.1, 136.8, 162.0 (d, 1JCF = 246.3 
Hz), 174.3, 174.4. 19F-NMR (CDCl3, 282 MHz): δ -115.9 (s, 1F). HRMS (ES) calc. for (M++1) 
C18H21FO4: 321.1497, found: 321.1491.  
 
 
Trans-diethyl 4-(3,4-difluorophenyl)-4-cyclohexene-1,2-dicarboxylate. Following the general 
procedure described above, 167 mg of 1.52 (99% yield) were obtained as a yellowish oil starting from 
69 mg of 1-ethynyl-2,4-difluorobenzene. 1H-NMR (CDCl3, 300 MHz): δ 1.23 (t, J =  Hz, 3H), 1.24 (t, 
J =  Hz, 3H), 2.28-2.74 (m, 3H), 2.82-3.01 (m, 2H), 4.10-4.18 (m, 4H), 5.99-6.00 (m, 1H), 7.01-7.14 
(m, 3H). 13C-NMR (CDCl3, 300 MHz): δ 14.0, 28.3, 29.7, 40.7, 41.6, 60.6, 60.7, 113.9 (d, 2JCF = 17.4 
CO2Et
CO2Et
OMe
CO2Et
CO2Et
F
CO2Et
CO2Et
F
F
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Hz), 116.8 (d, 2JCF = 17.4 Hz), 120.9 (dd, 3JCF = 6.0 Hz, 4JCF = 3.5 Hz), 122.94 (d, 5JCF = 1.3 Hz), 
133.2, 137.8 (dd, 3JCF = 5.6 Hz, 4JCF = 3.9 Hz), 148.1 (dd, 1JCF = 49.0 Hz, 2JCF = 13.3 Hz), 151.3 (1JCF 
= 49.0 Hz, 2JCF = 13.3 Hz), 174.2, 174.3. 19F-NMR (CDCl3, 282 MHz): δ -138.4 (d, 3JFF = 21.5 Hz, 
1F), -140.4 (d, 3JFF = 21.5 Hz, 1F). HRMS (ES) calc. for (M++1) C18H20F2O4: 339.1402, found: 
339.1400.  
 
 
Trans-diethyl 4-(2,4-difluorophenyl)-4-cyclohexene-1,2-dicarboxylate. Following the general 
procedure described above, 145 mg of 1.53 (86% yield) were obtained as a yellowish oil starting from 
69 mg of 1-ethynyl-3,4-difluorobenzene. 1H-NMR (CDCl3, 300 MHz): δ 1.23 (t, J = 7.0 Hz, 3H), 1.24 
(m, J = 7.2 Hz, 3H), 2.29-2.40 (m, 1H), 2.49-2.70 (m, 3H), 2.87-3.02 (m, 2H), 4.10-4.19 (m, 4H), 
5.84-5.85 (m, 1H), 6.71-6.82 (m, 2H), 7.11-7.19 (m, 1H). 13C-NMR (CDCl3, 300 MHz): δ 14.1, 28.3, 
31.0 (d, 5JCF = 3.0 Hz), 40.7, 41.65, 60.6, 60.7, 104.0 (t, 2JCF = 27.2 Hz), 111.0 (dd, 2JCF = 21.1 Hz, 
4JCF = 3.8 Hz), 125.6 (d, 4JCF = 2.3 Hz), 125.9 (d, 2JCF = 3.8 Hz), 129.9 (dd, 3JCF = 9.1 Hz, 3JCF = 6.0 
Hz), 131.0 (d, 3JCF = 1.5 Hz), 159.2 (dd, 1JCF = 160.1 Hz, 3JCF = 12.1 Hz), 162.5 (dd, 1JCF = 158.5 Hz, 
3JCF = 12.1 Hz), 174.3, 174.5. 19F-NMR (CDCl3, 282 MHz): δ -111.5 (d, 4JFF = 7.3 Hz, 1F), -112.4 (d, 
4JFF = 7.3 Hz, 1F). HRMS (ES) calc. for (M++1) C18H20F2O4: 339.1402, found: 339.1410.  
 
 
Trans-diethyl 4-(4-trifluoromethylphenyl)-4-cyclohexene-1,2-dicarboxylate. Following the general 
procedure described above, 183 mg of 1.54 (99% yield) were obtained as a yellowish oil starting from 
85 mg of 1-ethynyl-4-(trifluoromethyl)benzene. 1H-NMR (CDCl3, 300 MHz): δ 1.24 (t, J = 7.2 Hz, 
3H), 1.25 (t, J = 7.2 Hz, 3H), 2.32-2.44 (m, 1H), 2.51-2.69 (m, 2H), 2.73-2.81 (m, 1H), 2.86-3.04 (m, 
2H), 4.11-4.20 (m, 4H), 6.12-6.13 (m, 1H), 7.42 (d, J = 8.3 Hz, 2H), 7.53 (d, J = 8.2 Hz, 2H). 13C-
NMR (CDCl3, 300 MHz): δ 14.0, 28.4, 29.7, 40.7, 41.6, 60.6, 60.7, 124.1(q, 1JCF = 271.5 Hz), 124.1, 
125.1 (q, 3JCF = 3.7 Hz), 125.2, 128.9 (q, 2JCF = 32.6 Hz), 134.0, 144.1, 174.2, 174.3. 19F-NMR (CDCl3, 
282 MHz): δ -62.9 (s, 3F). HRMS (ES) calc. for (M++1) C19H21F3O4: 371.1465; found: 371.1462.  
 
CO2Et
CO2Et
F
F
CO2Et
CO2Et
F3C
	  	  
Ru
33 
 
Trans-diethyl 4-[3,5-bis(trifluoromethyl)phenyl]-4-cyclohexene-1,2-dicarboxylate. Following the 
general procedure described above, 207 mg of 1.55 (95% yield) were obtained as a yellowish oil 
starting from 119 mg of 1-ethynyl-3,5-bis(trifluoromethyl)benzene. 1H-NMR (CDCl3, 300 MHz): δ 
1.27 (t, J = 7.1 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H), 2.39-2.51 (m, 1H), 2.58-2.83 (m, 3H), 2.92-3.10 (m, 
2H), 4.18 (q, J = 7.1 Hz, 2H), 4.19 (q, J = 7.1 Hz, 2H), 6.21-6.23 (m, 1H), 7.74 (s, 1H), 7.76 (s, 2H). 
13C-NMR (CDCl3, 300 MHz): δ 14.1, 28.2, 29.5, 40.6, 41.5, 60.9, 61.0, 120.7 (sept, 3JCF = 3.8 Hz), 
123.3 (q, 1JCF = 272.5 Hz), 125.2, 125.8, 131.7 (q, 2JCF = 33.2 Hz), 133.1, 142.9, 174.0, 174.1. 19F-
NMR (CDCl3, 282 MHz): δ -63.4 (s, 6F). HRMS (ES) calc. for (M++1) C20H20F6O4: 439.1339, found: 
439.1341.  
 
 
Trans-diethyl 4-(3-pyridyl)-4-cyclohexene-1,2-dicarboxylate. Following the general procedure 
described above, 76 mg of 1.56 (50% yield) were obtained as a yellowish oil starting from 52 mg of 3-
ethynylpyridine. 1H-NMR (CDCl3, 300 MHz): δ 1.26 (t, J = 7.1 Hz, 3H), 1.27 (t, J = 7.1 Hz, 3H), 
2.35-2.46 (m, 1H), 2.52-2.71 (m, 2H), 2.75-2.83 (m, 1H), 2.89-3.07 (m, 2H), 4.16 (q, J = 7.1 Hz, 2H), 
4.19 (q, J = 7.1 Hz, 2H), 6.09-6.13 (m, 1H), 7.23 (ddd, J1 = 8.0 Hz, J2 = 4.8 Hz, J3 = 0.6 Hz, 1H), 7.62 
(ddd, J1 = 8.0 Hz, J2 = 2.2 Hz, J3 = 1.7 Hz, 1H), 8.47 (dd, J1 = 4.7 Hz, J2 = 1.1 Hz, 1H), 8.61 (d, J = 
1.8 Hz, 1H). 13C-NMR (CDCl3, 300 MHz): δ 14.1, 28.4, 29.6, 40.8, 41.6, 60.8, 60.8, 123.1, 123.9, 
132.3, 132.5, 136.2, 146.7, 148.4, 174.3, 174.4. HRMS (ES) calc. for (M++1) C17H21NO4: 304.1543, 
found: 304.1538.  
 
 
Trans-diethyl 4-acetoxymethyl-4-cyclohexene-1,2-dicarboxylate. Following the general procedure 
described above, 64 mg of 1.57 (42% yield) were obtained as a yellowish oil starting from 49 mg of 
prop-2-yn-1-yl acetate. 1H-NMR (CDCl3, 300 MHz): δ 1.25 (t, J = 7.1 Hz, 3H), 1.26 (t, J = 7.1 Hz, 
3H), 2.07 (s, 3H), 2.18-2.28 (m, 2H), 2.36-2.53 (m, 2H), 2.78-2.93 (m, 2H), 4.14 (q, J = 7.1 Hz, 2H), 
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4.16 (q, J = 7.1 Hz, 2H), 4.46 (s, 2H), 5.74-5.75 (m, 1H). 13C-NMR (CDCl3, 300 MHz): δ 14.1, 20.9, 
27.8, 28.6, 41.0, 41.3, 60.7, 60.7, 67.6, 124.0, 131.3, 170.8, 174.4, 174.5. HRMS (ES) calc. for (M++1) 
C15H22O6: 299.1489, found: 299.1492.  
 
 
Trans-diethyl 4-methoxycarbonyl-4-cyclohexene-1,2-dicarboxylate. Following the general 
procedure described above, 65 mg of 1.58 (46% yield) were obtained as a yellowish oil starting from 
42 mg of methyl propiolate. 1H-NMR (CDCl3, 300 MHz): δ 1.24 (t, J = 7.1 Hz, 3H), 1.25 (t, J = 7.1 
Hz, 3H), 2.30-2.42 (m, 2H), 2.57-2.68 (m, 1H), 2.74-2.89 (m, 3H), 3.73 (s, 3H), 4.15 (q, J = 7.1 Hz, 
2H), 4.15 (q, J = 7.1 Hz, 2H), 6.93-6.95 (m, 1H). 13C-NMR (CDCl3, 300 MHz): δ 13.9, 26.5, 28.0, 
40.2, 40.9, 51.6, 60.6, 128.3, 136.7, 166.4, 173.8, 173.9. HRMS (ES) calc. for (M++1) C14H20O6: 
285.1333, found: 285.1327.  
 
 
Trans-diethyl 4-(triisopropylsilyl)-4-cyclohexene-1,2-dicarboxylate. Following the general 
procedure described above, 44 mg of 1.59 (31% yield) were obtained as a yellowish oil starting from 
112 mg of ethynyltriisopropylsilane. 1H-NMR (CDCl3, 300 MHz): δ 1.03-1.05 (m, 21H), 1.25 (t, J = 
7.1 Hz, 3H), 1.25 (t, J = 7.1 Hz, 3H), 2.14-2.32 (m, 2H), 2.41-2.57 (m, 2H), 2.73-2.90 (m, 2H), 4.14 (q, 
J = 7.1 Hz, 2H), 4.15 (q, J = 7.1 Hz, 2H), 5.94-5.97 (m, 1H). 13C-NMR (CDCl3, 300 MHz): δ 14.2, 
17.7, 18.7, 29.7, 31.5, 41.3, 41.9, 60.5, 132.3, 135.5, 175.0, 175.2. HRMS (ES) calc. for (M++1) 
C21H38O4Si: 383.2612, found: 283.2623.  
 
 
Dimethyl 1-vinyl-3-cyclohexene-1,4-dicarboxylate.  Following the general procedure described 
above, 75 mg of 1.60 (70% yield) were obtained as a yellowish oil starting from 42 mg of methyl 
propiolate. 1H-NMR (CDCl3, 300 MHz): δ 1.75-1.84 (m, 1H), 2.03-2.12 (m, 1H), 2.26-2.39 (m, 3H), 
2.74-2.83 (m, 1H), 3.67 (s, 3H), 3.70 (s, 3H), 5.08 (d, J = 17.5 Hz, 1H), 5.14 (d, J = 10.7 Hz, 1H), 5.85 
(dd, J1 = 17.4 Hz, J2 = 10.7 Hz, 1H), 6.92-6.96 (m, 1H). 13C-NMR (CDCl3, 300 MHz): δ 21.7, 29.4, 
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32.1, 47.2, 51.5, 52.2, 115.2, 129.3, 137.0, 139.3, 167.3, 174.8. HRMS (ES) calc. for (M++1) 
C12H16O4: 225.1121, found: 225.1110.  
 
 
1.5.2. Validation of 1,7-octadiene-assisted tandem protocol versus Mori’s conditions.54  
 
 
Method A. A solution of Hoveyda-Grubbs catalyst second generation (5 mol%), 1,7-octadiene (4.0 
equiv), alkyne (1.0 equiv, 0.12 mmol), and the corresponding dienophile (3.0 equiv) in dry toluene 
(0.05 M, 2.4 mL) was heated at 90 ºC in a sealed tube. The reaction mixture was stirred at this 
temperature until TLC showed total consumption of the starting material. Then, solvents were 
removed under reduced pressure and the crude mixture was purified by flash column chromatography.  
 
Method B. Ethylene gas was bubbled through a solution of Hoveyda-Grubbs catalyst second 
generation (5 mol%) in dry toluene (0.05 M, 2.4 mL) for 3 minutes at room temperature in a sealed 
tube. Difluoroalkyne (1.0 equiv, 0.12 mmol) was added next and it was heated at 90 ºC for 2 hours. 
Once the intermediate diene was formed (by TLC), it was cooled to room temperature and the 
corresponding dienophile (3.0 equiv) was added. After the indicated time, solvent was removed and 
the reaction mixture was purified by flash column chromatography.  
 
 
 
                                                       
54 Starting fluorinated amides and ketone were previously reported: (a) Fustero, S.; Fernández, B.; Bello, P.; del Pozo, C.; 
Arimitsu, S.; Hammond, G. B. Org. Lett. 2007, 9, 4251. (b) Fustero, S.; Bello, P.; Fernández, B.; del Pozo, C.; Hammond, G. 
B. J. Org. Chem. 2009, 74, 7690. (c) Ref. 26.  
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Trans-diethyl 4-(2-(benzylamino)-1,1-difluoro-2-oxoethyl)-4-cyclohexene-1,2-dicarboxylate. Fo-
llowing the general procedure described above (method A), 34 mg of 1.61 (70% yield) were obtained 
as a white solid starting from 25 mg of N-benzyl-2,2-difluorobut-3-ynamide. m.p. 61-63 ºC. 1H-NMR 
(CDCl3, 300 MHz): δ 1.24 (t, J= 7.2 Hz, 3H), 1.25 (t, J= 7.2 Hz, 3H), 2.23-2.38 (m, 2H), 2.51-2.61 (m, 
2H), 2.81-2.95 (m, 2H), 4.14 (q, J= 7.11 Hz, 4H), 4.50 (d, J= 5.8 Hz, 2H), 6.22 (br s, 1H), 6.70 (br s, 
1H), 7.27-7.39 (m, 5H). 13C-NMR (CDCl3, 300 MHz): δ. 14.1, 25.0, 27.3, 40.3, 40.6, 43.6, 60.9, 60.9, 
114.7 (t, 1JCF= 251.4 Hz), 127.5, 127.84, 128.0, 128.9, 128.9 (t, 2JCF= 24.2 Hz), 136.72, 163.2 (t, 2JCF= 
30.9 Hz), 173.7, 173.9. 19F-NMR (CDCl3, 282 MHz): -136.4 (d, JFF= 258.2 Hz, 1F), -137.5 (d, JFF= 
258.2 Hz, 1F). HRMS (ES) calc. for (M++1) C21H26F2NO5: 410.1774, found: 410.1776.  
 
 
Diethyl 4-(2-(benzylamino)-1,1-difluoro-2-oxoethyl)-1,4-cyclohexadiene-1,2-dicarboxylate. Follo-
wing the general procedure described above (method A), 27 mg (55% yield) of 1.62 were obtained as 
a dark brown oil starting from 25 mg of N-benzyl-2,2-difluorobut-3-ynamide. 1H-NMR (CDCl3, 300 
MHz): δ 1.29 (t, J= 7.2 Hz, 3H), 1.30 (t, J= 7.2 Hz, 3H), 3.10 (s, 4H), 4.23 (q, J= 7.2 Hz, 4H), 4.50 (d, 
J= 6Hz, 2H), 6.22 (br s, 1H), 6.70 (br s, 1H), 7.26-7.39 (m, 5H). 13C-NMR (CDCl3, 300 MHz): δ 13.9, 
14.0, 25.3 (t, 3JCF= 3.0 Hz), 28.1, 43.6, 61.3, 61.4, 114.5 (t, 1JCF= 251.8 Hz), 125.1 (t, 3JCF= 8.7 Hz), 
126.9 (t, 2JCF= 24.0 Hz), 127.8, 128.0, 128.9, 131.1, 131.3, 136.6, 162.6 (t, 2JCF= 30.4 Hz),  167.0, 
167.3. 19F-NMR (CDCl3, 282 MHz): -108.6 (s, 2F). HRMS (EI) calc. for (M+) C21H23F2NO5: 407.1544, 
found: 407.1546.  
 
 
N-benzyl-2-(1,3-dioxo-2-phenyl-2,3,3a,4,7,7a-hexahydro-1H-isoindol-5-yl)-2,2-difluoroacetamide. 
Following the general procedure described above (method A), 31 mg of 1.63 (63% yield) were 
obtained as a dark brown oil starting from 25 mg of N-benzyl-2,2-difluorobut-3-ynamide. 1H-NMR 
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(CDCl3, 300 MHz): δ 2.32-2.47 (m, 2H), 2.82-2.93 (m, 2H), 3.27-3.38 (m, 2H), 4.46 (d, J= 5.7 Hz, 
2H), 6.49-6.55 (m, 1H), 6.68 (br s, 1H), 7.27-7.47 (m, 10H). 13C-NMR (CDCl3, 300 MHz): δ 22.8, 
23.9, 38.7, 39.1, 43.7, 114.2 (t, 1JCF= 251.0 Hz), 126.5, 127.9, 128.0, 128.7, 128.9, 129.1, 129.9 (t, 
3JCF= 8.9 Hz), 131.8, 131.9 (t, 2JCF= 24.4 Hz), 136.6, 162.8 (t, 2JCF= 30.1 Hz), 177.7, 178.1. 19F-NMR 
(CDCl3, 282 MHz): δ -106.5 (d, JFF= 258.1 Hz, 1F), -108.7 (d, JFF= 258.4 Hz, 1F). HRMS (EI) calc. 
for (M+) C23H20F2N2O3: 410.1442, found: 410.1445.  
 
 
N-benzyl-2-(9,10-dioxo-1,4,4a,9,9a,10-hexahydroanthracen-2-yl)-2,2-difluoroacetamide. Follo-
wing the general procedure described above (method A), 24 mg (50% yield) or 1.64 were obtained as 
a dark brown oil starting from 25 mg of N-benzyl-2,2-difluorobut-3-ynamide. 1H-NMR (CDCl3, 300 
MHz): δ 2.35-2.45 (m, 2H), 2.57-2.70 (m, 2H), 3.37-3.43 (m, 1H), 3.45-3.50 (m, 1H), 4.50 (d, J = 5.8 
Hz, 2H), 6.23-6.28 (m, 1H), 6.8 (br s, 1H), 7.27-7.38 (m, 5H), 7.73-7.79 (m, 2H), 7.99-8.07 (m, 2H). 
13C-NMR (CDCl3, 300 MHz): δ. 22.0, 24.3, 43.6, 45.6, 45.8, 114.6 (t, 1JCF= 250.9 Hz), 126.9, 127.0, 
127.4 (t, 3JCF= 8.6 Hz),127.8, 127.9, 128.6 (t, 2JCF= 29.2 Hz), 128.8, 133.6, 133.7, 134.6, 136.1, 163.1 
(t, 2JCF= 30.6 Hz), 197.0, 197.1. 19F-NMR (CDCl3, 282 MHz): -107.5 (s, 2F). HRMS (ES) calc. for 
(M++1) C23H20F2NO3: 396.1406, found: 396.1404.  
 
 
Trans-diethyl 4-(1,1-difluoro-2-oxo-2-((S)-1-phenylethylamino)ethyl)-4-cyclohexene-1,2-dicarbo-
xylate. Following the general procedure described above (method A), 37 mg (73% yield) of 1.65 were 
obtained as a dark brown oil starting from 27 mg of (R)-2,2-difluoro-N-(1-phenylethyl)but-3-ynamide. 
1H-NMR (CDCl3, 300 MHz): δ 1.23 (t, J= 7.2 Hz, 6H), 1.54 (d, J= 6.9 Hz, 3H), 2.20-2.31 (m, 2H), 
2.52- 2.58 (m, 2H), 2.79-2.92 (m, 2H), 4.13 (c, J= 7.2 Hz, 4H), 5.08-5.18 (m, 1H), 6.17 (br s, 1H), 
6.64 (d, J= 6.64 Hz, 1H), 7.27-7.39 (m, 5H). 13C-NMR (CDCl3, 300 MHz): δ 14.1, 21.3, 24.9, 27.2, 
40.3, 40.6, 49.2, 60.8, 60.9, 114.6 (t, 1JCF= 251.7 Hz), 126.1, 127.8, 127.8 (t, 3JCF= 8.7 Hz), 128.8, 
128.9 (t, 2JCF= 24.0 Hz), 141.7, 162.3 (t, 2JCF= 30.5 Hz), 173.7, 173.8. 19F-NMR (CDCl3, 282 MHz): -
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106.7 (d, JFF= 258.7 Hz, 1F), -106.8 (d, JFF= 258.1 Hz, 1F), -107.9 (d, JFF = 258.9 Hz, 1F), -107.9 (d, 
JFF= 258.7 Hz, 1F). HRMS (ES) calc. for (M++1) C22H28F2NO5: 424.1936, found: 424.1940.  
 
 
2-(1,3-Dioxo-2-phenyl-2,3,3a,4,7,7a-hexahydro-1H-isoindol-5-yl)-2,2-difluoro-N-((S)-1-phenyle-
thyl) acetamide. Following the general procedure described above (method A), 36 mg (70% yield) of 
1.66 were obtained as a dark brown solid starting from 27 mg of (R)-2,2-difluoro-N-(1-
phenylethyl)but-3-ynamide. m.p. 113-115 ºC. 1H-NMR (CDCl3, 300 MHz): δ 1.53 (d, J= 6.9 Hz, 3H), 
2.31-2.46 (m, 2H), 2.76-2.91 (m, 2H), 3.25-3.36 (m, 2H), 5.04-5.16 (m, 1H), 6.45-6.51 (m, 1H), 6.65 
(br s, 1H), 7.22-7.48 (m, 10H). 13C-NMR (CDCl3, 300 MHz): δ 21.1, 21.3, 22.7, 23.8, 38.7, 39.0, 49.2, 
49.3, 114.0 (t, 1JCF= 251.6 Hz), 114.1, (t, 1JCF= 252 Hz), 126.1, 126.2, 126.4, 126.5, 127.7, 127.8, 
128.6, 128.7, 128.8, 129.1, 129.8 (t, 3JCF= 8.7 Hz), 129.8 (t, 3JCF= 8.8 Hz),  131.7, 131.8, 131.8 (t, 
2JCF= 24.6 Hz), 131.9 (t, 2JCF= 24.6 Hz), 161.9 (t, 2JCF= 30 Hz), 177.7, 177.8, 178.1, 178.2. 19F-NMR 
(CDCl3, 282 MHz): -105.9 (d, JFF=259.7 Hz, 1F), -106.4 (d, JFF=257.6 Hz, 1F), -108.6 (d, JFF=259.7 
Hz, 1F), -108.8 (d, JFF=257.6 Hz, 1F). HRMS (EI) calc. for (M+) C24H22F2N2O3: 424.1598, found: 
424.1599.  
 
 
(R)-Diethyl 4-(1,1-difluoro-2-oxo-2-(1-phenylethylamino)ethyl)cyclohexa-1,4-diene-1,2-dicarbo-
xylate. Following the general procedure described above (method A), 30 mg (60% yield) of 1.67 were 
obtained as a dark brown oil starting from 27 mg of (R)-2,2-difluoro-N-(1-phenylethyl)but-3-ynamide. 
[α]25D = -88.9 (c = 1.0 in CHCl3). 1H-NMR (CDCl3, 300 MHz): δ 1.29 (t, J = 7.2 Hz, 6H), 1.56 (d,  J = 
6.9 Hz, 3H), 3.12 (s, 4H), 4.23 (q,  J = 7.2 Hz, 4H), 5.14 (quint, J = 7.2 Hz, 1H), 6.17-6.19 (m, 1H), 
6.58 (br s, 1H), 7.29-7.39 (m, 5H). 13C-NMR (CDCl3, 300 MHz): δ 14.4, 14.4, 21.8, 25.7 (t, 4JCF = 2.6 
Hz), 28.5, 49.7, 61.8, 62.4, 114.9 (t, 1JCF =  251.6 Hz), 125.6 (t, 3JCF = 8.7 Hz), 126.6, 127.3 (t, 3JCF = 
24.2 Hz), 128.3, 129.3, 131.6, 131.8, 142.1, 162.6 (t, 3JCF = 30.4 Hz), 167.5, 167.8. 19F-NMR (CDCl3, 
282 MHz): δ -106.8 (d, JFF = 258.7 Hz, 1F), -106.9 (d, JFF = 258.6 Hz, 1F), -107.9 (d, JFF = 258.6 Hz, 
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1F), -108.0 (d, JFF = 258.7 Hz, 1F). HRMS (EI) calc. for (M++1) C22H6F2NO5: 422.1774, found: 
422.1753.  
 
 
Diethyl 4-(1,1-difluoro-2-oxo-2-phenylethyl)-1,4-cyclohexadiene-1,2-dicarboxylate. Following the 
general procedure described above (method A), 25 mg (55% yield) of 1.68 were obtained as a dark 
brown oil starting from 22 mg of 2,2-difluoro-1-phenylbut-3-yn-1-one. 1H-NMR (CDCl3, 300 MHz): 
δ 1.23 (t, J = 7.2Hz, 3H), 1.24 (t, J = 7.2 Hz, 3H), 3.16 (s, 4H), 4.17 (q, J = 7.2 Hz, 2H), 4.17 (q, J = 
7.2 Hz, 2H), 6.19-6.20 (br m, 1H), 7.47 (dd, J1 = J2 = 6 Hz, 2H), 7.63 (tt, J1 = 7.2 Hz, J2 = 1.5 Hz, 1H), 
8.03 (d, J = 7.2 Hz, 2H).  13C-NMR (CDCl3, 300 MHz): δ 13.9, 14.0, 25.3 (t, 4JCF = 2.8 Hz), 28.1, 61.4, 
61.5, 116.3 (t, 1JCF = 251.9 Hz), 125.7 (t, 3JCF = 8.6 Hz), 128.0 (t, 2JCF = 23.8 Hz), 128.7, 130.2 (t, 4JCF 
= 2.9 Hz), 131.2, 131.3, 132.0, 134.5, 167.0, 167.3, 188.5 (t, 2JCF = 30.6 Hz). 19F-NMR (CDCl3, 282 
MHz): -103.2 (s, 2F). HRMS (EI) calc. for (M+) C20H20F2O5: 378.1269, found: 378.1279.  
 
 
Trans-diethyl 4-(1,1-difluoro-2-oxo-2-(phenylamino)ethyl)-4-cyclohexene-1,2-dicarboxylate. Fo-
llowing the general procedure described above (method A), 32 mg (70% yield) of 1.69 were obtained 
as a yellow oil starting from 22 mg of 2,2-difluoro-1-phenylbut-3-yn-1-one. 1H-NMR (CDCl3, 300 
MHz): δ 1.24 (t, J = 7.2 Hz, 3H), 1.25 (t, J = 7.2 Hz, 3H), 2.23-2.41 (m, 2H), 2.51-2.64 (m, 2H), 2.84-
2.98 (m, 2H), 4.14 (q, J= 7.2 Hz, 4H), 6.17-6.22 (m, 1H), 7.48 (dd, J1 = J2 = 7.8 Hz, 2H), 7.63 (tt, J1 = 
7.2 Hz, J2 = 1.5 Hz, 1H), 8.03 (d, J = 7.2 Hz, 2H). 13C-NMR (CDCl3, 300 MHz): δ 14.1, 25.0, 27.3, 
40.4, 40.6, 60.9, 61.0, 116.4 (t, 1JCF = 251.42 Hz), 128.3 (t, 3JCF = 8.3 Hz), 128.7, 130.1 (t, 2JCF = 24.2 
Hz), 130.1 (t, 4JCF = 2.27 Hz), 132.2, 134.4, 173.7, 173.9, 188.8 (t, 2JCF = 30.96 Hz). 19F-NMR (CDCl3, 
282 MHz): δ -111.7 (d, JFF = 272.2 Hz, 1F), -112.8 (d, JFF = 272.2 Hz, 1F). HRMS (EI) calc. for 
(M++1) C20H23F2O5: 381.1508, found: 381.1514.  
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Chapter 2  
Differential reactivity of fluorinated homopropargyl-α-amino esters versus 
Au(I) complexes. The role of nitrogen protecting group  
 
 
2.1. Introduction and current state-of-the-art.  
 
2.1.1. A brief on gold catalysis.  
 
Despite the ubiquitous presence of gold along the history (jewelry, currency or medicine), not 
up to the end of the last century gold became a precious metal for chemists. By this short period of 
time, gold catalysis has become a fundamental and innovative synthetic tool for the generation of C–C 
and C-heteroatom bonds. This golden age is most likely due to the unique ability exhibited by Au(I) 
species to act as a π-soft Lewis acids towards non-activated multiple C–C bonds (alkynes, allenes, 
alkenes, 1,3-dienes or enynes),55 promoting the addition of a wide variety of nucleophiles, both inter- 
and intra-molecularly, under mild reaction conditions while showing high functional group 
tolerance.56 
Under this scenario, gold complexes emerged as well-suited catalysts for the combination of 
several transformations in a tandem fashion, opening new avenues to build up molecular complexity.57 
These tandem methodologies are becoming increasingly important among different areas of organic 
chemistry, as one of the main interests for both academia and industry is the enhancement of synthetic 
efficiency. 
                                                       
55 (a) Hashmi, A. S. K. Acc. Chem. Res. 2014, 47, 864. (b) Zhang, L. Acc. Chem. Res. 2014, 47, 877. (c) Wang, Y.-M.; 
Lackner, A. D.; Toste, F. D. Acc. Chem. Res. 2014, 47, 889. (d) Obradors, C.; Echavarren, A. M. Acc. Chem. Res. 2014, 47, 
902. (e) Zhang, D.-H.; Tang, X.-Y.; Shi, M. Acc. Chem. Res. 2014, 47, 913. (f) Fürstner, A. Acc. Chem. Res. 2014, 47, 925. 
(g) Alcaide, B.; Almendros, P. Acc. Chem. Res. 2014, 47, 939. (h) Fensterbank, L.; Malacria, M. Acc. Chem. Res. 2014, 47, 
953. (i) Yeom, H.-S.; Shin, S. Acc. Chem. Res. 2014, 47, 966. (j) Obradors, C.; Echavarren, A. M. Chem. Commun. 2014, 50, 
16. (k) Muratore, M. E.; Homs, A.; Obradors, C.; Echavarren, A. M. Chem. Asian J. 2014, 9, 3066.  
56 Cycloisomerization and cycloaddition reactions of polyunsaturated compounds should be noted as well. 	  
57 (a) Pflästerer, D.; Hashmi, A. S. K. Chem. Soc. Rev. 2016, 45, 1331. (b) Dorel, R.; Echavarren, A. M. Chem. Rev. 2015, 
115, 9028. 	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Even though less Lewis acidic Ag(I) or Pt(II) complexes, among others, can occasionally 
accomplish gold-catalyzed transformations,58 no other late transition metal shows the breadth of 
applications displayed by homogeneous Au(I) complexes. This singular behavior has been attributed 
to relativistic effects.59  
As soft centers, gold species show low oxophilicity.60 Thus, gold-catalyzed reactions do not 
require rigorous inert conditions. Nevertheless, in the presence of water or alcohols, gold species may 
interact with them enhancing their Brönsted acidity, rendering actually Lewis acid assisted-Brönsted 
acid catalyzed processes.61  
Among the different species susceptible to be activated by gold complexes, alkyne activation 
has been the most commonly exploited. Frenking and coworkers studied Au+-acetylene and Au+-
ethylene interactions, showing that the latter is 10 kcal·mol-1 more stable.62 That means that the 
alkynophilicity exhibited by gold complexes responds to a kinetic origin. Compared to alkynes, higher 
π* energy levels for alkenes result in larger gaps with nucleophile’s HOMO.  
It is commonly accepted that these types of gold-catalyzed nucleophilic additions over C–C 
multiple bonds involves two steps (Scheme 2.1). Nucleophilic anti-addition over a π-C–C bond 
activated by the gold complex,63 gives rise to a trans-alk(en)yl-gold intermediate64 that is now prone to 
be trapped by any electrophile present in the reaction media, commonly a proton through a 
protodeauration step, rendering the product and restoring the catalytically active species. 
Alternatively, these vinyl gold intermediates may evolve through the coined carbene pathway, 
displaying versatile reactivities.65  
                                                       
58 (a) Muñoz, M. P. Chem. Soc. Rev. 2014, 43, 3164. (b) Fürstner, A. Chem. Soc. Rev. 2009, 38, 3208. 	  
59 (a) Leyva-Pérez, A.; Corma, A. Angew. Chem. Int. Ed. 2012, 51, 614. (b) Gorin, D. J.; Toste, F. D. Nature 2007, 446, 395. 	  
60 (a) Fürstner, A.; Davies, P. W. Angew. Chem. Int. Ed. 2007, 46, 3410. (b) Yamamoto, Y. J. Org. Chem. 2007, 72, 7817. 	  
61 (a) Yamamoto, H.; Futatsugi, K. Angew. Chem. Int. Ed. 2005, 44, 1924. (b) Kanno, O.; Kuriyama, W.; Wang, Z. J.; Toste, 
F. D. Angew. Chem. Int. Ed. 2011, 50, 9919. (c) Chen, C. H.; Wang, C. D.; Hsieh, Y. F.; Liu, R. S. Org. Biomol. Chem. 2014, 
12, 9831. 	  
62 Nechaev, M. S.; Rayón, V. M.; Frenking, G. J. Phys. Chem. A 2004, 108, 3134. 	  
63 (a) Das, A.; Dash, C.; Celik, M. A.; Yousufuddin, M.; Frenking, G.; Dias, H. V. R. Organometallics 2013, 32, 3135. (b) 
Jašíková, L.; Roithová, J. Organometallics 2013, 32, 7025. (c) Jašíková, L.; Roithová, J. Organometallics 2012, 31, 1935. (d) 
Das, A.; Dash, C.; Yousufuddin, M.; Celik, M. A.; Frenking, G.; Dias, H. V. R. Angew. Chem. Int. Ed. 2012, 51, 3940. (e) 
Brown, T. J.; Widenhoefer, R. A. J. Organomet. Chem. 2011, 696, 1216. (f) Brown, T. J.; Widenhoefer, R. A. 
Organometallics 2011, 30, 6003. (g) Hooper, T. N.; Green, M.; Russell, C. A. Chem. Commun. 2010, 46, 2313. (h) Flügge, 
S.; Anoop, A.; Goddard, R.; Thiel, W.; Fürstner, A. Chem. Eur. J. 2009, 15, 8558. (i) Shapiro, N. D.; Toste, F. D. Proc. Nat. 
Acad. Sci. U.S.A. 2008, 105, 2779. (j) Lavallo, V.; Frey, G. D.; Kousar, S.; Donnadieu, B.; Bertrand, G. Proc. Nat. Acad. Sci. 
U.S.A. 2007, 104, 13569.	  
64 (a) Zhu, Y.; Yu, B. Angew. Chem. Int. Ed. 2011, 50, 8329. (b) Melchionna, M.; Nieger, M.; Helaja, J. Chem. Eur. J. 2010, 
16, 8262. (c) LaLonde, R. L.; Brenzovich Jr., W. E.; Benítez, D.; Tkatchouk, E.; Kelley, K.; Goddard III, W. A.; Toste, F. D. 
Chem. Sci. 2010, 1, 226. (d) Hashmi, A. S. K. Angew. Chem. Int. Ed. 2010, 49, 5232. (e) Weber, D.; Tarselli, M. A.; Gagné, 
M. R. Angew. Chem. Int. Ed. 2009, 48, 5733. (f) Liu, L.-P; Xu, B.; Mashuta, M. S.; Hammond, G. B. J. Am. Chem. Soc. 
2008, 130, 17642. 	  
65 (a) Ji, K.; Zhao, Y.; Zhang, L. Angew. Chem. Int. Ed. 2013, 52, 6508. (b) Hashmi, A. S. K.; Wang, T.; Shi, S.; Rudolph, M. 
J. Org. Chem. 2012, 77, 7761. (c) Jadhav, A. M.; Pagar, V. V.; Liu, R.-S. Angew. Chem. Int. Ed. 2012, 51, 11809. (d) 
Shapiro, N. D.; Shi, Y.; Toste, F. D. J. Am. Chem. Soc. 2009, 131, 11654. (e) Shi, X. D.; Gorin, D. J.; Toste, F. D. J. Am. 
Chem. Soc. 2005, 127, 5802. 	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In order to implement catalysis, ancillary ligands play a pivotal role tuning reactivity of gold 
catalysts.66 So a careful choice of an appropriate ligand (with accurate steric and electronic properties) 
comes essential to endorse the desired reactivity. For instance, deauration is usually a fast step, being 
the electronic activation the rate-limiting step, especially when dealing with soft nucleophiles or less 
reactive substrates such as alkenes or allenes. Under this scenario, gold complexes derived from 
electron-withdrawing ligands would favour nucleophilic addition, increasing the overall efficiency of 
the process. Nevertheless, deauration might be the rate-limiting step as well. In the presence of basic 
nucleophiles like amines, any acid present in the media will see diminished its acidity. Under these 
conditions, the use of electron-rich ligands would favour the electrophilic attack over the vinyl-gold 
intermediate.  
But beyond this simplistic picture of gold-catalysis, ligand effects may influence catalysis 
from different angles, tuning reactivity and selectivity. Additionally, despite significant efforts were 
directed towards gold asymmetric catalysis67 based on the application of chiral ligands, the linear 
geometry of Au(I) complexes68  converted this strategy in a challenging task, which prompted 
alternative strategies, namely the use of chiral counterions.69 Counterion effects may have deep 
outcomes in gold-catalyzed transformations.70 Linear gold chloride complexes bearing phosphines or 
N-heterocyclic carbenes as ligands are quite common precatalysts that need to be activated by chloride 
abstraction with a silver salt. In this manner, chloride is replaced by a weakly coordinating ligand, 
generating more active gold species and in turn enabling its replacement by the reactive substrate via 
π-coordination. Nevertheless, this ligand exchange occurs via an associative mechanism,71 a triggering 
                                                       
66 (a) Wang, W.; Hammond, G. B.; Xu, B. J. Am. Chem. Soc. 2012, 134, 5697. (b) Gorin, D. J.; Sherry, B. D.; Toste, F. D. 
Chem. Rev. 2008, 108, 3351. 	  
67 Zi, W.; Toste, F. D. Chem. Soc. Rev. 2016, 45, 4567.  
68 Highly enantioselective Au(III)-catalyzed transformations remain unreported. 	  
69 Pioneering work by Toste et al., see: Hamilton, G. L.; Kang, E. J.; Miriam, M.; Toste, F. D. Science, 2007, 317, 496. 	  
70 (a) Wegener, M.; Huber, F.; Bolli, C.; Jenne, C.; Kirsch, S. F. Chem. Eur. J. 2015, 21, 1328. (b) Homs, A.; Obradors, C.; 
Leboeuf, D.; Echavarren, A. M. Adv. Synth. Catal. 2014, 356, 221. 	  
71 (a) Xi, Y.; Wang, Q.; Su, Y.; Li, M.; Shi, X. Chem. Commun. 2014, 50, 2158. (b) Brooner, R. E. M.; Robertson, B. D.; 
Widenhoefer, R. A. Organometallics, 2014, 33, 6466. (c) Zhdanko, A.; Maier, M. E. Organometallics 2013, 32, 2000. 	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Scheme 2.1. Catalytic cycle for gold-catalyzed nucleophilic additions.
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aspect in gold catalysts preparation that should not be overlooked, since the invoked and so-called 
“silver effects” have demonstrated not play an innocent role in gold catalysis.72  
On the other hand, while most of gold-catalyzed reactions are based on its ability to act as soft 
Lewis acids, activating C–C multiple bonds, its competency towards the formation of σ-complexes 
with heteroatoms has been proved as well. This bifunctional character exhibited by gold salts as σ- 
and π-Lewis acids was highlighted in the regiodivergent cyclization of halogenated allenones reported 
by Gevorgyan in 2005.73 Regardless the use of Au(III) species as precatalysts for the activation of 
unsaturated C–C bonds, it has been also proved their competency towards the formation of σ-
complexes with heteroatoms. At higher oxidation states, gold species act as hard Lewis acids. It is at 
lower oxidation states when relativistic effects raise their greatest sway, i.e. when gold catalysis’ 
genuineness arises. Nevertheless, the use of Au(III) precatalysts is still surrounded by many 
uncertainties regarding the actual oxidation state and structure of the catalytic species.74  
Furthermore, despite their soft Lewis acidity, Au(I) species can form as well σ-acetylide 
complexes with terminal alkynes. Since Toste group highlighted a dual σ,π-activation mode in the 
Au(I)-catalyzed cycloisomerization of 1,5-allenynes,75 σ,π-digold complexes have been recognized as 
relevant complexes in homogeneous Au(I) catalysis, mainly in reactions of diynes.76 
Beyond their use as π-carbophilic Lewis acids, gold-complexes have been also successfully 
applied in cross-coupling reactions. The high redox potential of Au(I)/Au(III) redox couple (+1.41V)77 
was the reason because the use of gold variants on cross coupling reactions, following an analogous 
catalytic mode to other transition metal like Pd(0)/Pd(II) redox couple (+0.92V), were a significant 
challenge. The use of external oxidants such as Selectfluor has changed this tendency allowing 
catalytic turnover of Au(I) to Au(III) and finally the generation of C–C and C-heteroatom bonds via 
reductive elimination from Au(III) species (Scheme 2.2).78 These transformations constitute a new 
paradigm in gold chemistry, expanding the utility of gold catalysis.  
                                                       
72 (a) Homs, A.; Escofet, I.; Echavarren, A. M. Org. Lett. 2013, 15, 5782. (b) Zhu, Y.; Day, C. S.; Zhang, L.; Hauser, K. J.; 
Jones, A. C. Chem.  Eur. J. 2013, 19, 12264. (c) Wang, D.; Cai, R.; Sharma, S.; Jirak, J.; Thummanapelli, S. K.; Akhmedov, 
N. G.; Zhang, H.; Liu, X.; Petersen, J. L.; Shi, X. J. Am. Chem. Soc. 2012, 134, 9012. 	  
73 Sromek, A. W.; Rubina, M.; Gevorgyan, V. J. Am. Chem. Soc. 2005, 127, 10500. 	  
74 Schmidbaur, H.; Schier, A. Arab. J. Sci. Eng. 2012, 37, 1187. 	  
75 Cheong, P. H.-Y.; Morganelli, P.; Luzung, M. R.; Houk, K. N.; Toste, F. D. J. Am. Chem. Soc. 2008, 130, 4517. 	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2013, 52, 2593. (c) Wang, Y.; Yepremyan, A.; Ghorai, S.; Todd, R.; Aue, D. H.; Zhang, L. Angew. Chem. Int. Ed. 2013, 52, 
7795. (d) Vachhani, D. D.; Galli, M.; Jacobs, J.; Van Meervelt, L.; Van der Eycken, E. V. Chem. Commun. 2013, 49, 7171. 
(e) Nösel, P.; Lauterbach, T.; Rudolph, M.; Rominger, F.; Hashmi, A. S. K. Chem. Eur. J. 2013, 19, 8634. (f) Ye, L.; Wang, 
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M.; Rominger, F. Adv. Synth. Catal. 2012, 354, 555.  
77 Bratsch, S. G. J. Phys. Chem. Ref. Data 1989, 18, 1. 	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Considering the unique modes of activation of unsaturated bonds exhibited by gold salts, its 
combination with either fluorinated building blocks or fluorinated reagents will open new avenues for 
the development of new methodologies in fluoroorganic chemistry. Indeed, gold and fluorine 
faithfully form a fruitful partnership,79 and different types of reactivity arise from their combination.  
 
 
2.1.2. Fluorinated building blocks in gold-catalyzed processes.  
 
The use of fluorinated building blocks is one of the main approaches to access fluorinated 
scaffolds. Its combination with gold salts, proficient to promote new activation modes triggering 
unconventional reactivity patterns, opens new avenues in organofluorine chemistry. This partnership 
allows the preparation of great-demanded fluorinated skeletons, otherwise difficult to access. 
Nevertheless, only a few reports concerning the use of fluorinated starting materials have been devised 
to date.  
The first contribution in this area was due to Hayashi and coworkers. An in-depth study was 
carried out in their laboratory, evaluating the aldol condensation of isocyanoacetic acid derivatives 2.1 
with fluorinated prochiral aldehydes, 80  ketones 81  and imines. 82  Hydrolysis of the corresponding 
oxazolines 2.2, 2.3 or imidazolines 2.4 resulted in a new family of fluorinated α-amino acid 
derivatives (Scheme 2.3).  
 
                                                                                                                                                                            
Gouverneur, V. Chem. Eur. J. 2011, 17, 8248. (e) Garcia, P.; Malacria, M.; Aubert, C.; Gandon, V.; Fensterbank, L. 
ChemCatChem 2010, 2, 493. 	  
79 (a) Miró, J.; del Pozo, C. Chem. Rev. 2016, 116, 11924. (b) Hopkinson, M. N.; Gee, A. D.; Gouverneur, V. Isr. J. Chem. 
2010, 50, 675.  
80 (a) Soloshonok, V. A.; Kacharov, A. D.; Hayashi, T. Tetrahedron, 1996, 52, 245. (b) Soloshonok, V. A.; Hayashi, T. 
Tetrahedron: Asymmetry, 1994, 5, 1091. (c) Soloshonok, V. A.; Hayashi, T. Tetrahedron Lett. 1994, 35, 2713.  
81 (a) Soloshonok, V. A.; Kacharov, A. D.; Avilov, D. V.; Ishikawa, K.; Nagashima, M.; Hayashi, T. J. Org. Chem. 1997, 62, 
3470. (b) Soloshonok, V. A.; Kacharov, A. D.; Avilov, D. V.; Hayashi T. Tetrahedron Lett. 1996, 37, 7845. 	  
82 Hayashi, T.; Kishi, E.; Soloshonok, V. A.; Uozumi, Y. Tetrahedron Lett. 1996, 37, 4969. 	  
Scheme 2.2. Catalytic cycle for Au(I)/Au(III) coupling reactions.
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Among other transition metal species, gold was able to coordinate the isonitrile moiety, 
lowering the pka of hydrogens at the α-position of the isocyanoacetate derivative 2.1 and, in turn, 
promoting an aldol-type condensation with a carbonyl derivative in the presence of a properly base. 
The participation of gold became essential enabling milder reaction conditions, since stronger bases 
employed in conventional aldol-type reactions would adversely affect functional group tolerance.  
Nevertheless, this former contribution lacks from the singularity commonly ascribed to gold, 
and other transition metal complexes, such as Cu(I), Pd(II), Ag(I) or Rh(I), enabled this transformation 
as well. This feature might be significant regarding the role displayed by gold in this transformation, 
performing a σ-activation rather than a π-activation, being this latter closely related with its recent 
breakthrough in organometallic catalysis as a soft Lewis acid. 
Taking this into account, Gouverneur’s contribution in 200883 may be considered at the 
starting line of this on-going race. The relatively lateness-stage of this work compared to the gold rush 
emergence in the early 200084 is meaningful. Furthermore, the relevance of this pioneering work goes 
beyond being one of the first examples combining fluorinated building-blocks and gold catalysis, 
placing the first stone on the probably most fruitful outcomes resulting from the gold-fluorine 
partnership, as it constitutes one of the first examples of gold-mediated C–F bond formation.  
Gouverneur’s work described the Au(I)-catalyzed 6-endo-dig heterocyclization of β-hydroxy-
α,α-difluoroynones 2.5, leading access to a new family of fluorinated dihydropyranones 2.6. This 
cyclization is efficiently promoted by AuCl in DCM, independently of the alkyne substitution or the 
                                                       
83 Schuler, M.; Silva, F.; Bobbio, C.; Tessier, A.; Gouverneur, V. Angew. Chem. Int. Ed. 2008, 47, 7927.  
84 Hashmi, A. S. K. Gold Bull. 2004, 51. 	  
Scheme 2.3. Previous work by Hayashi (90s).
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ancillary group attached to the β-hydroxy group (Scheme 2.4). Despite this transformation is extensive 
to their non-fluorinated counterparts, remarkably, gem-difluoro substitution does not come innocent. 
Fluorine does reduce nucleophilicity of the proximal hydroxyl group preventing cyclization under 
basic or acidic conditions or by alternative catalytic systems. Just gold proves capable to catalyze this 
transformation in an efficient manner. This methodology was further applied for the synthesis of 
fluorinated carbohydrate analogues.85  
 
 
 
This type of gold-catalyzed alkoxycyclizations were further exploited in the synthesis of 
diversely substituted β-fluorofurans, great demanded submotifs in the pharmaceutical industry. 
According to the significance of furan ring featuring among lead compounds and biologically active 
natural products, 86  fluorinated derivatives may provide implemented pharmacological profiles. 
Previously reported methodologies were scarce and operate in low yields or with poor selectivity, 
normally entailing aggressive conditions.87  
In 2010, Dembinski and coworkers reported the gold-catalyzed preparation of fluorofurans 
2.11 starting from monofluoroynones 2.10.88 These ketones are readily accessed by electrophilic 
monofluorination with Selectfluor of silyl enol ethers 2.9 derived from their corresponding non-
fluorinated ynones. Whereas AuCl3 gave rise to complex reaction mixtures, combination of 
Au(PPh3)Cl and AgOTf in DCM at room temperature provided unsymmetrically 2,5-substituted-3-
fluorofurans 2.11 in good yields (Scheme 2.5).  
 
                                                       
85 Giuffredi, G. T.; Bernet, B.; Gouverneur, V. Eur. J. Org. Chem. 2011, 3825. 	  
86 (a) Wu, Y.-J. Progress in Heterocyclic Chem. 2012, 24, 1-53. (b) Yeung, K.-S.; Peng, X.-S.; Wu, J.; Hou, X.-L. Progress 
in Heterocyclic Chem. 2012, 24, 205-241. 	  
87 Serdyuk, O.; Butin, A.; Abaev, V. J. Fluorine Chem. 2010, 131, 296. 	  
88 Li, Y.; Wheeler, K. A.; Dembinski, R. Adv. Synth. Catal. 2010, 352, 2761. 	  
Scheme 2.4. Previous work by Gouverneur (2008).
CO2R3Br
F F
[M]
R2
R1CHO
alkynylation
Reformatsky O
R2
F
F
OHR1 O R2
O
F
R1
F
5 mol% AuCl
DCM, rt, 18 h
75-94% yield
O
OH
F
F
BnO O
F
FHO
E
OR
Luche 
reduction
2.8 (E = H, F, OH)(+/-)-cis-2.7
2.5 2.6
	  	  48 
 
 
Besides oxygen-containing heterocycles, gold catalysis has opened new and efficient synthetic 
pathways for the preparation of fluorinated nitrogen-containing heterocycles by means of the 
intramolecular hydroamination reaction. Fluorine-containing pyrroles, pyrazoles, imidazoles, 
isoindolines, or isoquinolines, among others, constitute a class of important structural units for both 
pharmaceutical and agrochemical industries. Hence, the development of new methods to access these 
privileged structures are of high value.89 
In 2009, De Kimpe and coworkers reported the preparation of 3-fluoropyrroles 2.14, readily 
accessible by means of a gold-catalyzed 5-endo-dig cyclization and spontaneous dehydrofluorination 
of electron-deficient gem-difluorohomopropargyl-N-tosyl amines 2.12 (Scheme 2.6).90 Starting amines 
were prepared by addition of the gem-difluoropropargyl bromides developed by Hammond and 
coworkers,91 to the corresponding N-tosyl imines, previous lithium-bromine exchange.  
 
 
 
These fluorinated building blocks were used as well in the preparation of gem-
difluoropropargyl amides 2.15. Intramolecular 4-exo-dig and 5-endo-dig hydroamination reactions of 
2.15 were reported by our research group under palladium catalysis and basic conditions respectively, 
                                                       
89 Petrov, C. A. Ed. Fluorinated Heterocyclic Compounds: Synthesis, Chemistry and Applications; John Wiley & Sons: 
Hoboken, NJ, USA, 2009. 	  
90 Surmont, R.; Verniest, G.; De Kimpe, N. Org. Lett. 2009, 11, 2920. 	  
91 Xu, B.; Mae, M.; Hong, J. A.; Li, Y.; Hammond, G. B. Synthesis 2006, 803. 	  
Scheme 2.5. Previous work by Dembinski (2010).
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Scheme 2.6. Previous work by De Kimpe (2009).
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rendering fluorinated β- and γ-lactams regioselectively.54a However, hydroamination was not 
accomplished under gold catalysis. Instead, in the presence of Au(III) salts an unprecedented head-to-
head dimerization of the starting amides 2.15 was observed.54b This novel reactivity pattern seems to 
be induced by the gem-difluoro moiety, which displays a critical role. According to the electron-
withdrawing effect imparted by fluorine, fluorine substitution decreases nucleophilicity of the nitrogen 
atom to such an extent to prevent hydroamination but, at the same time, assists the gold catalyst 
activating the triple bond towards the intermolecular nucleophilic addition of a halogen atom from the 
gold salt. Afforded vinyl Au(III) intermediate B then undergoes an additional halogen addition to 
generate divinyl intermediate C, which finally renders diene 2.16 by means of reductive elimination 
(Scheme 2.7). Attempts to perform the process catalytically by adding external oxidants and halogen 
sources failed, so the process results stoichiometric in gold.  
 
 
 
Gold complexes work efficiently as well catalyzing the formation of 5-difluoropyrazoles 2.19 
with high selectivity from fluorinated alkynyl ketones 2.17 and hydrazines 2.18 (Scheme 2.8).92 
Authors sustain that the observed regioselectivity results from a kinetic control, since nucleophilic 
attack by the primary amine is less sterically hindered.  
 
                                                       
92 Li, S.; Li, Z.; Peng, D.; Li, Y.; Zhu, J.; Xie, H.; Yuan, Y.; Chen, Z.; Wu, Y. Chin. J. Chem. 2011, 29, 2695. 	  
X2Au
Scheme 2.7. Previous work by Fustero (2009).
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On the other hand, fluorinated propargyl amidines 2.24 undergo, in the presence of Au(I) 
complexes, a 5-exo-dig cyclization to afford 2-fluorinated 5-methylimidazoles 2.22. 93  Under 
optimized conditions, their preparation could be set in a one-pot procedure from the corresponding 
fluorinated imidoyl chlorides 2.20 and propargyl amines 2.21. While the overall process showed good 
compatibility to several functional groups, its efficiency was affected by electronics on the arylamine, 
being slightly lowered with electron-deficient ones. Even though protodeauration step used to be the 
rate-limiting step when dealing with basic amines, reported results point to the electronic activation as 
the higher barrier to overcome. Presumably, electron-withdrawing groups reduce amine’s 
nucleophilicity, affecting the efficiency of the overall process. In contrast to terminal alkynes, the use 
of internal propargyl amines completely changed regioselectivity, rendering 1,4-dihydropyrimidines 
2.23 in high yield resulting from a 6-endo-dig cyclization (Scheme 2.9).  
  
 
 
A good example to illustrate the implications that fluorine substitution may have in gold-
catalyzed reactions was reported by our group in 2013.94 It was proved that fluorine substitution plays 
a critical role in the regiochemical outcome of the intramolecular hydroamination of ortho-alkynyl 
benzyl carbamates 2.25 (Scheme 2.10). Typically, regioselectivity in such type of processes is highly 
dependent on the electronics of the aryl substituent at the alkyne. While electron-donating substituents 
tends to favor 6-endo-dig cyclization (being the major products isoquinolines 2.27), electron-
withdrawing substituents favor 5-exo-dig pathway, with the preferred formation of isoindolines 2.26. 
In this case, likely a steric than an electronic effect was imparted by fluorine substitution, since 
gradual introduction of fluorine atoms at the α-position of the benzyl carbamate promoted 5-exo-dig 
                                                       
93 Li, S.; Li, Z.; Yuan, Y.; Peng, D.; Li, Y.; Zhang, L; Wu, Y. Org. Lett. 2012, 14, 1130. 	  
94 Fustero, S.; Ibáñez, I.; Barrio, P.; Maestro, M. A.; Catalán, S. Org. Lett. 2013, 15, 832. 	  
Scheme 2.9. Previous work by Wu (2012).
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cyclization over 6-endo-dig pathway, leading to isoindoline derivatives 2.26 as the major products, in 
striking contrast to their previously reported non-fluorinated counterparts.95  
 
 
Regiochemistry was also critical in the intramolecular hydroamination of N-(ortho-
alkynyl)aryl-N’-substituted trifluoro- and bromodifluoro-acetamidines 2.28,96 since up to three types 
of cyclization pathways may operate: 7-endo-dig, 6-exo-dig or 5-endo-dig. While copper and silver 
salts provided low conversions and poor selectivities respectively, 5-endo-dig cyclization took place 
efficiently in the presence of 5 mol% NaAuCl4·2H2O in toluene at room temperature to render indoles 
2.29 in good yields (Scheme 2.11). The process was highly selective independently of the electronics 
on the substituents at the alkyne moiety, unless terminal alkynes were employed.  
 
                                                       
95 (a) Patil, N. T.; Mutyala, A. K.; Lakshmi, P. G. V. V.; Raju, P. V. K.; Sridhar, B. Eur. J. Org. Chem. 2010, 1999. (b) 
Enomoto, T.; Girard, A.-L.; Obika, S.; Yasui, Y.; Takemoto, Y. J. Org. Chem. 2009, 74, 9158. (c) Enomoto, T.; Obika, S.; 
Yasui, Y.; Takemoto, Y. Synlett, 2008, 11, 1647. (d) Obika, S.; Kono, H.; Yasui, Y.; Yanada, R.; Takemoto, Y. J. Org. 
Chem. 2007, 72, 4462. 	  
96 Zhu, J.; Xie, H.; Chen, Z.; Li, S.; Wu, Y. Org. Biomol. Chem. 2012, 10, 516. 	  
Scheme 2.10. Previous work by Fustero (2013).
2.5 mol% Au(SPhos)NTf2 
EtOH (5.0 equiv), DCE, 40 ºC
2.25
N
H
RF
Ar
N
N
Ar
RF
Ar
RF
2.26 2.27
MeO
MeO
PCy2 SPhos
6-endo-dig 5-exo-dig
NHBoc
Ph
NHBoc
Ph
Me
NHBoc
Ph
CH2F
NHBoc
Ph
NHBoc
Ph
CF3
NHBoc
Ph
CF2CF3CHF2H
0:100 40:60 40:60 85:15 80:20 80:20
1:3
>30:1
Ratio 2.26:2.27
Ar = 4-MeO-C6H4  
Ar = 4-CF3-C6H4
RF = CF3
Boc
Boc
Boc
Scheme 2.11. Previous work by Wu (2012).
5 mol% NaAuCl4 
toluene, rt, 1 h
73-96% yield
2.28
RF NHR1
N
R2
N
R2
N
RFR1
2.29
	  	  52 
2.2. Gold-promoted differential reactivity of fluorinated homopropargyl-α-amino esters.  
 
Homopropargyl amines are ubiquitous substrates in gold catalysis.97 These compounds have 
been used as suitable starting materials in several processes that involve an initial intramolecular 
hydroamination of the triple bond. The subsequent combination of this C–N bond formation with 
further transformations in a tandem or a one-pot manner was traduced in the development of new 
methodologies for the preparation of a wide variety of nitrogen-containing heterocycles, including 
piperidines, pyrrolidines or tetrahydroquinolines, among others. However, very few reports 
concerning the use of fluorinated starting materials have been devised to date. This is probably due to 
the absence of efficient methods to access fluorinated homopropargyl amines.  
In this sense, fluorinated homopropargyl amino esters were synthesized to date by addition of 
allenyl magnesium bromide to the corresponding α-imino esters. However, only highly electrophilic 
imino esters (bearing carbamates or sulphonamides at the nitrogen end) were compatible with this 
methodology. Resulting amino esters were used as starting materials in dipolar type cycloadditions 
with azides and nitrile oxides.98 The functionalization of the terminal alkyne position was possible by 
means of a Sonogashira type coupling.99 Alternatively, the propargylation of the nitrogen afforded the 
corresponding alkylated product, which in its reaction with another alkyne in the presence of a 
ruthenium catalyst afforded the cyclotrimerization product (Scheme 2.12).100  
 
                                                       
97 Selected examples: (a) Shu, C.; Li, L.; Yu, Y.-F.; Jiang, S.; Ye, L.-W. Chem. Commun. 2014, 50, 2522. (b) Zheng, Z.; Tu, 
H.; Zhang, L. Chem. Eur. J. 2014, 20, 2445. (c) Yu, Y.-F.; Shu, C.; Shen, C.-H.; Li, T.-Y.; Ye, L.-W. Chem. Asian J. 2013, 8, 
2920. (d) Shu, C.; Liu, M.-Q.; Wnag, S.-S.; Li, L.; Ye, L.-W. J. Org. Chem. 2013, 78, 3292. (e) Liu, L.; Zhang, L. Angew. 
Chem. Int. Ed. 2012, 51, 7301. (f) Kim, H.; Rhee, Y. H. J. Am. Chem. Soc. 2012, 134, 4011. (g) Gronnier, C.; Odabachian, 
Y.; Gagosz, F. Chem. Commun. 2011, 47, 218. (h) Yeom, H.-S.; So, E.; Shin, S. Chem. Eur. J. 2011, 17, 1764. (i) Cui, L.; Li, 
C.; Zhang, L. Angew. Chem. Int. Ed. 2010, 49, 9178. (j) Kim, C.; Bae, H. J.; Lee, J. H.; Jeong, W.; Kim, H.; Sampath, V.; 
Rhee, Y. H. J. Am. Chem. Soc. 2009, 131, 14660. (k) Robles-Machín, R.; Adrio, J.; Carretero, J. C. J. Org. Chem. 2006, 71, 
5023. 	  
98 (a) Vorobyeba, D. V.; Sokolova, N. V.; Nenajdenko, V. G.; Peregudov, A. S.; Osipov, S. N. Tetrahedron, 2012, 68, 872. 
(b) Vorobyeba, D. V.; Karimova, N. M.; Odinets, I. L.; Röschenthaler, G.-V.; Osipov, S. N. Org. Biomol. Chem. 2011, 9, 
7335. (c) Shchetnikov, G. T.; Peregudov, A. S.; Osipov, S. N. Synlett, 2007, 136.  
99 Shchetnikov, G. T.; Zotova, M. A.; Bruneau, C.; Dixneuf, P. H.; Osipov, S. N. Eur. J. Org. Chem. 2010, 1587.  
100 Shchetnikov, G. T.; Osipov, S. N.; Bruneau, C.; Dixneuf, P. H. Synlett, 2008, 578.	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Pleasantly, we found suitable conditions to access to these templates (2.21) in an efficient 
manner. This methodology was based on the addition of propargyl zinc to the corresponding 
fluorinated α-imino esters 2.20, employing DMF such as solvent, under Barbier-type conditions 
(Scheme 2.13).101  
 
 
 
Given the new activation modes of alkynes promoted by gold, besides its peculiar reactivity, 
we envisioned the possibility of performing a differential reactivity of those amino esters in the 
presence of gold salts, just by changing the substitution pattern on the nitrogen atom;102 thus, leading 
access to new families of fluorinated N-heterocycles (Scheme 2.14).  
                                                       
101 Following conditions developed by Bonnet-Delpon et al.: Magueur, G.; Legros, J.; Meyer, F.; Ourévitch, M.; Crousse, B.; 
Bonnet-Delpon, D. Eur. J. Org. Chem. 2005, 1258.   
102 For a previous example of switching the pathway when placing a substituent on the amine group, see: Hashmi, A. S. K.; 
Molinari, L.; Rominger, F.; Oeser, T. Eur. J. Org. Chem. 2011, 2256.  
Scheme 2.12. Reactivity of fluorinated homopropargyl amines (Osipov).
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Hence, we could expect that with substrates containing an aromatic substituent, a 
hydroamination-type process would occur. However, the blockage of the amine group by alkylation 
would avoid the hydroamination step, and a hydroarylation-type process could be expected instead. 
Finally, if the nitrogen substituent is protected as a carbamate or an amide, in the presence of an 
appropriate gold catalyst, we hypothesize that the reaction would start by attack of the carbonyl 
oxygen atom onto the activated triple bond.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Au
Scheme 2.14. Outline: differential reactivity.
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2.3. Results and discussion.  
2.3.1. Gold-catalyzed tandem hydroamination-formal aza-Diels Alder reaction.  
 
Given this perspective, we firstly envisioned the access to a new family of fluorinated proline 
derivatives by means of an intramolecular hydroamination reaction. Along this search, we found that 
substrates containing aromatic groups evolved in a tandem hydroamination-formal aza-Diels Alder 
cascade reaction (Scheme 2.15a), generating tetracyclic frameworks 2.22 in a single step.103  
 
                                                       
103 This work was developed along with Dr. Paula Bello: (a) Fustero, S.; Bello, P.; Miró, J.; Sánchez-Roselló, M.; Maestro, 
M. A.; González, J.; del Pozo, C. Chem. Commun. 2013, 49, 1336. This one and the herein presented work inspired Liu and 
coworkers to further extend this protocol and develop an enantioselective version: (b) Yu, X.-L.; Kuang, L.; Chen, S.; Zhu, 
X.-L.; Li, Z.-L.; Tan, B.; Liu, X.-Y. ACS Catal. 2016, 6, 6182. (c) Ma, C.-L.; Li, X.-H; Yu, X.-L; Zhu, X.-L.; Hu, Y.-Z.; 
Dong, X.-W.; Tan, B.; Liu, X.-Y. Org. Chem. Front. 2016, 3, 324.  
Scheme 2.15. (a) Our previous work: tandem hydroamination-formal aza-Diels Alder reaction. (b) Natural 
octahydro-dipyrroloquinoline alkaloids.
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In the overall process, the simultaneous generation of four new bonds and three stereocenters 
occurred, giving rise to the final products as single diastereoisomers. Notably, the accessed octahydro-
dipyrroloquinoline framework is found in a wide range of biologically active alkaloid natural products 
such as incargranine B and seneciobipyrrolidine (Scheme 2.15b).  
The initial results of the tandem process showed that several fluorinated and non-fluorinated 
starting amino esters 2.21 were compatible with the tandem protocol. Besides, this reaction was very 
efficient when the aryl substituent on the nitrogen atom is a PMP (para-methoxyphenyl) group; 
however, attempts to extend the tandem protocol to starting substrates containing other aromatic 
groups with different electronic properties were ineffective, leading to a dramatic decrease in the 
product yields.  
When fluorinated propargyl amino ester 2.21a was treated with Au(PPh3)Cl and AgOTf in 
toluene at room temperature, tetracyclic compound 2.22a was obtained in 76% yield, together with a 
small amount (13% yield) of the hydroamination product 2.23a (Scheme 2.16). With substrate 2.21b, 
bearing a para-tolyl group, an equimolecular amount of 2.22b and the hydroamination product 2.23b 
were obtained; whereas with substrate 2.21c, which contained an unsubstituted phenyl group at the N-
terminus, the hydroamination product 2.23c was the major product (64% yield).  
 
 
 
In order to gain some insights into the mechanistic details of this transformation,104  a 
theoretical study using the Density-Functional Theory (DFT) was carried out.105 In the aforementioned 
Au(I)-mediated cascade reaction, Au(PPh3)OTf was assumed to be the catalytically active species and 
the complex [Me3PAu]+ was used as a model in the theoretical study.106 Full methodological details of 
this theoretical study are shown in the Experimental Section 2.5.1.5.  
                                                       
104 Hashmi, A. S. K. Angew. Chem. Int. Ed. 2010, 49, 5232.  
105 Theorethical calculations were carried out by Dr. J. González from Universidad de Oviedo.   
106 For a theoretical study on the nature of the catalytically active species in Au(I)-mediated reactions, see: Kovács, G.; 
Ujaque, G.; Lledós, A. J. Am. Chem. Soc. 2008, 130, 853.  
Scheme 2.16. Au(I)-mediated tandem protocol with amines 2.21a-c.
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Based on the results of these calculations, we propose a plausible mechanistic explanation for 
the formation of the tetracyclic structures 2.22, involving an initial hydroamination reaction followed 
by an asymmetric dimerization pathway. The full process, which can be viewed as a Povarov-type 
reaction, is depicted in Scheme 2.17 and Scheme 2.18.107  
The initial step is the activation of the alkyne moiety of substrate 2.21a through the 
coordination of the gold catalyst, which acts as a π-Lewis acid, with the triple bond. This step has a 
negligible energy barrier and proceeds to give complex I, which is 16.6 kcal·mol-1 more stable than 
the reactants. Cyclic intermediate A is then formed by the attack of the amine nitrogen atom on the 
triple bond in a favored 5-endo-dig cyclization.108 Then, intermediate A releases a proton, which leads 
to the formation of triflic acid and intermediate B, which in turn reacts with this released triflic acid 
molecule to give two diastereomeric iminium salts, Csyn and Canti. Intermediates C undergo now 
deauration to lead enamine derivative 2.23a, whereas the catalyst Au(Ln)OTf is regenerated.  
 
 
 
 
 
 
 
                                                       
107 Only the intermediates with relative configuration that lead to the experimentally observed product are represented. For a 
related gold-catalyzed Povarov-type reaction further developed in our lab involving fluorinated α-imino esters and furans, 
see: Sanz-Vidal, A.; Miró, J.; Sánchez-Roselló, M.; del Pozo, C.; Fustero, C. J. Org. Chem. 2016, 81, 6515.  
108 For a review on Baldwin’s rules in alkynes’ cyclization reactions, see: Gilmore, K.; Alabugin, I. V. Chem. Rev. 2011, 111, 
6513.  
AuLn
Scheme 2.17. Mechanistic proposal (first stage).
LnAuCl 
AgOTf 
-AgCl
NH
F3C
EtO2C
PMP
NH
F3C
EtO2C
PMP
N
F3C
EtO2C
PMP
AuLn
HTS1
TfO-
TfOH
TS2
N
F3C
EtO2C
PMP
AuLn TfOH
TfO-
TS4
N
F3C
EtO2C
PMP
TS3
H
AuLn
N
F3C
EtO2C
PMP
AuLn
H
TfO- 
-LnAuOTf
N
F3C
EtO2C
PMP
TS6
TS5
A
B
Csyn
Canti
2.23a
I2.21a
	  	  58 
The most relevant geometrical and energetic features of the stationary points that were found 
for the transformation of compound 2.21a into intermediates C and 2.23a are depicted in Figure 
2.1.109  
 
 
 
 
Complex I, corresponding to alkyne’s activation by gold, shows an asymmetric coordination 
of the [AuPMe3]+ complex to the triple blond, and the C–C bond length is slightly increased (1.230 Å 
vs 1.208 Å in 2.21a). Transition state TS1 shows one imaginary vibrational frequency with a normal 
mode that corresponds to the formation of the N–C bond in a hydroamination process. The distance 
between the two carbon atoms, which initially corresponds to a triple bond, increases from 1.208 Å in 
2.21a up to 2.264 Å in TS1. Transition state TS2, involved in the deprotonation of intermediate A, 
shows an imaginary normal mode that corresponds to the proton transfer from the nitrogen atom of A 
to the oxygen atom of the triflate anion, then leading to the formation of intermediate B. As can be 
seen from the values of the N–H (1.420 Å) and O–H (1.129 Å) bond lengths in TS2, the proton has 
already been transferred from the nitrogen atom of A to the oxygen atom of the triflate. The activation 
Gibbs free energy for each of these reactions was calculated to be 11.5 and 0.2 kcal·mol-1, 
respectively.  
The reaction at the β-position of the enamine intermediate B with triflic acid, which gives rise 
to the diastereoisomeric iminium intermediates Csyn and Canti, takes place through two possible 
transition states, TS3 or TS4, depending on the stereochemistry of the proton addition. The imaginary 
normal mode in these transition states involves both the proton transfer and the shortening of the N–C 
bond. TS3, which gives rise to intermediate Csyn, presents an activation barrier of 2.3 kcal·mol-1; 
                                                       
109 Lengths are in Å and Gibbs free energies in kcal·mol-1.  
Figure 2.1. Stationary points located for the cyclization reaction of 2.21a, leading to intermediates Csyn and Canti.
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whereas TS4, which renders intermediate Canti, is predicted to be 1.3 kcal·mol-1 less stable than TS3. 
On the other hand, levels of stability for both intermediates, Csyn and Canti, are similar, being this later 
slightly favored (0.3 kcal·mol-1).  
The stationary points for the deauration reaction of these intermediates are shown in Figure 
2.2.109 In this step, the hydroamination product 2.23a is formed and the catalytically active species 
Au(Ln)OTf is regenerated. Product 2.23a can be formed from either Csyn or Canti via TS5 and TS6, 
respectively. The imaginary normal mode in these transition states corresponds to the Au–O bond 
formation and the C–Au bond cleavage, as might be expected from nucleophilic attack of the triflate 
anion onto the AuL moiety. Deauration step from both Csyn and Canti intermediates is slightly 
endothermic (-15.4 and -17.0 kcal·mol-1), with activation barriers of 14.5 and 13.2 kcal·mol-1.  
 
 
 
 
After the hydroamination step, an asymmetric dimerization pathway involving 
hydroamination product 2.23a and either of the iminium intermediates C, accounts for the formation 
of the tetracyclic skeleton (Scheme 2.18). Since both the nucleophilic carbon atom of 2.23a and the 
electrophilic iminium carbon atom of C are prochiral, addition could lead to the formation of up to 
eight diastereoisomers of intermediate D (4 from Csyn and 4 from Canti). Then, a new enamine attack, 
but in an intramolecular fashion through the ortho position of the PMP ring, builds the tetracyclic 
skeleton (intermediate E). Overall, these last two steps may be considered together as a formal, step-
wise aza-Diels Alder reaction. The triflate-promoted re-aromatization of E gives rise to intermediate F 
and triflic acid, which in turn will participate in the protodeauration of F to form the final product 
2.22a.  
 
Figure 2.2. Stationary points for the deauration reaction that leads to intermediate 2.23a, and Au(PPh3)OTf.
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According to the experimental evidence, the tetracyclic structures 2.22a were obtained in most 
cases as single diastereoisomers, attesting for a high level of facial stereoselectivity in the addition of 
2.23a onto iminium intermediate C. In Figure 2.3109 are depicted the four reaction pathways with 
lowest Gibbs free energies for the transformation of 2.23a into tetracyclic intermediate E.  
For the reaction of 2.23a with Canti or Csyn, the lowest Gibbs free energies for the first enamine 
attack are 27.6 (TS17), 28.2 (TS7), 29.6 (TS9), and 31.9 kcal·mol-1 (TS13). For TS17 and TS9, 
intermediates D6 and D2 are not very stable (26.3 and 29.2 kcal·mol-1), so they can easily revert back 
towards the reactants. On the other hand, intermediate D1 is 3.2 kcal·mol-1 more stable than TS7. 
However, the Gibbs free energy for the cyclization step via TS8 is very high (37.5 kcal·mol-1). The 
reaction of 2.23a with Canti with a relative Si/Si approach appears as the more energetically favorable 
pathway, yielding intermediate E4 preferentially.  
Examination of the geometry of the transition state structures (TS7, TS9, TS13, TS17) and the 
corresponding intermediates (D1, D2, D4, D6) helps to shed some light on the origin of the observed 
stereochemical outcome. In D1 and D4, the more stable intermediates, the trifluoromethyl groups 
appear in an anti relative disposition, which minimizes the steric interactions. Besides, the steric effect 
of the trifluoromethyl group appears to strongly destabilize the transition state structure TS8 relative 
to TS14. The combination of these two steric effects explains the selective formation of intermediate 
E4 and the observed diastereisomer of final product 2.22a.  
 
Scheme 2.18. Mechanistic proposal (second stage).
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Considering this computational mechanistic study, the key step for the success of the tandem 
process is enamine attack of pyrroline 2.23 to the iminium functionality of Canti. As the 
hydroamination product 2.23a arises from the deauration of Canti, a low rate of reaction is required in 
this step to increase the effective concentration of intermediate Canti, enabling its reaction with 2.23a.  
Additional experiments were performed to provide further evidence for the mechanistic 
pathway proposed above. For instance, the formal aza-Diels Alder reaction might be further promoted 
by the triflic acid instead of gold. Several authors have suggested that hydroamination products 
analogous to 2.23a could be protonated by triflic acid, which would give rise to iminium intermediates 
Figure 2.3. Stationary points located for the addition reaction of 2.23a to intermediates C, with the spe-
cification of the reaction stereochemistry.
Csyn-si + 2.23a-si Canti-re + 2.23a-re Canti-re + 2.23a-si Canti-si + 2.23a-si 
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of type C, thus initiating a dimerization protocol.110 Likewise, it is well known that gold itself can 
activate enamines and enol ethers for the nucleophilic attack.111 To prove our mechanistic proposal, 
substrate 2.23a was independently treated with Au(PPh3)OTf (Scheme 2.19a, conditions A), triflic acid 
(Scheme 2.19a, conditions B), and silver triflate (Scheme 2.19a, conditions C). In all cases, the starting 
material remained unaltered, even when the reaction was heated up to 80 ºC for several hours.  
 
 
 
Alternatively, hydroamination reactions can also be promoted by Brönsted acids;112 therefore, 
triflic acid could be the catalyst of the tandem protocol. However, no reaction was observed when 
compound 2.21a was treated with triflic acid in toluene after 24 h at room temperature (Scheme 
2.19b); therefore, TfOH is not the catalyst of the process. These observations are in agreement with 
                                                       
110 Similar mechanistic outcomes were simultaneously reported: (a) Galván, A.; Calleja, J.; Fañanás, F. J.; Rodríguez, F. 
Angew. Chem. Int. Ed. 2013, 52, 6038. (b) Ref. 97c: Yu, Y.-F.; Shu, C.; Shen, C.-H.; Li, T.-Y.; Ye, L.-W. Chem. Asian J. 
2013, 8, 2920.  
111 For some representative examples, see: (a) Goutham, K.; Rao Mangina, N. S. V. M.; Suresh, S.; Raghavaiah, P.; 
Karunakar, G. V. Org. Biomol. Chem. 2014, 12, 2869. (b) Chiarucci, M.; di Lillo, M.; Romaniello, A.; Cozzi, P. G. Cera, G.; 
Bandini, M. Chem. Sci. 2012, 3, 2859. (c) Kozak, J. A.; Patrick, B. O.; Dake, G. R. J. Org. Chem. 2010, 75, 8585. (d) Saito, 
A.; Yang, T.; Ferrali, A.; Campbell, L.; Dixon, D. J. Chem. Commun. 2008, 2923.  
112 (a) Zhang, J.; Yang, C.-G.; He, C. J. Am. Chem. Soc. 2006, 128, 1798. (b) Li, Z.; Zhang, J.; Brouver, C.; Yang, C.-G.; 
Reich, N. W.; He, C. Org. Lett. 2006, 8, 4175. (c) Rosenfeld, D. C.; Shekhar, S.; Takemiya, A.; Utsunomiya, M.; Hartwig, J. 
F. Org. Lett. 2006, 8, 4179. (d) Miura, K.; Hosomi, A. Synlett, 2003, 143.  
Scheme 2.19. Mechanistic insights.
N
PMP
EtO2C
F3C (A) Au(PPh3)OTf, toluene or DCM, rt 
(B) TfOH, toluene, rt or 80 ºC 
(C) AgOTf, toluene, rt
no reaction
F3C
HN
CO2Et
PMP 10 mol% TfOH
toluene, rt
no reaction
F3C
HN
CO2Et
PMP
N
P
N
Me
Me
NEt2
NtBu
BEMP cat. 
5 mol% Au(PPh3)Cl, 5 mol% AgOTf 
toluene, rt
non-poisoning base
BEMP
N
N
PMP
OMe
EtO2C
F3C
H
H
H
CO2Et
CF3
22% conversion (1 mol% BEMP) 
not observed (10 mol% BEMP)
(a)
(b)
(c)
2.23a
2.21a
2.21a 2.22a
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the relevance of intermediate C in the tandem process and corroborate that the hydroamination 
product, by itself, does not undergo the tandem protocol.  
In addition, compound 2.21a was subjected to the reaction conditions in the presence of 
BEMP (2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine), a non-
poisoning base. In the presence of 10 mol% BEMP and 5 mol% Au(PPh3)OTf, the reaction did not 
proceed and the starting material was recovered unaltered (Scheme 2.19c). With 1 mol% BEMP and 5 
mol% Au(PPh3)OTf, the rate of the reaction was slowed, and after 20 h at room temperature only 22% 
conversion was reached (Scheme 2.19c). The former experiment, with 10 mol% BEMP, indicates that 
all the triflic acid necessary to close the catalytic cycle is captured by this strong phosphazene base, 
which inhibits the tandem sequence. However, with 1 mol% BEMP, the tandem process is diminished 
but not eliminated at all. As the catalytic activity of gold is diminished but not eliminated, an 
alternative mechanism where gold species act as a Brönsted acid instead of a Lewis acid to catalyze 
the formal aza-Diels Alder reaction cannot be overruled.113 Arguably, neither a Lewis acid-assisted 
Brönsted acid catalysis may be discarded.61a  
With these considerations and on the basis of the above-introduced categorization of gold-
catalyzed reactions reported by Bo Xu and Hammond (see Section 2.1.1),66a in the present case, 
deauration would be the rate-limiting step. The triflic acid present in the media, released during the 
generation of the catalytic gold species, will be partially neutralized by the amine; thus, decreasing the 
rate of the deauration step and favoring the tandem sequence.  
Additionally, in most of the isolated tetracycles 2.22, the aromatic amine functionality is 
flanked with two electron-withdrawing groups, which compromise the basicity of the amine. 
However, when the aromatic substituent at the nitrogen atom is the PMP group (2.21a), the electon-
donating properties of the methoxy group help to preserve the basicity on the nitrogen atom, which 
lowers the protodeauration rate, and this is subsequently translated into an improved ability for the 
tandem reaction to proceed. On the other hand, with less activated para-tolyl and phenyl groups 
(2.21b, 2.21c), the basicity of the amine decreases, which increases the rate of deauration and, in turn, 
diminishes the formation of the tandem products, i.e. intermolecular enamine attack is not fast enough 
to compete with deauration.  
According to the aforementioned studies of ligand effects on the kinetics of the deauration 
step, an electron-rich ligand should accelerate the deauration step. Conversely, electron-withdrawing 
ligands would decelerate it and, based on the previous mechanistic discussion, they would favour the 
tandem transformation.  
                                                       
113 The behavior of gold salts as Brönsted acids was previously invoked in gold-catalyzed processes: Yang, T.; Campbell, L; 
Dixon, D. J. J. Am. Chem. Soc. 2007, 129, 12070.  
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To test this hypothesis, substrate 2.21c was subjected to the tandem reaction conditions in the 
presence of gold complexes bearing electronically deficient ligands relative to triphenylphosphine 
(Table 2.1, entry 1).  
 
 
 
In the first attempt with ligand L1, we observed that, after 24 h, only 60% conversion was 
achieved. Nevertheless, the exclusive formation of tetracycles was detected, albeit as a mixture of 
diastereoisomers, in which the major compound was 2.22c, which was isolated in 47% yield (entry 2). 
The use of DCM as the solvent led to an unexpected increase in the reaction rate, with the reaction 
being completed in 1 h even at 0 ºC. In this case, the major isomer 2.22c was isolated in 72% yield 
together with <5% yield of the hydroamination product 2.23c (entry 3). Therefore, according to our 
Table 2.1. Exploration of ligand effects.
PPh3 
L1
L1 
L2
L2
L3
L3
L3
L4
L4
entry
 1
2
3
4
5
6
7
8
9
10
ligand
14%
47%b
72%
51% 
55%
48%
51%
58%
55% 
53%
yield 2.22ca
5 h
24 h 
1 h
12 h 
2 h 
1 h
2 h
2 h
24 h 
15 h
time
64% 
- 
<5%
<5% 
<5% 
<5%
<5% 
<5% 
<5%
<5%
yield 2.23c
toluene, 25 ºC 
toluene, 25 ºC  
DCM, 0 ºC  
toluene, 25 ºC 
DCM, 0 ºC
toluene, 25 ºC 
DCM, 0 ºC
toluene, 0 ºC 
toluene, 25 ºC 
DCM, 0 ºC
solvent, T
a Isolated yield of the major diastereoisomer. b 60% conversion.
P
R R
R
P
OO
O
tBu
tBu
tButBu
tBu
tBu
P
iPr
iPr
iPr
MeO
OMe
CF3
F3C
CF3
CF3
L1 (R = CF3) 
L2 (R = F) L3
L4
JackiePhos
F3C
HN
CO2Et
Ph
N
N
CF3
CO2Et
EtO2C
F3C
Ph
H
H
H
5 mol% Au(Ln)Cl 
5 mol% AgOTf 
solvent 0.05 M
2.21c 2.22c
N
Ph
CF3
CO2Et+
2.23c
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hypothesis, ligand L1 decreases the protodeauration rate, which favours the tandem process, albeit 
with some erosion of the selectivity, and minimizes the formation of the hydroamination product. 
Following the same reaction trend, the use of ligand L2, provided tetracycle 2.22c in 51% yield after 
12 h in toluene, with complete conversion being achieve in this case (entry 4). When DCM was used 
as the solvent and the reaction was performed at 0 ºC, 2.22c was isolated in 55% yield (entry 5). When 
ligand L3, which contains the phosphite unit with the most electron-deficient substituents, was used in 
the tandem reaction, either in toluene or in DCM, the reaction was completed in 2 h; however, these 
conditions did not improve the reaction yield (entries 6-8). Finally, the use of JackiePhos L4, afforded 
comparable results to L2 in terms of reaction time and yield, in either toluene or DCM (entries 9-10).  
We concluded that the optimum conditions to carry out the tandem process involved the use of 
ligand L1 in DCM at 0 ºC, when the amino ester substrates contain non-activated or deactivated 
aromatic substituents attached to the nitrogen. These conditions were applied to other homopropargyl 
amines 2.21 and the obtained results are summarized in Table 2.2.  
 
 
 
Table 2.2. Broadening the scope of the tandem protocol.a
F3C
HN
CO2Et
N
N
CF3
CO2Et
EtO2C
F3C
H
H
H
5 mol% Au(Ln)Cl 
5 mol% AgOTf 
solvent 0.05 M, 0 ºC
Ar
Ar
Ar
N
N
CF3
CO2Et
EtO2C
F3C
H
H
H
MeO
OMe
2.22a, 76% yield (PPh3, toluene)
N
N
CF3
CO2Et
EtO2C
F3C
H
H
H
Me
Me
2.22b, 68% yield (L1, DCM)
N
N
CF3
CO2Et
EtO2C
F3C
H
H
H
2.22c, 72% yield (L1, DCM)
N
N
CF3
CO2Et
EtO2C
F3C
H
H
H
MeS
SMe
2.22d, 65% yield (L1, DCM)
N
N
CF3
CO2Et
EtO2C
F3C
H
H
H
F
F
2.22e, 56% yield (L1, DCM)
N
N
CF3
CO2Et
EtO2C
F3C
H
H
H
2.22f, 57% yield (L1, DCM)
F3C
CF3
2.21,  0.20 mmol
a Isolated yields.
2.22
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Substrates 2.21b-f, bearing a variety of electron-donating and electron-withdrawing 
substitutents on the aromatic ring other than PMP, underwent the tandem protocol very efficiently to 
afford tetracycles 2.22b-f in good yields.  
In summary, the results from the experimental ligand study and the theoretical calculations, 
led us to identify suitable conditions to broaden the scope of our tandem protocol, just by changing the 
ligand on Au(I) and the solvent.114  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                       
114 Miró, J.; Sánchez-Roselló, M.; González, J.; del Pozo, C.; Fustero, S. Chem. Eur. J. 2015, 21, 5459.  
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2.3.2. Gold-catalyzed synthesis of fluorinated 1,2-dihydroquinoline derivatives.  
 
As it was mentioned above (Scheme 2.14), the blockage of the N–H bond of those aryl amines 
2.21 by alkylation would inhibit the aforementioned tandem sequence. Instead, a hydroarylation-type 
reaction would be expected.115 Nevertheless, the introduction of alkyl groups in compounds 2.21 
proved to be troublesome. This is probably due to the low nucleophilicity of the nitrogen atom, since 
the α-carbon contains two electron-withdrawing groups. After several attempts, only substrates 
containing a para-methoxyphenyl group were alkylated in synthetically useful yields (Table 2.3).  
 
 
 
Presumably, once again PMP group re-establishes the basicity of the nitrogen atom. Selected 
conditions involved the treatment of substrates 2.21 with benzyl bromide, using NaHCO3 as base with 
a catalytic amount of KI in acetonitrile, heating the reaction mixture in a sealed tube at 100 ºC for 5 
days. In this manner, benzylated propargyl amines 2.24 were isolated in moderate yields (Table 2.3).  
 
 
 
 
 
 
                                                       
115 For the first example of gold-catalyzed hydroarylation, see: Hashmi, A. S. K.; Schwarz, L.; Choi, J.-Y.; Frost, T. M. 
Angew. Chem. Int. Ed. 2000, 39, 2285.  
Table 2.3. Preparation of benzylated homopropargyl amino esters.a
RF
HN
CO2R
BnBr (3.0 equiv) 
NaHCO3 (5.0 equiv), 10 mol% KI 
MeCN 0.33 M, 100 ºC 
sealed tube, 5 days
OMe
RF
N
CO2R
OMe
Bn
F3C
N
CO2Et
OMe
Bn
2.24a, 92% yield (58% conv)
ClF2C
N
CO2Et
OMe
Bn
2.24b, 48% yield (39% conv)
PhF2C
N
CO2Et
OMe
Bn
2.24c, 72% yield (64% conv)
(allyl)F2C
N
CO2Bn
OMe
Bn
2.24d, 37% yield (53% conv)
2.21, 1.0 mmol
a Isolated yields.
2.24
	  	  68 
With these substrates in hand, compound 2.24a was used as a model substrate to evaluate its 
reactivity versus gold salts (Table 2.4).  
 
 
 
With AuCl and AuCl3 as the gold source, substrate 2.24a was inert (entries 1-2). The change 
to Au(PPh3)Cl was critical, and an equimolecular mixture of 2.25a and 2.26a was detected in 69% 
yield (entry 3), this later arising from the isomerization of the former hydroarylation product 2.25a. 
The use of other solvents and temperatures was traduced in an improvement of the 2.25a:2.26a ratio, 
but in detriment of the final yield (entries 4-6). Other silver salts again yielded a better 2.25a:2.26a 
ratio, but in moderate yields (entries 7-9). Finally, the influence of the gold species was evaluated 
Table 2.4. Optimization of the tandem hydroarylation-isomerization reaction.
AuCl 
AuCl3  
I
I 
I
I 
I 
I 
I 
II 
III 
IV 
V 
-
-
entry
 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Au catalyst
-
-
69%
48%
28%
38% 
45%
47%
30%
57%
40% 
41%
90% 
- 
-
yielda
24 h 
24 h 
4 h 
12 h 
10 h 
9 h 
24 h 
6 h 
4 h 
1 h 
1 h 
3 h 
0.5 h 
24 h 
24 h
time
-
-
1:1 
1:1 
1:4 
1:2 
1:1 
0:1 
0:1
0:1 
0:1
0:1 
0:1
-
-
ratio 
2.25a:2.26a
DCM, rt 
DCM, rt 
DCM, rt 
MeCN, 85 ºC 
MeOH, 65 ºC 
toluene, rt 
DCM, rt 
DCM, rt 
DCM, rt 
DCM, rt 
DCM, rt 
DCM, rt 
DCM, rt 
DCM, rt 
DCM, rt
solvent, T
a Isolated yield.
F3C
N
CO2Et
5 mol% Au catalyst  
5 mol% additive 
solvent
2.24a 2.25a
Bn
OMe
N
OMe
Bn
F3C CO2Et
2.26a
N
OMe
Bn
F3C CO2Et
Mehydroarylation isomerization
Au
Cl
NN
iPr
iPr
iPr
iPr
P
Ph
AuCl
tBu tBu
tBu
tBu
O
PAuCl
3
I, Au(PPh3)Cl
II, Au[P(4-CF3-C6H4)3]Cl
III, Au(IPr)Cl IV V
-
-
AgOTf 
AgOTf 
AgOTf 
AgOTf 
AgNTf2 
AgSbF6 
AgBF4 
AgOTf
AgOTf 
AgOTf
AgOTf 
AgOTf
TfOH
additive
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(entries 10-13). Among them, gold complex V, with a phosphite ligand, gave the best result in terms 
of yield and 2.25a:2.26a ratio (entry 13). Worthy to note, neither the silver salt itself, nor triflic acid, 
catalyze the process (entries 14-15).  
Optimized conditions were further extended to the rest of substrates 2.24, giving rise to a new 
family of fluorinated dihydroquinoline derivatives 2.26 (Table 2.5).  
 
 
 
To summarize, when starting amino esters bearing an aromatic substituent were benzylated at 
the nitrogen atom, the reaction with Au(I) species led to the formation of a new family of fluorinated 
dihydroquinolines 2.26 in a tandem hydroarylation-isomerization sequence.116  
 
 
 
 
 
 
 
 
 
 
                                                       
116 (a) Sánchez-Roselló, M.; Miró, J.; del Pozo, C.; Fustero, S. J. Fluorine Chem. 2015, 171, 60. A similar hydroarylation 
process with fluorinated propargyl amines was previously reported: (b) Zhu, M.; Fu, W.; Zou, G.; Xun, C.; Deng, D.; Ji, B. J. 
Fluorine Chem. 2012, 135, 195.  
Table 2.5. Gold-catalyzed tandem hydroarylation-isomerization scope.a
RF
N
CO2R
5 mol% Au catalyst V  
5 mol% AgOTf  
DCM, 0.5 h, rt
OMe
RF
N
CO2R
OMe
Bn
F3C
N
CO2Et
OMe
Bn
2.26a, 90% yield
ClF2C
N
CO2Et
OMe
Bn
2.26b, 91% yield
PhF2C
N
CO2Et
OMe
Bn
2.26c, 53% yield
(allyl)F2C
N
CO2Bn
OMe
Bn
2.26d, 75% yield
Bn
Me
Me Me Me Me
2.24, 0.12 mmol
a Isolated yields.
2.26
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2.3.3. Gold-catalyzed O-addition with concomitant loss of isobutene.  
 
We then synthesized the corresponding starting materials bearing a carbamate as the nitrogen 
protecting group (Scheme 2.20). Ketoesters 2.27 were treated with Boc-phosphazene 2.28 to render the 
corresponding N-Boc-imino esters 2.29 that were propargylated in situ, without further purification, to 
avoid decomposition.  
 
 
Using compound 2.29a as model substrate, we tested its reactivity versus gold species (Table 
2.6). First attempts with AuCl and AuCl3, provided moderate yields of a six membered-ring carbamate 
2.30a with an exocyclic double bond (entries 1-2), derived from the carbonyl addition over the 
activated triple bond with concomitant loss of the tert-butyl moiety as isobutene (Scheme 2.21), i.e. the 
same reactivity pattern shown by its non-fluorinated counterparts.97k 
 
 
 
Scheme 2.20. Preparation of starting N-Boc-propargyl amino esters.
RF CO2Et
O
RF CO2Et
N
Boc
RF
HN
Boc
CO2Et
N
PPh3
Boc
toluene, 80 ºC  
overnight
activated Zn 
propargyl bromide 
DMF
2.29a, RF = CF3, 66% yield
2.29b, RF = CF2Ph, 56% yield 
2.29c, RF = CF2Bn, 67% yield 
2.29d, RF = CF2(allyl), 70% yield
2.27 2.28
Au(PPh3)
Scheme 2.21. Proposed mechanism.
Au(PPh3)OTf
RF
HN
CO2Et
OtBu
O
RF
HN
CO2Et
Boc
N O
O
Au(PPh3)
H
Me Me
H
RF CO2Et
HN O
O
Au(PPh3)
RF CO2Et
HN O
O
RF CO2Et
TfO-
TfOH +
Me
Me
TfOH
2.29
2.30
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A significant improvement was observed with Au(PPh3)Cl, giving rise to 2.30a in 71% yield 
in only 30 min (entry 3). The yield increased up to 91% when the reaction was performed in toluene 
(entry 5). The use of other gold species (entries 6-7) or other silver salts (entries 8-10) did not improve 
the efficiency of the reaction.  
 
 
Optimized condition were further extended to the rest of substrates 2.29, giving rise to a small 
family of fluorinated oxazinanone derivatives 2.30 (Table 2.7).116a  
 
Table 2.6. Optimization of the gold-mediated carbonyl addition.
AuCl 
AuCl3
Au(PPh3)Cl
Au(PPh3)Cl
Au(PPh3)Cl  
IV
VI
Au(PPh3)Cl
Au(PPh3)Cl
Au(PPh3)Cl
entry
 1
2
3
4
5
6
7
8
9
10
Au catalyst
58%
35%
71%
56%
91%
63% 
73%
71%
80%
37%
yielda
20 h 
20 h 
0.5 h 
20 h 
0.5 h 
20 h 
0.5 h 
1 h 
1 h 
20 h
time
DCM, rt 
DCM, rt 
DCM, 0 ºC 
MeCN, rt 
toluene, 0 ºC 
toluene, 0 ºC 
toluene, 0 ºC 
toluene, 0 ºC 
toluene, 0 ºC 
toluene, rt
solvent, T
a Isolated yield.
F3C
HN
CO2Et
Boc
5 mol% Au catalyst  
5 mol% additive 
solvent 0.05 M
2.29a 2.30a
HN O
O
F3C CO2Et
P
Ph
AuCl
tBu tBu
IV
-
-
AgOTf 
AgOTf 
AgOTf 
AgOTf 
AgOTf
AgNTf2 
AgSbF6 
AgBF4
additive
P
tBu tBu
VI
MeO
MeO
AuCl
Table 2.7. Scope of the gold-catalyzed cyclization.a
RF
HN
CO2Et
Boc
5 mol% Au(PPh3)Cl  
5 mol% AgOTf  
toluene 0.05 M, 0.5 h, 0 ºC RF
HN
CO2Et
O
O
F3C
HN
CO2Et
O
O
2.30a, 91% yield
PhF2C
HN
CO2Et
O
O
2.30b, 88% yield
BnF2C
HN
CO2Et
O
O
2.30c, 71% yield
(allyl)F2C
HN
CO2Et
O
O
2.30d, 77% yield
2.29, 0.20 mmol
a Isolated yields.
2.30
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The next step of our study was an asymmetric version of this sequence (Scheme 2.22). To this 
end, para-toluenesulfinyl amide was used as chiral auxiliary. Thus, ethyl trifluoropyruvate was 
subjected to an aza-Wittig reaction with chiral phosphazene 2.31. The corresponding imino ester 2.32 
was treated in situ with propargyl bromide and activated zinc in DMF under Barbier-type conditions. 
The addition of propargyl zinc was completely selective, affording homopropargyl sulfinyl amine 2.33 
as a single diastereoisomer. Chiral auxiliary was removed and nitrogen reprotected with Boc to obtain 
the enantiomerically pure substrate (S)-(+)-2.29a. When 2.29a was subjected to the optimized reaction 
conditions, the corresponding carbamate (S)-(-)-2.30a was obtained in excellent yield (Scheme 2.22a). 
Absolute configuration of the newly created stereocenter could be determined by X-ray analysis of the 
corresponding acetyl derivative 2.34a, in turn obtained from sulfinyl amine 2.33 (Scheme 2.22b). The 
observed selectivity can be rationalized assuming the transition state depicted in Scheme 2.22c, in 
analogy with either proposed by Yus and Foubelo,117 where zinc is doubly chelated.  
 
 
 
                                                       
117 García-Muñoz, M. J.; Zacconi, F.; Foubelo, F.; Yus, M. Eur. J. Org. Chem. 2013, 1287.  
Scheme 2.22. (a) Asymmetric preparation of oxazine (S)-(-)-2.30a. (b) Absolute configuration. (c) Pro-
posed transition state.
F3C CO2Et
O
F3C CO2Et
N
SOpTol
F3C
HN
SOpTol
CO2Et
N
PPh3
SOpTol
toluene, 80 ºC, 12 h
activated Zn
propargyl bromide
 
DMF, 0 ºC
2.33, 56% yield, 99:1 dr
1) HCl/dioxane, 2 h, rt 
2) (Boc)2O (20 equiv), 
DMAP (5 equiv), 1 h, rt
F3C
HN
Boc
CO2Et
(S)-(+)-2.29a, 80% yield
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5 mol% AgOTf 
toluene, 0 ºC, 0.5 h F3C
HN
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(b)
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2.3.4. Tandem gold self-relay catalysis for the synthesis of dihydropyridinones. Combining σ  
and π  Lewis acid properties of gold species.  
 
Tert-butyl carbamate derivatives 2.29 can be easily converted into the corresponding 
homopropargyl amides 2.34, giving access to a new candidate ready to extend our differential 
reactivity study. Compound 2.34a was used as a model substrate to evaluate the reactivity towards 
gold species (Table 2.8).  
 
 
 
Initially, we treated substrate 2.34a with AuCl3 in DCM at room temperature. Oxazine 2.35a, 
which arises from the addition of the carbonyl group to the triple bond according to the “classical” 
reactivity imparted by gold salts as soft π-carbophilic Lewis acids,118 was obtained after 24 hours in 
40% yield, besides 40% of 2.36a, which comes from the hydration of the alkyne (entry 1). Similar 
results were obtained with AuCl (entry 2). However, the use of Au(PPh3)Cl in combination with 
AgOTf, led to a drastic decrease in reaction time. Total consumption of the starting material was 
observed after 3 hours, and oxazine 2.35a was isolated in 57% yield, again with the acetyl derivative 
                                                       
118 For a preceding example of gold-catalyzed oxazine synthesis, see: Hashmi, A. S. K.; Schuster, A. M.; Litters, S.; 
Rominger, F.; Pernpointner, M. Chem. Eur. J. 2011, 17, 5661.  
Table 2.8. Reactivity of homopropargyl acetamide 2.34a vs Au species.a
AuCl3 
AuCl
Au(PPh3)Cl
Au(PPh3)Cl
Au(PPh3)Cl  
-
-
Au(PPh3)Cl
Au(PPh3)Cl
Au(PPh3)Cl
Au(PPh3)Cl
AuCl
entry
 1
2
3
4
5
6
7
8
9
10
11
12
Au catalyst
40%
37%
57%
50%
73(83)%b
- 
-
25%c
35%c
-
-
-
2.35a yield
24 h 
24 h 
3 h 
6 h 
3 h 
24 h 
24 h 
24 h 
22 h 
3 h
5 h
24 h
time
DCM 
DCM 
DCM 
DCM
DCM
DCM
DCM 
toluene
MeCN
MeOH
MeOH
MeOH
solvent
a Isolated yields. b Yield determined by GC-MS in brackets. c Incomplete conversion.
F3C
HN
CO2Et
5 mol% Au catalyst  
5 mol% additive 
solvent 0.05 M, rt
2.34a 2.35a
N O
F3C CO2Et
-
-
AgOTf 
AgNTf2 
AgOTf  + 3 A MS
AgOTf
TfOH
AgOTf
AgOTf
AgOTf
AgNTf2 
-
additive
Me
O
Me
2.36a
HN
Ac
Ac
F3C CO2Et
2.37a
HN
F3C CO2Et
O
Me
40%
35%
30%
30%
-
- 
-
35%
34%
-
-
33%
2.36a yield
-
-
-
-
-
-
-
-
-
93%
87%
47%
2.37a yield
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2.36a (entry 3). The use of different silver salts led to comparable results (entry 4). At this point, it is 
important to mention that TLC (thin-layer chromatography) analysis revealed that product 2.36a was 
derived from oxazine 2.35a and it can be assumed to be formed from traces of water present in the 
reaction medium. The addition of molecular sieves 3 Å was enough to avoid hydrolysis, leading to a 
significant improvement in final yield (entry 5). Although the yield determined by GC-MS was 83%, 
the yield of the isolated oxazine 2.35a was 72%, thus indicating that this compound is labile and 
decomposes during purification. Substrate 2.34a was inert either in the presence of the silver salt or 
triflic acid, thus indicating the role of gold in catalyzing the reaction (entries 6-7). We then evaluated 
the effect of solvent. The use of toluene or acetonitrile diminished efficiency of the process (entries 8-
9). However, the use of methanol gave a surprising result, in which the exclusive formation of 
dihydropyridinone 2.37a was observed in excellent yield after 3 hours (entry 10). The use of silver 
triflimide gave comparable results, although with longer reaction times (entry 11). On the other hand, 
it took 24 h to complete the process when AuCl was used in methanol (entry 12). Moreover, in this 
case, dihydropyridinone 2.37a was obtained besides 2.36a.  
Notably, accessed dihydropyridinone 2.37a appears as a novel fluorinated analogous of the 
non-proteinogenic pipecolic acid. Furthermore, piperidine scaffold is a structural motif present in a 
large variety of biologically active natural alkaloids and drugs.119 Several methodologies have been 
published giving access to this skeleton. In fact, later reported strategies are based on gold-catalyzed 
transformations. 
For instance, the Zhang group developed a one-pot synthesis of 4-piperidinones via a formal 
[4+2] cycloaddition (Scheme 2.23).120  Once nitrone A is generated, gold catalyst promotes O-
transference over the triple bond, rendering 4-piperidinone 2.39 after cycloisomerization.  
 
 
                                                       
119 (a) Comins, D. L.; O’Connor, S.; Al-awar, R. S. In Comprehensive Heterocyclic Chemistry III, (Eds: R. K. Alan, A. R. 
Christopher, F. V. S. Eric, J. K. T. Richard), ELSEVIER: Oxford, 2008; p 41. (b) Buffat, M. G. P. Tetrahedron, 2004, 60, 
1701. (c) Weintraub, P. M.; Sabol, J. S.; Kane, J. M.; Borcherding, D. R. Tetrahedron, 2003, 59, 2953.  
120 Cui, L.; Peng, Y.; Zhang, L. J. Am. Chem. Soc. 2009, 131, 8394.  
Au+
Scheme 2.23. Previous work by Zhang (2009).
R1
NH
R2
OTs
(  )n+ N
R2
R1 O
(  )n
1) NaHCO3, NaI, MeCN, reflux, 12-36 h
2) mCPBA, 4 A MS, 0 ºC, 1 h 
3) 5 mol% LnAuNTf2
n = 1, Ln = PPh3 
n = 2, Ln = PCy2(2-biphenyl)
R1
N
R2
(  )n
O
N (  )n
R2
R1[O] N (  )n
R2
R1
O
Au
N
R2
O
Au+
H
R1 (  )n N
O
Au
(  )n
R2
R1
2.39
2.38 A B C D
	  Au
75 	  
Alongside, Rhee demonstrated these heterocycles (2.42) were also readily accessible by means 
of a gold-catalyzed formal aza-Prins cyclization over mixed acetals 2.40 derived from homopropargyl 
amines (Scheme 2.24).97j  
 
 
 
In 2011, Gouault et al. described the preparation of enantioenriched dihydropyridinones 2.44 
by means of an intramolecular hydroamination reaction starting from chiral β-amino ynones 2.43 
(Scheme 2.25).121  
 
 
 
On the other hand, Zhang and coworkers reported that the alkyne moiety of N-homopropargyl 
amides 2.45 can be activated by gold, thus promoting addition of a carbonyl group to furnish the 
oxazine skeleton A. Furthermore, due to their high lability, these compounds were reduced in situ with 
catecholborane to the hemiaminal B, which in turn underwent a spontaneous aza-Petasis-Ferrier 
rearrangement, rendering piperidinones D and final reduction to the corresponding 4-piperidinols 2.46 
(Scheme 2.26).97i  
 
                                                       
121 Gouault, N.; Le Roch, M.; Cheignon, A.; Uriac, P.; David, M. Org. Lett. 2011, 13, 4371.  
Scheme 2.24. Previous work by Rhee (2009).
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They further extended this methodology to alternative nucleophiles instead of hydride. 
Moreover, the installation of the nucleophile over the amide group, enabled the preparation of bicyclic 
piperidinones 2.48.97e Better results were obtained using indoles such as nucleophiles and formyl 
amides in order to minimize steric effects towards nucleophilic attack (Scheme 2.27).  
 
 
Scheme 2.26. Previous work by Zhang (2010).
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Among reported gold-catalyzed reactions to access to this piperidine scaffold, our 
autocatalysis proposal fulfils the principle of synthetic efficiency.  
With these results, we then decided to survey the scope of the process (Table 2.9).  
 
 
 
Thus, when homopropargyl amides 2.34 were treated with Au(PPh3)Cl in combination with 
AgOTf in DCM in the presence of molecular sieves, a clean formation of oxazines 2.35 was observed. 
Given their readily hydrolysis, these compounds partially decompose during purification, but was 
possible to obtain good yields of the isolated products. Hydrolysis of oxazines 2.35 took place in 
almost quantitative yields in all cases to render the formal alkyne’s hydration products 2.36. We might 
say that triple bond’s hydration is assisted by the carbonyl moiety, throughout oxazine’s formation and 
subsequent hydrolysis. As mentioned above, the solvent played a crucial role in the process, and the 
exclusive formation of dihydropyridinones 2.37 in MeOH was observed in good to excellent yields.  
Table 2.9. Preparation of oxazines 2.35, acetyl derivatives 2.36, and dihydropyridinones 2.37.a,b
CF3 
CF2Ph 
CF2Bn 
CF2(allyl) 
CF3 
Ph 
CF3 
Ph
entry
 1
2
3
4
5
6
7
8
2.35a, 72(83)%
2.35b, 70(86)%
2.35c, 80(94)%
2.35d, 88(98)%
2.35e, 61(95)%
2.35f, 76%
2.35g, 74%
-e
2.35 yield
Me 
Me 
Me 
Me 
Et 
Me 
Me 
Me
a Isolated yields. b Yield determined by GC-MS is given in brackets. c The formation of 28%
of 2.36e was also observed. d Hydrolysis required the addition of 5 mol% of Au(PPh3)-
Cl to activate oxazine 2.35g. e The substrate remained unaltered in MeOH.
R1
HN
R2
5 mol% Au(PPh3)Cl 
5 mol% AgOTf 
MeOH 0.05 M, rt, 4 h
2.35
N O
R1
R2
CO2Et 
CO2Et 
CO2Et 
CO2Et 
CO2Et 
CO2Et 
Ph 
H
R3
O
R3
2.36
HN
Ac
R1
R2
2.37
HN
R1
R2
O
R3
5 mol% Au(PPh3)Cl 
5 mol% AgOTf 
DCM 0.05 M, 3 A MS, rt
H2O, rt
R3
O
R1 R2 R3
2.36a, 99%
2.36b, 99%
2.36c, 99%
2.36d, 99%
2.36e, 99%
2.36f, 84%
2.36g, 99%d
-
2.36 yield
2.37a, 93%
2.37b, 93%
2.37c, 80%
2.37d, 94%
2.37e, 70%c
2.37f, 75%
2.37g, 76%d
-
2.37 yield
2.34
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Thus, this protocol was extensive to both fluorinated (entries 1-5) and non-fluorinated (entry 
6) ketoesters, other alkyl amides (entry 5), and even to ketimines (entry 7), obtaining the O-addition 
products 2.35, alkyne’s hydration diacetyls 2.36 and final dihydropyridinones 2.37 in general good 
yields.  
In all cases, a quaternary center is present in the starting amides 2.34. The reactivity of 
substrates arising from non-fluorinated aldimines was previously described.97i However, this type of 
substrates was inert under our conditions (entry 8), even in the presence of acidic additives to prevent 
the complexation of gold by the basic nitrogen atom. As in the tandem hydroamination-formal aza-
Diels Alder reaction, the presence of the quaternary center plays a significant role, but we do not have 
an explanation so far for this different behaviour.  
As for the carbamate derivatives, the employment of sulfinyl imines led us to access those 
entities in an enantiomerically pure form (Scheme 2.28). After completely selective addition of 
propargyl zinc to sulfinyl imine 2.32, protecting group removal and acetylation led to the starting 
amide 2.34a in enantiomerically pure form. Reaction of 2.34a with Au(PPh3)OTf gave oxazine 2.35a 
in DCM, acetyl derivative 2.36a upon hydrolysis, and dihydropyridinone 2.37a in MeOH.   
 
 
 
At this point, we decided to carry out some essays that shed some light onto the formation of 
the dihydropiridinone core 2.37. Firstly, we discarded the low probable hypothesis that the hydration 
product was involved in its formation. Under initial conditions, diacetylated product 2.36a remains 
unaltered after 24 hours.  
On the other hand, TLC analysis confirmed the intermediacy of oxazine 2.35 when the 
reaction was performed in methanol, since we detected its formation and subsequent disappearance. 
Scheme 2.28. Asymmetric version.
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Thereby, it was clear that the first part of this transformation proceeded according to the “classical” 
reactivity exhibited by gold species as soft carbophilic π-Lewis acids; but, we were intrigued if gold, 
silver or even triflic acid might be involved in the evolution from the oxazine intermediate 2.35a to the 
final dihydropyridinone 2.37a (Table 2.10).  
 
 
 
When oxazine 2.35a was dissolved in dry methanol, it remained unaltered after 24 h at room 
temperature (entry 1). When a catalytic amount of triflic acid was added to the reaction mixture, total 
consumption of the starting material was observed after 6 hours, giving rise to 2.37a in 61% yield 
(entry 2). On the other hand, the reaction in the presence of silver triflate did not proceed (entry 3). A 
completely different situation emerged with the addition of Au(PPh3)Cl in combination with AgOTf. 
The reaction was completed after 30 minutes, affording 2.37a in 71% yield (entry 4). Finally, the use 
of a Lewis acid such as BF3·OEt2 gave rise to the final product 2.37a in 4 h and 84% yield (entry 5). 
These results hint the likely role displayed by gold species at the second stage of the process.  
As it was discussed above (see Section 2.1.1), while great part of gold-catalyzed reactions 
stand on its ability to act as soft Lewis acids activating C–C multiple bonds, its competency towards 
the formation of σ-complexes with heteroatoms was also proved.  
The dual role imparted by gold is supported by the use of AuCl as a suitable catalyst for the 
tandem sequence (Table 2.8, entry 12). Nevertheless, with this neutral species, softer than cationic 
Au(PPh3)OTf, σ-activation is less efficient, which is traduced in longer reaction times and the 
appearance of some hydration product. The same effect was observed using silver triflimide that 
renders less cationic (softer) gold complexes (Table 2.8, entry 11). Furthermore, a Lewis acid such as 
Table 2.10. Transformation of oxazine 2.35a into dihydropyridinone 2.37a.
- 
TfOH 
AgOTf 
Au(PPh3)Cl/AgOTf 
BF3·OEt2
entry
 1
2
3
4
5
24 h
6 h
24 h 
0.5 h 
4 h
a Isolated yield after column chromatography.
5 mol% catalyst  
MeOH 0.05 M, rt
2.35a
N O
F3C CO2Et
Me
2.37a
HN
F3C CO2Et
O
Me
catalyst time
-
61%
-
71%
84%
yielda
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boron trifluoride was able to promote oxazine conversion into final dihydropyridinone (Table 2.10, 
entry 5), depicting the likely role played by gold.  
Thereafter, we decided to firmly establish the ability of gold complex Au(PPh3)OTf to 
perform a σ-activation. For this purpose, we planned the isolation of an hypothetical intermediate 
complex of Au(PPh3)OTf with oxazine 2.35, thus proving the identity of the involved species. To this 
end, oxazine 2.35a was treated with 1.0 equivalents of the gold complex, previous filtration of the 
AgCl salt, in CDCl3. After 10 minutes, clean formation of a new gold-oxazine species in 1:1 
stoichiometry was observed by NMR. 1H NMR signals of oxazine 2.35a·Au(PPh3)OTf appeared 
shifted downfield when comparing with free oxazine 2.35a (Figure 2.4), in agreement with a σ-
coordination with the cationic gold species.  
 
  
 
 
Even more illustrative were the shifts registered in 13C NMR, depicted in the below presented 
residual plot (Figure 2.5). In agreement with higher deviations registered for a and b carbon atoms, we 
hypothesized gold species was likely forming a σ-complex with oxazine 2.35a through its imidate 
group. On the other hand, deviations registered for c and d carbon centers might be explained 
regarding to π-conjugation, once gold is coordinated to imidate group.  
It is worth noting that although this σ-coordination is represented as a complexation through 
the nitrogen atom, gold coordination through the oxygen atom of the imidate group cannot be ruled 
out.  
 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5
Figure 2.4. 1H NMR of oxazine 2.35a and gold-oxazine complex 2.35a·Au(PPh3)OTf.
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In addition, 31P NMR spectroscopic analysis showed a singlet at δ 29.6 ppm, shifted lowfield 
in comparison with the signal for free Au(PPh3)OTf, which appears at δ 27.5 ppm, according to its less 
cationic character after forming the σ-complex with oxazine 2.35a. 19F NMR analysis revealed two 
signals corresponding to the trifluoromethyl groups from the oxazine moiety and the triflate 
counterion. Low resolution mass spectrometric analysis (MALDI-TOF, matrix-assisted laser 
desorption ionization-time of flight) spectra indicated the existence of complex 2.35a·Au(PPh3)OTf, 
m/z 710.27. As expected, complex 2.35a·Au(PPh3)OTf turned into dihydropyridinone 2.37a after 
removal of the solvent and the addition of methanol (Scheme 2.29).122  
 
 
 
                                                       
122 Although several gold intermediates were previously isolated, most of them are related to the π-Lewis acidity of gold 
species. (a) Liu, L.-P.; Hammond, G. B. Chem. Soc. Rev. 2012, 41, 3129. (b) Hashmi, A. S. K. Angew. Chem. Int. Ed. 2010, 
49, 5232.  
Figure 2.5. Residual plot for 13C NMR shift differences between 2.35a and 2.35a·Au(PPh3)OTf.
Scheme 2.29. Preparation of σ gold complex 2.35a·Au(PPh3)OTf.
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A plausible explanation of the reaction outcome is depicted in Scheme 2.30. After 
intramolecular carbonyl addition (first stage), σ-complexation of gold complex with intermediate 
oxazine 2.35a promotes nucleophilic addition of an external nucleophile. When the nucleophile was 
water (R = H), the addition to complex 2.35a·Au(PPh3)OTf gave rise to hemiacetal A, in equilibrium 
with the opened intermediate B, thus rendering hydration product 2.36a after tautomerization. A 
completely different situation appeared when the nucleophile was methanol (R = Me). Namely, the 
mixed acetal C formed, is susceptible to undergo a gold-catalyzed Petasis-Ferrier-type 
rearrangement.123 Thus, the acetal moiety undergoes ring opening to form the imidate D, which 
cyclized again into piperidine F. Methanol elimination and further isomerization renders final 
dihyropyridinone 2.37a.  
 
 
 
Isotopic labeling experiments starting from the oxazine intermediate 2.35a and using 
deuterated solvents, showed labels in the final dihydropiridinone 2.37a and the hydration product 
2.36a that were in agreement with our mechanistic proposal (Scheme 2.31).  
 
                                                       
123 (a) Minbiole, E. C.; Minbiole, K. P. C. J. Antibiotics. 2016, 69, 213-219. (b) Simth III, A. B.; Fox, R. J.; Razler, T. M. 
Acc. Chem. Res. 2008, 41, 675. (c) Adriaenssens, L. V.; Hartley, R. C. J. Org. Chem. 2007, 72, 10287.  
Scheme 2.30. Mechanistic proposal (second stage).
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According to Patil and coworkers’ categorization,124 this process constitutes a new example on 
the challenging self-relay catalysis (also named autocatalysis),125 as up to three distinct reactions, 
carbonyl addition-nucleophilic addition-Petasis-Ferrier rearrangement, are likely promoted by the 
same gold catalyst, standing on the dual ability of gold salts to act as σ and π Lewis acids (Figure 2.6).  
 
 
 
To the best of our knowledge, just a few examples have been described to date where gold 
imparts simultaneously both acidities, not only in self-relay processes, but also in an orthogonal-relay 
                                                       
124 Patil, N. T.; Shinde, V. S.; Gajula, B. Org. Biomol. Chem. 2012, 10, 211. 	  
125 Camp, J. E. Eur. J. Org. Chem. 2016, DOI: 10.1002/ejoc.201600803.  
Scheme 2.31. Isotopic labelling experiments.
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catalysis, combining two gold salts with different hard-soft character (the so-called dual hard-soft gold 
catalysis).  
For instance, the Pale group demonstrated that alkynyl aziridines 2.49, can evolve, in the 
presence of Au(I) complexes, rendering the spyrocycles 2.50 through an intramolecular Friedel-Crafts 
reaction followed by the cyclization of the intermediate aminoallene 2.51, based on a double gold σ 
and π activation (Scheme 2.32a).126  
Following this principle, they were also able to access to divinyl ketones 2.52, suitable to be 
activated by gold and render cyclopentenones 2.53 in a Nazarov-type reaction (Scheme 2.32b).127  
 
 
 
Latest contribution from the Dalla group disclosed their preliminary results in a new one-pot 
cascade α-amidoalkylation-hydroarylation procedure.128 The novelty introduced by this work stands 
on the orthogonal-relay catalysis as a new manner to take advantage from the bifunctional character 
exhibited by gold salts (Scheme 2.33). It involved the sequential and combined use of two gold salts: 
one harder (AuOTf, AuNTf2) promoting the N-acyl iminium formation (A), and either one softer 
(PPh3AuNTf2), able to activate the triple bond (B) towards the final hydroarylation step.  
 
                                                       
126 Kern, N.; Blanc, A.; Weibel, J.-M.; Pale, P. Chem. Commun. 2011, 47, 6665.  
127 (a) Hoffmann, M.; Weibel, J.-M.; De Frémont, P.; Pale, P.; Blanc, A. Org. Lett. 2014, 16, 908. (b) Cordonnier, M.-C.; 
Blanc, A.; Pale, P. Org. Lett. 2008, 10, 1569.	  
128 Boiaryna, L.; El Mkaddem, M. K.; Taillier, C.; Dalla, V.; Othman, M. Chem. Eur. J. 2012, 18, 14192.	  
Scheme 2.32. Previous work by Pale.
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To conclude, a new self-relay gold-catalyzed cascade reaction was developed.129 This triple 
tandem process emerges as one of the few described examples that takes advantage and unify both the 
σ- and π-Lewis acid properties of gold salts, giving rise to a new family of dihydropyridinones, 
important structural pattern for the synthesis of biologically-relevant products.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                       
129 Fustero, S.; Miró, J.; Sánchez-Roselló, M.; del Pozo, C. Chem. Eur. J. 2014, 20, 14126.  
Scheme 2.33. Previous work by Dalla (2012).
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2.4. Conclusions.  
 
In conclusion, the differential reactivity of homopropargyl α-amino esters was studied. Gold 
catalysis led us to access up to five different families of fluorinated nitrogen-containing heterocycles 
just by modifying the substitution pattern on the nitrogen atom (Scheme 2.34). It is important to point 
out that all new compounds contain, at least, one quaternary α-amino acid unit.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.34. Summary.
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2.5. Experimental section.  
 
General remarks: Unless otherwise noted, reactions were carried out under argon atmosphere and all 
reagents were purchased from commercial suppliers and used without further purification. The 
solvents were purified prior to use: THF, diethyl ether and toluene were distilled from 
sodium/benzophenone, dichloromethane and acetonitrile were distilled from calcium hydride. The 
reactions were monitored with the aid of thin-layer chromatography (TLC) on 0.25 mm precoated 
silica gel plates. Visualization was carried out with UV light and aqueous potassium permanganate 
stain. Flash column chromatography was performed with the indicated solvents on silica gel 60 
(particle size 0.040-0.063 mm). Melting points were measured on Büchi B-540 apparatus. 1H, 13C and 
19F spectra were recorded on 300 MHz and 500 MHz Bruker spectrometers. Chemical shifts (δ) are 
given in ppm relative to the residual solvent signals (chloroform, 7.26 ppm for 1H NMR and 77.00 
ppm for 13C NMR). Coupling constants (J) are given in Hertz (Hz). Letters m, s, d, t and q stand for 
multiplet, singlet, doublet, triplet and quartet, respectively. Letters br indicate that the signal is broad. 
High-resolution mass spectra were carried out on an AB SCIEX TripleTOF™ 5600 LC/MS/MS 
system in ESI mode [Conditions: Ion source gas 1 (GC1): 35 psi; Ion source gas 2 (GC2): 35 psi; 
Curtain gas 1: 25 psi; Temperature: 450 ºC; Ion Spray Voltage (ISVF): 5500; Infusion positive mode] 
by the University of Valencia Mass Spectrometry Service. Enantiomeric ratios were determined with 
the aid of HPLC analysis with ChiralPak OD-H, ChiralPak IC, or ChiralPak AD columns (25 cm x 
0.46 cm). 
 
 
2.5.1. Gold-catalyzed tandem hydroamination-formal aza-Diels Alder reaction.  
 
2.5.1.1. Preparation of N-aryl-α-imino esters.  
 
 
Method A: Aza-Wittig reaction. To a solution of the corresponding N-aryl-iminophosphorane130 (1.0 
equiv, 4.0 mmol) in dry toluene (0.2 M, 20 mL) was added dropwise the corresponding ketoester (1.0 
equiv, 4.0 mmol, neat) and the resulting solution was refluxed overnight. Then, the mixture was 
                                                       
130 For the preparation of iminophosphoranes, see: (a) Alajarin, M.; López-Leonardo, C.; Berna, J. Science of Synthesis 2007, 
31b, 1539. (b) Stauffer, S. R.; Sun, Y.; Katzenellenbogen, B. S.; Katzenellenbogen, J. A. Bioorg. Med. Chem. 2000, 8, 1293. 
(c) Horner, L.; Oediger, H. Justus Liebig Ann. Chem. 1959, 627, 142.  
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cooled to room temperature, and solvents evaporated under vacuum. Diethyl ether was then added (20 
mL) and a white precipitated of triphenylphosphine oxide was formed. The solid was filtrated and 
washed with diethyl ether (3 x 10 mL) and after removal of solvents, the crude was subjected to flash 
column chromatography.  
 
 
Method B: Alcoxycarbonylation reaction.131 NaI (1.6 equiv, 11.5 mmol) was added to a solution of 
the corresponding imidoyl chloride 2.58132 (1.0 equiv, 7.0 mmol) in dry acetone (0.35 M, 20 mL) and 
the mixture was stirred at room temperature protected from light until total disappearance of the 
starting imidoyl chloride (as confirmed by GC-MS). The reaction mixture was then quenched with a 
saturated aqueous solution of Na2S2O3 and the aqueous layer was extracted with EtOAc (3 x 15 mL). 
The combined organic layers were washed with brine (3 x 15 mL) and dried over anhydrous Na2SO4. 
Filtration and evaporation of solvents quantitatively gave the corresponding crude imidoyl iodide 2.59, 
which was subsequently used in the next step of the synthesis without further purification.  
A solution of imidoyl iodide 2.59 in a 10:1 toluene/DMF mixture (0.6M) and the corresponding 
alcohol (1.2 equiv, 8.5 mmol) were both added to a two-necked flask containing K2CO3 (2.0 equiv, 
14.2 mmol) and 4 mol% of Pd2(dba)3·CHCl3 (0.28 mmol). The reaction mixture was stirred at room 
temperature under CO atmosphere (1 atm) until the starting material was consumed, as confirmed by 
TLC. The crude reaction mixture was then filtered through a silica pad and washed with DCM. The 
solvents were removed under reduced pressure and the mixture was purified by flash column 
chromatography.  
 
 
Ethyl (E)-3,3,3-trifluoro-2-((4-methoxyphenyl)imino)propanoate. Following the general procedure 
described above (method A), 946 mg of 2.20a (yellow oil) were obtained from 680 mg of ethyl 
                                                       
131 (a) Fustero, S.; Navarro, A.; Pina, B.; García Soler, J.; Bartolomé, A.; Asensio, A.; Simón, A.; Bravo, P.; Fronza, G.; 
Volonterio, A.; Zanda, M. Org. Lett. 2001, 3, 2621. (b) Amii, H.; Kishikawa, Y.; Kageyama, K.; Uneyama, K. J. Org. Chem. 
2000, 65, 3404.  
132 For the preparation of imidoyl chlorides, see: (a) Uneyama, K. J. Fluorine Chem. 1999, 97, 11. (b) Tamura, K.; 
Mizukami, H.; Maeda, K.; Watanabe, H.; Uneyama, K. J. Org. Chem. 1993, 58, 32.  
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trifluoropyruvate and 1.53 g of 4-methoxy-N-(triphenylphosphoranilidene)aniline in 86% yield. The 
spectroscopic data were in agreement with previously reported data.103a  
 
 
Ethyl (E)-3,3,3-trifluoro-2-(p-tolylimino)propanoate. Following the general procedure described 
above (method A), 912 mg of 2.20b (yellow oil) were obtained from 680 mg of ethyl trifluoropyruvate 
and 1.47 g of 4-methyl-N-(triphenylphosphoranilidene)aniline in 88% yield. The spectroscopic data 
were in agreement with previously reported data.103a 
 
 
Ethyl (E)-3,3,3-trifluoro-2-(phenylimino)propanoate. Following the general procedure described 
above (method A), 735 mg of 2.20c (yellow solid) were obtained from 680 mg of ethyl 
trifluoropyruvate and 1.41 g of N-(triphenylphosphoranilidene)aniline in 75% yield. The spectroscopic 
data were in agreement with previously reported data.103a 
 
 
Ethyl (E)-3,3,3-trifluoro-2-((4-(methylthio)phenyl)imino)propanoate. Following the general 
procedure described above (method A), 759 mg of 2.20d (yellow oil) were obtained from 0.68 g ethyl 
trifluoropyruvate and 1.60 g of 4-methylthio-N-(triphenylphosphoranilidene)aniline in 65% yield. 1H-
NMR (CDCl3, 300 MHz): δ 1.13 (t, J = 7.2 Hz, 3H), 2.47 (s, 3H), 4.22 (q, J = 7.1 Hz, 2H), 6.93 (d, Jo 
= 8.4 Hz, 2H), 7.23 (d, Jo = 8.7 Hz, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.6, 15.6, 62.8, 118.2 (q, 
1JCF = 278.6 Hz), 120.5, 126.7, 138.4, 143.1, 148.1 (q, 2JCF = 36.7 Hz), 159.6; 19F-NMR (CDCl3, 282 
MHz): δ -70.1 (s, 3F); HRMS (ES) calc. for (M++1) C12H13F3NO2S: 292.0614; found: 292.0611.  
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Ethyl (E)-3,3,3-trifluoro-2-((4-fluorophenyl)imino)propanoate. Following the general procedure 
described above (method B), 630 mg of 2.20e (yellow oil) were obtained from 1.00 g of the 
corresponding imidoyl chloride in 54% yield. 1H-NMR (CDCl3, 300 MHz): δ 1.13 (t, J = 7.2 Hz, 3H), 
4.22 (q, J = 7.1 Hz, 2H), 6.92-6.99 (m, 2H), 7.05-7.10 (m, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.6, 
62.9, 116.0 (d, 2JCF = 22.7 Hz), 118.1 (q, 1JCF = 278.6 Hz), 121.4 (d, 3JCF = 8.3 Hz), 142.4 (d, 4JCF = 
3.0 Hz), 149.1 (q, 2JCF = 37.8 Hz), 160.0, 161.3 (d, 1JCF = 295.2 Hz); 19F-NMR (CDCl3, 282 MHz): δ -
70.3 (s, 3F), -115.2 (dddd, 3JFH = J1 = J2 = 8.2 Hz, 4JFH = J3 = J4 = 4.8 Hz, 1F); HRMS (ES) calc. for 
(M++1) C11H10F4NO2: 264.0642; found: 264.0634.  
 
 
Ethyl (E)-3,3,3-trifluoro-2-((4-(trifluoromethyl)phenyl)imino)propanoate. Following the general 
procedure described above (method A), 1.22 g of 2.20f (yellow liquid) were obtained from 807 mg 
ethyl trifluoropyruvate and 2.00 g of 4-trifluoromethyl-N-(triphenylphosphoranilidene)aniline in 82% 
yield. 1H-NMR (CDCl3, 300 MHz): δ 1.06 (t, J = 7.2 Hz, 3H), 4.18 (q, J = 7.1 Hz, 2H), 7.01 (d, Jo = 
8.1 Hz, 2H), 7.64 (d, Jo = 8.4 Hz, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.5, 63.1, 117.9 (q, 1JCF = 
278.6 Hz), 118.8, 123.8 (q, 1JCF = 271.8 Hz), 126.3 (q, 3JCF = 3.8 Hz), 128.8 (q, 2JCF = 33.0 Hz), 149.5, 
150.3 (q, 2JCF = 37.0 Hz), 158.3; 19F-NMR (CDCl3, 282 MHz): δ -62.9 (s, 3F), -70.5 (s, 3F); HRMS 
(ES) calc. for (M++1) C12H10F6NO2: 314.0610; found: 314.0612.  
 
 
2.5.1.2. General procedure for the preparation of N-aryl propargyl-α-amino esters.  
 
 
N-aryl imino ester 2.20 (1.0 equiv, 1.0 mmol) and propargyl bromide (1.5 equiv, 222 mg, 1.5 mmol) 
were dissolved in DMF (0.33 M, 3 mL). The solution was cooled to 0 °C, then activated zinc powder 
(1.5 equiv, 98 mg, 1.5 mmol) was added. The reaction mixture was then slowly warmed to room 
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temperature. After 2-10 h (the reaction was monitored by TLC), the medium was cooled to 0°C and 
hydrolyzed with a saturated aqueous solution of NH4Cl (20 mL), then extracted with Et2O (3 × 10 
mL). The combined organic layers were washed with brine (30 mL), dried with anhydrous MgSO4, 
filtered, and then solvents were evaporated. The residue was purified by flash column 
chromatography.  
 
 
Ethyl 2-((4-methoxyphenyl)amino)-2-(trifluoromethyl)-4-pentynoate. Following the general 
procedure described above, 281 mg of 2.21a (89% yield) were obtained as a light yellow oil starting 
from 275 mg of 2.20a. Both enantiomers could be separated by HPLC semipreparative IC column 
chromatography in n-hexane:iPrOH (95:5, isocratic method, 4 mL/min flux). (+)-(S)-2.21a: tR = 
10.693 min. [α]25D = +56.9 (c = 1.0 in CHCl3). (-)-(R)-2.21a: tR = 9.280 min. [α]25D = -56.9 (c = 1.0 in 
CHCl3). Spectroscopic data were agreed with previously reported data.103a Absolute configuration 
could be established by its derivatization to compound 2.34a, reported in section 2.5.4.1, following the 
general procedure (method B) described in that section. Following this methodology, 260 mg of (S)-
2.34a (white solid) were obtained from 400 mg of (S)-2.21a in 80% yield. [α]25D = -6.4 (c = 1.0 in 
CHCl3).  
 
 
Ethyl 2-(p-tolylamino)-2-(trifluoromethyl)pent-4-ynoate. Following the general procedure 
described above, 249 mg of 2.21b (96% yield) were obtained as a light yellow oil starting from 259 
mg of 2.20b. The spectroscopic data were in agreement with previously reported data.103a  
 
 
Ethyl 2-(phenylamino)-2-(trifluoromethyl)pent-4-ynoate. Following the general procedure 
described above, 277 mg of 2.21c (97% yield) were obtained as a light yellow oil starting from 245 
mg of 2.20c. The spectroscopic data were in agreement with previously reported data.103a  
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Ethyl 2-((4-(methylthio)phenyl)amino)-2-(trifluoromethyl)pent-4-ynoate. Following the method 
described above, 255 mg of 2.21d (77% yield) were obtained as yellowish oil starting from 291 mg of 
2.20d. 1H-NMR (CDCl3, 300 MHz) δ 1.33 (t, J = 7.2 Hz, 3H), 2.01 (t, J = 2.6 Hz, 1H), 2.44 (s, 3H), 
3.11 (d, J = 2.7 Hz, 2H), 4.34-4.41 (m, 2H), 4.77 (br s, 1H), 6.87 (d, Jo = 8.7 Hz, 2H), 7.18 (d, Jo = 8.7 
Hz, 2H); 13C-NMR (CDCl3, 75.5 MHz) δ 13.7, 17.0, 21.2 (q, 3JCF = 2.3 Hz), 63.5, 67.1 (q, 2JCF = 27.2 
Hz), 72.6, 76.2, 120.8 (q, 5JCF = 2.0 Hz), 123.9 (q, 1JCF = 289.2 Hz), 128.7, 130.3, 140.5, 166.9 (q, 3JCF 
= 1.5 Hz); 19F-NMR (CDCl3, 282 MHz) δ -73.4 (s, 3F); HRMS (ES) calc. for (M++1) C15H17F3NO2S: 
332.0927; found: 332.0937.  
 
 
Ethyl 2-((4-fluorophenyl)amino)-2-(trifluoromethyl)pent-4-ynoate. Following method described 
above, 237 mg of 2.21e (78% yield) were obtained as a brown oil starting from 263 mg of 2.20e. 1H-
NMR (CDCl3, 300 MHz) δ 1.33 (t, J = 7.1 Hz, 3H), 2.01 (t, J = 2.6 Hz, 1H), 3.00 (dd, J1 = 17.1 Hz, J2 
= 2.7 Hz, 1H), 3.09 (dd, J1 = 17.1 Hz, J2 = 2.7 Hz, 1H), 4.32-4.42 (m, 2H), 4.71 (br s, 1H), 6.89-6.99 
(m, 4H); 13C-NMR (CDCl3, 75.5 MHz) δ 13.8, 21.1 (q, 3JCF = 2.3 Hz), 63.6, 67.6 (q, 2JCF = 26.8 Hz), 
72.6, 76.5, 115.6 (d, 2JCF = 21.9 Hz), 123.4 (d, 3JCF = 1.5 Hz), 123.5 (d, 3JCF = 1.5 Hz), 123.9 (q, 1JCF = 
289.2 Hz), 138.3 (d, 4JCF = 2.3 Hz), 158.8 (d, 1JCF = 240.8 Hz), 167.0 (q, 3JCF = 1.5 Hz); 19F-NMR 
(CDCl3, 282 MHz) δ -73.7 (s, 3F), -121.6 (dddd, 3JFH = J1 = J2 = 7.9 Hz, 4JFH = J3 = J4 = 5.1 Hz, 1F); 
HRMS (ES) calc. for (M++1) C14H14F4NO2: 304.0955; found: 304.0950.  
 
 
Ethyl 2-(trifluoromethyl)-2-((4-(trifluoromethyl)phenyl)amino)pent-4-ynoate. Following method 
described above, 300 mg of 2.21f (85% yield) were obtained as a yellowish solid starting from 313 mg 
of 2.20f. m.p. 50-52 ºC. 1H-NMR (CDCl3, 300 MHz) δ 1.33 (t, J = 7.2 Hz, 3H), 2.00 (t, J = 2.7 Hz, 
1H), 3.17 (dd, J1 = 17.4 Hz, J2 = 2.7 Hz, 1H), 3.28 (dd, J1 = 17.1 Hz, J2 = 2.7 Hz, 1H), 4.39 (q, J = 7.1 
Hz, 2H), 5.19 (br s, 1H), 6.88 (d, Jo = 8.4 Hz, 2H), 7.45 (d, Jo = 8.4 Hz, 2H); 13C-NMR (CDCl3, 75.5 
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MHz) δ 13.8, 21.4 (q, 3JCF = 1.5 Hz), 64.0, 66.6 (q, 2JCF = 27.9 Hz), 73.2, 75.4, 117.3 (q, 4JCF = 2.3 
Hz), 122.5 (q, 2JCF = 32.5 Hz), 124.0 (q, 1JCF = 288.4 Hz), 124.5 (q, 1JCF = 271.5 Hz), 126.4 (q, 3JCF = 
3.8 Hz), 146.0, 166.7 (q, 3JCF = 0.8 Hz); 19F-NMR (CDCl3, 282 MHz) δ -62.2 (s, 3F), -73.0 (s, 3F); 
HRMS (ES) calc. for (M++1) C15H14F6NO2: 354.0923; found: 354.0919.  
 
 
2.5.1.3. General procedure for the gold-catalyzed tandem hydroamination-formal aza-Diels 
Alder reaction.  
 
 
Active catalyst was form by stirring at 0 ºC a suspension of Au(Ln)Cl (5 mol%, Ln = PPh3 or P(4-CF3-
C6H4)3) and AgOTf (5 mol%) in dry toluene (Ln = PPh3) or DCM (Ln = P(4-CF3-C6H4)3) (0.05 M, 4.0 
mL) for 5 minutes. The corresponding propargyl-α-amino ester (1.0 equiv, 0.2 mmol) was added next. 
The reaction mixture was stirred at this temperature until TLC showed total consumption of starting 
material. Then, solvents were removed under reduced pressure and crude mixture was purified by 
flash column chromatography.  
 
 
(2R*,3aS*,3bS*,6R*,11bS*)-Diethyl 10-methoxy-1-(4-methoxyphenyl)-2,6-bis(trifluorome-thyl)-
2,3,3a,3b,4,5,6,11b-octahydro-1H-dipyrrolo[1,2-a:3',2'-c] quinoline-2,6-dicarboxylate. Following 
the procedure described above (Ln = PPh3), 48 mg of (+)-2.22a (76% yield) were obtained as a white 
solid starting from 63 mg of (+)-(S)-2.21a. [α]25D = +91.5 (c = 1.0 in CHCl3). On the other hand, the 
opposite enantiomer (-)-2.22a was obtained in comparable yield starting from (-)-(R)-2.21a. [α]25D = -
91.5 (c = 1.0 in CHCl3). Spectroscopic data were agreed with previously reported data.103a  
 
F3C
HN
CO2Et
N
N
CF3
CO2Et
EtO2C
F3C
H
H
H
5 mol% Au(Ln)Cl 
5 mol% AgOTf 
solvent 0.05 M, 0 ºC
Ar
Ar
Ar
2.21, 0.20 mmol 2.22
N
NEtO2C
F3C CF3
CO2Et
OMe
MeO
H
H
H
N
NF3C
EtO2C CO2Et
CF3
OMe
MeO
H
H
H
	  	  94 
 
(2R*,3aS*,3bS*,6R*,11bS*)-Diethyl 10-methyl-1-p-tolyl-2,6-bis(trifluoromethyl)-2,3,3a,3b,4,5,6, 
11b-octahydro-1H-dipyrrolo[1,2-a:3',2'-c]quinoline-2,6-dicarboxylate. Following the procedure 
described above, 20 mg of 2.22b (34% yield) were obtained as a yellow oil starting from 60 mg of 
2.21b when Ln = PPh3. This yield could be increased up to 68% (41 mg) employing the gold complex 
derived from Ln = P(4-CF3-C6H4)3. Spectroscopic data were agreed with previously reported data.103a  
 
 
(2R*,3aS*,3bS*,6R*,11bS*)-Diethyl 1-phenyl-2,6-bis(trifluoromethyl)-2,3,3a,3b,4,5,6,11b-octa-
hydro-1H-dipyrrolo[1,2-a:3',2'-c]quinoline-2,6-dicarboxylate. Following the procedure described 
above, 8 mg of 2.22c (14% yield) were obtained as a yellow oil starting from 57 mg of 2.21c when Ln 
= PPh3. The use of the gold species derived from Ln = P(4-CF3-C6H4)3 led us to increased the yield up 
to 72% (41 mg). Spectroscopic data were agreed with previously reported data.103a  
 
 
(2R*,3aS*,3bS*,6R*,11bS*)-Diethyl 10-(methylthio)-1-[4-(methylthio)phenyl]-2,6-bis(tri-fluoro-
methyl)-2,3,3a,3b,4,5,6,11b-octahydro-1H-dipyrrolo[1,2-a:3',2'-c]quinoline-2,6-di-carboxylate. 
Following the procedure described above (Ln = P(4-CF3-C6H4)3), 43 mg of 2.22d (65% yield) were 
obtained as a colourless oil starting from 66 mg of 2.21d. 1H-NMR (CDCl3, 300 MHz): δ 0.98 (t, J = 
7.1 Hz, 3H), 1.23 (t, J = 7.2 Hz, 3H), 1.89-1.95 (m, 1H), 1.98 (s, 3H), 2.16-2.23 (m, 1H), 2.42 (s, 3H), 
2.44-2.56 (m, 4H), 2.80 (dd, J1 = 14.4 Hz, J2 = 7.2 Hz, 1H), 3.98-4.11 (m, 3H), 4.13-4.25 (m, 2H), 
4.75 (d, J = 4.8 Hz, 1H), 6.60 (d, Jm = 2.4 Hz, 1H), 6.67 (d, Jo = 8.4 Hz, 1H), 6.96 (dd, Jo = 8.7 Hz, Jm 
= 2.4 Hz, 1H), 7.07-7.24 (m, 4H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.7, 13.8, 15.9, 18.4, 27.8, 33.6, 
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35.9, 37.5, 59.0, 62.2, 62.2, 62.3, 72.4 (q, 2JCF = 25.9 Hz), 74.0 (q, 2JCF = 27.6 Hz), 115.3 (q, 5JCF = 5.4 
Hz), 122.2, 125.5 (q, 1JCF = 286.9 Hz), 125.8, 126.1 (q, 1JCF = 290.7 Hz), 126.4, 129.9, 131.5, 131.5, 
133.9, 136.8, 139.1, 140.2, 168.2, 169.0; 19F-NMR (CDCl3, 282 MHz): δ -69.0 (s, 3F), -70.9 (s, 3F); 
HRMS (ES) calc. for (M++H) C30H33F6N2O4S2: 663.1780; found: 663.1786.  
 
 
(2R*,3aS*,3bS*,6R*,11bS*)-Diethyl 10-fluoro-1-(4-fluorophenyl)-2,6-bis(trifluoromethyl)-2,3,3a, 
3b,4,5,6,11b-octahydro-1H-dipyrrolo[1,2-a:3',2'-c]quinoline-2,6-dicarboxylate.  Following the 
procedure described above (Ln = P(4-CF3-C6H4)3), 40 mg of 2.22e (66% yield) were obtained as a 
colourless oil starting from 61 mg of 2.21e. 1H-NMR (CDCl3, 300 MHz): δ 0.96 (t, J = 7.2 Hz, 3H), 
1.22 (t, J = 7.2 Hz, 3H), 1.89-1.98 (m, 1H), 2.16-2.24 (m, 1H), 2.34-2.61 (m, 4H), 2.80 (dd, J1 = 14.4 
Hz, J2 = 7.5 Hz, 1H), 4.00 (q, J = 7.2 Hz, 2H), 4.02-4.08 (m, 1H), 4.14-4.26 (m, 2H), 4.73 (d, J = 4.5 
Hz, 1H), 6.29 (dd, Jo = 9.6 Hz, Jm = 2.7 Hz, 1H), 6.65-6.79 (m, 2H), 6.90-7.00 (m, 2H), 7.21 (dd, Jo = 
8.7 Hz, Jm = 5.1 Hz, 2H); 13C-NMR (CDCl3, 150.9 MHz): δ 13.6, 13.8, 27.7, 33.5, 35.9, 36.9, 59.2, 
62.1, 62.3, 72.5 (q, 2JCF = 26.2 Hz), 74.6 (q, 2JCF = 27.7 Hz), 115.0 (d, 2JCF = 22.6 Hz), 115.2 (d, 2JCF = 
22.6 Hz), 116.7 (m), 118.4 (d, 2JCF = 22.6 Hz), 123.2 (d, 3JCF = 6.0 Hz), 125.5 (q, 1JCF = 288.2 Hz), 
126.1 (q, 1JCF = 291.2 Hz), 132.3 (d, 3JCF = 9.1 Hz), 137.6 (d, 4JCF = 3.0 Hz), 138.0 (d, 4JCF = 3.0 Hz), 
155.5 (d, 1JCF = 238.4 Hz), 161.2 (d, 1JCF = 246.0 Hz), 168.1, 168.9; 19F-NMR (CDCl3, 282 MHz): δ -
68.7 (s, 1F), -69.1 (s, 3F), -69.4 (s, 1F), -71.3 (s, 3F); HRMS (ES) calc. for (M++H) C28H27F8N2O4: 
607.1838; found: 607.1849.  
 
 
(2R*,3aS*,3bS*,6R*,11bS*)-Diethyl 2,6,10-tris(trifluoromethyl)-1-[4-(trifluoromethyl)phenyl]-
2,3,3a,3b,4,5,6,11b-octahydro-1H-dipyrrolo[1,2-a:3',2'-c]quinoline-2,6-dicarboxylate. Following 
the procedure described above (Ln = P(4-CF3-C6H4)3), 40 mg of 2.22f (57% yield) were obtained as a 
yellowish oil starting from 70 mg of 2.21f. 1H-NMR (CDCl3, 300 MHz): δ 1.06 (t, J = 7.2 Hz, 3H), 
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1.23 (t, J = 7.2 Hz, 3H), 1.90-1.99 (m, 1H), 2.27-2.35 (m, 1H), 2.44-2.65 (m, 4H), 2.87 (dd, J1 = 14.4 
Hz, J2 = 6.9 Hz, 1H), 4.03-4.16 (m, 3H), 4.19-4.26 (m, 2H), 4.88 (d, J = 5.1 Hz, 1H), 6.75 (d, Jo = 8.7 
Hz, 1H), 6.86 (d, Jm = 1.8 Hz, 1H), 7.20 (dd, Jo = 10.9 Hz, Jm = 1.8 Hz, 1H), 7.30 (d, Jo = 8.4 Hz, 2H), 
7.50 (d, Jo = 8.4 Hz, 2H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.7, 13.8, 28.4, 33.8, 36.4, 38.3, 59.1, 
62.0, 62.5, 62.6, 72.6 (q, 2JCF = 26.3 Hz), 73.4 (q, 2JCF = 28.0 Hz), 114.3 (q, 4JCF = 5.4 Hz), 119.8 (q, 
2JCF = 33.0 Hz), 120.4, 124.0 (q, 1JCF = 270.6 Hz), 124.1 (q, 1JCF = 269.4 Hz), 125.3 (q, 3JCF = 3.8 Hz), 
125.5 (q, 1JCF = 286.9 Hz), 125.6 (q, 3JCF = 3.8 Hz), 125.8 (q, 1JCF = 290.7 Hz), 128.2 (q, 2JCF = 32.6 
Hz), 129.3 (q, 3JCF = 3.8 Hz), 129.5 (q, 4JCF = 1.3 Hz), 144.2, 145.3 (q, 4JCF = 1.3 Hz), 167.8, 168.6; 
19F-NMR (CDCl3, 282 MHz): δ -62.6 (s, 3F), -63.1 (s, 3F), -68.8 (s, 3F), -70.4 (s, 3F); HRMS (ES) 
calc. for (M++H) C30H27F12N2O4: 707.1774; found: 707.1774.  
  
 
Ethyl 1-p-tolyl-2-(trifluoromethyl)-2,3-dihydro-1H-pyrrole-2-carboxylate. Following the 
procedure described above (Ln = PPh3), 21 mg of 2.23b (34% yield) were obtained as a colourless oil 
starting from 63 mg of 2.21b. The use of the gold species derived from Ln = P(4-CF3-C6H4)3 reduced 
the formation of the hydroamination product down to 2% yield. Spectroscopic data were agreed with 
previously reported data.103a  
 
 
Ethyl 1-phenyl-2-(trifluoromethyl)-2,3-dihydro-1H-pyrrole-2-carboxylate. Following the 
procedure described above (Ln = PPh3), 36 mg of 2.23c (64% yield) were obtained as a colourless oil 
starting from 57 mg of 2.21c. The use of the gold species derived from Ln = P(4-CF3-C6H4)3 reduced 
the formation of the hydroamination product down to 3% yield. Spectroscopic data were agreed with 
previously reported data.103a  
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2.5.1.4. HPLC data.  
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2.5.1.5. Computational study.133  
 
Theoretical methodology. The quantum chemical calculations described in this work were carried out 
with Gaussian09 package,134 using density functional theory. A good theoretical treatment of gold is a 
challenge, mainly due to the importance of the relativistic effects.135 However, a good balance between 
accuracy and computational cost can be achieved with the use of the hybrid functional B3LYP, using 
the 6-31G(d) basis set for the non-metalic atoms (C, H, N, P, F, O, S) and the Hay and Wadt 
pseudopotentials, in which the core orbitals are replaced by an effective core potential (ECP) and the 
valence orbitals are described by ab initio methods.136 In this study, the pseudopotential LANL2DZ 
was employed. This level of theory has been shown to be adequate for the description of several 
catalytic systems.137  
The potential energy surface for the reaction of amine 2.21a and the model catalyst [Au(PMe3)]+, was 
extensively explored and the geometry of all the stationary points located was fully optimized. Each 
stationary point was characterized to be a minimum or a first-order saddle point (transition structure) 
by computing the harmonic vibrational frequencies. The connection of either, the reactants or 
products, with the corresponding transition structure was established by computation of the intrinsic 
reaction coordinate (IRC).138  
 
Stationary points located for the reaction of 2.23a with intermediates Csyn and Canti. According 
with the stereochemistry of reactants 2.23a, Csyn, and Canti, the potential energy surface for these 
reactions will have 16 possible transition structures and 16 possible minima. All these stationary 
points were located and characterized and are collected in tables 2.11-2.14.139  
                                                       
133 For the cartesian coordinates, imaginary frequency (for the first-order saddle points), total electronic energy E (in 
hartrees), Gibbs free energy G (in hartrees), charge and multiplicity of the stationary points located, see ref. 114: Miró, J.; 
Sánchez-Roselló, M.; González, J.; del Pozo, C.; Fustero, S. Chem. Eur. J. 2015, 21, 5459.  
134 Gaussian 09, Revision B.01, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. 
R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, 
A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; 
Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A. Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; 
Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, 
A. J.; Burant, C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, 
V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, 
J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. J.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, 
A. D.; Farkas, O.; Foresman, J. B.; Ortiz, J. V.; Cioslowski J.; Fox, D. J. Gaussian, Inc., Wallingford CT, 2010.  
135 For a review of the theoretical treatment of gold, see: Pykko, P. Angew. Chem. Int. Ed. 2004, 43, 4412.  
136 Hay, P. J.; Wadt, W. R. J. Chem. Phys. 1985, 82, 299.  
137 See, for example: (a) Faza, O. N.; Rodríguez, R. A.; López, C. S. Theor. Chem. Acc. 2011, 128, 647. (b) Noey, E. L.; Luo, 
Y.; Zhang, L.; Houk, K. N. J. Am. Chem. Soc. 2012, 134, 1078. (c) Comas-Vives, A.; González-Arellano, C.; Corma, A.; 
Iglesias, M.; Sánchez, F.; Ujaque, G. J. Am. Chem. Soc. 2006, 128, 4756. (d) Straub, B. F. Chem. Commun. 2004, 1726. (e) 
Soriano, E.; Marco-Contelles, J. Organometallics, 2006, 25, 4542. (f) Nevado, C.; Echavarren, A. M. Chem. Eur. J. 2005, 11, 
3155.  
138 For a detailed presentation of the theoretical methods, see: Jensen, F. Introduction to Computational Chemistry, 2nd 
edition, Wiley 2007.  
139 ΔG in kcal·mol-1 and leghts in Å.  
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Table 2.11. Stationary points located for the reaction of intermediate Canti (addition to the Re-face) with 
2.23a (TS7 for the Re-face, TS9 for the Si-face).
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Table 2.12. Stationary points located for the reaction of intermediate Canti (addition to the Si-face) with 
2.23a (TS11 for the Re-face, TS13 for the Si-face).
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Table 2.13. Stationary points located for the reaction of intermediate Csyn (addition to the Si-face) with 
2.23a (TS15 for the Re-face, TS17 for the Si-face).
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Table 2.14. Stationary points located for the reaction of intermediate Csyn (addition to the Re-face) with 
2.23a (TS19 for the Re-face, TS21 for the Si-face).
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2.5.2. Gold-catalyzed synthesis of fluorinated 1,2-dihydroquinoline derivatives.  
 
2.5.2.1. General procedure for the alkylation of propargyl-α-amino esters.   
 
 
Benzyl bromide (3.0 equiv, 3.0 mmol), NaHCO3 (5.0 equiv, 5.0 mmol) and KI (10 mol%, 0.1 mmol) 
were added to a solution of the corresponding propargyl-α-amino ester 2.21140 (1.0 equiv, 1.0 mmol) 
in MeCN (0.33 M, 3 mL). The reaction mixture was heated in a sealed tube for five days at 90-100 ºC. 
The mixture was then cooled to room temperature, brine was added (10 mL) and the mixture extracted 
with Et2O (3 x 10 mL). Combined organic phases were dried with anhydrous Na2SO4 and the solvents 
were evaporated. The crude product was purified over silica gel at least twice using mixtures of n-
hexane:EtOAc and toluene:DCM.   
 
 
Ethyl 2-(benzyl(4-methoxyphenyl)amino)-2-(trifluoromethyl)pent-4-ynoate. Following the general 
procedure described above, starting from 315 mg of substrate 2.21a, 216 mg of compound 2.24a 
(yellow oil) were obtained in 92% yield and 58% conversion. 1H-NMR (CDCl3, 300 MHz): δ 1.32 (t, 
J = 7.1 Hz, 3H), 1.97 (t, J = 2.7 Hz, 1H), 2.43 (dd, J1 = 16.8 Hz, J2 = 2.7 Hz, 1H), 2.58 (dd, J1 = 16.8 
Hz, J2 = 2.1 Hz, 1H), 3.60 (s, 3H), 4.22-4.36 (m, 4H), 6.59 (d, Jo = 9.0 Hz, 2H), 6.98-7.16 (m, 7H); 
13C-NMR (CDCl3, 75.5 MHz): δ 14.2, 24.6 (q, 3JCF = 1.5 Hz), 55.1, 57.1, 62.2, 72.0, 72.1 (q, 2JCF = 
24.9 Hz), 77.1, 113.6, 125.3 (q, 1JCF = 289.2 Hz), 126.8, 127.9, 128.4, 131.4, 136.5, 138.4, 157.7, 
167.2; 19F-NMR (CDCl3, 282 MHz): δ -71.1 (s, 3F); HRMS (ES) calc. para (M++1) C22H23F3NO3: 
405.1625; found: 405.1622.  
 
                                                       
140 Prepared according to general procedure indicated in section 2.5.1.2 from the corresponding α-imino ester, in turn 
prepared by method A described in section 2.5.1.1.  
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Ethyl 2-(benzyl(4-methoxyphenyl)amino)-2-(chlorodifluoromethyl)pent-4-ynoate. Following the 
general procedure described above, starting from 332 mg of substrate 2.21g, 79 mg of compound 
2.24b (yellowish oil) were obtained in 48% yield and 39% conversion. 1H-NMR (CDCl3, 300 MHz): δ 
1.45 (t, J = 7.1 Hz, 3H), 2.13 (t, J = 2.4 Hz, 1H), 2.68 (dd, J1 = 17.1 Hz, J2 = 2.7 Hz, 1H), 2.77 (dt, J1 
= 16.8 Hz, J2 = 2.4 Hz, 1H), 3.74 (s, 3H), 4.38-4.56 (m, 4H), 6.74 (d, Jo = 8.7 Hz, 2H), 7.13-7.33 (m, 
5H), 7.31 (d, Jo = 9.0 Hz, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 14.1, 26.0, 55.1, 57.6, 62.2, 72.2, 75.6 
(t, 2JCF = 20.0 Hz), 77.4, 113.6, 126.7, 127.8, 128.6, 131.3, 131.7 (t, 1JCF = 307.2 Hz), 137.0, 138.3, 
157.8, 167.1; 19F-NMR (CDCl3, 282 MHz): δ -52.8 (d, JFF = 166.4 Hz, 1F), -56.13 (d, JFF = 166.4 Hz, 
1F); HRMS (ES) calc. for (M++1) C22H23ClF2NO3: 422.1329; found: 422.1331.  
 
 
Ethyl 2-(benzyl(4-methoxyphenyl)amino)-2-(difluoro(phenyl)methyl)pent-4-ynoate. Following 
the general procedure described above, starting from 373 mg of substrate 2.21h, 213 mg of compound 
2.24c (yellowish oil) were obtained in 72% yield and 64% conversion. 1H-NMR (CDCl3, 300 MHz): δ 
1.53 (t, J = 7.2 Hz, 3H), 2.16 (t, J = 2.4 Hz, 1H), 2.23 (dd, J1 = 16.8 Hz, J2 = 2.7 Hz, 1H), 2.59 (dt, J1 
= 16.5 Hz, J2 = 2.9 Hz, 1H), 3.77 (s, 3H), 4.48-4.59 (m, 3H), 4.69 (d, J = 13.8 Hz, 1H), 6.70 (d, Jo = 
9.0 Hz, 2H), 6.94 (d, Jo = 9.0 Hz, 2H), 7.23-7.28 (m, 5H), 7.46-7.57 (m, 3H), 7.86 (d, Jo = 8.4 Hz, 
2H); 13C-NMR (CDCl3, 75.5 MHz): δ 14.2, 25.9, 55.1, 57.3, 61.5, 71.9, 73.6 (t, 2JCF = 24.5 Hz), 78.6, 
113.4, 122.8 (t, 1JCF = 258.2 Hz), 126.6, 127.5, 127.7, 127.9 (t, 3JCF = 6.8 Hz), 129.0, 130.0, 130.8, 
134.9 (t, 2JCF = 26.8 Hz), 138.1, 138.7, 157.3, 168.7; 19F-NMR (CDCl3, 282 MHz): δ -94.6 (d, JFF = 
253.8 Hz, 1F), -98.4 (d, JFF = 253.8 Hz, 1F); HRMS (ES) calc. for (M+-C7H6) C21H22F2NO3: 374.1562; 
found: 374.1562.  
 
 
Benzyl 2-(benzyl(4-methoxyphenyl)amino)-3,3-difluoro-2-(prop-2-yn-1-yl)hex-5-enoate. Follo-
wing the general procedure described above, starting from 400 mg of substrate 2.21i, 96 mg of 
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compound 2.24d (colourless oil) were obtained in 37% yield and 53% conversion. 1H-NMR (CDCl3, 
300 MHz): δ 2.03 (t, J = 2.6 Hz, 1H), 2.60 (dd, J1 = 16.8 Hz, J2 = 2.4 Hz, 1H), 2.75 (dt, J1 = 16.8 Hz, 
J2 = 2.4 Hz, 1H), 3.18-3.33 (m, 2H), 3.70 (s, 3H), 4.36 (d, J = 14.4 Hz, 1H), 4.42 (d, J = 14.4 Hz, 1H), 
5.20-5.36 (m, 4H), 6.01 (dddd, J1 = 14.1 Hz, J2 = 10.5 Hz, J3 = J4 = 7.2 Hz, 1H), 6.64 (d, Jo = 9.0 Hz, 
2H), 7.05-7.16 (m, 7H), 7.36-7.47 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 24.2 (t, 3JCF = 3.8 Hz), 
39.0 (t, 2JCF = 23.8 Hz), 55.2, 57.1, 67.6, 72.1, 74.0 (t, 2JCF = 23.0 Hz), 79.4, 113.5, 120.1, 124.2 (t, 
1JCF = 252.2 Hz), 126.6, 127.8, 128.4, 128.6, 128.8, 129.3 (t, 3JCF = 4.9 Hz), 131.1, 135.1, 138.0, 
138.9, 157.3, 168.9; 19F-NMR (CDCl3, 282 MHz): δ -100.5 (ddd, JFF = 254.1 Hz, (JFH)1 = 27.1 Hz, 
(JFH)2 = 13.3 Hz, 1F), -102.5 (ddd, JFF = 254.6 Hz, (JFH)1 = 27.1 Hz, (JFH)2 = 13.0 Hz, 1F); HRMS (ES) 
calc. for (M++1) C30H30F2NO3: 490.2188; found: 490.2190.  
 
 
2.5.2.2. General procedure for the tandem hydroarylation-isomerization reaction.  
  
 
Over a solution of AuP[O(2,4-tBu-C6H3)]3Cl V (5 mol%) 141  and the corresponding N-benzyl 
propargyl-α-amino ester 2.24 (1.0 equiv, 0.12 mmol) in dry DCM (0.05 M, 2.5 mL), AgOTf (5 mol%) 
was added. After 20 minutes at room temperature, total consumption of the starting material was 
observed by TLC, and the reaction crude was purified after removal of the solvents by column 
chromatography.  
 
 
Ethyl 1-benzyl-6-methoxy-4-methyl-2-(trifluoromethyl)-1,2-dihydroquinoline-2-carboxylate. 
Starting from 50 mg of 2.24a, according to general procedure described above, 45 mg of compound 
2.26a (yellow oil) were obtained in 90% yield. 1H-NMR (CDCl3, 300 MHz): δ 1.15 (t, J = 7.1 Hz, 
3H), 2.15 (d, J = 1.5 Hz, 3H), 3.70 (s, 3H), 4.22 (q, J = 7.1 Hz, 2H), 4.48 (d, J = 17.4 Hz, 1H), 4.57 (d, 
                                                       
141 This gold species were prepared from Au(SMe2)Cl. Over a solution of the phosphine P[O(2,4-tBu-C6H3)]3 in dry DCM 
cooled at 0 ºC, 1 equiv of Au(SMe2)Cl was added. The mixture was stirred at room temperature until the reaction was 
completed (TLC or 31P NMR). Removal of the solvent led to the gold complex.  
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J = 17.4 Hz, 1H), 5.51 (s, 1H), 6.28 (d, Jo = 9.0 Hz, 1H), 6.54 (dd, Jo = 8.7 Hz, Jm = 3.0 Hz, 1H), 6.80 
(d, Jm = 3.0 Hz, 1H), 7.17-7.37 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.8, 19.0, 52.7, 55.5, 62.7, 
72.0 (q, 2JCF = 26.4 Hz), 111.1, 113.8, 113.9, 114.2, 122.3, 124.7 (q, 1JCF = 295.2 Hz), 126.4, 126.7, 
128.3, 135.7, 136.0, 137.3, 152.0, 167.3; 19F-NMR (CDCl3, 282 MHz): δ -74.1 (s, 3F); HRMS (ES) 
calc. for (M++1) C22H23F3NO3: 406.1625; found: 406.1620.  
 
  
Ethyl 1-benzyl-2-(chlorodifluoromethyl)-6-methoxy-4-methyl-1,2-dihydroquinoline-2-carboxyla-
te. Following the general procedure described above, 46 mg of 2.26b (colourless oil) were obtained in 
91% yield, starting from 50 mg of 2.24b. 1H-NMR (CDCl3, 300 MHz): δ 1.12 (t, J = 7.1 Hz, 3H), 2.18 
(d, J = 1.5 Hz, 3H), 3.70 (s, 3H), 4.14-4.24 (m, 2H), 4.59 (d, J = 17.7 Hz, 1H), 4.67 (d, J = 17.4 Hz, 
1H), 5.62 (s, 1H), 6.30 (d, Jo = 8.7 Hz, 1H), 6.55 (dd, Jo = 9.0 Hz, Jm = 3.0 Hz, 1H), 6.81 (d, Jm = 3.0 
Hz, 1H), 7.16-7.34 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.7, 19.0, 52.5, 55.5, 62.7, 75.5 (t, 2JCF 
= 21.9 Hz), 110.9, 113.9, 114.1, 115.4, 122.6, 126.5, 126.7, 128.3, 130.3 (t, 1JCF = 310.2 Hz), 135.6, 
135.6, 137.3, 151.9, 167.3; 19F-NMR (CDCl3, 282 MHz): δ -59.3 (d, JFF = 160.7 Hz), -60.5 (d, JFF = 
160.7 Hz); HRMS (ES) calc. for (M++1) C22H23ClF2NO3: 422.1329; found: 422.1335.  
 
  
Ethyl 1-benzyl-2-(difluoro(phenyl)methyl)-6-methoxy-4-methyl-1,2-dihydroquinoline-2-carboxy-
late. Following the general procedure described above, 27 mg of 2.26c (yellow oil) were obtained in 
53% yield, starting from 50 mg of 2.24c. 1H-NMR (CDCl3, 300 MHz): δ 1.07 (t, J = 7.2 Hz, 3H), 2.09 
(d, J = 1.5 Hz, 3H), 3.66 (s, 3H), 4.07-4.18 (m, 2H), 4.68 (d, J = 17.7 Hz, 1H), 4.78 (d, J = 17.7 Hz, 
1H), 5.41 (s, 1H), 6.14 (d, Jo = 9.0 Hz, 1H), 6.43 (dd, Jo = 9.0 Hz, Jm = 3.0 Hz, 1H), 6.61 (d, Jm = 3.0 
Hz, 1H), 7.13-7.32 (m, 8 H), 7.45-7.48 (m, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.7, 18.8, 52.6, 
55.6, 62.1, 74.3 (t, 2JCF = 26.8 Hz), 110.6, 113.4, 113.6, 117.6 (t, 4JCF = 3.0 Hz), 122.5, 123.0 (t, 1JCF = 
261.2 Hz), 126.4, 126.6, 127.0, 127.5 (t, 3JCF = 6.8 Hz), 128.1, 129.7, 134.2 (t, 2JCF = 25.3 Hz), 134.4, 
136.5, 138.0, 151.3, 168.6; 19F-NMR (CDCl3, 282 MHz): δ -100.4 (d, J = 14.1 Hz); HRMS (ES) calc. 
for (M++1) C28H28F2NO3: 464.2032; found: 464.2028.  
 
ClF2C
N
CO2Et
OMe
Bn
Me
PhF2C
N
CO2Et
OMe
Bn
Me
	  Au
107 	  
 
Benzyl 1-benzyl-2-(1,1-difluorobut-3-en-1-yl)-6-methoxy-4-methyl-1,2-dihydroquinoline-2-car-
boxylate. Following the general procedure described above, 38 mg of 2.26d (yellowish oil) were 
obtained in 75% yield, starting from 50 mg of 2.24d. 1H-NMR (CDCl3, 300 MHz): δ 2.03 (d, J = 1.2 
Hz, 3H), 2.51-2.91 (m, 2H), 3.61 (s, 3H), 4.43 (d, J = 17.7 Hz, 1H), 4.55 (d, J = 17.7 Hz, 1H), 4.96 
(dd, Jtrans = 17.1 Hz, Jgem = 1.5 Hz, 1H), 5.01 (d, J = 12.9 Hz, 1H), 5.06 (dd, Jcis = 10.2 Hz, Jgem = 1.5 
Hz, 1H), 5.11 (d, J = 12.3 Hz, 1H), 5.48 (s, 1H), 5.71 (dddd, J1 = 13.5 Hz, J2 = 9.9 Hz, J3 = J4 = 6.9 
Hz, 1H), 6.17 (d, Jo = 8.7 Hz, 1H), 6.44 (dd, Jo = 9.0 Hz, Jm = 3.0 Hz, 1H), 6.67 (d, Jm = 2.7 Hz, 1H), 
7.05-7.22 (m, 10H); 13C-NMR (CDCl3, 75.5 MHz): δ 18.9, 37.9 (t, 2JCF = 23.8 Hz), 52.8, 55.5, 67.7, 
73.7 (t, 2JCF = 23.8 Hz), 110.9, 113.8, 113.9, 117.4, 120.1, 122.5, 126.4, 126.6, 128.2, 128.3, 128.4, 
128.6, 129.0, 129.7, 134.5, 135.0, 136.9, 137.9, 151.7, 168.7; 19F-NMR (CDCl3, 282 MHz): δ -102.9 
(ddd, JFF = 250.1 Hz, (JFH)1 = 30.5 Hz, (JFH)2 = 8.7 Hz, 1F), -104.6 (ddd, JFF = 250.1 Hz, (JFH)1 = 28.2 
Hz, (JFH)2 = 7.9 Hz, 1F); HRMS (ES) calc. for (M++1) C30H30F2NO3: 490.2188; found: 490.2191.  
 
 
2.5.3. Gold-catalyzed O-addition with concomitant loss of isobutene.  
 
2.5.3.1. General procedure for the preparation of N-Boc-propargyl-α-amino esters.  
 
 
To a solution of N-Boc-iminophosphorane142 (1.0 equiv, 4.0 mmol) in dry toluene (0.2 M, 20 mL), 
was added dropwise the corresponding ketoester143 (1.0 equiv, 4.0 mmol) and the resulting solution 
was refluxed overnight. Once the mixture was cooled to room temperature, toluene was removed 
under reduced pressure. Diethyl ether was then added (20 mL) and a white precipitated of 
triphenylphosphine oxide was formed. The mixture was decanted and the solution was transferred to 
another flask under inert conditions; the residual solid was washed with diethyl ether (10 mL), 
                                                       
142 N-Boc-iminophosphorane was prepared according to the procedure described in the literature: Vidal, J.; Guy, L.; Stérin, 
S.; Colle, A. J. Org. Chem., 1993, 58, 4791.  
143 Ketoesters were obtained according to previously reported procedures: (a) Schlosser, M.; Brügger, N.; Schmidt, W.; 
Amrhein, N. Tetrahedron, 2004, 60, 7731. (b) Parisi, M. F.; Gattuso, G.; Notti, A.; Raymo, F. M. J. Org. Chem. 1995, 60, 
5174. (c) Shi, G.; Cai, W. J. Org. Chem. 1995, 60, 6289.	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decanted and transferred again. The process was repeated 2 more times. After removal of the 
combined solvents, the crude was directly used in the next step without further purification due to the 
instability shown by the imino esters 2.28 towards hydrolysis. The crude was dissolved in DMF (0.33 
M, 12 mL) and then propargyl bromide was added (1.5 equiv, 888 mg, 6.0 mmol). The solution was 
cooled to 0 °C, then activated zinc powder (1.5 equiv, 392 mg, 6.0 mmol) was added. The reaction 
mixture was then slowly warmed to room temperature. After 2-10 h (the reaction was monitored by 
TLC) the medium was cooled to 0°C and hydrolyzed with a saturated aqueous solution of NH4Cl (50 
mL), then extracted with Et2O (3 × 20 mL). The combined organic layers were washed with brine (60 
mL), dried with MgSO4, filtered, and the solvents were evaporated. The residue was purified by flash 
chromatography over silica gel (hexanes/EtOAc 20:1) to afford N-Boc-homopropargyl amines 2.29.  
 
 
Ethyl 2-((tert-butoxycarbonyl)amino)-2-(trifluoromethyl)-4-pentynoate. Following the general 
procedure described above, 0.82 g of 2.29a (colourless oil) were obtained from 0.68 g of ethyl 
trifluoropyruvate and 1.51 g of N-Boc-iminophosphorane in 66% yield. 1H-NMR (CDCl3, 300 MHz): 
δ 1.34 (t, J = 7.2 Hz, 3H), 1.46 (s, 9H), 2.05 (t, J = 2.7 Hz, 1H), 3.10 (dd, J1 = 17.1 Hz, J2 = 2.7 Hz, 
1H), 3.74 (d, J = 17.1 Hz, 1H), 4.28-4.43 (m, 2H), 5.72 (br s, 1H); 13C-NMR (CDCl3, 75.5 MHz): δ 
13.7, 20.7, 28.1, 63.7, 64.5 (q, 2JCF = 28.7 Hz), 72.0, 76.3, 80.8, 123.4 (q, 1JCF = 287.9 Hz), 153.2, 
165.7; 19F-NMR (CDCl3, 282 MHz): δ -74.7 (s, 3F); HRMS (ES) calc. for (M++1) C13H19F3NO4: 
348.0820; found: 348.0819. 
 
 
Ethyl 2-((tert-butoxycarbonyl)amino)-2-(difluoro(phenyl)methyl)-4-pentynoate. Following the 
general procedure described above, 0.54 g of 2.29b (yellowish oil) were obtained from 0.60 g of 
ketoester 2.27b and 1.00 g of N-Boc-iminophosphorane in 56% yield. 1H-NMR (CDCl3, 300 MHz): δ 
1.30 (t, J = 7.2 Hz, 3H), 1.38 (s, 9H), 1.95 (t, J = 2.6 Hz, 1H), 3.22 (dd, J1 = 16.5 Hz, J2 = 2.1 Hz, 1H), 
3.69 (d, J = 15.3 Hz, 1H), 4.19-4.36 (m, 2H), 5.73 (br s, 1H), 7.37-7.48 (m, 5H); 13C-NMR (CDCl3, 
125.3 MHz): δ 13.8, 20.4, 28.1, 63.1, 67.6 (t, 2JCF = 28.2 Hz), 70.9, 78.1, 79.9, 120.2 (t, 1JCF = 257.5 
Hz), 126.3 (t, 3JCF = 6.3 Hz), 128.1, 130.5 (t, 4JCF = 1.3 Hz), 132.9 (t, 2JCF = 25.7 Hz), 153.2, 167.7; 
19F-NMR (CDCl3, 282 MHz): δ -101.4 (d, JFF = 245.3 Hz, 1F), -102.8 (d, JFF = 245.3 Hz, 1F); HRMS 
(ES) calc. for (M++1) C19H24F2NO4: 368.1668; found: 368.1666.  
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Ethyl 2-((tert-butoxycarbonyl)amino)-2-(1,1-difluoro-2-phenylethyl)-4-pentynoate. Following the 
general procedure described above, 0.42 g of 2.29c (colourless oil) were obtained from 0.40 g of 
ketoester 2.27c and 0.62 g of N-Boc-iminophosphorane in 67% yield. 1H-NMR (CDCl3, 300 MHz): δ 
1.22 (t, J = 7.2 Hz, 3H), 1.40 (s, 9H), 1.94 (t, J = 2.7 Hz, 1H), 3.08-3.34 (m, 3H), 3.60 (d, J = 17.4 Hz, 
1H), 4.17-4.28 (m, 2H), 5.72 (br s, 1H), 7.17-7.25 (m, 5H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.9, 
20.7, 28.2, 38.9 (t, 2JCF = 23.8 Hz), 63.1, 66.6 (t, 2JCF = 26.0 Hz), 71.3, 78.1, 80.5, 121.5 (t, 1JCF = 
255.2 Hz), 127.4, 128.2, 130.8, 131.6, 154.0, 168.1 (t, 3JCF = 2.3 Hz); 19F-NMR (CDCl3, 282 MHz): δ -
104.0 (ddd, JFF = 251.0 Hz, (JFH)1 = 28.2 Hz, (JFH)2 = 11.3 Hz, 1F), -105.5 (ddd, JFF = 251.0 Hz, (JFH)1 
= 28.2 Hz, (JFH)2 = 11.3 Hz, 1F); HRMS (ES) calc. for (M++Na) C20H25F2NO4Na: 404.1644; found: 
404.1631.  
 
 
Ethyl 2-((tert-butoxycarbonyl)amino)-3,3-difluoro-2-(prop-2-yn-1-yl)-5-hexenoate. Following the 
general procedure described above, 0.75 g of 2.29d (colourless oil) were obtained from 0.80 g of 
ketoester 2.27d and 1.22 g of N-Boc-iminophosphorane in 70% yield. 1H-NMR (CDCl3, 300 MHz): δ 
1.31 (t, J = 7.1 Hz, 3H), 1.45 (s, 9H), 1.98 (t, J = 2.6 Hz, 1H), 2.63-2.92 (m, 2H), 3.14 (dd, J1 = 16.8 
Hz, J2 = 2.4 Hz, 1H), 3.59 (d, J = 16.8 Hz, 1H), 4.31 (q, J = 7.2 Hz, 2H), 5.20 (dd, J1 = 9.9 Hz, J2 = 
1.5 Hz, 1H), 5.25 (d, J = 1.2 Hz, 1H), 5.73 (br s, 1H), 5.73-5.89 (m, 1H); 13C-NMR (CDCl3, 75.5 
MHz): δ 13.9, 20.6, 28.2, 37.5 (t, 2JCF = 24.2 Hz), 63.1, 66.4 (t, 2JCF = 26.0 Hz), 71.2, 78.1, 80.4, 
120.9, 121.8 (t, 1JCF = 254.8 Hz), 127.9 (t, 3JCF = 4.9 Hz), 153.9, 168.1 (t, 3JCF = 2.3 Hz); 19F-NMR 
(CDCl3, 282 MHz): δ -104.6 (ddd, JFF = 251.0 Hz, (JFH)1 = 28.2 Hz, (JFH)2 = 14.1 Hz, 1F), -105.8 (ddd, 
JFF = 248.2 Hz, (JFH)1 = 25.4 Hz, (JFH)2 = 11.3 Hz, 1F); HRMS (ES) calc. for (M++1) C16H24F2NO4: 
332.1668; found: 332.1681.  
 
 
 
 
BnF2C
HN
Boc
CO2Et
(allyl)F2C
HN
Boc
CO2Et
	  	  110 
 
Synthesis of ethyl (S,S)-2-(4-methylphenylsulfinamido)-2-(trifluoromethyl)-4-pentynoate. Prepa-
ration of the propargyl-α-amino ester 2.33 was carried out according to the general procedure 2.5.3.1, 
starting in this case from the (S)-N-(p-tolylsulfinylimino)triphenylphosphorane.144 As occurred with N-
Boc-imino esters, sulfinimine 2.32 was used in situ in the propargylation step, without further 
purification (attempts to purify it by flash chromatography on silica gel gave rise to extended 
hydrolysis). Following that procedure, 1.17 g of 2.33 (yellow dense oil) were obtained from 1.0 mL of 
ethyl trifluoropyruvate and 2.50 g of the iminophosphorane in 56% yield and 99:1 dr. Major 
diastereoisomer: [α]25D = -12.5 (c = 1.0 in CHCl3); 1H-NMR (CDCl3, 300 MHz): δ 1.26 (t, J = 7.2 Hz, 
3H), 2.12 (t, J = 2.7 Hz, 1H), 2.33 (s, 3H), 3.22 (d, J = 2.7 Hz, 2H), 4.21-4.37 (m, 2H), 5.24 (br s, 1H), 
7.23 (d, Jo = 7.8 Hz, 2H), 7.65 (d, Jo = 8.1 Hz, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.7, 21.0 (q, 3JCF 
= 2.3 Hz), 21.2, 63.9, 66.9 (q, 2JCF = 28.9 Hz), 72.9, 76.3, 122.9 (q, 1JCF = 288.4 Hz), 125.7, 129.5, 
141.7, 142.4, 165.0 (q, 3JCF = 1.5 Hz); 19F-NMR (CDCl3, 282 MHz): δ -75.7 (s, 3F); HRMS (ES) calc. 
for (M++1) C15H17F3NO3S: 348.0876; found: 348.0866.  
 
 
Ethyl (S)-2-((tert-butoxycarbonyl)amino)-2-(trifluoromethyl)pent-4-ynoate. The enantiomerically 
pure N-Boc-homopropargyl amine (S)-2.29a was obtained as a colourless oil following general 
procedure described bellow in 80% yield (71 mg) starting from 100 mg of sulfinylamine (S,S)-2.33. 
[α]25D = +2.8 (c = 1.0 in CHCl3). Spectroscopic data were agreed with those indicated above.  
Starting p-tolilsulfinamide (S,S)-2.33 (1.0 equiv, 0.29 mmol) was treated with 20 equivalents of HCl in 
dioxane 4.0 M (1.5 mL, 5.76 mmol). After total consumption of the starting material (TLC), solvents 
were removed at reduced pressure. The crude was treated with tert-butyl carbamate anhydride (20.0 
equiv, 1.26 g, 5.76 mmol) and DMAP (5.0 equiv, 141 mg, 1.15 mmol). After stirring the reaction 
mixture for half an hour at room temperature, the reaction mixture was hydrolyzed with an aqueous 
solution of NH4Cl (5 mL) and extracted with EtOAc (3 x 10 mL). Combined organic layers were dried 
                                                       
144 Preparation of (S)-N-(p-tolylsulfinylimino)triphenylphosphorane was afforded following the methodology previously 
described by our research group: Asensio, A.; Bravo, P.; Crucianelli, M.; Farina, A.; Fustero, S.; Soler, J. G.; Meille, S. V.; 
Panzeri, W.; Viani, F.; Volonterio, A.; Zanda, M. Eur. J. Org. Chem. 2001, 1449.  
F3C
HN
S
CO2Et
N
PPh3
S
pTol
OpTol
O
F3C CO2Et
O
F3C CO2Et
N
SOpTol            (1.0 equiv)
toluene 0.2 M, 80 ºC  
overnight
activated Zn (1.5 equiv) 
propargyl bromide (1.5 equiv) 
DMF 0.33 M, 0 ºC
2.33, 56% yield, 99:1 dr2.32
1) HCl/dioxane, 2 h, rt 
2) (Boc)2O (20 equiv), 
DMAP (5 equiv), 1 h, rt
F3C
HN
Boc
CO2Et
(S)-(+)-2.29a, 80% yield
F3C
HN
S
CO2Et
pTol
O
2.33
	  Au
111 	  
over anhydrous Na2SO4 and solvents were removed at reduced pressure. The crude was purified by 
column flash chromatography.  
 
 
2.5.3.2. General procedure for the synthesis of the fluorinated alkylidene oxazinones.  
 
 
Over a solution of Au(PPh3)Cl (5 mol%)145 and the corresponding N-Boc-propargyl-α-amino ester 
2.29 (1.0 equiv, 0.20 mmol) in dry toluene (0.05 M, 4.0 mL) at room temperature, AgOTf (5 mol%) 
was added. Once total consumption of the starting material was observed by TLC, the reaction crude 
was purified after removal of the solvents by column chromatography.  
 
 
Ethyl (S)-6-methylene-2-oxo-4-(trifluoromethyl)-1,3-oxazinane-4-carboxylate. Following the 
general procedure described above, 46 mg of 2.30a were obtained in 91% yield as a white solid, 
starting from 62 mg of 2.29a. m.p. 121-123 ºC; [α]25D = -0.6 (c = 1.0 in CHCl3); 1H-NMR (CDCl3, 
300 MHz): δ 1.33 (t, J = 7.2 Hz, 3H), 2.87 (dd, J1 = 15.3 Hz, J2 = 0.9 Hz, 1H), 3.09 (d, J = 15.3 Hz, 
1H), 4.31-4.41 (m, 2H), 4.51 (t, J = 1.8 Hz, 1H), 4.87 (dd, J1 = 2.1 Hz, J2 = 1.5 Hz, 1H), 6.60 (br s, 
1H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.8, 27.9, 61.8 (q, 2JCF = 29.4 Hz), 64.2, 97.3, 122.7 (q, 1JCF = 
287.2 Hz), 147.3, 148.7, 164.7; 19F-NMR (CDCl3, 282 MHz): δ -76.5 (s, 3F); HRMS (ES) calc. for 
(M++1) C9H11F3NO4: 254.0635; found: 254.0631.  
 
 
Ethyl 4-(difluoro(phenyl)methyl)-6-methylene-2-oxo-1,3-oxazinane-4-carboxylate. Following the 
general procedure described above, 55 mg of 2.30b were obtained in 88% yield as a white solid, 
                                                       
145 Non-commercially available gold species were prepared from Au(SMe2)Cl. Over a solution of the corresponding 
phosphine (Ln) in dry DCM cooled at 0 ºC, 1 equiv of Au(SMe2)Cl was added. The mixture was stirred at room temperature 
until the reaction was completed (TLC or 31P-NMR). Removal of the solvent led to the corresponding Au(Ln)Cl complex.  
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starting from 73 mg of 2.29b. m.p. 149-151 ºC; 1H-NMR (CDCl3, 300 MHz): δ 1.22 (t, J = 7.1 Hz, 
3H), 2.86 (d, J = 15.3 Hz, 1H), 3.08 (d, J = 15.0 Hz, 1H), 4.11-4.27 (m, 2H), 4.38 (s, 1H), 4.74 (dd, J1 
= 2.1 Hz, J2 = 1.5 Hz, 1H), 6.12 (br s, 1H), 7.38-7.53 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.8, 
28.1 (t, 3JCF = 2.6 Hz), 63.3, 64.5 (t, 2JCF = 29.4 Hz), 96.2, 119.5 (t, 1JCF = 256.7 Hz), 126.1 (t, 3JCF = 
6.4 Hz), 128.5, 131.2, 131.5 (t, 2JCF = 25.7 Hz), 148.6, 149.2, 166.6; 19F-NMR (CDCl3, 282 MHz): δ -
104.5 (d, JFF = 248.2 Hz, 1F), -106.0 (d, JFF = 248.2 Hz, 1F); HRMS (ES) calc. for (M++1) 
C15H16F2NO4: 312.1042; found: 312.1048.  
 
 
Ethyl 4-(1,1-difluoro-2-phenylethyl)-6-methylene-2-oxo-1,3-oxazinane-4-carboxylate. Following 
the general procedure described above, 46 mg of 2.30c were obtained in 71% yield as a white solid, 
starting from 76 mg of 2.29c. m.p. 113-115 ºC; 1H-NMR (CDCl3, 500 MHz): δ 1.34 (t, J = 7.5 Hz, 
3H), 2.85 (d, J = 15.0 Hz, 1H), 3.02 (d, J = 15.0 Hz, 1H), 3.12-3.23 (m, 1H), 3.30-3.40 (m, 1H), 4.29-
4.33 (m, 2H), 4.42 (d, J = 1.5 Hz, 1H), 4.81 (dd, J1 = 2.0 Hz, J2 = 1.0 Hz, 1H), 6.23 (br s, 1H), 7.24-
7.25 (m, 2H), 7.31-7.35 (m, 3H); 13C-NMR (CDCl3, 75.5 MHz): δ 14.0, 28.7 (t, 3JCF = 3.4 Hz), 38.6 (t, 
2JCF = 24.2 Hz), 63.6, 64.1 (t, 2JCF = 26.4 Hz), 96.5, 120.5 (t, 1JCF = 254.4 Hz), 127.9, 128.5, 130.6, 
130.7, 148.5, 149.3, 167.3 (t, 3JCF = 2.3 Hz); 19F-NMR (CDCl3, 468.9 MHz): δ -105.7 (ddd, JFF = 
253.2 Hz, (JFH)1 = 28.1 Hz, (JFH)2 = 9.4 Hz, 1F), -106.8 (ddd, JFF = 253.2 Hz, (JFH)1 = 28.1 Hz, (JFH)2 = 
9.4 Hz, 1F); HRMS (ES) calc. for (M++1) C16H18F2NO4: 326.1198; found: 326.1192.  
 
 
Ethyl 4-(1,1-difluorobut-3-en-1-yl)-6-methylene-2-oxo-1,3-oxazinane-4-carboxylate. Following 
the general procedure described above, 42 mg of 2.30d were obtained in 77% yield as a colourless oil, 
starting from 66 mg of 2.29d. 1H-NMR (CDCl3, 300 MHz): δ 1.31 (t, J = 7.1 Hz, 3H), 2.57-2.91 (m, 
2H), 2.85 (d, J = 15.0 Hz, 1H), 3.00 (d, J = 15.0 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 4.44 (s, 1H), 4.80 
(d, J = 1.5 Hz, 1H), 5.21-5.29 (m, 2H), 5.79 (dddd, J1 = 17.2 Hz, J2 = 10.3 Hz, J3 = 6.9 Hz, J4 = 6.9 
Hz, 1H), 6.49 (br s, 1H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.9, 28.5 (t, 3JCF = 3.0 Hz), 37.1 (t, 2JCF = 
24.2 Hz), 63.5, 63.9 (t, 2JCF = 26.4 Hz), 96.3, 120.6 (t, 1JCF = 254.4 Hz), 121.6, 127.0 (t, 3JCF = 4.9 Hz), 
148.6, 149.4, 167.2 (t, 3JCF = 2.3 Hz); 19F-NMR (CDCl3, 282 MHz): δ -106.3 (ddd, JFF = 251.0 Hz, 
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(JFH)1 = 25.4 Hz, (JFH)2 = 14.1 Hz, 1F), -107.6 (ddd, JFF = 251.0 Hz, (JFH)1 = 25.4 Hz, (JFH)2 = 11.3 Hz, 
1F); HRMS (ES) calc. for (M++1) C12H16F2NO4: 276.1042; found: 276.1044.  
 
 
2.5.4. Tandem gold self-relay catalysis for the synthesis of dihydropyridinones.  
 
2.5.4.1. General procedure for the preparation of homopropargyl amides.   
 
 
Method A. Over a solution of the corresponding N-Boc-propargyl-α-amino ester 2.29 (1.0 equiv, 1.3 
mmol) in DCM (0.1 M, 13 mL) cooled at 0 ºC, trifluoroacetic acid (8.0 equiv, 0.8 mL, 10.4 mmol) 
was slowly added. The reaction mixture was stirred at room temperature until consumption of the 
starting material (detection by TLC). After removal of solvents at reduced pressure, the crude was 
dissolved in acetic/propionic anhydride (13 mL) and the mixture was cooled to 0 ºC. Then, sodium 
hydride (6.0 equiv, 187 mg, 7.8 mmol) was added in small amounts under vigorous stirring and the 
mixture was stirred at room temperature. Once the reaction was completed, anhydride was removed 
under vacuum and water was added to the crude mixture in order to exclude any trace of the 
anhydride. The mixture was extracted with EtOAc (3 x 50 mL). Combined organic layers were dried 
with anhydrous MgSO4, filtered, and solvents were evaporated. The residue was purified by flash 
chromatography over silica gel.  
 
 
Method B. Over a solution of the corresponding homopropargyl aryl amine 2.20 (1.0 equiv, 0.1 
mmol) in MeCN (0.05 M, 2 mL) cooled to 0 ºC, a solution of ceric ammonium nitrate, CAN (3.0 
equiv, 0.3 mmol), in water (1 mL) was dropwise added. After one hour at this temperature, the starting 
material was consumed (TLC). Then, an aqueous solution of HCl 3N (5 mL) was added to the 
mixture, which was stirred for an additional hour at room temperature in order to hydrolyze the 
iminium intermediate. The mixture was neutralized with a saturated aqueous solution of NaHCO3 and 
then extracted with EtOAc (4 x 10 mL). Combined organic layers were washed with Na2SO3 20% 
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R3
O
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HN
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solution (10 mL) and dried over anhydrous Na2SO4. After removal of solvents under reduced pressure, 
the acetylation reaction was carried out as in method A without the need to add NaH.  
 
 
Ethyl (S)-2-acetamido-2-(trifluoromethyl)-4-pentynoate. Following the general procedure 
described above (method A), 260 mg of 2.34a (white solid) were obtained from 400 mg of 2.29a in 
80% yield. The enantiomerically pure acetamide (S)-2.34a was obtained following general procedure 
described above (method A)146 in 89% yield (186 mg) starting from 300 mg of sulfinylamine (S,S)-
2.33. m.p. 68-70 ºC; [α]25D = -6.4 (c = 1.0 in CHCl3);  1H-NMR (CDCl3, 300 MHz): δ 1.32 (t, J = 7.2 
Hz, 3H), 2.02 (t, J = 2.7 Hz, 1H), 2.08 (s, 3H), 3.14 (dd, J1 = 16.8 Hz, J2 = 2.7 Hz, 1H), 3.78 (dd, J1 = 
17.1 Hz, J2 = 2.7 Hz, 1H), 4.29-4.39 (m, 2H), 6.60 (br s, 1H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.7, 
20.5, 23.7, 63.8, 64.7 (q, 2JCF = 28.9 Hz), 71.9, 76.5, 123.2 (q, 1JCF = 287.7 Hz), 165.6, 169.5; 19F-
NMR (CDCl3, 282 MHz): δ -74.0 (s, 3F); HRMS (ES) calc. for (M++1) C10H13F3NO3: 252.0842; 
found: 252.0842.  
 
 
Ethyl 2-acetamido-2-(difluoro(phenyl)methyl)-4-pentynoate. Following the method described 
above (method A), 215 mg of 2.34b (85% yield) were obtained as a white solid starting from 300 mg 
of 2.29b. m.p. 87-89 ºC; 1H-NMR (CDCl3, 300 MHz): δ 1.26 (t, J = 7.2 Hz, 3H), 1.96 (t, J = 2.8 Hz, 
1H), 2.04 (s, 3H), 3.28 (dd, J1 = 16.8 Hz, J2 = 2.7 Hz, 1H), 3.68 (dd, J1 = 16.8 Hz, J2 = 2.7 Hz, 1H), 
4.13-4.33 (m, 2H), 6.46 (br s, 1H), 7.37-7.50 (m, 5H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.8, 20.3 (t, 
3JCF = 2.5 Hz), 24.0, 63.1, 68.1 (t, 2JCF = 27.6 Hz), 70.9, 78.3, 120.2 (t, 1JCF = 257.5 Hz), 126.1 (t, 3JCF 
= 6.9 Hz), 128.1, 130.7 (t, 4JCF = 1.3 Hz), 132.6 (t, 2JCF = 25.7 Hz), 167.5 (t, 3JCF = 3.1 Hz), 169.4; 19F-
NMR (CDCl3, 282 MHz): δ -101.4 (s, 2F); HRMS (ES) calc. for (M++1) C16H18F2NO3: 310.1249; 
found: 310.1237.  
 
 
Ethyl 2-acetamido-2-(1,1-difluoro-2-phenylethyl)-4-pentynoate. Following the general procedure 
described above (method A), 154 mg of 2.34c (yellow sticky oil) were obtained from 200 mg of 2.29c 
                                                       
146 In this case, deprotection of the corresponding sulfinyl amine was achieved by treatment with HCl in dioxane.  
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in 91% yield. 1H-NMR (CDCl3, 500 MHz): δ 1.24 (t, J = 7.0 Hz, 3H), 1.92 (t, J = 2.8 Hz, 1H), 1.99 (s, 
3H), 3.14-3.29 (m, 3H), 3.69 (dd, J1 = 17.0 Hz, J2 = 2.5 Hz, 1H), 4.19-4.27 (m, 2H), 6.50 (br s, 1H), 
7.17-7.25 (m, 5H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.8, 20.5 (t, 3JCF = 3.8 Hz), 23.9, 39.2 (t, 2JCF = 
23.2 Hz), 63.2, 67.1 (t, 2JCF = 25.7 Hz), 71.2, 78.1, 121.4 (t, 1JCF = 253.7 Hz), 127.4, 128.2, 130.8, 
131.5 (t, 3JCF = 1.9 Hz), 167.9 (t, 3JCF = 2.5 Hz), 169.9; 19F-NMR (CDCl3, 468.9 MHz): δ -103.1 (ddd, 
JFF = 248.5 Hz, (JFH)1 = 28.1 Hz, (JFH)2 = 9.4 Hz, 1F), -104.3 (ddd, JFF = 248.5 Hz, (JFH)1 = 28.1 Hz, 
(JFH)2 = 9.4 Hz, 1F); HRMS (ES) calc. for (M++1) C17H20F2NO3: 324.1406; found: 324.1393.  
 
 
Ethyl 2-acetamido-3,3-difluoro-2-(prop-2-yn-1-yl)-5-hexenoate. Starting from 500 mg of 2.34d, 
according to general procedure described above (method A), 408 mg of a white solid corresponding to 
2.29d were isolated in 99% yield. m.p. 48-50 ºC; 1H-NMR (CDCl3, 300 MHz): δ 1.23 (t, J = 7.2 Hz, 
3H), 1.93 (t, J = 2.6 Hz, 1H), 2.00 (s, 3H), 2.64-2.80 (m, 2H), 3.12 (dd, J1 = 16.8 Hz, J2 = 2.7 Hz, 1H), 
3.52 (dd, J1 = 16.8 Hz, J2 = 2.7 Hz, 1H), 4.17-4.27 (m, 2H), 5.13 (ddd, J1 = 8.4 Hz, J2 = 2.7 Hz, J3 = 
1.2 Hz, 1H), 5.17 (dd, J1 = 2.1 Hz, J2 = 0.9 Hz, 1H), 5.67-5.80 (m, 1H), 6.73 (br s, 1H); 13C-NMR 
(CDCl3, 125.3 MHz): δ 13.6, 20.3 (t, 3JCF = 3.8 Hz), 23.5, 37.5 (t, 2JCF = 23.2 Hz), 62.9, 66.6 (t, 2JCF = 
25.7 Hz), 71.0, 78.0, 120.7, 121.6 (t, 1JCF = 253.7 Hz), 127.6 (t, 3JCF = 5.0 Hz), 167.6 (t, 3JCF = 2.5 Hz), 
169.9; 19F-NMR (CDCl3, 282 MHz): δ -103.9 (ddd, JFF = 251.0 Hz, (JFH)1 = 22.6 Hz, (JFH)2 = 14.1 Hz, 
1F), -104.9 (ddd, JFF = 251.0 Hz, (JFH)1 = 22.6 Hz, (JFH)2 = 14.1 Hz, 1F); HRMS (ES) calc. for (M++1) 
C13H18F2NO3: 274.1249; found: 274.1242.  
 
 
Ethyl 2-propionamido-2-(trifluoromethyl)-4-pentynoate. Following the general procedure 
described above (method A), using propionic anhydride instead of acetic anhydride, 216 mg of 2.34e 
(white solid) were obtained from 400 mg of 2.29a in 63% yield. m.p. 52-54 ºC; 1H-NMR (CDCl3, 300 
MHz): δ 1.18 (t, J = 7.7 Hz, 3H), 1.33 (t, J = 7.2 Hz, 3H), 2.01 (t, J = 2.6 Hz, 1H), 2.30 (d, J = 7.5 Hz, 
1H), 2.35 (dd, J1 = 7.8 Hz, J2 = 0.3 Hz, 1H), 3.14 (dd, J1 = 17.1 Hz, J2 = 2.4 Hz, 1H), 3.84 (dd, J1 = 
16.8 Hz, J2 = 2.7 Hz, 1H), 4.35 (dq, J1 = 7.1 Hz, J2 = 1.2 Hz, 2H), 6.46 (br s, 1H); 13C-NMR (CDCl3, 
75.5 MHz): δ 9.5, 13.8, 20.5 (q, 3JCF = 1.5 Hz), 30.2, 63.9, 64.7 (q, 2JCF = 28.9 Hz), 71.9, 76.6, 123.3 
(q, 1JCF = 287.7 Hz), 165.7, 173.2; 19F-NMR (CDCl3, 282 MHz): δ -74.1 (s, 3F); HRMS (ES) calc. for 
(M++1) C11H15F3NO3: 266.0999; found: 266.0990.   
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Ethyl 2-acetamido-2-phenyl-4-pentynoate. Following the general procedure described above 
(method B), 69 mg of 2.34f (brown solid) were obtained from 200 mg of 2.20g in 43% yield. m.p. 98-
100 ºC; 1H-NMR (CDCl3, 300 MHz): δ 1.21 (t, J = 7.1 Hz, 3H), 2.00 (t, J = 2.7 Hz, 1H), 2.04 (s, 3H), 
3.50 (dd, J1 = 16.5 Hz, J2 = 2.4 Hz, 1H), 3.76 (dd, J1 = 16.8 Hz, J2 = 2.7 Hz, 1H), 4.08-4.31 (m, 2H), 
7.11 (br s, 1H), 7.30-7.41 (m, 3H), 7.45-7.49 (m, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.7, 23.3, 
24.0, 62.3, 64.3, 71.0, 79.5, 125.7, 128.0, 128.4, 137.7, 169.1, 171.1; HRMS (ES) calc. for (M++1) 
C15H18NO3: 260.1208; found: 260.1195. 
 
 
N-(1,1,1-trifluoro-2-phenylpent-4-yn-2-yl)acetamide. Starting from 200 mg of 2.20h, according to 
general procedure described above (method B), 123 mg of a brown solid corresponding to 2.34g were 
isolated in 77% yield. m.p. 114-116 ºC; 1H-NMR (CDCl3, 300 MHz): δ 2.10 (t, J = 2.6 Hz, 1H), 2.12 
(s, 3H), 3.51 (dd, J1 = 17.1 Hz, J2 = 2.4 Hz, 1H), 3.60 (dd, J1 = 17.1 Hz, J2 = 2.1 Hz, 1H), 6.16 (br s, 
1H), 7.35-7.45 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 23.8, 23.9 (q, 3JCF = 1.5 Hz), 63.7 (q, 2JCF = 
26.7 Hz), 71.9, 78.0, 125.0 (q, 1JCF = 286.1 Hz), 126.5 (q, 4JCF = 1.5 Hz), 128.5, 128.8, 135.1, 169.6; 
19F-NMR (CDCl3, 282 MHz): δ -75.5 (s, 3F); HRMS (ES) calc. for (M++1) C13H13F3NO: 256.0871; 
found: 256.0870.  
 
 
N-(1-phenylbut-3-yn-1-yl)acetamide. Acetamide 2.34h was prepared according to the procedure 
reported in the literature. Spectral data were in agreement with previously reported data.97i  
 
 
 
 
 
 
 
 
 
Ph
HN
CO2Et
Ac
Ph
HN
CF3
Ac
Ph
HN
Ac
	  Au
117 	  
2.5.4.2. General procedure for the isolation of oxazines.  
 
 
Over a solution of the corresponding homopropargyl amide 2.34 (1.0 equiv, 0.1 mmol) in dried DCM 
(0.05 M, 2 mL) prepared in a sealed tube charged with 3 Å molecular sieves, Au(PPh3)Cl (5 mol%) 
and AgOTf (5 mol%) were successively added. Once the reaction was completed, and after removal of 
solvents, the crude was purified by flash chromatography over silica gel.147  
 
 
Ethyl (S)-2-methyl-6-methylene-4-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazine-4-carboxylate. 
Following the general procedure described above, 36 mg of (S)-2.35a (colourless oil) were obtained 
from 50 mg of (S)-2.34a in 72% (83%) yield. [α]25D = +73.4 (c = 1.0 in CHCl3); 1H-NMR (CDCl3, 
300 MHz): δ 1.28 (t, J = 7.1 Hz, 3H), 2.14 (s, 3H), 2.61 (dt, J1 = 14.4 Hz, J2 = 1.8 Hz, 1H), 2.96 (d, J 
= 14.7 Hz, 1H), 4.26 (q, J = 7.2 Hz, 2H), 4.36 (t, J = 2.0 Hz, 1H), 4.72 (t, J = 1.8 Hz, 1H); 13C-NMR 
(CDCl3, 75.5 MHz): δ 13.9, 21.1, 27.9 (q, 3JCF = 2.3 Hz), 62.9, 65.1 (q, 2JCF = 28.2 Hz), 95.0, 123.5 (q, 
1JCF = 283.1 Hz), 147.9, 159.4, 166.2; 19F-NMR (CDCl3, 282 MHz): δ -77.5 (s, 3F); HRMS (ES) calc. 
for (M++1) C10H13F3NO3: 252.0842; found: 252.0839.  
 
 
Ethyl 4-(difluoro(phenyl)methyl)-2-methyl-6-methylene-5,6-dihydro-4H-1,3-oxazine-4-carboxy-
late. Starting from 50 mg of 2.34b, according to general procedure described above, 35 mg of a 
colourless oil corresponding to 2.35b were isolated in 70% (86%) yield. 1H-NMR (CDCl3, 300 MHz): 
δ 1.17 (t, J = 7.1 Hz, 3H), 2.08 (s, 3H), 2.52 (dt, J1 = 14.4 Hz, J2 = 1.8 Hz, 1H), 3.08 (d, J = 14.4 Hz, 
1H), 4.14 (q, J = 7.1 Hz, 2H), 4.29 (t, J = 1.8 Hz, 1H), 4.62 (t, J = 1.7 Hz, 1H), 7.35-7.46 (m, 3H), 
7.59-7.62 (m, 2H); 13C-NMR (CDCl3, 125.3 MHz): δ 14.0, 21.1, 28.7 (t, 3JCF = 3.8 Hz), 62.2, 67.6 (t, 
2JCF = 28.2 Hz), 94.0, 119.9 (t, 1JCF = 252.5 Hz), 127.2 (t, 3JCF = 6.9 Hz), 127.7, 130.2, 133.5 (t, 2JCF = 
                                                       
147 Yields in brackets were determined by GC/MS before purification by column chromatography.  
5 mol% Au(PPh3)Cl 
5 mol% AgOTf 
DCM 0.05 M, 3 A MS, rt
N O
R1
R2
R3
R1
HN
R2
R3
O
2.34 2.35
N O
F3C CO2Et
Me
N O
PhF2C CO2Et
Me
	  	  118 
25.7 Hz), 149.3, 157.6, 168.3 (d, 3JCF = 1.3 Hz); 19F-NMR (CDCl3, 282 MHz): δ -104.5 (s, 2F); HRMS 
(ES) calc. for (M++1) C16H18F2NO3: 310.1249; found: 310.1246.  
 
 
Ethyl 4-(1,1-difluoro-2-phenylethyl)-2-methyl-6-methylene-5,6-dihydro-4H-1,3-oxazine-4-carbo-
xylate. Following the method described above, 40 mg of 2.35c were obtained as a colourless oil in 
80% (94%) yield starting from 50 mg of 2.34c. 1H-NMR (CDCl3, 300 MHz): δ 1.27 (t, J = 7.1 Hz, 
3H), 2.15 (s, 3H), 2.60 (dt, J1 = 14.7 Hz, J2 = 1.8 Hz, 1H), 2.96 (d, J = 14.4 Hz, 1H), 3.18-3.35 (m, 
1H), 3.45-3.63 (m, 1H), 4.20 (q, J = 7.1 Hz, 2H), 4.28 (t, J = 1.7 Hz, 1H), 4.65 (t, J = 1.7 Hz, 1H), 
7.27-7.35 (m, 5H); 13C-NMR (CDCl3, 125.3 MHz): δ 14.0, 21.1, 27.7 (t, 3JCF = 4.4 Hz), 38.2 (t, 2JCF = 
23.8 Hz), 62.2, 66.7 (dd, (2JCF)1 = 27.6 Hz, (2JCF)2 = 25.1 Hz), 93.9, 121.4 (t, 1JCF = 250.6 Hz), 127.2, 
128.1, 130.9, 132.3 (t, 3JCF = 1.9 Hz), 149.4, 157.9, 168.5 (d, 3JCF = 5.0 Hz); 19F-NMR (CDCl3, 282 
MHz): δ -107.8 (ddd, JFF = 245.3 Hz, (JFH)1 = 28.2 Hz, (JFH)2 = 11.3 Hz, 1F), -109.2 (ddd, JFF = 245.3 
Hz, (JFH)1 = 28.2 Hz, (JFH)2 = 11.3 Hz, 1F); HRMS (ES) calc. for (M++1) C17H20F2NO3: 324.1406; 
found: 324.1406.  
 
 
Ethyl 4-(1,1-difluorobut-3-en-1-yl)-2-methyl-6-methylene-5,6-dihydro-4H-1,3-oxazine-4-carbo-
xylate. Starting from 50 mg of 2.34d, according to general procedure described above, 44 mg of a 
colourless oil corresponding to 2.35d were isolated in 88% (98%) yield. 1H-NMR (CDCl3, 300 MHz): 
δ 1.25 (t, J = 7.1 Hz, 3H), 2.10 (s, 3H), 2.60 (dt, J1 = 14.4 Hz, J2 = 1.8 Hz, 1H), 2.64-2.82 (m, 1H), 
2.94 (d, J = 14.7 Hz, 1H), 2.90-3.10 (m, 1H), 4.21 (q, J = 7.2 Hz, 2H), 4.28 (t, J = 1.7 Hz, 1H), 4.63 (t, 
J = 1.7 Hz, 1H), 5.17-5.20 (m, 1H), 5.24 (dd, J1 = 2.7 Hz, J2 = 1.4 Hz, 1H), 5.79-5.93 (m, 1H); 13C-
NMR (CDCl3, 125.3 MHz): δ 14.0, 21.0, 27.7, 36.8 (t, 2JCF = 23.8 Hz), 62.2, 66.5 (dd, (2JCF)1 = 26.3 
Hz, (2JCF)2 = 25.1 Hz), 93.9, 120.4, 121.6 (t, 1JCF = 250.0 Hz), 128.5 (t, 3JCF = 4.4 Hz), 149.4, 157.8, 
168.5 (d, 3JCF = 3.8 Hz); 19F-NMR (CDCl3, 282 MHz): δ -108.6 (ddd, JFF = 248.2 Hz, (JFH)1 = 25.4 Hz, 
(JFH)2 = 11.3 Hz, 1F), -109.8 (ddd, JFF = 248.2 Hz, (JFH)1 = 25.4 Hz, (JFH)2 = 11.3 Hz, 1F); HRMS (ES) 
calc. for (M++1) C13H18F2NO3: 274.1249; found: 274.1248.  
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Ethyl 2-ethyl-6-methylene-4-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazine-4-carboxylate. Follo-
wing the general procedure described above, 31 mg of 2.35e as a colourless oil in 61% (95%) yield, 
starting from 50 mg of 2.34e. 1H-NMR (CDCl3, 300 MHz): δ 1.21 (t, J = 7.5 Hz, 3H), 1.27 (t, J = 7.1 
Hz, 3H), 2.40 (q, J = 7.6 Hz, 2H), 2.60 (dt, J1 = 14.7 Hz, J2 = 1.8 Hz, 1H), 2.96 (d, J = 14.4 Hz, 1H), 
4.20-4.31 (m, 2H), 4.34 (t, J = 1.8 Hz, 1H), 4.72 (t, J = 1.8 Hz, 1H); 13C-NMR (CDCl3, 125.3 MHz): δ 
10.4, 13.9, 28.1, 28.1 (q, 3JCF = 2.5 Hz), 62.8, 65.0 (q, 2JCF = 28.0 Hz), 94.8, 123.5 (q, 1JCF = 281.9 
Hz), 148.0, 162.9, 166.3; 19F-NMR (CDCl3, 282 MHz): δ -77.6 (s, 3F); HRMS (ES) calc. for (M++1) 
C11H15F3NO3: 266.0999; found: 266.0987.  
 
 
Ethyl 2-methyl-6-methylene-4-phenyl-5,6-dihydro-4H-1,3-oxazine-4-carboxylate. Following the 
general procedure described above, 38 mg of 2.35f as a colourless oil in 76% yield, starting from 50 
mg of 2.34f. 1H-NMR (CDCl3, 300 MHz): δ 1.09 (t, J = 7.1 Hz, 3H), 2.11 (s, 3H), 2.62 (d, J = 14.4 
Hz, 1H), 3.07 (d, J = 14.1 Hz, 1H), 4.00-4.19 (m, 2H), 4.10-4.11 (m, 1H), 4.47 (dt, J1 = 1.5 Hz, J2 = 
0.9 Hz, 1H), 7.16-7.29 (m, 3H), 7.36-7.40 (m, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 14.0, 21.2, 35.0, 
61.8, 64.3, 93.2, 125.6, 127.6, 128.5, 140.9, 150.5, 156.3, 172.1; HRMS (ES) calc. for (M++1) 
C15H18NO3: 260.1208; found: 260.1218.  
 
 
2-Methyl-6-methylene-4-phenyl-4-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazine. Following the 
method described above, 37 mg of 2.35g were obtained as a colourless oil in 74% yield starting from 
50 mg of 2.34g. 1H-NMR (CDCl3, 300 MHz): δ 2.18 (s, 3H), 2.86 (dt, J1 = 14.4 Hz, J2 = 1.8 Hz, 1H), 
3.06 (d, J = 14.4 Hz, 1H), 4.18 (t, J = 1.8 Hz, 1H), 4.53 (t, J = 1.8 Hz, 1H), 7.31-7.40 (m, 3H), 7.48-
7.51 (m, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 21.1, 30.3, 62.3 (q, 2JCF = 27.4 Hz), 94.1, 125.3 (q, 1JCF 
= 283.1 Hz), 127.3, 128.4, 128.5, 136.7, 148.9, 157.4; 19F-NMR (CDCl3, 282 MHz): δ -79.0 (s, 3F); 
HRMS (ES) calc. for (M++1) C13H12F3NO: 256.0871; found: 256.0860.  
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2.5.4.3. General procedure for the hydrolysis of oxazines.  
 
 
A suspension of the corresponding oxazine 2.35 in water was stirred at room temperature until TLC 
showed total consumption of the starting material. The mixture was extracted with EtOAc. Combined 
organic layers were dried over anhydrous Na2SO4. Then, solvents were removed under reduced 
pressure and crude mixture was purified by flash chromatography, isolating the final products in 
quantitative yields.  
 
 
Ethyl (S)-2-acetamido-4-oxo-2-(trifluoromethyl)pentanoate. Following the general procedure 
described above, starting from 30 mg of (S)-2.35a, 32 mg of (S)-2.36a were isolated as a yellow oil in 
99% yield. [α]25D = +9.1 (c = 1.0 in CHCl3); 1H-NMR (CDCl3, 300 MHz): δ 1.29 (t, J = 7.2 Hz, 3H), 
2.01 (s, 3H), 2.19 (s, 3H), 3.27 (d, J = 18.0 Hz, 1H), 4.28-4.38 (m, 2H), 4.57 (d, J = 17.7 Hz, 1H), 6.67 
(br s, 1H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.7, 24.5, 29.4, 41.1, 62.3 (q, 2JCF = 28.9 Hz), 63.9, 123.4 
(q, 1JCF = 286.9 Hz), 166.3, 170.0, 203.2; 19F-NMR (CDCl3, 282 MHz): δ -75.9 (s, 3F); HRMS (ES) 
calc. for (M++1) C10H15F3NO4: 270.0948; found: 270.0945.  
 
 
Ethyl 2-acetamido-2-(difluoro(phenyl)methyl)-4-oxopentanoate. Starting from 30 mg of 2.35b, 
according to general procedure described above, 31 mg of a colourless oil corresponding to 2.36b 
were isolated in 99% yield. 1H-NMR (CDCl3, 300 MHz): δ 1.24 (t, J = 7.1 Hz, 3H), 1.93 (s, 3H), 2.16 
(s, 3H), 3.36 (d, J = 18.0 Hz, 1H), 4.18-4.28 (m, 2H), 4.53 (d, J = 18.0 Hz, 1H), 6.46 (br s, 1H), 7.34-
7.50 (m, 5H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.8, 24.6, 29.5, 41.8, 63.1, 66.2 (t, 2JCF = 29.4 Hz), 
120.3 (t, 1JCF = 256.9 Hz), 126.3 (t, 3JCF = 6.3 Hz), 128.1, 130.6, 132.7 (t, 2JCF = 26.3 Hz), 168.2 (dd, 
(3JCF)1 = 3.4 Hz, (3JCF)2 = 1.3 Hz), 169.5, 204.1; 19F-NMR (CDCl3, 282 MHz): δ -102.4 (d, JFF = 245.3 
Hz, 1F), -103.9 (d, JFF = 242.5 Hz, 1F); HRMS (ES) calc. for (M++1) C16H20F2NO4: 328.1355; found: 
328.1347.  
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Ethyl 2-acetamido-2-(1,1-difluoro-2-phenylethyl)-4-oxopentanoate. According to the general 
procedure described above, 21 mg of 2.36c were isolated in 99% yield as a colourless oil starting from 
20 mg of 2.35c. 1H-NMR (CDCl3, 300 MHz): δ 1.28 (t, J = 7.2 Hz, 3H), 1.98 (s, 3H), 2.19 (s, 3H), 
3.16-3.28 (m, 2H), 3.29 (d, J = 17.7 Hz, 1H), 4.24-4.35 (m, 2H), 4.47 (d, J = 17.7 Hz, 1H), 6.80 (br s, 
1H), 7.24-7.34 (m, 5H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.8, 24.5, 29.6, 39.0 (t, 2JCF = 23.8 Hz), 
41.5 (t, 3JCF = 2.5 Hz), 63.2, 65.4 (t, 2JCF = 26.3 Hz), 121.6 (t, 1JCF = 254.3 Hz), 127.4, 128.3, 130.7, 
131.7 (t, 3JCF = 2.5 Hz), 168.6 (t, 3JCF = 2.5 Hz), 170.2, 204.3; 19F-NMR (CDCl3, 282 MHz): δ -105.2 
(dt, (JFH)1 = 22.6 Hz, (JFH)2 = 14.1 Hz, 2F);  HRMS (ES) calc. for (M++1) C17H21F2NO4: 342.1511; 
found: 342.1519.  
 
 
Ethyl 2-acetamido-3,3-difluoro-2-(2-oxopropyl)-5-hexenoate. Following the general procedure 
described above, starting from 20 mg of 2.35d, 21 mg of 2.36d were isolated as a colourless oil in 
99% yield. 1H-NMR (CDCl3, 300 MHz): δ 1.26 (t, J = 7.2 Hz, 3H), 1.98 (s, 3H), 2.15 (s, 3H), 2.54-
2.86 (m, 2H), 3.22 (d, J = 17.7 Hz, 1H), 4.23-4.33 (m, 2H), 4.39 (d, J = 17.7 Hz, 1H), 5.19 (ddd, J1 = 
10.5 Hz, J2 = 3.0 Hz, J3 = 1.2 Hz, 1H), 5.22-5.25 (m, 1H), 5.79 (dddd, J1 = 17.1 Hz, J2 = 10.2 Hz, J3 = 
6.9 Hz, J4 = 6.9 Hz, 1H), 6.75 (br s, 1H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.8, 24.5, 29.5, 37.4 (t, 
2JCF = 23.8 Hz), 41.5 (t, 3JCF = 1.9 Hz), 63.2, 65.1 (t, 2JCF = 26.3 Hz), 120.7, 121.9 (t, 1JCF = 253.7 Hz), 
127.9 (t, 3JCF = 4.4 Hz), 168.4 (t, 3JCF = 2.5 Hz), 170.1, 204.2; 19F-NMR (CDCl3, 282 MHz): δ -106.0 
(ddd, (JFH)1 = 21.9 Hz, (JFH)2 = 18.6 Hz, (JFH)3 = 15.0 Hz, 2F); HRMS (ES) calc. for (M++1) 
C13H20F2NO4: 292.1355; found: 292.1351.  
 
 
Ethyl 4-oxo-2-propionamido-2-(trifluoromethyl)pentanoate. Following the method described 
above, 32 mg of 2.36e (99% yield) were obtained as a colourless oil starting from 30 mg of 2.35e. 1H-
NMR (CDCl3, 300 MHz): δ 1.11 (t, J = 7.7 Hz, 3H), 1.29 (t, J = 7.2 Hz, 3H), 2.18 (s, 3H), 2.25 (q, J = 
7.6 Hz, 2H), 3.26 (dd, J1 = 18.0 Hz, J2 = 0.9 Hz, 1H), 4.28-4.38 (m, 2H), 4.58 (d, J = 17.7 Hz, 1H), 
6.66 (br s, 1H); 13C-NMR (CDCl3, 125.3 MHz): δ 9.4, 13.7, 29.5, 30.6, 41.2, 62.9 (q, 2JCF = 28.8 Hz), 
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63.9, 123.5 (q, 1JCF = 286.9 Hz), 166.4, 173.7, 203.2; 19F-NMR (CDCl3, 282 MHz): δ -76.0 (s, 3F); 
HRMS (ES) calc. for (M++1) C11H17F3NO4: 284.1104; found: 284.1113.  
 
 
Ethyl 2-acetamido-4-oxo-2-phenylpentanoate. Following the general procedure described above, 
starting from 20 mg of 2.35f, 18 mg of 2.36f were isolated as a colourless oil in 84% yield. 1H-NMR 
(CDCl3, 300 MHz): δ 1.15 (t, J = 7.1 Hz, 3H), 2.00 (s, 3H), 2.19 (s, 3H), 3.67 (d, J = 18.0 Hz, 1H), 
4.05-4.25 (m, 2H), 4.40 (d, J = 18.0 Hz, 1H), 7.21 (br s, 1H), 7.25-7.37 (m, 3H), 7.40-7.44 (m, 2H); 
13C-NMR (CDCl3, 75.5 MHz): δ 13.7, 24.0, 30.2, 46.6, 62.3, 62.4, 125.5, 128.0, 128.6, 138.4, 168.9, 
171.8, 205.8; HRMS (ES) calc. for (M++1) C15H20NO4: 278.1314; found: 278.1322.  
 
 
N-(1,1,1-trifluoro-4-oxo-2-phenylpentan-2-yl)acetamide. According to the general procedure 
described above,148 21 mg of 2.36g were isolated in 99% yield as a white solid starting from 20 mg of 
2.35g. m.p. 144-146 ºC; 1H-NMR (CDCl3, 300 MHz): δ 2.08 (s, 3H), 2.17 (s, 3H), 3.40 (d, J = 16.8 
Hz, 1H), 3.82 (d, J = 16.8 Hz, 1H), 6.47 (br s, 1H), 7.33-7.46 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): 
δ 24.2, 31.5, 43.4 (q, 3JCF = 0.8 Hz), 63.3 (q, 2JCF = 27.9 Hz), 125.2 (q, 1JCF = 286.1 Hz), 126.0 (q, 4JCF 
= 1.5 Hz), 128.6, 128.7, 135.8 (q, 3JCF = 0.8 Hz), 170.1, 203.9; 19F-NMR (CDCl3, 282 MHz): δ -74.6 
(s, 3F); HRMS (ES) calc. for (M++1) C13H15F3NO2: 274.0977; found: 274.9994.  
 
 
2.5.4.4. General procedure for the preparation of dihydropyridinones.  
 
 
Over a suspension of the corresponding homopropargyl amide 2.34 or oxazines 2.35 (1.0 equiv, 0.12 
mmol) and Au(PPh3)Cl (5 mol%) in dried MeOH (0.05 M, 2.5 mL), AgOTf (5 mol%) was added. The 
reaction mixture was stirred at room temperature until TLC showed total consumption of starting 
                                                       
148 In this case, a catalytic amount of a Lewis acid such as Au(PPh3)Cl (5 mol%) was necessary to achieve the hydrolysis.  
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material. Then, solvents were removed under reduced pressure and crude mixture was purified by 
flash chromatography.  
 
 
Ethyl (S)-6-methyl-4-oxo-2-(trifluoromethyl)-1,2,3,4-tetrahydropyridin-2-carboxylate. Following 
the general procedure described above, 47 mg of (S)-2.37a (colourless oil) were obtained from 50 mg 
of (S)-2.34a in 93% yield. [α]25D = +64.4 (c = 1.0 in CHCl3); 1H-NMR (CDCl3, 300 MHz): δ 1.30 (t, J 
= 7.1 Hz, 3H), 2.06 (s, 3H), 2.87 (d, J = 16.8 Hz, 1H), 3.00 (d, J = 16.8 Hz, 1H), 4.26-4.36 (m, 2H), 
5.05 (s, 1H), 5.33 (br s, 1H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.8, 21.3, 36.6, 63.9, 65.6 (q, 2JCF = 
28.9 Hz), 101.2, 123.5 (q, 1JCF = 286.9 Hz), 159.7, 166.7, 187.4; 19F-NMR (CDCl3, 282 MHz): δ -77.5 
(s, 3F); HRMS (ES) calc. for (M++1) C10H13F3NO3: 252.0842; found: 252.0835.  
 
 
Ethyl 2-(difluoro(phenyl)methyl)-6-methyl-4-oxo-1,2,3,4-tetrahydropyridin-2-carboxylate. Follo-
wing the method described above, 47 mg of 2.37b (93% yield) were obtained as a white solid starting 
from 50 mg of 2.34b. m.p. 147-149 ºC; 1H-NMR (CDCl3, 300 MHz): δ 1.18 (t, J = 7.2 Hz, 3H), 1.99 
(s, 3H), 2.82 (d, J = 16.5 Hz, 1H), 2.90 (d, J = 16.8 Hz, 1H), 4.12-4.23 (m, 2H), 4.86 (s, 1H), 5.36 (br 
s, 1H), 7.32-7.50 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.8, 21.4, 37.6 (t, 3JCF = 2.3 Hz), 63.0, 
68.5 (t, 2JCF = 28.3 Hz), 100.8, 120.2 (t, 1JCF = 256.3 Hz), 126.2 (t, 3JCF = 6.4 Hz), 128.3, 130.9, 132.0 
(t, 2JCF = 26.0 Hz), 160.1, 168.8 (d, 3JCF = 2.3 Hz), 188.7; 19F-NMR (CDCl3, 282 MHz): δ -104.2 (d, 
JFF = 248.2 Hz, 1F), -107.0 (d, JFF = 248.2 Hz, 1F); HRMS (ES) calc. for (M++1) C16H18F2NO3: 
310.1249; found: 310.1260.  
 
 
Ethyl 2-(1,1-difluoro-2-phenylethyl)-6-methyl-4-oxo-1,2,3,4-tetrahydropyridin-2-carboxylate. 
Following the general procedure described above, 40 mg of 2.37c (white solid) were obtained from 50 
mg of 2.34c in 80% yield. m.p. 104-106 ºC; 1H-NMR (CDCl3, 300 MHz): δ 1.41 (t, J = 7.2 Hz, 3H), 
2.11 (s, 3H), 2.95 (d, J = 16.5 Hz, 1H), 3.13 (d, J = 16.2 Hz, 1H), 3.38-3.45 (m, 2H), 4.36-4.43 (m, 
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2H), 5.14 (s, 1H), 5.39 (br s, 1H), 7.36-7.49 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 14.0, 21.4, 37.9 
(t, 3JCF = 2.3 Hz), 38.7 (t, 2JCF = 24.2 Hz), 63.2, 68.3 (t, 2JCF = 25.3 Hz), 100.9, 121.1 (t, 1JCF = 252.9 
Hz), 127.7, 128.4, 130.7, 130.9 (t, 3JCF = 2.3 Hz), 160.6, 169.1 (d, 3JCF = 3.0 Hz), 188.5; 19F-NMR 
(CDCl3, 282 MHz): δ -106.1 (ddd, JFF = 251.0 Hz, (JFH)1 = 25.4 Hz, (JFH)2 = 11.3 Hz, 1F), -108.4 (ddd, 
JFF = 251.0 Hz, (JFH)1 = 25.4 Hz, (JFH)2 = 11.3 Hz, 1F); HRMS (ES) calc. for (M++1) C17H20F2NO3: 
324.14.06; found: 324.1408.  
 
 
Ethyl 2-(1,1-difluorobut-3-en-1-yl)-6-methyl-4-oxo-1,2,3,4-tetrahydropyridin-2-carboxylate. 
Starting from 50 mg of 2.34d, according to general procedure described above, 36 mg of a colourless 
oil corresponding to 2.37d were isolated in 72% yield. 1H-NMR (CDCl3, 300 MHz): δ 1.27 (t, J = 7.2 
Hz, 3H), 2.03 (s, 3H), 2.62-2.79 (m, 2H), 2.75 (d, J = 16.2 Hz, 1H), 2.95 (d, J = 16.5 Hz, 1H), 4.20-
4.30 (m, 2H), 5.00 (s, 1H), 5.22 (ddd, J1 = 12.6 Hz, J2 = 2.7 Hz, J3 = 1.2 Hz, 1H), 5.28 (ddd, J1 = 6.0 
Hz, J2 = 2.4 Hz, J3 = 1.2 Hz, 1H), 5.42 (br s, 1H), 5.80 (dddd, J1 = 17.1 Hz, J2 = 10.5 Hz, J3 = J4 = 6.9 
Hz, 1H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.9, 21.4, 37.1 (t, 2JCF = 24.2 Hz), 37.9 (t, 3JCF = 2.3 Hz), 
63.1, 68.1 (t, 2JCF = 24.9 Hz), 100.8, 121.3 (t, 1JCF = 253.3 Hz), 121.3, 127.2 (t, 3JCF = 4.9 Hz), 160.7, 
169.0 (d, 3JCF = 3.0 Hz), 188.5; 19F-NMR (CDCl3, 282 MHz): δ -107.1 (ddd, JFF = 251.0 Hz, (JFH)1 = 
25.4 Hz, (JFH)2 = 14.1 Hz, 1F), -109.0 (ddd, JFF = 251.0 Hz, (JFH)1 = 25.4 Hz, (JFH)2 = 14.1 Hz, 1F); 
HRMS (ES) calc. for (M++1) C13H18F2NO3: 274.1249; found: 274.1254.  
 
 
Ethyl 6-ethyl-4-oxo-2-(trifluoromethyl)-1,2,3,4-tetrahydropyridin-2-carboxylate. Following the 
general procedure described above, starting from 50 mg of 2.34e, 35 mg of 2.37e were isolated as a 
yellow oil in 70% yield. 1H-NMR (CDCl3, 300 MHz): δ 1.20 (t, J = 7.5 Hz, 3H), 1.31 (t, J = 7.2 Hz, 
3H), 2.31 (q, J = 7.6 Hz, 2H), 2.89 (d, J = 17.1 Hz, 1H), 3.02 (d, J = 16.8 Hz, 1H), 4.27-4.37 (m, 2H), 
5.09 (s, 1H), 5.20 (br s, 1H); 13C-NMR (CDCl3, 75.5 MHz): δ 11.3, 13.8, 28.2, 36.8, 63.9, 65.5 (q, 2JCF 
= 28.9 Hz), 99.6, 123.5 (q, 1JCF = 287.2 Hz), 164.8, 166.7, 187.7; 19F-NMR (CDCl3, 282 MHz): δ -
77.5 (s, 3F); HRMS (ES) calc. for (M++1) C11H15F3NO3: 266.0999; found: 266.0991.  
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Ethyl 6-methyl-4-oxo-2-phenyl-1,2,3,4-tetrahydropyridine-2-carboxylate. Starting from 50 mg of 
2.34f, according to general procedure described above, 38 mg of a yellowish oil corresponding to 
2.37f were isolated in 75% yield. 1H-NMR (CDCl3, 300 MHz): δ 1.07 (t, J = 7.2 Hz, 3H), 1.92 (s, 3H), 
2.90 (d, J = 2.4 Hz, 2H), 4.00-4.14 (m, 2H), 4.83 (d, J = 0.9 Hz, 1H), 5.79 (br s, 1H), 7.17-7.29 (m, 
5H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.9, 21.2, 43.9, 62.4, 65.7, 100.7, 125.2, 128.5, 128.8, 138.2, 
160.2, 171.9, 190.0; HRMS (ES) calc. for (M++1) C15H18NO3: 260.1208; found: 260.1218.  
 
 
6-Methyl-2-phenyl-2-(trifluoromethyl)-2,3-dihydropyridin-4(1H)-one. Following the general 
procedure described above, 38 mg of 2.37g (white solid) were obtained from 50 mg of 2.34g in 76% 
yield. m.p. 130-132 ºC; 1H-NMR (CDCl3, 300 MHz): δ 2.10 (s, 3H), 3.11 (s, 2H), 4.99 (s, 1H), 5.63 
(br s, 1H), 7.37-7.45 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 21.4, 40.1, 64.6 (q, 2JCF = 27.9 Hz), 
101.2, 125.0 (q, 1JCF = 284.6 Hz), 126.5, 128.9, 129.4, 134.3, 158.7, 188.5; 19F-NMR (CDCl3, 282 
MHz): δ -78.2 (s, 3F); HRMS (ES) calc. for (M++1) C13H13F3NO: 256.0871; found: 256.0859.  
 
 
2.5.4.5. Isolation and characterization of intermediate complex 2.35a·Au(PPh3)OTf. 
 
 
In a flask under inert atmosphere, a suspension of Au(PPh3)Cl (1.0 equiv, 20 mg, 0.04 mmol) and 
AgOTf (1.0 equiv, 10 mg, 0.04 mmol) in CDCl3, previously distilled over P2O5, was prepared. The 
mixture was stirred for 10 minutes at room temperature and then filtered over Celite in order to 
remove the precipitated silver salt. The filtrate was transferred to another flask containing oxazine 
2.35a (1.0 equiv, 10 mg, 0.04 mmol), previously prepared according to the procedure described in 
section 2.5.4.2. The mixture was stirred for ca. 10 minutes and immediately characterized by NMR 
spectroscopy. 1H-NMR (CDCl3, 500 MHz): δ 1.28 (t, J = 7.1 Hz, 3H), 2.73 (s, 3H), 3.23 (d, J = 15.6 
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Hz, 1H), 3.39 (d, J = 15.6 Hz, 1H), 4.35 (q, J = 7.1 Hz, 2H), 4.71 (t, J = 2.1 Hz, 1H), 5.01(t, J = 2.0 
Hz, 1H), 7.49-7.59 (m, 15H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.7, 25.7, 27.3, 64.6, 66.0 (q, 2JCF = 
28.0 Hz), 98.8, 120.8 (q, 1JCF = 319.5 Hz), 122.7 (q, 1JCF = 285.3 Hz), 127.4 (d, 1JCP = 65.2 Hz), 129.5 
(d, 3JCP = 11.3 Hz), 132.5 (d, 4JCP = 2.5 Hz), 134.0 (d, 2JCP = 13.8 Hz), 146.1, 165.5, 171.8; 19F-NMR 
(CDCl3, 468.9 MHz): δ -73.6 (s, 3F), -78.5 (s, 3F); 31P-NMR (CDCl3, 201.8 MHz): δ 29.6 (s, 1P); 
LRMS (MALDI-TOF) calc. for (M+-OTf) C28H27AuF3NO3P: 710.13; found: 710.27.  
 
 
2.5.4.6. X-Ray ORTEP of compound (-)-(S)-2.34a.149 
 
 
Figure 2.7. ORTEP of compound (S)-2.34a. 
 
                                                       
149 CCDC 984448 contains the supplementary crystallographic data of compound (S)-2.34a. These data can be obtained free 
of charge at www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12 Union 
Road, Cambridge CB2 1EZ, UK; fax: (internat.) +44(1223)336-033, e-mail: deposit@ccdc.cam.ac.uk]. 
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Chapter 3  
Enantioselective 1,1-arylborylation of terminal alkenes.  Merging chiral 
anion phase-transfer (CAPT) and transition metal catalysis  
 
 
3.1. Introduction and current state-of-the-art.  
 
Probably, one of the most important and challenging issues for reaching new achievements in 
asymmetric catalysis stands on the identification of novel and generic activation modes, induction and 
reactivity. Once an activation mode is established, it is relatively straightforward to use it as a platform 
for designing new asymmetric transformations, as well as new families of catalysts.  
A generic activation mode in asymmetric catalysis describes a reactive species that can 
participate in many reaction types with consistently high levels of enantioselectivity. Such reactive 
species arises from the interaction of a chiral catalyst with a key functional group on the substrate in a 
highly organized and predictable manner. Based on the nature of this interaction, a well-defined 
number of key activation modes have been established (Figure 3.1).  
 
 
 
Among them, Lewis acid catalysis is possibly the most venerable mode (Figure 3.1a).150 Most 
commonly, this activation mode involves a Lewis basic ligand, holding chirality, ancillary attached to 
                                                       
150 Parmar, D.; Sugiono, E.; Raja, S.; Rueping, M. Chem. Rev. 2014, 114, 9047.  
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Figure 3.1. Activation modes in asymmetric catalysis.
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a Lewis acidic metal, which ultimately transfers chiral information to the substrate through the 
establishment of coordinative interactions.  
A conceptually analogous activation mode, wherein the metal is replaced by a proton, is 
referred to as Brönsted acid catalysis (Figure 3.1b).151 In this respect, chiral phosphoric acids, 
introduced by Akiyama and Terada,152 have been extensively used. Their high acidity permits the 
activation of a broad range of substrates. Nevertheless, it also leads to an element of mechanistic 
uncertainty, as to whether the electrophile is essentially completely protonated and, thus, 
enantioinduction stands on an electrostatic ion-pairing interaction with the catalyst, or whether 
hydrogen-bonding interactions are responsible.  
Taking this idea further, a mode of catalysis based on an ion-pair linked by electrostatic 
interactions can be considered apart, which is referred to as ion-pairing catalysis (Figure 3.1c).153 
Charged reagents and intermediates are ubiquitous species in organic chemistry. The interaction of 
these ionic species with chiral opposite-charged molecules has emerged as a powerful strategy in 
asymmetric catalysis.  
Ion-pairing catalysis is ruled by Coulomb’s law, E=(q1·q2)/(4π·ε·ε0·r), which describes the 
attractive potential energy (E) between two opposite charged species (q1, q2). The magnitude of the 
electrostatic interaction is inversely related to the dielectric constant of the medium (ε). Thus, contact 
ion pairs would be energetically favourable in nonpolar solvents of low dielectric constant, whereas in 
solvents with higher dielectric constant, those pairs tend to be disrupted.  
According to Anslyn and Dougherty,154 an ion pair exists “when a cation and an anion are 
close enough in space that the energy associated with their electrostatic attraction is larger than the 
thermal energy (RT) available to separate them. This means that the ions stay associated longer than 
the time required for Brownian motion to separate non-interacting species”. Arguably, inherent less 
directionality ascribed to coulombic interactions underlies the main challenge in designing 
stereoselective catalysts that operate under ion-pair principle.  
The implementation of this ion-pairing activation mode by its merge with phase-transfer 
principle, established an innovative and general approach in asymmetric synthesis coined as chiral 
anion phase-transfer (CAPT) catalysis by the Toste group in 2011.155 Attending to this principle, a 
lipophilic chiral phosphate salt (organocatalyst) activates, through ion-exchange, a cationic reagent or 
intermediate, otherwise insoluble and unreactive in a nonpolar media, bringing it into solution, while 
providing a chiral environment (Scheme 3.1). As a result, unselective background reactivity is 
                                                       
151 (a) Terada, M. Synthesis, 2010, 1929. (b) Akiyama, T. Chem. Rev. 2007, 107, 5744. 	  
152 (a) Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K. Angew. Chem. Int. Ed. 2004, 43, 1566. (b) Uraguchi, D.; Terada, M. J. 
Am. Chem. Soc. 2004, 126, 5356. 	  
153 (a) Brak, K.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2013, 52, 534. (b) Phipps, R. J.; Hamilton, G. L.; Toste, F. D. Nature 
Chem. 2012, 4, 603. (c) Mahlau, M.; List, B. Isr. J. Chem. 2012, 52, 630. (d) Mayer, S.; List, B. Angew. Chem. Int. Ed. 2006, 
45, 4193. 	  
154 Anslyn, E. V.; Dougherty, D. A. Modern Physical Organic Chemistry, University Science Books, Sausalito, 2006. 	  
155 Rauniyar, V.; Lackner, A. D.; Hamilton, G. L.; Toste, F. D. Science, 2011, 334, 1681. 	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minimal, despite the use of a large excess of reagent relative to the catalyst or its high intrinsic 
reactivity.  
 
 
 
The potential of chiral anion phase-transfer technology was recently established throughout 
the enantioselective fluorination of olefins (Scheme 3.2). Excellent yields and enantioselectivities were 
achieved using Selectfluor as the electrophilic fluorinating reagent operating under CAPT principle.  
 
 
 
Since their seminal contribution in 2011, the Toste group has vastly explored this state-of-the-
art principle, applying CAPT strategy to carry out the enantioselective halofunctionalization of 
Scheme 3.1. Chiral anion phase-transfer (CAPT) catalysis (Toste, 2011).
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different olefinic systems (Scheme 3.2), including enamides,156 1,3-dienes,157 phenols,158 or allylic 
alcohols,159 besides showcasing the versatility of this protocol by its successful combination with 
classical chemical approaches like enamine catalysis160 or the use of directing groups.161  
The excellent results obtained in terms of yield and enantioinduction led to the exploration of 
alternative amenable electrophilic reagents (Figure 3.2), pushing the boundaries of CAPT catalysis.  
 
 
 
Besides halogen-based electrophiles,162 CAPT strategy was amenable applicable in oxidative 
reactions.163 Ongoing work in the Toste lab showed aryl diazonium salts’ competency as nitrogen-
centered electrophiles, since electron-rich olefins 3.1 were efficiently diazenated in high yields and 
enantioselectivities (Scheme 3.3).164 Aryl diazonium salts have properties akin to other reagents 
successfully employed in CAPT, as they are highly reactive electrophiles that are sparsely soluble in a 
range of nonpolar solvents.  
 
                                                       
156 (a) Phipps, R. J.; Hiramatsu, K.; Toste, F. D. J. Am. Chem. Soc. 2012, 134, 8376. (b) Honjo, T.; Phipps, R. J.; Rauniyar, 
V.; Toste, F. D. Angew. Chem. Int. Ed. 2012, 51, 9684. 	  
157 Shunatona, H. P.; Früh, N.; Wang, Y.-M.; Rauniyar, V.; Toste, F. D. Angew. Chem. Int. Ed. 2013, 52, 7724. 	  
158 Phipps, R. J.; Toste, F. D. J. Am. Chem. Soc. 2013, 135, 1268. 	  
159 Zi, W.; Wang, Y.-M.; Toste, F. D. J. Am. Chem. Soc. 2014, 136, 12864. 	  
160 Yang, X.; Phipps, R. J.; Toste, F. D. J. Am. Chem. Soc. 2014, 136, 5225. 	  
161 Wu, J.; Wang, Y.-M.; Drljevic, A.; Rauniyar, V.; Phipps, R. J.; Toste, F. D. Proc. Nat. Acad. Sci. U.S.A. 2013, 110, 
13729. 	  
162 Wang, Y.-M.; Wu, J.; Hoong, C.; Rauniyar, V.; Toste, F. D. J. Am. Chem. Soc. 2012, 134, 12928.  
163 (a) Neel, A. J.; Hehn, J. P.; Tripet, P. F.; Toste, F. D. J. Am. Chem. Soc. 2013, 135, 14044; (b) Lackner, A. D.; Samant, A. 
V.; Toste, F. D. J. Am. Chem. Soc. 2013, 135, 14090. 	  
164 (a) Nelson, H. M.; Patel, J. S.; Shunatona, H. P.; Toste, F. D. Chem. Sci. 2015, 6, 170. (b) Nelson, H. M.; Reisberg, S. H.; 
Shunatona, H. P.; Patel, J. S.; Toste, F. D. Angew. Chem. Int. Ed. 2014, 53, 5600. 	  
(X =  F, Br, I)
halogenation oxidation C-N bond formation
Figure 3.2. Cationic electrophiles amenable in CAPT catalysis.
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Actually, aryl diazonium species are also proven electrophiles utilized for the construction of 
C–C bonds. So we wondered if aryl diazonium salts may act as a viable source of electrophilic carbon 
in CAPT catalysis. In this respect, the Heck-Matsuda reaction is a variant of the Heck reaction that 
employs aryl diazonium salts as the electrophilic coupling partner instead of aryl halides or aryl 
triflates. In a recent related example, Sigman and coworkers reported the 1,1-diarylation of ethylene 
and allylic carbonates (Scheme 3.4a).165 Outstandingly, the unusual 1,1-regioselectivity observed 
stands on the reversibility of the migratory insertion step and the intermediacy of stabilized π-benzyl-
palladium species. The observed 1,1-regioselectivity was supported by isotopic labelling experiments 
(Scheme 3.4b), with 95% D-migration to β-carbon when deuterium-labelled substrate 3.3 was treated 
under reaction conditions.  
 
 
 
Nevertheless, enantioinduction in the Heck-Matsuda reaction has been always challenging, 
based on the reported incompatibility between the aryl diazonium salts and phosphine-type ligands 
routinely employed to transfer chiral information. Thus, despite the Heck-Matsuda reaction’s ease of 
operation, the transformation has resisted numerous attempts to render it enantioselective, until 
Sigman reported in 2012 the use of chiral bidentate diimine ligands, which allowed raising good levels 
of enantioinduction (Scheme 3.5).166  
 
                                                       
165 Saini, V.; Liao, L.; Wang, Q.; Jana, R.; Sigman, M. S. Org. Lett. 2013, 15, 5008.  
166 Werner, E. W.; Mei, T.-S.; Burckle, A. J.; Sigman, M. S. Science, 2012, 338, 1455.  
Scheme 3.4. (a) Previous work by Sigman (2013). (b) Deuterium labelling experiments.
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Under this scenario, we posited the union of CAPT with transition metal catalysis to utilize 
aryl diazonium salts as a source of electrophilic carbon. We envisaged that the combination of aryl 
diazonium salts with unprecedented cooperative transition metal-CAPT catalysis167 would provide an 
orthogonal approach to enantioselective arylation reactions.  
In this sense, we were specially intrigued by the aforementioned 1,1-difunctionalization 
reaction manifold. However, instead of an aryl boronic acid, we opted for the use of a boron 
nucleophilic source such as bis(pinacolato)diboron ester, B2(pin)2, which would ultimately provide 
chiral benzyl boronic esters.  
Enantioenriched organoboranes are ubiquitous substrates in modern organic chemistry. These 
are extremely valuable intermediates/reagents in chemical synthesis, since they can undergo a broad 
array of stereospecific and well-established transformations for the construction of either C–O, C–N, 
or C–C bonds (Figure 3.3).168 These transformations include synthetically useful oxidation, amination, 
protodeborylation, arylation, and importantly series of C-based homologations. Outstandingly, such 
further functionalization usually occurs preserving the stereogenic integrity of the C–B linkage.  
 
 
 
                                                       
167 Inamdar, S. M.; Shinde, V. S.; Patil, N. T. Org. Biomol. Chem. 2015, 13, 8116.  
168 Hall, D. G. Boronic Acids, 2nd ed.; Wiley-VCH: Weinheim, 2011. 	  
Scheme 3.5. Enantioselective Heck arylation of acyclic alkenyl alcohols (Sigman, 2012).
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Figure 3.3. Boronic ester transformations.
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The shown versatility attests for their privileged role in diversity-oriented synthesis (DOS),169 
providing remarkable breakthroughs in this arena.  
In particular, substituted scaffolds derived from benzyl boronic esters are common motifs 
featuring among current pharmaceuticals and natural products (Figure 3.4), becoming compelling 
chemical scaffolds/building blocks in drug discovery as well.  
 
 
 
Given the well-established and valuable role ascribed to organoboranes, borylation reactions 
constructing C–B bonds in a reliable, efficient and stereoselective manner are highly desirable. 
Devoted efforts from the chemical community have resulted in several catalytic enantioselective 
approaches, including:  
 
-Hydroborylation of alkenes. 170  Since the pioneered work by Brown in the 1950s, 171 
hydroborylation reaction, i.e. the syn-addition of a B–H bond across a C–C multiple bond, have been 
widely implemented, resulting in multiple metal-catalytic reactive systems, enabling boryl addition 
even onto C–heteroatom multiple bonds such as imines or aldehydes.  
 
 
 
                                                       
169 Schreiber, S. L. Nature 2009, 457, 153.  
170 Carroll, A. M.; O’Sullivan, T. P.; Guiry, P. J. Adv. Synth. Catal. 2005, 347, 609. For recent selected examples, see: (a) 
Guisán-Ceinos, M.; Parra, A.; Martín-Heras, V.; Tortosa, M. Angew. Chem. Int. Ed. 2016, 55, 6969. (b) Kubota, K.; 
Watanabe, Y.; Hayama, K.; Ito, H. J. Am. Chem. Soc. 2016, 138, 4338. (c) Shoba, V. M.; Thacker, N. C.; Bochat, A. J.; 
Takacs, J. M. Angew. Chem. Int. Ed. 2016, 55, 1465. (d) Kubota, K.; Yamamoto, E.; Ito, H. J. Am. Chem. Soc. 2015, 137, 
420.  
171 Brown, H. C.; Subba Rao, B. C. J. Am. Chem. Soc. 1956, 78, 2582.  
Figure 3.4. Selected pharmaceuticals.
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-Reduction of vinyl boronates.172 A few examples lying on the metal-catalyzed asymmetric 
hydrogenation of different families of alkenyl boronates, obtained by hydro- or diborylation reaction 
of alkynes, constitute another route of access.  
 
 
 
-Conjugate borylation.173 The metal-catalyzed β-borylation of α,β-unsaturated systems is 
probably the most extensively investigated strategy for the last years. Most of the reported 
transformations entail in situ generation of metal-boron species displaying as formal boron 
nucleophiles. In this sense, Cu(I) salts, in combination with different chiral ligands, have resulted quite 
effective. 174  Besides these, other metal-catalyzed (e.g. Rh) 175  and metal-free 176  selective boron 
additions onto α,β-unsaturated carbonyl-derived systems, including imines,177 nitriles,178 sulfones179 
and phosphine oxides,180 have been reported. Likewise, the stereocontrolled addition of organometallic 
reagents onto preformed β-borylated conjugated systems is known.181  
 
 
 
-Allylic borylation. Seminal report by Masuda and co-workers on the borylation of alkenyl 
triflates, 182  inspired the Hall group in the development of a new catalytic method for the 
                                                       
172 (a) Smilovic, I. G.; Casas-Arcé, E.; Roseblade, S. J.; Nettekoven, U.; Zanotti-Gerosa, A.; Kovacevic, M.; Casar, Z. 
Angew. Chem. Int. Ed. 2012, 51, 1014. (b) Ding, J.; Lee, J. C. H.; Hall, D. G. Org. Lett. 2012, 14, 4462. (c) Jung, H.-Y.; 
Feng, X.; Kim, H.; Yun, J. Tetrahedron, 2012, 68, 3444. (d) Morgan, J. B.; Morken, J. P. J. Am. Chem. Soc. 2004, 126, 
15338.  
173 Calow, A. D.; Whiting, A. Org. Biomol. Chem. 2012, 10, 5485.  
174 For recent selected examples, see: (a) Kubota, K.; Hayama, K.; Iwamoto, H.; Ito, H. Angew. Chem. Int. Ed. 2015, 54, 
8809. (b) Zhu, L.; Kitanosono, T.; Xu, P.; Kobayashi, S. Chem. Commun. 2015, 51, 11685. (c) Niu, Z.; Chen, J.; Chen, Z.; 
Ma, M.; Song, C.; Ma, Y. J. Org. Chem. 2015, 80, 602. (d) Luo, Y.; Roy, I. D.; Madec, A. G. E.; Lam, H. W. Angew. Chem. 
Int. Ed. 2014, 53, 4186.  
175 Toribatake, K.; Zhou, L.; Tsuruta, A.; Nishiyama, H. Tetrahedron, 2013, 69, 3551.  
176 (a) Wu, H.; Garcia, J. M.; Haeffner, F.; Radomkit, S.; Zhugralin, A. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2015, 137, 
10585. (b) La Cascia, E.; Sanz, X.; Bo, C.; Whiting, A.; Fernández, E. Org. Biomol. Chem. 2015, 13, 1328. (c) Wu, H. 
Radomkit, S.; O’Brien, J. M.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 8277. (d) Ibrahem, I.; Breistein, P.; Córdova, A. 
Chem. Eur. J. 2012, 18, 5175. (e) Bonet, A.; Gulyás, H.; Fernández, E. Angew. Chem. Int. Ed. 2010, 49, 5130.  
177 Solé, C.; Whiting, A.; Gulyás, H.; Fernández, E. Adv. Synth. Catal. 2011, 353, 376.  
178 Hirsch-Weil, D.; Abboud, K. A.; Hong, S. Chem. Commun. 2010, 46, 7525.  
179 Moure, A. L.; Arrayás, R. G.; Carretero, J. C. Chem. Commun. 2011, 47, 6701.  
180 Hornillos, V.; Vila, C.; Otten, E.; Feringa, B. L. Angew. Chem. Int. Ed. 2015, 54, 7867.  
181 Lee, J. C. H.; Hall, D. G. J. Am. Chem. Soc. 2010, 132, 5544.  
182 Murata, M.; Oyama, T.; Watanabe, S.; Masuda, Y. Synthesis, 2000, 778.  
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stereoselective preparation of allylboronates.183 Since that time, a few more contributions from Hall 
himself,184 Hoveyda185 and Ito,186 have appeared leading to the preparation of optically active linear 
and carbocyclic (γ-alkoxyallyl)boronates, all of them based on the metal-catalyzed enantioselective 
boryl substitution of either allyl triflates, carbonates, or acetals, respectively.  
 
 
 
-1,2-Metalate rearrangements. Organoboronate (negatively charged boron) species, resulting 
from the addition of an organometallic reagent to the electrophilic boron atom of an organoboron 
species, are known to participate in a wide range of reactions that occur by stereospecific 1,2-metallate 
rearrangements.187 These rearrangements usually occur via 1,2-carbon shift from boron to an adjacent 
sp3-hybridized electrophilic center, with concomitant released of an appropriate attached leaving 
group. Based on the aforementioned stereospecific 1,2-metalate rearrangement, the Aggarwal group 
showed that chiral boronic esters can be generated in high enantiomeric ratios from the reaction of 
boronic esters with lithiated non-racemic carbamates derived from the corresponding alcohols.188 The 
feasibility of Aggarwal’s approach is implemented by the very well established methodology for the 
preparation of chiral benzylic alcohols. Potential and versatility of this lithiation-borylation 
methodology has been firmly established through the highly stereocontrolled total synthesis of diverse 
natural products and pharmaceuticals, and constitutes the mainstream in a one-pot assembly line 
protocol for the iterative extension of a starting boronic ester, through what they coined as a reagent-
controlled homologation.189 Though in Aggarwal’s approach stereoselectivity of the metallate shift is 
driven by substrate control, a recent example from Morken’s laboratory showcased that it can be 
dictated as well by a chiral catalyst.190  
 
 
                                                       
183 Lessard, S.; Peng, F.; Hall, D. G. J. Am. Chem. Soc. 2009, 131, 9612.  
184 Ding, Y.; Hall, D. G. Angew. Chem. Int. Ed. 2013, 52, 8069. 	  
185 Guzman-Martínez, A.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10634. 	  
186 (a) Yamamoto, E.; Takenouchi, Y.; Ozaki, T.; Miya, T.; Ito, H. J. Am. Chem. Soc. 2014, 136, 16515. (b) Ito, H.; Okura, 
T.; Matsuura, K.; Sawamura, M. Angew. Chem. Int. Ed. 2010, 49, 560. 	  
187 (a) Negishi, E.-I. Org. React. 1985, 33, 1-246. (b) Aggarwal, V. K.; Fang, G. Y.; Ginesta, X.; Howells, D. M.; Zaja, M. 
Pure Appl. Chem. 2006, 78, 215.  
188 Scott, H. K.; Aggarwal, V. K. Chem. Eur. J. 2011, 17, 13124.  
189 Leonori, D.; Aggarwal, V. K. Acc. Chem. Res. 2014, 47, 3174.  
190 Zhang, L.; Lovinger, G. J.; Edelstein, E. K.; Szymaniak, A. A.; Chierchia, M. P.; Morken, J. P. Science, 2016, 351, 70.  
[Cu] cat.
LG
B(OR)2
R1
R2
R1
R2
(LG = leaving group)
R1
Li
OCbz
R2
R3B(OR)2
R1
B(OR)2
OCbz
R2
R3
B(OR)2
R1
R2
R3
R4
Li
OCbz
R5 B(OR)2
R3 R5
R1 R2
R4
	   136 
Beyond “classical” approaches, several methods have been recently reported for the 
preparation of enantioenriched benzyl boronates relying on further transformations over pre-formed 
gem-bis-boronic alkanes, but in multistep synthetic sequences (Scheme 3.6).  
 
 
 
For instance, Hall and Yun reported the use of chiral non-racemic gem-diboronates in chemo- 
but non-stereoselective coupling reactions (Scheme 3.6a-b). 191  Enantioenriched gem-diboronyl 
derivatives were accessed through the asymmetric borylation of β-boronyl acrylic derivatives and 
styrenes, respectively, prepared in turn by hydroborylation of corresponding propiolates, in which can 
be considered as a sophisticated evolution of the above-discussed classical approaches.  
More recently, in 2014, Morken et al. demonstrated the feasibility of an alternative related 
strategy entailing the palladium-catalyzed enantioselective Suzuki-Miyaura mono-cross-coupling of 
aryl and vinyl halides over readily accessed symmetric prochiral gem-diboronates (Scheme 3.6c).192 
Seminal Morken’s contribution served to inspire new useful routes for the desymmetrization of 
prochiral gem-diboronates, such as the copper-catalyzed addition of gem-diboron reagents to aryl and 
vinyl aldehydes.193  
 
 
                                                       
191 (a) Lee, J. C. H.; McDonald, R.; Hall, D. G. Nat. Chem. 2011, 3, 894. (b) Feng, X.; Jeon, H.; Yun, J. Angew. Chem. Int. 
Ed. 2013, 52, 3989.  
192 Sun, C.; Potter, B.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 6534.  
193 (a) Joannou, M. V.; Moyer, B. S.; Meek, S. J. J. Am. Chem. Soc. 2015, 137, 6176. (b) Potter, B.; Szymaniak, A. A.; 
Edelstein, E. K.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 17918.  
Scheme 3.6. Recent examples of enantioselective 1,1-arylborylation.
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3.2. Enantioselective Pd-catalyzed 1,1-arylborylation reaction.  
 
Given this perspective, the single-step installation of both the boronate and the aryl functional 
groups would be an ideal transformation from the perspective of both step-economy and synthetic 
divergence. Inspired by Sigman’s reported examples on 1,1-difunctionalization of alkenes,194 we 
consequently sought to expand CAPT strategy towards the direct 1,1-arylborylation of alkenes via a 
three-component Heck-Matsuda arylation-Miyaura borylation cascade reaction (Scheme 3.7).  
 
 
 
We hypothesized that a CAPT strategy could enable association of a chiral anion (PTC) with 
the key cationic Pd(II) intermediates involved in the enantiodetermining step (Scheme 3.8). Under 
basic conditions, metathesis between the insoluble aryl diazonium salt and a chiral lipophilic 
phosphate anion (PTC), would provide a soluble, chiral ion pair A. Oxidative addition of a Pd(0) 
complex, followed by migratory insertion of the alkenyl coupling partner would render the 
enantioenriched cationic Pd(II) complex C. Then, reversibility of migratory insertion would result in 
the formation of a stabilized π-benzyl palladium species E through sequential β-hydride elimination 
and reinsertion steps. Transmetalation with a nucleophilic boron source and final reductive elimination 
would yield the enantioenriched borylated product, while regenerate both catalysts, the Pd(0) species 
and the phase-transfer catalyst.  
 
                                                       
194 (a) Ref. 165.: Saini, V.; Liao, L.; Wang, Q.; Jana, R.; Sigman, M. S. Org. Lett. 2013, 15, 5008. (b) Saini, V.; Sigman, M. 
S. J. Am. Chem. Soc. 2012, 134, 11372. (c) Liao, L.; Jana, R.; Urkalan, K. B.; Sigman, M. S. J. Am. Chem. Soc. 2011, 133, 
5784. (d) Werner, E. W.; Urkalan, K. B.; Sigman, M. S. Org. Lett. 2010, 12, 2848.  
Scheme 3.7. Enantioselective Pd-catalyzed 1,1-arylborylation reaction via CAPT catalysis.
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Scheme 3.8. Proposed dual catalytic cycle for cooperative Pd-CAPT 1,1-arylborylation.
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3.3. Results and discussion.  
 
Given the lack of precedents for the devised transformation, we sought to provide proof-of-
principle with the development of a non-stereoselective version under homogeneous conditions. This 
would serve as a testing ground of the potential applicability of the designed protocol as a general 
synthetic methodology.  
 
 
Table 3.1. Non-enantioselective scope.a
R
0.10 mmol
ArN2BF4 (1.0 equiv), B2(pin)2 (1.2 equiv) 
2.5 mol% Pd2(dba)3, NaHCO3 (1.2 equiv)
THF 0.086 M, 25 ºC, 2-8 h Ar
B(pin)
R
B(pin)
OCO2Me
3.7, 72% yield b
B(pin)
OCO2Me
3.8, 90% yield b
Me
B(pin)
OCO2Me
3.9, 89% yield b
Me
B(pin)
OCO2Me
3.10, 90% yield
B(pin)
OCO2Me
3.11, 94% yield b
B(pin)
OCO2Me
3.12, 71% yield
MeO F F3C
ArN2BF4 scope
Olefin scope
a Isolated yields. b Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard.
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COR
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3.20, 57% yield b (R = H)
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As starting point, we subjected allyl methyl carbonate under similar conditions to those 
previously reported by Sigman.165 Pleasantly, after brief exploration on reaction conditions, we found 
that a THF suspension of catalytic Pd2(dba)3, NaHCO3, phenyl diazonium tetrafluoroborate, allyl 
methyl carbonate, and B2(pin)2, smoothly provided racemic benzylboronate 3.7 in 72% yield at room 
temperature (Table 3.1). Both electron-rich and electron-poor aryl diazonium salts proved competent 
in this transformation, providing boronic esters 3.10 and 3.12 in 90% and 71% yield, respectively. 
Notably, the use of meta- and ortho-substituted aryl diazonium cations also provided the products in 
good yields (3.8-3.9). The utilization of homoallylic carbonates, as well as protected allylic amines, 
furnished the borylated products in good to excellent yields (3.13, 3.15-3.16). Notably, the presence of 
chelating groups did not prevent catalysis (3.17). Furthermore, the cascade was even extensive to non-
activated (3.14) and deactivated terminal alkenes (3.18-3.20), albeit in diminished yields.  
Once provided proof-of-principle for the 1,1-arylborylation reaction, we focus our efforts 
towards rendering this process enantioselective via CAPT technology. Essentially, that would involve 
switching to a non-polar media while adding a phase-transfer catalyst. Nevertheless, it is expected that 
reactions that generate such complexity in one step, require fine-tuning in order to achieve the 
optimum results. Identification of an appropriate phase-transfer catalyst, base, solvent, etc, were 
instrumental for the successful phase-transfer event and are discussed vide infra.  
-Phase-Transfer Catalyst (PTC). One catalyst must both effectively phase-transfer and, 
subsequently, provide an adequate chiral environment around the cationic electrophile source to 
achieve high levels of stereoinduction. Successful enantioinduction heavily relies on the judiciously 
selection of the appropriate PTC, which is the workhorse of the reaction. Fortuitously, the Toste group 
had a large library of chiral phosphoric acids, which greatly expedited the screening of these catalysts 
(Figure 3.5). Effects on varying the R and R’ groups of the catalyst were examined as well as 
catalysts’s lipophilicity through partial saturation of the naphthyl moiety or the installation of extended 
alkyl chains at 6 and 6’ positions. Poor selectivity in the reaction could be attributed to the PTC if 
either the phase-transfer event and/or the PTC’s chiral environment were unsatisfactory.  
 Figure 3.5. Phase-Transfer Catalyst (PTC) scaffolds.
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-Electrophile. Presumably, electronics and sterics on the diazonium coupling partner will 
affect the stability of the π-benzyl palladium intermediate species. The identity of the diazonium 
counterion might be significant too, as it is directly correlated with salt’s solubility.  
-Base. In CAPT protocols, the PTC is commonly added to the reaction as a protonated 
phosphoric acid; thus, a base is required for deprotonation to generate the active anionic phase-transfer 
agent. However, an excess of base may be displaying alternative roles (Scheme 3.9), such as activating 
the nucleophilic boryl source, or facilitating PTC turnover by hydrolysis of the “chelated” (borylated) 
phase-transfer catalyst that may result after transmetalation. Additionally, base may be responsible of 
termination via β-hydride elimination through deprotonation of the cationic palladium hydride D, 
producing the Heck byproduct by ligand dissociation. Because of the envisioned multifaceted nature 
of base, we posited that the judicious choice of base and/or additive(s) would be crucial for the success 
on the attempted aim. An extensive base screening was conducted exploring the effect of pKa, 
counterion (i.e. Na, K, Cs), as well as the equivalency of base.  
 
 
 
-Transmetalating agent. Differences in steric bulk and hydrogen bonding between e.g. R–
B(pin) and R–B(OH), are likely to affect transmetalation and, thus, selectivity and/or efficiency.  
 
Scheme 3.9. Plausible role(s) of base.
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-Olefin. Hydrogen-bonding interactions were reported to be highly beneficial for CAPT161 and 
thus may lead to further enantioinduction (Figure 3.6).  
 
 
 
-Solvent. A general trend in CAPT catalysis is that nonpolar solvents tend to afford higher 
levels of enantioinduction than more polar solvents. This observation is consistent with the proposed 
mode of chirality transfer. A chiral ion pair is likely to be disrupted in solvents with greater polarity. 
With the knowledge of this CAPT trend, solvent screenings focused on hydrophobic aprotic solvents.  
-Other parameters. Parameters such as stirring rate, equivalents of the coupling components 
or concentration had resulted really impactful in previous reported transformations operating under 
phase-transfer principle, and were considered as well.  
Thus, utilizing again allyl methyl carbonate and a non-biased coupling partner such as phenyl 
diazonium tetrafluoroborate,195 an extensive study of reaction conditions was undertaken. A summary 
data is compiled in Table 3.2.196  
Initial experiments showed that nonpolar solvents such as hexanes provided poor conversion 
(entry 1), whereas THF allowed for excellent conversion albeit with poor enantioselectivity (entry 2). 
After further solvent screening, Et2O was identified as optimal, furnishing the product in 45% yield 
and 67:33 er (entry 3).197 Examination of several PTCs identified PTC 2, TCyP-PA, as superior in 
terms of enantioselectivity, providing desired product in 94:6 er (entry 5). Among different tested 
bases, Na3PO4 provided the highest yield, furnishing the product in 26% yield (entry 7). Notably, with 
stronger bases such as tBuOK, borylation of the aryl diazonium salt was observed, presumably due to 
boron species’ activation (see Scheme 3.9). Finally, we noticed the addition of exogenous 
dibenzylideneacetone-type ligands improved the efficiency of the reaction. Among different tested 
ligands, 3,3’-CF3-dba enabled to increase yield up to 39%, with retention of enantioselectivity (entry 
9).198 While the actual role of dba-type ligand improving the efficiency of the process was not 
                                                       
195 Notably, PF6 salts were tested as well in Et2O achieving high yields but poor ee, probably due to their higher solubility 
(avoiding counterion exchange, and thus, chirality transfer).  
196 For further details see Experimental Section 3.5.2.  
197 Combination of solvents (e.g. Et2O/THF) provided better yields, but at the expense of er. On the other hand, addition of 
increasing amounts of water resulted in loss of enantioinduction. 
198 We also prepared and tested Pd2(3,3’-CF3-dba)3 complex, but it did not provide better results. Kapdi, A. R.; Whitwood, A. 
C.; Williamson, D. C.; Lynam, J. M.; Burns, M. J.; Williams, T. J.; Reay, A. J.; Holmes, J.; Fairlamb, I. J. S. J. Am. Chem. 
Soc. 2013, 135, 8388.  
Figure 3.6. Reported H-boding model.
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rigorously investigated, we attributed this effect to the stabilization of palladium intermediate species 
along the catalytic cycle.  
 
 
 
In addition to protected allylic alcohols, α,β-unsaturated esters were utilized as alternative 
olefinic coupling partners for the enantioselective transformation. A similar screening was carried out 
for the acrylate system, with similar reaction conditions rendering the best results.199 Notably, with 
acrylate coupling partners, use of 3,3’-CF3-dba did not improve efficiency nor selectivity.  
In order to determine the efficiency of phase-transference, we carried out a qualitative 19F 
NMR study (Figure 3.7) consisting on comparing the solubility of the 4-fluoro-phenyl diazonium salt 
                                                       
199 For further details, see Experimental Section 3.5.4.  
Table 3.2. Optimization of the enantioselective 1,1-arylborylation reaction.
10 mol% PTC 1, NaHCO3 (2.4 equiv)
5 mol% Pd2(dba)3
solvent 0.043 M, 25 ºC, 2-8 h Ph
B(pin)
OCO2Me
OCO2Me
PhN2BF4 (2.0 equiv), B2(pin)2 (2.4 equiv)
as shown 
as shown
as shown 
PTC 3  
PTC 2  
PTC 2, K2CO3 
PTC 2, Na3PO4   
PTC 2, Na3PO4
PTC 2, Na3PO4
entry
 1
2
3
4
5
6
7
8
9
conditions
<5%
72%
45%
14% 
25%
25%
26%
40%
39%
yielda
hexanes 
THF 
Et2O 
Et2O 
Et2O 
Et2O 
Et2O 
Et2O 
Et2O
solvent
-
53:47
67:33
53:47 
94:6
97:3
97:3
85:15
96:4
erb
- 
- 
- 
- 
- 
- 
- 
4,4'-CF3-dba 
3,3'-CF3-dba
additive
16 mol% additive
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enan-
tiomeric ratio determined by chiral phase HPLC.
O
O
PO2H
R
R
R
R
R
R
O
O PO2H
iPr
iPriPr
iPriPr
iPr
Ar
O
Ar
Ar = 4-CF3-C6H4, 4,4'-CF3-dba
Ar = 3-CF3-C6H4, 3,3'-CF3-dba
R = iPr, PTC 1 (TRIP-PA) 
R = Cy, PTC 2 (TCyP-PA)
PTC 3 (SPINOL-PA)
0.043 mmol 3.7
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4-F–C6H4N2BF4 in different solvents, with and without the sodium salt of the PTC 2 (TCyP-PA-Na). 
In tetrahydrofuran-d8, the solvent selected for the racemic reaction, without the PTC, aryl diazonium 
salt was soluble, providing a 19F NMR signal around -88 ppm. However, no fluorine signal was 
detected in diethyl ether-d10. Addition of increasing amounts of the PTC, provided a signal. These 
results showcased the operability of a phase-transfer event under optimized conditions.  
 
 
 
With optimized conditions in hand, we examined the aryl diazonium scope (Table 3.3).200 In 
general, the developed methodology provided benzylic boronic esters in synthetically useful yields 
and good to excellent enantioselectivities.  
 
                                                       
200 In order to get isolated yields, an oxidative work-up was required. See Experimental Section 3.5.3 & 3.5.5.  
Figure 3.7. 19F NMR experiments.
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Whereas para- and meta-substituents were well tolerated (see Table 3.3), the stereoselective 
process was highly sensitive to ortho- substitution, providing very low yields. As regards to 
Table 3.3. Enantioselective scope.a,b
B(pin)
OCO2Me
3.21, 46% yield, 93:7 er
10 mol% TCyP-PA, Na3PO4 (2.4 equiv)
5 mol% Pd2(dba)3
Et2O 0.043 M, 25 ºC, 8-10 h Ar
B(pin)
OCO2Me
OCO2Me
ArN2BF4 (2.0 equiv), B2(pin)2 (2.4 equiv)
16 mol% 3,3'-CF3-dba
B(pin)
OCO2Me
3.8, 50% yield, 94:6 er
B(pin)
OCO2Me
3.22, 58% yield, 94:6 er
B(pin)
OCO2Me
3.23, 32% yield, 98:2 er
B(pin)
OCO2Me
3.24, 50% yield, 93:7 er
B(pin)
OCO2Me
3.25, 40% yield, 99:1 er
MeO
tBu
Me
10 mol% TCyP-PA, Na3PO4 (2.4 equiv)
4 mol% Pd2(dba)3
Et2O 0.1 M, 25 ºC, 8-10 h Ar
B(pin)
CO2Et
CO2Et
ArN2BF4 (1.0 equiv), B2(pin)2 (2.2 equiv)
B(pin)
CO2Et
3.18, 47% yield, 95:5 er
B(pin)
CO2Et
3.26, 44% yield, 92:8 er
Me
B(pin)
CO2Et
3.27, 33% yield, 99:1 er
tBu
B(pin)
CO2Et
3.29, 29% yield, 99:1 er
Me
Me
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enantiomeric ra-
tio determined by chiral phase HPLC.
0.043 mmol
0.09 mmol
Me
Me
Me
Me
Me
B(pin)
CO2Et
3.28, 40% yield, 99:1 er
PivO
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electronics, the stereoselective process was amenable applicable over non-highly electronically biased 
aryl diazonium salts. On the one hand, when substituted with electron-withdrawing groups, the 
efficiency of the process was harshly affected. We assume this is related with the stabilization of the 
π-benzyl palladium intermediate species (E, Scheme 3.8). According to its cationic character, its 
stability would be presumably compromised by electron-withdrawing groups. On the other hand, 
electron-rich aryl diazonium salts adversely affected selectivity. We hypothesize electron-donating 
properties of the aryl group contribute to disrupt the tight ion pair with the chiral phosphate 
counterion. However, the aryl moiety of the diazonium salt was tolerant of substitution of the meta- 
and para-positions with less-activating heteroatoms (3.22, 3.28) or alkyl functional groups (3.8, 3.23-
3.24, 3.26-3.27), providing a variety of 1,1-arylborylated esters in excellent enantioselectivities. 
Finally, substitution with a vinyl group at the para-position also afforded enriched boronic esters 3.25 
and 3.29 in 99:1 er for both cases.  
Despite moderate yields, conversions for both carbonate and acrylate systems were completed, 
detecting the corresponding Heck-product as the major byproduct. Unlike the non-stereoselective 
reaction in THF, the use of Et2O and a phase-transfer catalyst resulted in significant termination via β-
hydride elimination.  
Finally, an interesting mechanistic insight might be inferred from Sigman’s previous results. 
Attending to crossover experiments, which resulted in non-crossover products (Scheme 3.10a), we can 
assume an inner-sphere mechanism wherein the styrene does not dissociate prior transmetalation. 
Thereby, considering syn-stereoespecificity of both β-hydride elimination and insertion steps, we 
hypothesize chirality is established in the first insertion step. Then, stereospecificity of subsequent 
steps, besides kinetically prompted inner-sphere character, preserve chiral environment determined in 
the first migratory insertion step, in what might be considered as an illustration of “memory of 
chirality”. As depicted in Scheme 3.10b, chiral PTC would favor migratory insertion over one of the 
enantiotopic faces of the olefin (pathway A vs pathway B). Then, syn-β-hydride elimination would 
take place over less energetic alternate conformation rather than over an eclipsed one. This is 
supported by the experimental detection of trans-styrene. Cis-styrene was never observed. Finally, an 
inner-sphere mechanism guarantees a stereospecific reinsertion.  
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Scheme 3.10. (a) Crossover experiments (Sigman). (b) Mechanistic hypothesis.
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3.4. Conclusions.  
 
Chapter 3 discloses a single-step method for the ready preparation of enantioenriched benzyl 
boronates from terminal alkenes.201 This process was rendered highly enantioselective by means of the 
unprecedented “ligand-less” combination of CAPT and transition metal catalysis (Scheme 3.11). 
Though this methodology provides moderate yields, the modularity and step economy in this three-
component coupling protocol can compensate for this limitation.  
 
 
 
This strategy emerges as a feasible strategy to achieve enantioinduction in reaction manifolds 
where chiral ancillary ligands have a deleterious effect, such as in the Heck-Matsuda reaction. The 
significance of the developed transformation is implemented by the synthetic relevance of the 
accessed motifs, providing the basis for scaffold diversity. Novel applications of the developed 
strategy have been already reported.202  
 
 
 
 
 
 
 
 
 
 
                                                       
201 Nelson, H. M.; Williams, B. D.; Miró, J.; Toste, F. D. J. Am. Chem. Soc. 2015, 137, 3213.  
202 (a) Yamamoto, E.; Hilton, M. J.; Orlandi, M.; Saini, V.; Toste, F. D.; Sigman, M. S. J. Am. Chem. Soc. 2016, 138, 15877. 
(b) Tao, Z.-L.; Adili, A.; Shen, H.-C.; Han, Z.-Y.; Gong, L.-Z. Angew. Chem. Int. Ed. 2016, 55, 4322. (c) Yang, K.; Song, Q. 
Org. Lett. 2016, 18, 5460.  
Scheme 3.11. Cooperative CAPT-Pd catalysis.
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3.5. Experimental section.  
General remarks: Unless otherwise noted, all reagents were purchased from commercial suppliers and 
used without further purification. Chiral anion phase-transfer (CAPT) reactions were performed in 1-
dram (0.5” x 1.75”) vials equipped with a screw cap and stirred using a magnetic Teflon stir bar (1/2” 
x 5/16”), placed on the surface of a magnetic stir plate. Due to the heterogeneous nature of these 
reactions, it is important that fast and efficient stirring be maintained over the course of the reaction in 
order to obtain optimal results. Diethyl ether (Et2O) was used as purchased from Fischer Scientific. 
Thin-layer chromatography (TLC) analysis of reaction mixtures was performed using Merck silica gel 
60 F254 TLC plates, and visualized under UV or by staining with ceric ammonium molybdate or 
KMnO4. Column chromatography was performed on Merck Silica Gel 60 Å, 230 X 400 mesh. Nuclear 
magnetic resonance (NMR) spectra were recorded using Bruker AV-600, AV-500, DRX-500, AVQ-
400, AVB-400 and AV-300 spectrometers. 1H and 13C chemical shifts are reported in ppm downfield 
of tetramethylsilane and referenced to residual solvent peak (CHCl3, δH = 7.27 ppm and δC = 77.23 
ppm; DMSO, δH = 2.50 and δC = 39.5 ppm; CH2Cl2, δH = 5.32 and δC = 53.8 ppm). Multiplicities 
are reported using the following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, app t = 
apparent triplet, m = multiplet, br = broad resonance. Solvent abbreviations are reported as follows: 
B2(pin)2 = bis(pinicaloato)diboron, MTBE = methyl tert-butyl ether, EtOAc = ethyl acetate, hex = 
hexanes, DCM = dichloromethane, Et2O = diethyl ether, MeOH = methanol, iPrOH = isopropanol, 
THF = tetrahydrofuran, DMF = N,N-dimethylformamide, Et3N = triethylamine. Mass spectral data 
were obtained from the Micro-Mass/Analytical Facility operated by the College of Chemistry, 
University of California, Berkeley or by usage of an Agilent Time of Flight (Q-TOF) mass 
spectrometer in ESI mode. Enantiomeric excesses were measured on a Shimadzu VP Series Chiral 
HPLC using Chiralpak IA, IB, or IC columns. The syntheses of chiral phosphoric acids, e.g. TRIP-PA, 
H8-TCyP-PA, TCyP-PA, STRIP-PA, have been previously reported.152 Dibenzylideneacetone (dba) 
derivatives were prepared under basic conditions by aldol reaction between acetone and the 
corresponding benzaldehyde according to reported procedures.203 Caution: Although we have not 
experienced any problems during the preparation and handling of the aryldiazonium tetrafluoroborates 
reported herein, appropriate safety precautions should be taken due to the explosive nature of 
diazonium salts, including the use of a blast shield.204 Racemic products were synthesized utilizing 
homogeneous conditions in the absence of phase-transfer catalyst with THF as a solvent.  
 
                                                       
203 Zhou, X.; Li, X.; Zhang, W.; Chen, J. Tetrahedron Lett. 2014, 55, 5137.  
204 Aryldiazonium salts were prepared according to general procedure reported in ref. 164b: Nelson, H. M.; Reisberg, S. H.; 
Shunatona, H. P.; Patel, J. S.; Toste, F. D. Angew. Chem. Int. Ed. 2014, 53, 5600.  
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3.5.1. General procedure A: Racemic three-component 1,1-arylborylation reaction.  
 
 
A 1 dram vial was charged with B2(pin)2 (1.2 equiv), Pd2dba3 (2.5 mol%), NaHCO3 (1.2 equiv), the 
ArN2BF4 (1.0 equiv). To the solid reagents was added a solution of the appropriate olefin (1.0 equiv, 
0.10 mmol) in THF (0.086 M). The headspace of the reaction vessel was sparged with N2 for ca. 0.5 
min, and then the vial was capped and the heterogeneous reaction mixture was stirred vigorously. The 
reaction progress monitored via TLC analysis. Upon completion the reaction was concentrated in 
vacuo and the crude reactions were purified by flash column chromatography (EtOAc/hexanes) to 
provide pure boronic esters. 
   
 
Methyl (3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl) carbonate. Following 
the general procedure A, 3.7 was obtained in 72% yield. 1H NMR (600 MHz, Chloroform-d) δ 7.29-
7.23 (m, 2H), 7.23-7.17 (m, 2H), 7.15 (t, J = 7.5 Hz, 1H), 4.14 (dt, J = 10.6, 6.3 Hz, 1H), 4.05 (dt, J = 
10.7, 6.9 Hz, 1H), 3.77 (s, 3H), 2.44 (t, J = 7.9 Hz, 1H), 2.24 (dq, J = 14.4, 7.2 Hz, 1H), 2.02 (tt, J = 
14.1, 6.4 Hz, 1H), 1.20 (d, J = 13.5 Hz, 12H). 13C NMR (151 MHz, CDCl3) 156.02, 142.05, 128.69, 
128.56, 125.76, 83.74, 67.62, 54.80, 31.43, 24.77. HRMS (ESI) m/z [M+K]+ calcd. for C17H25BKO5 
359.1427, found 359.1429. 
 
 
Methyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(m-tolyl)propyl) carbonate. Following 
the general procedure A, 3.8 was obtained in 90% yield. 1H NMR (500 MHz, Chloroform-d) δ 7.15 (t, 
J = 7.5 Hz, 1H), 7.03 – 6.94 (m, 3H), 4.14 (ddd, J = 10.6, 6.8, 5.8 Hz, 1H), 4.05 (dt, J = 10.6, 6.9 Hz, 
1H), 3.77 (s, 3H), 2.39 (t, J = 7.9 Hz, 1H), 2.31 (s, 3H), 2.22 (dq, J = 14.4, 7.3 Hz, 1H), 1.99 (ddt, J = 
14.1, 8.2, 6.2 Hz, 1H), 1.20 (d, J = 11.0 Hz, 12H).13C NMR (126 MHz, CDCl3) δ 156.02, 141.90, 
138.16, 129.43, 128.55, 126.55, 125.50, 83.70, 67.69, 54.81, 31.49, 24.79, 21.66. HRMS (ESI) m/z 
[M+K]+ calcd. for C18H27BKO5 373.1583, found 373.1582. 
 
R Ar
B(pin)
R
2.5 mol% Pd2(dba)3, NaHCO3 (1.2 equiv) 
ArN2BF4 (1.0 equiv), B2(pin)2 (1.2 equiv)  
THF 0.086 M, 25 ºC, 2-8 h
B(pin)
OCO2Me
B(pin)
OCO2Me
Me
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Methyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(o-tolyl)propyl) carbonate. Follo-wing 
the general procedure A, 3.9 was obtained in 89% yield. 1H NMR (500 MHz, Chloroform-d) δ 7.20 
(dd, J = 8.0, 1.5 Hz, 1H), 7.15 (tt, J = 5.5, 1.5 Hz, 2H), 7.08 (td, J = 7.2, 1.5 Hz, 1H), 4.18 (dt, J = 
10.7, 6.3 Hz, 1H), 4.07 (dt, J = 10.5, 6.9 Hz, 1H), 3.79 (s, 3H), 2.66 (t, J = 7.8 Hz, 1H), 2.35 (s, 3H), 
2.27 (dq, J = 14.3, 7.2 Hz, 1H), 2.02 (ddt, J = 14.0, 7.9, 6.2 Hz, 1H), 1.22 (d, J = 12.1 Hz, 12H). 13C 
NMR (126 MHz, CDCl3) δ 156.03, 140.49, 136.31, 130.54, 127.95, 126.27, 125.60, 83.65, 67.75, 
54.82, 31.01, 24.88, 24.77, 20.29. HRMS (ESI) m/z [M+K]+ calcd. for C18H27BKO5 373.1583, 
373.1584.  
 
 
3-(4-Methoxyphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl methyl carbonate. 
Following the general procedure A, 3.10 was obtained in 90% yield. 1H NMR (500 MHz, Chloroform-
d) δ 7.17 – 7.05 (m, 2H), 6.87 – 6.75 (m, 2H), 4.13 (ddd, J = 10.6, 6.8, 5.8 Hz, 1H), 4.04 (dt, J = 10.6, 
7.0 Hz, 1H), 3.78 (s, 3H), 3.76 (s, 3H), 2.38 (t, J = 7.9 Hz, 1H), 2.19 (dq, J = 14.3, 7.2 Hz, 1H), 1.96 
(ddt, J = 14.2, 8.5, 6.2 Hz, 1H), 1.20 (d, J = 10.7 Hz, 12H). 13C NMR (126 MHz, CDCl3) δ 157.75, 
156.02, 133.91, 129.46, 114.13, 83.68, 67.58, 55.39, 54.82, 31.63, 24.82, 24.78. HRMS (ESI) m/z 
[M+Na]+ calcd. for C18H27BNaO6 373.1793, found 373.1797. 
 
 
3-(4-Fluorophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl methyl carbonate. Fo-
llowing the general procedure A, 3.11 was obtained in 94% yield. 1H NMR (300 MHz, Chloroform-d) 
δ 7.08 (dd, J = 9.0, 6.0 Hz, 2H), 6.87 (t, J = 9.0 Hz, 2H), 4.09 – 3.91 (m, 2H), 3.68 (s, 3H), 2.35 (t, J = 
7.5 Hz, 1H), 2.13 (td, J = 14.1, 7.4 Hz, 1H), 1.97 – 1.83 (m, 1H), 1.12 (d, J = 6.0 Hz, 12H). 13C NMR 
(75.5 MHz, CDCl3) 161.09 (d, JCF = 243.1 Hz), 155.75, 137.39 (d, JCF = 3.0 Hz), 129.61 (d, JCF = 7.6 
Hz), 115.20 (d, JCF = 21.1 Hz), 83.59, 67.15, 54.59, 31.29, 24.57, 24.52. 19F NMR (282 MHz, CDCl3) 
-118.58 (tt, J = 8.8, 5.4 Hz). HRMS (ESI) m/z [M+H]+ calcd. for C17H25BFO5 339.1774, found 
339.1785. 
 
B(pin)
OCO2Me
Me
B(pin)
OCO2Me
MeO
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OCO2Me
F
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Methyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(4-(trifluoromethyl)phenyl)propyl) 
carbonate. Following the general procedure A, 3.12 was obtained in 71% yield. 1H NMR (600 MHz, 
Chloroform-d) δ 7.51 (d, J = 8.0 Hz, 2H), 7.31 (d, J = 7.9 Hz, 2H), 4.14 (dt, J = 10.8, 6.2 Hz, 1H), 
4.03 (ddd, J = 10.7, 7.3, 6.2 Hz, 1H), 3.76 (s, 3H), 2.52 (t, J = 7.9 Hz, 1H), 2.25 (dq, J = 14.2, 7.2 Hz, 
1H), 2.02 (ddd, J = 14.0, 8.1, 6.0 Hz, 1H), 1.20 (d, J = 10.5 Hz, 12H). 13C NMR (151 MHz, CDCl3) δ 
155.96, 146.52, 128.80, 128.24, 128.03, 125.61 (q, J = 7.5 Hz), 123.71, 84.05, 67.29, 54.87, 31.18, 
24.83, 24.79. HRMS (EI) m/z [M]+ calcd. for C18H24BF3O5 388.1669, found 388.1665. 
 
 
4-(4-Methoxyphenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butyl methyl carbonate. Fo-
llowing the general procedure A, 3.13 was obtained in 74% yield. 1H NMR (500 MHz, Chloroform-d) 
δ 7.17 – 7.02 (m, 2H), 6.88 – 6.73 (m, 2H), 4.12 (td, J = 6.6, 1.8 Hz, 2H), 3.80 (s, 3H), 3.78 (s, 3H), 
2.26 (t, J = 7.7 Hz, 1H), 1.96 – 1.83 (m, 1H), 1.76 – 1.57 (m, 3H), 1.22 (d, J = 11.4 Hz, 12H). 13C 
NMR (126 MHz, CDCl3) δ 157.61, 156.01, 134.72, 129.43, 114.01, 83.54, 68.43, 55.37, 54.82, 28.95, 
28.33, 24.84, 24.79. HRMS (ESI) m/z [M+Na]+ calcd. for C19H29BNaO6 387.1949, found 387.1951. 
 
 
2-(1-(4-Methoxyphenyl)octyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. Following the general 
procedure A, 3.14 was obtained in 90% yield. 1H NMR (300 MHz, Chloroform-d) δ 7.13 (d, J = 9.0 
Hz, 2H), 6.81 (d, J = 9.0 Hz, 2H), 3.77 (s, 3H), 2.23 (t, J = 9.0 Hz, 1H), 1.85 – 1.74 (m, 1H), 1.65 – 
1.54 (m, 1H), 1.30 – 1.19 (m, 22H), 0.86 (t, J = 9.0 Hz, 3H). 13C NMR (75.5 MHz, CDCl3) 157.21, 
135.49, 129.15, 113.65, 83.13, 55.14, 32.86, 31.84, 29.58, 29.24, 29.21, 24.63, 24.57, 22.64, 14.09. 
HRMS (ESI) m/z [M+NH4]+ calcd. for C21H39BNO3 364.3029, found 364.3028. 
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N-(3-(4-methoxyphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)-4-methyl-N-phe-
nylbenzenesulfonamide. Following the general procedure A, utilizing deoxygenated THF, 3.15 was 
obtained in 84% yield. 1H NMR (600 MHz, Chloroform-d) δ 7.46 – 7.38 (m, 2H), 7.27 (dt, J = 4.5, 3.1 
Hz, 3H), 7.20 (d, J = 8.1 Hz, 2H), 7.06 – 6.93 (m, 4H), 6.81 – 6.67 (m, 2H), 3.75 (s, 3H), 3.48 (t, J = 
7.2 Hz, 2H), 2.40 (s, 3H), 2.32 (t, J = 7.9 Hz, 1H), 1.94 (dq, J = 14.4, 7.2 Hz, 1H), 1.71 (dq, J = 13.6, 
7.6 Hz, 1H), 1.17 (d, J = 18.5 Hz, 12H).13C NMR (151 MHz, CDCl3) δ 157.61, 143.32, 139.51, 
135.50, 134.18, 129.46, 129.38, 129.05, 128.95, 127.90, 127.84, 113.99, 83.61, 55.36, 50.11, 31.41, 
24.85, 24.73, 21.73. HRMS (EI) m/z [M]+ calcd. for C29H36BNO5S 521.2407, found 521.2399. 
 
 
N-(3-(4-methoxyphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)-4-methyl-benze-
nesulfonamide. Following the general procedure A, utilizing deoxygenated THF, 3.16 was obtained 
in 91% yield. 1H NMR (500 MHz, Chloroform-d) δ 7.72 (d, J = 7.6 Hz, 2H), 7.32 (d, J = 9.8 Hz, 2H), 
7.01 (d, J = 7.9 Hz, 2H), 6.78 (d, J = 8.7 Hz, 2H), 4.63 (t, J = 6.2 Hz, 1H), 3.79 (d, J = 2.5 Hz, 3H), 
2.99 – 2.76 (m, 2H), 2.44 (d, J = 2.5 Hz, 3H), 2.26 (t, J = 7.7 Hz, 1H), 1.95 (dq, J = 14.6, 7.4 Hz, 1H), 
1.79 (dq, J = 14.1, 7.0 Hz, 1H), 1.20 (dd, J = 12.8, 2.6 Hz, 12H). 13C NMR (126 MHz, CDCl3) δ 
157.75, 143.40, 137.05, 133.81, 129.81, 129.41, 127.34, 114.14, 83.85, 83.34, 55.37, 42.73, 32.43, 
24.81, 24.76, 21.71. HRMS (ESI) m/z [M+Na]+ calcd. for C23H32BNNaO5S 468.1986, found 
468.1985. 
 
 
5-(4-Methoxyphenyl)-2,2-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentane-nitri-
le. Following the general procedure A, 3.17 was obtained in 99% yield. 1H NMR (500 MHz, 
Chloroform-d) δ 7.41 – 7.23 (m, 10H), 7.10 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.9 Hz, 2H), 3.81 (s, 3H), 
2.41 – 2.30 (m, 2H), 2.28 (dd, J = 8.8, 6.7 Hz, 1H), 2.02 (ddd, J = 16.8, 13.7, 7.3 Hz, 1H), 1.87 – 1.73 
(m, 1H), 1.21 (d, J = 10.4 Hz, 12H). 13C NMR (126 MHz, CDCl3) δ 157.67, 140.72, 140.06, 134.10, 
129.47, 128.97, 128.96, 127.88, 127.05, 127.01, 122.63, 114.01, 83.60, 55.37, 51.85, 39.13, 28.43, 
24.86, 24.76. HRMS (ESI) m/z [M+Na]+ calcd. for C30H34BNNaO3 490.2524, found 490.2524.  
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Ethyl 3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate. Following the general 
procedure A, 3.18 was obtained in 46% yield. 1H NMR (600 MHz, Chloroform-d) δ 7.33 – 7.23 (m, 
4H), 7.22 – 7.16 (m, 1H), 4.24 – 4.06 (m, 2H), 2.92 (dd, J = 16.4, 10.2 Hz, 1H), 2.78 (dd, J = 10.2, 6.1 
Hz, 1H), 2.70 (dd, J = 16.4, 6.1 Hz, 1H), 1.29 – 1.19 (m, 15H). 13C NMR (151 MHz, CDCl3) δ 173.60, 
141.60, 128.65, 128.40, 125.84, 83.74, 60.54, 37.53, 24.79, 24.70, 14.45. HRMS (ESI) m/z [M+Na]+ 
calcd. for C17H25BNaO4 343.1477, found 343.1479.  
 
 
4-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one. Following the general 
procedure A, 3.19 was obtained in 45% yield. Spectra matches previously reported spectra.205  
 
 
3.5.2. Optimization of the enantioselective three-component 1,1-arylborylation reaction of 
methyl allyl carbonate. Summary data.  
 
 ·Solvent  
 
                                                       
205 Lawson, Y. G.; Lesley, M. J. G.; Marder, T. B.; Norman, N. C.; Rice, C. R. Chem. Commun. 1997, 2051.  
B(pin)
CO2Et
B(pin)
COMe
10 mol% TRIP-PA, NaHCO3 (2.4 equiv)
5 mol% Pd2(dba)3
solvent 0.043 M, 25 ºC, 2-8 h Ph
B(pin)
OCO2Me
OCO2Me
PhN2BF4 (2.0 equiv), B2(pin)2 (2.4 equiv)
entry
 1
2
3
4
5
<5%
72%
45%
<10% 
91%
yielda
hexanes 
THF 
Et2O 
Et2O/H2O (50 µg) 
Et2O/THF (1:1)
solvent
nd
6%
34%
80% 
<5%
eeb
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enan-
tiomeric ratio determined by chiral phase HPLC.
0.043 mmol 3.7
O
O
PO2H
iPr
iPr
iPr
iPr
iPr
iPr
TRIP-PA
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 ·Time study  
 
 
 
 
 ·Others  
 
-Pd2(dba)3 loading (1.25-10 mol%) had no effect.  
  -Increasing equivalents of base had minor effect on ee.  
  -Increasing equivalents of ArN2BF4 had detrimental effect on yield.  
-Decreasing equivalents of B2(pin)2 had detrimental effect on yield, while ee was 
unaffected. Increasing equivalents from standard conditions had positive effect on 
yield, but ee was reduced.  
-Increasing equivalents of olefin had a detrimental effect on yield. Decreasing 
equivalents increased yield (ee was maintained).  
 
 
 
 
 
 
 
 
 
 
entry
 1
2
3
4
5.7%
6.6%
21%
19%
yielda
2 h 
4 h 
6 h 
14 h
time
94% 
90% 
92% 
92%
eeb
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enan-
tiomeric ratio determined by chiral phase HPLC.
10 mol% TRIP-PA, NaHCO3 (2.4 equiv)
5 mol% Pd2(dba)3
Et2O 0.043 M, 25 ºC Ph
B(pin)
OCO2Me
OCO2Me
PhN2BF4 (2.0 equiv), B2(pin)2 (2.4 equiv)
0.043 mmol 3.7
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3.5.3. General procedure B: Enantioselective three-component 1,1-arylborylation reaction of 
allyl carbonate.  
 
 
 
A 1 dram vial was charged with B2(pin)2 (2.4 equiv) , Pd2dba3 (5 mol%), TCyP-PA (10 mol%), 3,3’-
CF3-dba (16 mol%), Na3PO4 (2.4 equiv), the ArN2BF4 (2.0 equiv). To the solid reagents was added a 
solution of allyl methyl carbonate (1.0 equiv, 0.043 mmol) in Et2O (0.043 M in allyl methyl 
carbonate). The headspace of the reaction vessel was sparged with N2 for ca. 10 seconds then the vial 
was capped and the heterogeneous reaction mixture was stirred vigorously. The reaction progress was 
monitored via TLC analysis. Upon completion the reaction was filtered through a plug of cotton to 
remove solid particulates and then concentrated in vacuo.  
1H NMR yield: The crude reaction mixture was dissolved in a solution of CD2Cl2 and dimethyl 
sulfone (1 equiv) to obtain the NMR yield.  
Isolated yield of diol (over two steps): The crude reaction mixture was concentrated and purified via 
column chromatograph (EtOAc/hexanes) to obtain the boronic ester product contaminated with 
residual B2(pin)2. To this mixture was added THF (1.0 mL), 1 M NaOH (0.50 mL), and 30% v/v aq. 
H2O2 (0.25 mL) and then reaction mixture was stirred under a N2 atmosphere. Reaction progress was 
monitored via TLC analysis. Upon complete conversion to the diol, the reaction was quenched with 
sat. aq. Na2S2O3 (5 mL) and extracted with EtOAc (3 x 10 mL). The organic layers were combined, 
dried with anhydrous Na2SO4, concentrated, and then purified via column chromatography (40-60% 
EtOAc/hexanes) to provide pure diol.  
 
 
1-Phenylpropane-1,3-diol. Following the general procedure B, 3.30 was isolated in 23% yield over 
two steps. 1H NMR (600 MHz, Chloroform-d) δ 7.38 (d, J = 6.5 Hz, 3H), 7.33 – 7.22 (m, 2H), 4.98 
(dd, J = 9.0, 3.6 Hz, 1H), 3.88 (t, J = 5.5 Hz, 2H), 2.80 (s, 1H), 2.35 (s, 1H), 2.10 – 1.98 (m, 1H), 1.96 
(dq, J = 14.2, 4.6 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 144.52, 128.76, 127.84, 125.86, 74.63, 
Ar
B(pin)
5 mol% Pd2(dba)3 
10 mol% TCyP-PA, Na3PO4 (2.4 equiv) 
ArN2BF4 (2.0 equiv), B2(pin)2 (2.4 equiv)  
16 mol% 3,3'-CF3-dba 
Et2O 0.043 M, 25 ºC, 8-10 h
OCO2Me
OCO2Me
H2O2, NaOH 
THF Ar
OH
OH
OH
OH
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61.73, 40.75. Spectra matches previously reported spectra.206 HPLC (ChiralPak IC column) 90:10 
(hexane/iPrOH) 1 mL/min; Tmajor (15.4 min), Tminor (11.8 min); 96:4 er (92% ee).  
 
 
Methyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(p-tolyl)propyl) carbonate. Following 
the general procedure B, 3.21 was provided in 46% yield (via 1H NMR analysis). 1H NMR (500 MHz, 
Chloroform-d) δ 7.16 – 7.02 (m, 4H), 4.15 (ddd, J = 10.6, 6.8, 5.8 Hz, 1H), 4.06 (dt, J = 10.7, 7.0 Hz, 
1H), 3.78 (s, 3H), 2.42 (t, J = 7.9 Hz, 1H), 2.32 (s, 3H), 2.23 (dq, J = 14.3, 7.2 Hz, 1H), 2.00 (ddt, J = 
14.2, 8.4, 6.2 Hz, 1H), 1.22 (d, J = 10.6 Hz, 12H). 13C NMR (126 MHz, CDCl3) δ 156.02, 138.83, 
135.13, 129.41, 128.44, 83.67, 67.62, 54.80, 31.56, 24.82, 24.79, 21.20. HRMS (ESI) m/z [M+Na]+ 
calcd. for C18H27BNaO5 357.1844, found 357.1844. 
 
 
1-(p-Tolyl)propane-1,3-diol. Following the general procedure B, 3.31 was isolated in 35% yield over 
two steps. 1H NMR (500 MHz, Chloroform-d) = 7.29 (d, J = 8.0 Hz, 2H), 7.20 (d, J = 7.9 Hz, 2H), 
4.97 (dd, J = 9.0, 3.6 Hz, 1H), 3.89 (t, J = 5.5 Hz, 2H), 2.72 (s, 1H), 2.38 (s, 4H), 2.11-2.00 (m, 1H), 
2.00-1.90 (m, 1H). 13C NMR (126 MHz, CDCl3) = 141.52, 137.55, 129.41, 125.80, 74.59, 61.80, 
40.65, 21.33. Spectra matches previously reported spectra.207 HPLC (ChiralPak IC column) 90:10 
(hexane/iPrOH) 1 mL/min; Tmajor (18.9 min), Tminor (14.2 min); 95:5 er (90% ee).  
 
 
1-(m-Tolyl)propane-1,3-diol. Following the general procedure B, 3.32 was isolated in 30% yield over 
two steps. 1H NMR (500 MHz, Chloroform-d)  7.27 (d, J = 7.6 Hz, 1H), 7.23 (s, 1H), 7.19 (d, J = 7.7 
Hz, 1H), 7.13 (d, J = 7.5 Hz, 1H), 4.97 (dd, J = 8.9, 3.6 Hz, 1H), 3.90 (dd, J = 6.5, 4.6 Hz, 2H), 2.77 
(s, 1H), 2.39 (s, 4H), 2.11-2.01 (m, 1H), 1.96 (dtd, J = 14.6, 5.2, 3.9 Hz, 1H). 13C NMR (126 MHz, 
CDCl3) 144.44, 138.44, 128.65, 128.58, 126.54, 122.89, 74.75, 61.82, 40.65, 21.69. Spectra matches 
                                                       
206 Borowiecki, P.; Wawro, A. M.; Winska, P.; Wielechowska, M.; Bretner, M. Eur. J. Med. Chem. 2014, 84, 364.  
207 Kim, J.; De Castro, K. A.; Lim, M.; Rhee, H. Tetrahedron, 2010, 66, 3995.  
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previously reported spectra.208 HPLC (ChiralPak IC column) 90:10 (hexane/iPrOH) 1 mL/min; Tmajor 
(18.2 min), Tminor (12.3 min); 94:6 er (88% ee).  
 
 
1-(3-Methoxyphenyl)propane-1,3-diol. Following the general procedure B, 3.33 was isolated in a 
37% yield over two steps. 1H NMR (500 MHz, Chloroform-d) 7.33-7.21 (m, 1H), 7.01-6.91 (m, 2H), 
6.87-6.77 (m, 1H), 4.96 (dd, J = 8.8, 3.7 Hz, 1H), 3.88 (dd, J = 6.6, 4.4 Hz, 2H), 3.83 (s, 3H), 2.82 (s, 
1H), 2.33 (s, 1H), 2.10-1.99 (m, 1H), 1.99-1.88 (m, 1H). 13C NMR (126 MHz, CDCl3) 159.99, 146.23, 
129.78, 118.11, 113.24, 111.32, 74.58, 61.76, 55.46, 40.64. Spectra matches previously reported 
spectra.209 HPLC (ChiralPak IC column) 90:10 (hexane/iPrOH) 1 mL/min; Tmajor (19.6 min), Tminor 
(11.1 min); 94:6 er (88% ee).  
 
 
3-(4-(Tert-butyl)phenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl methyl carbonate. 
Following the general procedure B, 3.23 was provided in 32% yield (via 1H NMR analysis). 1H NMR 
(600 MHz, Chloroform-d) 7.26 (d, J = 8.3 Hz, 2H), 7.11 (d, J = 8.7 Hz, 2H), 4.14 (dt, J = 10.6, 6.3 Hz, 
1H), 4.05 (dt, J = 10.6, 6.9 Hz, 1H), 3.76 (s, 3H), 2.41 (t, J = 7.9 Hz, 1H), 2.25-2.14 (m, 1H), 1.99 (dq, 
J = 13.9, 6.3 Hz, 1H), 1.28 (s, 9H), 1.21 (d, J = 12.4 Hz, 12H). 13C NMR (151 MHz, CDCl3)  156.06, 
148.38, 138.77, 128.20, 125.58, 83.69, 67.73, 54.79, 34.51, 31.66, 31.62, 24.84. HRMS (ESI) m/z 
[M+K]+ calcd. for C21H33BKO5 415.2053, found 415.2051. 
 
 
1-(4-(Tert-butyl)phenyl)propane-1,3-diol. Following the general procedure B, 3.34 was isolated in 
32% yield over two steps. 1H NMR (500 MHz, Chloroform-d) 7.42 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 
8.2 Hz, 2H), 4.99 (dd, J = 9.1, 3.6 Hz, 1H), 3.91 (s, 2H), 2.59 (s, 1H), 2.36 (s, 1H), 2.11-2.05 (m, 1H), 
2.01-1.92 (m, 1H), 1.35 (s, 10H), 1.29 (t, J = 7.2 Hz, 1H). 13C NMR (126 MHz, CDCl3) 150.87, 
141.47, 125.68, 125.61, 74.58, 61.87, 40.56, 34.75, 31.57. Spectra matches previously reported 
                                                       
208 Boyer, S. H.; Sun, Z.; Jiang, H.; Esterbrook, J.; Gómez-Galeno, J. E.; Craigo, W.; Reddy, K. R.; Ugarkar, B. G.; 
MacKenna, D. A.; Erion, M. D. J. Med. Chem. 2006, 49, 7711.  
209 Borowiecki, P.; Wawro, A. M.; Winska, P.; Wielechowska, M.; Bretner, M. Eur. J. Med. Chem. 2014, 84, 364.  
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spectra.210 HPLC (ChiralPak IC column) 90:10 (hexane/iPrOH) 1 mL/min; Tmajor (14.9 min), Tminor 
(11.4 min); 98:2 er (96% ee).  
 
 
3-(3,5-Dimethylphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl methyl carbonate. 
Following the general procedure B, 3.24 was provided in a 60% yield (via 1H NMR analysis). 1H 
NMR (500 MHz, Chloroform-d) = 6.71 (s, 2H), 6.69 (s, 1H), 4.04 (ddd, J = 10.8, 6.9, 5.9 Hz, 1H), 
3.96 (dt, J = 10.5, 6.9 Hz, 1H), 3.67 (s, 3H), 2.25 (t, J = 7.9 Hz, 1H), 2.17 (s, 6H), 2.11 (dq, J = 14.5, 
7.3 Hz, 1H), 1.91-1.83 (m, 1H), 1.11 (d, J = 10.6 Hz, 12H). 13C NMR (126 MHz, CDCl3) 156.01, 
141.80, 137.97, 128.51, 127.48, 126.38, 83.64, 67.74, 54.77, 31.56, 24.74, 21.51. HRMS (ESI) m/z 
[M+K]+ calcd. for C19H29BKO5 387.1740, found 387.1739. 
 
 
1-(3,5-Dimethylphenyl)propane-1,3-diol. Following the general procedure B, 3.35 was isolated in a 
42% yield over two steps. 1H NMR (600 MHz, Chloroform-d) = 6.99 (s, 2H), 6.94 (s, 1H), 4.91 (dd, J 
= 7.7, 4.5 Hz, 1H), 3.99-3.80 (m, 2H), 2.61 (s, 1H), 2.33 (s, 6H), 2.10-1.98 (m, 1H), 1.98-1.88 (m, 
1H), 1.60 (s, 2H), 1.25 (s, 2H). 13C NMR (151 MHz, CDCl3) 144.50, 138.37, 129.48, 123.64, 74.74, 
61.82, 40.74, 25.09, 21.55. Spectra matches previously reported spectra.210 HPLC (ChiralPak IC 
column) 90:10 (hexane/iPrOH) 1 mL/min; Tmajor (18.1 min), Tminor (11.9 min); 93:7 er (86% ee).  
 
 
Methyl 3-(4-(2-methylprop-1-en-1-yl)phenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pro-
pyl carbonate. Following the general procedure B, 3.25 was provided in a 40% yield (via 1H NMR 
analysis). 1H NMR (500 MHz, Chloroform-d) δ 7.14 (s, 4H), 6.22 (t, J = 1.6 Hz, 1H), 4.14 (dt, J = 
10.8, 6.3 Hz, 1H), 4.06 (dt, J = 10.6, 6.9 Hz, 1H), 3.76 (d, J = 0.8 Hz, 3H), 2.42 (t, J = 7.9 Hz, 1H), 
2.22 (dq, J = 14.4, 7.2 Hz, 1H), 2.05 – 1.95 (m, 1H), 1.89 (d, J = 1.3 Hz, 3H), 1.87 (d, J = 1.2 Hz, 3H), 
                                                       
210 Reddy, K. R.; Matelich, M. C.; Ugarkar, B. G.; Gómez-Galeno, J. E.; DaRe, J.; Ollis, K.; Sun, Z.; Craigo, W.; Colby, T. 
J.; Fujitaki, J. M.; Boyer, S. H.; van Poelje, P. D.; Erion, M. D. J. Med. Chem. 2008, 51, 666.  
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1.20 (d, J = 10.9 Hz, 12H). 13C NMR (126 MHz, CDCl3) δ 156.02, 139.42, 136.13, 134.99, 129.05, 
128.22, 125.13, 83.72, 67.66, 54.81, 31.41, 27.18, 24.82, 24.77, 19.68. HRMS (ESI) m/z [M+Na]+ 
calcd. for C21H31BNaO5 397.2157, found 397.2160.  
 
 
1-(4-(2-Methylprop-1-en-1-yl)phenyl)propane-1,3-diol. Following the general procedure B, 3.36 
was isolated in a 37% yield over two steps. 1H NMR (500 MHz, Chloroform-d) δ 7.33 (d, J = 8.0 Hz, 
2H), 7.23 (d, J = 8.1 Hz, 2H), 6.26 (s, 1H), 5.04 – 4.87 (m, 1H), 3.89 (q, J = 5.3, 4.8 Hz, 2H), 2.65 (d, 
J = 2.7 Hz, 1H), 2.30 (s, 1H), 2.11 – 2.00 (m, 1H), 2.00 – 1.94 (m, 1H), 1.91 (d, J = 1.4 Hz, 3H), 1.87 
(d, J = 1.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 141.82, 138.35, 135.97, 129.08, 125.59, 124.87, 
74.63, 61.84, 40.59, 27.14, 19.65. HRMS (EI) m/z [M]+ calcd. for C13H18O2 206.1307, found 
206.1310. HPLC (ChiralPak IC column) 90:10 (hexane/iPrOH) 1 mL/min; Tmajor (14.1 min), Tminor 
(11.8 min); 98:2 er (96% ee).  
 
 
3.5.4. Optimization of the enantioselective three-component 1,1-arylborylation reaction of ethyl 
acrylate. Summary data.  
 
 ·Solvent screening 
 
 
 
OH
OH
Me
Me
10 mol% TCyP-PA, NaHCO3 (2.4 equiv)
4 mol% Pd2(dba)3
solvent 0.1 M, 25 ºC, 2-8 h Ph
B(pin)
CO2Et
CO2Et
PhN2BF4 (1.0 equiv), B2(pin)2 (2.2 equiv)
entry
 1
2
3
4
33%
73%
47%
55%
yielda
hexanes 
toluene 
Et2O 
MTBE
solvent
38%
<5%
85%
47%
eeb
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enan-
tiomeric ratio determined by chiral phase HPLC.
0.09 mmol 3.18
O
O
PO2H
Cy
Cy
Cy
Cy
Cy
Cy
TCyP-PA
	  	  
CAPT Pd
161 
·Catalyst screening  
 
 
 
 
 
entry
1
2
3
4 
5 
6 
7 
8 
9
47%
35%
46%
54% 
52% 
24% 
29% 
28% 
60%
yielda
TCyP-PA 
H8-TCyP-PA 
C8-TCyP-PA 
TRIP-PA 
STRIP-PA 
9-Anthra-PA
4-CF3-BINAM 
3,5-diMe-BINAM 
TRIP-NHTf
85% 
82% 
76% 
46%
10% 
84% 
5% 
21% 
<5%
eeb
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enan-
tiomeric ratio determined by chiral phase HPLC.
10 mol% PTC, NaHCO3 (2.4 equiv)
4 mol% Pd2(dba)3
Et2O 0.1 M, 25 ºC, 2-8 h Ph
B(pin)
CO2Et
CO2Et
PhN2BF4 (1.0 equiv), B2(pin)2 (2.2 equiv)
0.09 mmol 3.18
PTC
O
O
PO2H
Cy
Cy
Cy
Cy
Cy
Cy
O
O
PO2H
Cy
Cy
Cy
Cy
Cy
Cy
C8H17
C8H17
O
O PO2H
iPr
iPriPr
iPriPr
iPr
O
O
PO2H
N
N
PO2H
Ar
Ar
O
O
PONHTf
iPr
iPr
iPr
iPr
iPr
iPr
C8-TCyP-PAH8-TCyP-PA STRIP-PA
4-CF3-BINAM (Ar = 4-CF3-C6H4) 
3,5-diMe-BINAM (Ar = 3,5-diMe-C6H4)9-Anthra-PA TRIP-NHTf
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·Base screening  
 
 
 
 
 ·Additives  
 
 
 
 
 
 
entry
1
2
3
4 
5 
6
42%
41%
<6%
36% 
32% 
not observed
yielda
NaHCO3 
Na3PO4 
K3PO4 
Na2CO3 
K2CO3 
Cs2CO3
86% 
89% 
nd 
96%
96% 
-
eeb
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enan-
tiomeric ratio determined by chiral phase HPLC.
10 mol% TCyP-PA, base (2.4 equiv)
4 mol% Pd2(dba)3
Et2O 0.1 M, 25 ºC, 2-8 h Ph
B(pin)
CO2Et
CO2Et
PhN2BF4 (1.0 equiv), B2(pin)2 (2.2 equiv)
0.09 mmol 3.18
base
entry
1
2
3
4 
5 
6
41%
36%
38%
39% 
34% 
31%
yielda
-
dba 
4-MeO-dba 
4-CF3-dba 
3-CF3-dba 
3,5-diCF3-dba
89% 
93% 
81% 
83%
85% 
66%
eeb
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enan-
tiomeric ratio determined by chiral phase HPLC.
10 mol% TCyP-PA, Na3PO4 (2.4 equiv)
4 mol% Pd2(dba)3
Et2O 0.1 M, 25 ºC, 2-8 h Ph
B(pin)
CO2Et
CO2Et
PhN2BF4 (1.0 equiv), B2(pin)2 (2.2 equiv)
0.09 mmol 3.18
additive
16 mol% additive
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 ·Time study  
 
 
 
3.5.5. General procedure C: Enantioselective three-component 1,1-arylborylation reaction of 
ethyl acrylate.  
 
 
 
A 1 dram vial was charged with B2(pin)2 (2.2 equiv) , Pd2dba3 (4 mol%), TCyP-PA (10 mol%), 
Na3PO4 (2.4 equiv), the ArN2BF4 (1.0 equiv). To the solid reagents was added a solution of ethyl 
acrylate (1.0 equiv, 0.09 mmol) in Et2O (0.1 M). The vial was capped and the heterogeneous reaction 
mixture was stirred vigorously. The reaction progress monitored via TLC analysis. Upon completion 
the reaction was filtered through a plug of Celite, and then concentrated in vacuo. 
1H NMR yield: The NMR yield was assessed by dissolving the crude reaction mixture in a solution of 
CD2Cl2 with dimethyl sulfone (1.0 equiv) as the internal standard.  
Isolated yield of alcohol (over two steps): The crude reaction mixture (containing dimethyl sulfone) 
was purified via flash column chromatography (EtOAc/hexanes) to provide the boronic ester product 
that was contaminated with residual B2(pin)2. The mixture of product and byproduct was treated with 
THF (1 mL), pH 7 phosphate buffer solution (0.5 mL) was added, followed by the dropwise addition 
of 30% v/v aq. hydrogen peroxide (0.25 mL). After 0.5 h, stirring under a N2 atmosphere, the reaction 
mixture was cautiously quenched with sat. aq. Na2S2O3 (2 mL), and then diluted with H2O. The 
aqueous layer was extracted with EtOAc (3 x 5 mL). The combined organic layers were dried over 
entry
1
2
3
4
15%
26%
36%
45%
yielda
2 h 
4 h 
6 h 
20 h
76% 
81% 
80% 
86%
eeb
a Yield determined by 1H NMR utilizing dimethyl sulfone as internal standard. b Enan-
tiomeric ratio determined by chiral phase HPLC.
10 mol% TCyP-PA, NaHCO3 (2.4 equiv)
4 mol% Pd2(dba)3
Et2O 0.1 M, 25 ºC Ph
B(pin)
CO2Et
CO2Et
PhN2BF4 (1.0 equiv), B2(pin)2 (2.2 equiv)
0.09 mmol 3.18
time
Ar
B(pin)
5 mol% Pd2(dba)3 
10 mol% TCyP-PA, Na3PO4 (2.4 equiv) 
ArN2BF4 (2.0 equiv), B2(pin)2 (2.4 equiv)  
Et2O 0.043 M, 25 ºC, 8-10 h
OEt
H2O2, pH 7 buffer 
THF
Ar
OH
OEtOEt
O O O
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anhydrous Na2SO4, filtered and concentrated in vacuo. The crude reaction mixture was purified via 
flash column chromatography (EtOAc/hexanes) to afford pure β-hydroxy ethyl esters as yellow oils.   
 
 
Ethyl 3-hydroxy-3-phenylpropanoate. Following the general procedure C, 3.37 was isolated in a 
46% yield over two steps. 1H NMR (600 MHz, Chloroform-d) δ 7.37 (dd, J = 13.5, 6.2 Hz, 4H), 7.30 
(t, J = 7.0 Hz, 1H), 5.15 (dt, J = 9.1, 3.3 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.28 (d, J = 3.4 Hz, 1H), 
2.83 – 2.64 (m, 2H), 1.28 (t, J = 7.2 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 172.63, 142.72, 128.77, 
128.02, 125.89, 70.56, 61.10, 43.55, 14.37. Spectra matches previously reported spectra.211 HPLC 
(ChiralPak IC column) (hexane/iPrOH) 1 mL/min; Tmajor (9.0 min), Tminor (8.2 min); 94:6 er (86% ee).  
 
 
Ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(p-tolyl)propanoate. Following the general 
procedure C, 3.26 was provided in a 44% yield (via 1H NMR analysis). 1H NMR (600 MHz, 
Chloroform-d) 7.12 (d, J = 8.1 Hz, 2H), 7.07 (d, J = 7.9 Hz, 2H), 4.21-4.01 (m, 2H), 2.86 (dd, J = 
16.3, 10.1 Hz, 1H), 2.70 (dd, J = 10.1, 6.1 Hz, 1H), 2.63 (dd, J = 16.4, 6.1 Hz, 1H), 2.30 (s, 3H), 1.24-
1.13 (m, 15H). 13C NMR (151 MHz, CDCl3) 173.66, 138.47, 135.22, 129.37, 128.29, 83.69, 60.50, 
37.73, 24.81, 24.73, 21.18, 14.46. HRMS (ESI) m/z [M+Na]+ calcd. for C18H27BNaO4 341.1895, found 
341.1894. 
 
 
Ethyl 3-hydroxy-3-(p-tolyl)propanoate. Following the general procedure C, 3.38 was isolated in a 
44% yield over two steps. 1H NMR (600 MHz, Chloroform-d) δ 7.34 – 7.22 (m, 2H), 7.17 (d, J = 7.7 
Hz, 2H), 5.11 (dd, J = 9.6, 3.4 Hz, 1H), 4.19 (qd, J = 7.1, 1.1 Hz, 2H), 3.21 (s, 1H), 2.76 (ddd, J = 
16.3, 9.4, 1.1 Hz, 1H), 2.70 (ddd, J = 16.3, 3.7, 1.1 Hz, 1H), 2.35 (s, 3H), 1.28 (td, J = 7.2, 1.2 Hz, 
3H). 13C NMR (151 MHz, CDCl3) δ 172.63, 139.80, 137.70, 129.41, 125.83, 70.41, 61.04, 43.55, 
21.31, 14.37. Spectra matches previously reported spectra.211 HPLC (ChiralPak IC column) 
(hexane/iPrOH) 1 mL/min; Tmajor (9.0 min), Tminor (8.2 min); 92:8 er (84% ee).  
 
                                                       
211 Wolf, C.; Moskowitz, M. J. Org. Chem. 2011, 76, 6372. 
OH
CO2Et
B(pin)
CO2Et
Me
OH
CO2Et
Me
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Ethyl 3-(4-(tert-butyl)phenyl)-3-hydroxypropanoate. Following the general procedure C, 3.39 was 
isolated in a 33% yield over two steps. 1H NMR (500 MHz, Methylene Chloride-d2) δ 7.42 (d, J = 8.3 
Hz, 2H), 7.34 (d, J = 8.3 Hz, 2H), 5.12 (dt, J = 7.3, 3.4 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.25 – 3.09 
(bs, 1H), 2.80 – 2.66 (m, 2H), 1.35 (s, 8H), 1.29 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CD2Cl2) δ 
172.65, 151.05, 140.17, 125.73, 125.68, 70.34, 61.10, 43.59, 34.74, 31.40, 14.30.  Spectra matches 
previously reported spectra.211 HPLC (ChiralPak IC column) (hexane/iPrOH) 1 mL/min; Tmajor (21.4 
min), Tminor (23.0 min); 99:1 er (98% ee).  
 
 
4-(3-Ethoxy-3-oxo-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)phenyl pivalate. Follo-
wing the general procedure C, 3.28 was provided in a 40% yield (via 1H NMR analysis). 1H NMR 
(500 MHz, Chloroform-d) 7.26-7.18 (m, 2H), 7.02-6.87 (m, 2H), 4.11 (qq, J = 10.8, 7.1 Hz, 2H), 2.86 
(dd, J = 16.3, 10.0 Hz, 1H), 2.74 (dd, J = 10.0, 6.0 Hz, 1H), 2.65 (dd, J = 16.3, 6.0 Hz, 1H), 1.34 (s, 
9H), 1.28-1.22 (m, 3H), 1.20 (app d, J = 20.4 Hz, 12H). 13C NMR (126 MHz, CDCl3) 177.41, 173.52, 
149.25, 138.84, 129.24, 121.57, 83.82, 60.65, 39.24, 37.57, 27.35, 24.79, 24.71, 14.46. HRMS (ESI) 
m/z [M+K]+ calcd. for C22H33BKO6 427.2262, found 427.2266.  
 
 
4-(3-Ethoxy-1-hydroxy-3-oxopropyl)phenyl pivalate. Following the general procedure C, 3.40 was 
isolated in a 37% yield over two steps. 1H NMR (500 MHz, Chloroform-d) δ 7.40 (d, J = 8.4 Hz, 2H), 
7.05 (d, J = 8.6 Hz, 2H), 5.15 (dt, J = 7.9, 3.4 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.33 (d, J = 3.3 Hz, 
1H), 2.81 – 2.63 (m, 2H), 1.36 (s, 9H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
177.34, 172.61, 150.76, 140.00, 126.92, 121.79, 70.04, 61.18, 43.50, 39.28, 27.34, 14.37. HRMS 
(ESI) m/z [M+Na]+ calcd. for C16H22NaO5 317.1359, found 317.1357. HPLC (ChiralPak IC column) 
(hexane/iPrOH) 1 mL/min; Tmajor (32.8 min), Tminor (38.8 min); 96:4 er (92% ee).  
 
 
OH
CO2Et
tBu
B(pin)
CO2Et
PivO
OH
CO2Et
PivO
	   166 
 
Ethyl 3-hydroxy-3-(4-(2-methylprop-1-en-1-yl)phenyl)propanoate. Following the general 
procedure C, 3.41 was isolated in a 27% yield over two steps. 1H NMR (500 MHz, Chloroform-d) δ 
7.33 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 8.1 Hz, 2H), 6.26 (s, 1H), 5.13 (dt, J = 9.3, 3.2 Hz, 1H), 4.20 (q, 
J = 7.1 Hz, 2H), 3.24 (d, J = 3.4 Hz, 1H), 2.84 – 2.64 (m, 2H), 1.91 (d, J = 1.4 Hz, 3H), 1.86 (d, J = 
1.4 Hz, 3H), 1.27 (d, J = 7.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 172.72, 140.00, 138.50, 136.03, 
129.08, 125.62, 124.86, 70.42, 61.10, 43.42, 27.13, 19.63, 14.38. HRMS (ESI) m/z [M+Na]+ calcd. for 
C15H20NaO3 271.1305, found 271.1306. HPLC (ChiralPak IC column) (hexane/iPrOH) 1 mL/min; 
Tmajor (21.0 min), Tminor (22.3 min); 98:2 er (96% ee).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OH
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3.5.6. HPLC data.  
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Chapter 4  
Enantioselective palladium-catalyzed oxidative β ,β-fluoroarylation  
of α ,β-unsaturated carbonyl derived systems  
 
 
4.1. Introduction and current state-of-the-art.  
 
The pivotal role displayed by fluorine in the growth and development of medicinal chemistry 
is firmly established, providing remarkable breakthroughs in this arena.212 Despite its widespread 
distribution in nature, the presence of fluorine in natural organic molecules is scarce, and most of the 
fluorine-containing organic molecules are synthetic.6d Given this reality, the development of new 
methodologies that gain access to new fluorinated derivatives is always in great demand, particularly 
those enabling selective fluorination at specific positions of an organic framework.  
Among current strategies for the asymmetric construction of sp3 C–F bonds,7a,7b α-fluorination 
of carbonyl derivatives is the strategy most commonly exploited. Distinct approaches, including 
organocatalytic methods,213 ring-opening of strained heterocycles,214 and transition metal-catalyzed 
fluorinations,215 have been developed. Compared to the other approaches, transition metal-catalyzed 
fluorinations remain the most challenging. Despite the high C–F bond energy (the strongest made with 
carbon at 456-486 KJ·mol-1, exceeding that of C–H bond), reductive elimination from transition metal 
complexes is extremely challenging.216 While the strength of the C–F bond offers a thermodynamic 
                                                       
212 (a) Wang, J.; Sánchez-Roselló, M.; Aceña, J. L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; Liu, H. 
Chem. Rev. 2014, 114, 2432. (b) Zhou, Y.; Wang, J.; Gu, Z.; Wang, S.; Zhu, W.; Aceña, J. L.; Soloshonok, V. A.; Izawa, K.; 
Liu, H. Chem. Rev. 2016, 116, 422.  
213 Selected examples: (a) Kwiatkowsky, P.; Beeson, T. D.; Conrad, J. C.; MacMillan, D. W. C. J. Am. Chem. Soc. 2011, 133, 
1738. (b) Lozano, O.; Blessley, G.; Martínez del Campo, T.; Thompson, A. L.; Giuffredi, G. T.; Bettati, M.; Walker, M.; 
Borman, R.; Gouverneur, V. Angew. Chem. Int. Ed. 2011, 50, 8105. (c) Ref. 155: Rauniyar, V.; Lackner, A. D.; Hamilton, G. 
L.; Toste, F. D. Science, 2011, 334, 1681. (d) Ishimaru, T.; Shibata, N.; Horikawa, T.; Yasuda, N.; Nakamura, S.; Toru, T.; 
Shiro, M. Angew. Chem. Int. Ed. 2008, 47, 4157.  
214 (a) Kalow, J. A.; Doyle, A. G. J. Am. Chem. Soc. 2010, 132, 3268. (b) Kalow, J. A.; Doyle, A. G. J. Am. Chem. Soc. 2011, 
133, 16001. (c) Zhu, J.; Tsui, G. C.; Lautens, M. Angew. Chem. Int. Ed. 2012, 51, 12353. (d) Kalow, J. A.; Doyle, A. G. 
Tetrahedron, 2013, 69, 5702. 
215 Hamashima, Y.; Yagi, K.; Takano, H.; Tamás, L.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 14530.  
216 (a) Liang, T.; Neumann, C. N.; Ritter, T. Angew. Chem. Int. Ed. 2013, 52, 8214. (b) Grushin, V. V. Acc. Chem. Res. 2010, 
43, 160. (c) Yandulov, D. V.; Tran, N. T. J. Am. Chem. Soc. 2007, 129, 1342. (d) Grushin, V. V.; Marshall, W. J. 
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driving force for elimination, the metal-fluoride bond is also strong, providing a certain degree of 
ground-state stabilization that limits the kinetic feasibility of C–F reductive elimination. Grushin’s in-
depth research in this area revealed the formation of stable, thus unreactive, [LnPdAr(F)]2 dimeric 
species as one of the key factors compromising reductive elimination.  
Nonetheless, in 2009, Buchwald and coworkers accomplished C–F reductive elimination from 
a Pd(II) fluoride complex through careful ligand design (Scheme 4.1).217 A sterically demanding, 
electron-rich biaryl monophosphine ligand, tBuBrettPhos, was able to promote reductive elimination. 
Due to its large size, the formation of the aforementioned dimeric Pd(II) species was prevented, 
enabling fluorination of aryl triflates.  
 
 
 
Alternatively, Doyle and coworkers proposed a complementary pathway to achieve C–F bond 
formation from a Pd(II) fluoride species. They accomplished the enantioselective fluorination of 
allylic chlorides with silver fluoride in a Pd(0)/Pd(II) redox cycle.218 However, authors point out that 
an outer-sphere nucleophilic attack of fluoride to an electrophilic π-allyl Pd(II) intermediate (A), 
rather than reductive elimination (B), is likely to be operating. They argue that precipitation of AgCl 
provides the driving force for the C–F bond formation.  
 
                                                                                                                                                                            
Organometallics, 2007, 26, 4997. (e) Grushin, V. V. Chem. Eur. J. 2002, 8, 1007.  
217 Watson, D. A.; Su, M.; Teverovskiy, G.; Zhang, Y.; García-Fortanet, J.; Kinzel, T.; Buchwald, S. L. Science, 2009, 325, 
1661.  
218 (a) Katcher, M. H.; Norrby, P.-O.; Doyle, A. G. Organometallics, 2014, 33, 2121. (b) Katcher, M. H.; Sha, A.; Doyle, A. 
G. J. Am. Chem. Soc. 2011, 133, 15902. (c) Katcher, M. H.; Doyle, A. G. J. Am. Chem. Soc. 2010, 132, 17402.  
OTf
Ar
F
Ar
CsF
6 mol% tBuBrettPhos
2 mol% [Pd(cinnamyl)Cl]2
toluene, 80-120 ºC, 12 h
PtBu2MeO
OMe
iPr
iPr
iPr
tBuBrettPhos
Scheme 4.1. C-F reductive elimination from a Pd(II) fluoride (Buchwald, 2009).
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As a hard base, fluoride is also well suited for stabilizing highly oxidized metal centers,219 and 
as Sanford and Ritter demonstrated, reductive elimination can be accomplished from high valent 
electron-deficient palladium species generated by oxidative fluorination (Scheme 4.3).220  
In 2006, the Sanford group reported a Pd-catalyzed C-H fluorination of 2-aryl pyridine 
derivatives 4.1 in the presence of 2,4,6-Me3-NFPy·BF4 under microwave irradiation conditions 
(Scheme 4.3a).221 Three years later, they demonstrated the intermediacy of a high-valent Pd(IV) 
species 4.4 in a related oxidative Pd-mediated fluorination reaction (Scheme 4.3b).222 Species 4.4 
constitutes the first characterized example of a Pd(IV) bifluoride.  
 
 
 
 
 
 
 
 
                                                       
219 S. Riedel, M. Kaupp, Coord. Chem. Rev. 2009, 253, 606.  
220 (a) Racowski, J. M.; Sanford, M. S. Top. Oranomet. Chem. 2011, 35, 61. (b) Sehnal, P.; Taylor, R. J. K.; Fairlamb, I. J. S. 
Chem. Rev. 2010, 110, 824. (c) Xu, L.-M.; Li, J.-J.; Yang, Z.; Shi, Z.-J. Chem. Soc. Rev. 2010, 39, 712.  
221 Hull, K. L.; Anani, W. Q.; Sanford, M. S. J. Am. Chem. Soc. 2006, 128, 7134.  
222 Ball, N. D.; Sanford, M. S. J. Am. Chem. Soc. 2009, 131, 3796.  
AgF
Pd2(dba)3 cat., Ln*
toluene, rt
Ln*
Scheme 4.2. Outer-sphere attack rather than reductive elimination (Doyle, 2010).
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Similarly, in 2008, Ritter and coworkers published a stoichiometric Pd-mediated fluorination 
of boronic acids using Selectfluor, affording aryl fluorides in moderate to good yields (Scheme 
4.3c).223 The intermediacy of an aryl Pd(IV) fluoride could be later demonstrated.224  
 
 
 
These seminal contributions set a foundation for the development of new catalytic transition 
metal-catalyzed fluorination reactions.  
In a more recent example, Toste and coworkers disclosed a palladium-catalyzed 1,2-
fluoroarylation of styrenes 4.7 with aryl boronic acids in the presence of Selectfluor, generating 
secondary benzyl fluorides 4.8 in good yields and good selectivities (Scheme 4.4).225 The authors 
believe the reaction is directed by the ortho-amide group, which can be removed in subsequent steps.  
 
                                                       
223 (a) Furuya, T.; Kaiser, H. M.; Ritter, T. Angew. Chem. Int. Ed. 2008, 47, 5993. (b) Furuya, T.; Ritter, T. J. Am. Chem. Soc. 
2008, 130, 10060.  
224 Furuya, T.; Benitez, D.; Tkatchouk, E.; Strom, A. E.; Tang, P.; Goddard, W. A.; Ritter, T. J. Am. Chem. Soc. 2010, 132, 
3793.  
225 Talbot, E. P. A.; Fernandes, T. A.; McKenna, J. M.; Toste, F. D. J. Am. Chem. Soc. 2014, 136, 4101.  
Scheme 4.3. C–F reductive elimination from high-valent Pd species (Sanford & Ritter).
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As previously mentioned, while great progress has been made in the assembly of C–F bonds 
adjacent to an electron-withdrawing group, very few protocols that incorporate fluorine at the β-
position of a carbonyl derivative have been reported to date, and most of them are racemic (Scheme 
4.5).  
 
 
 
Scheme 4.4. Pd-catalyzed oxidative 1,2-fluoroarylation of styrenes (Toste, 2014).
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Scheme 4.5. Approaches to β-fluoro carbonyl systems.
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Early contributions entailed prior installation of a functional group, e.g. alcohols, halides, 
sulfonates, or boronates, and further conversion into the corresponding β-fluorinated carbonyl 
compound using either nucleophilic or electrophilic fluorinating reagents (Scheme 4.5a).226  
Enantioselectivity was only achieved in fluorinative Wagner-Meerwein rearrangements on 
allylic alcohols 4.10 (Scheme 4.5b). In 2005, Tu and coworkers reported the combination of chiral 
alkaloids and Selectfluor as a means to induce an asymmetric semipinacol rearrangement (Scheme 
4.6).227  
 
 
 
More recently, the Alexakis group successfully applied CAPT technology to render these 
types of rearrangements highly enantioselective (Scheme 4.7).228  
 
 
                                                       
226 (a) Li, Z.; Wang, Z.; Zhu, L.; Tan, X.; Li, C. J. Am. Chem. Soc. 2014, 136, 16439. (b) Zhang, M.; Gong, Y.; Wang, W. 
Eur. J. Org. Chem. 2013, 7372. (c) Bonacorso, H. G.; Porte, L. M. F.; Navarini, J.; Paim, G. R.; Luz, F. M.; Oliveira, L. M.; 
Whietan, C. W.; Martins, M. A. P.; Zanatta, N. Tetrahedron Lett. 2011, 52, 3333. (d) Kim, K.-Y.; Kim, B. C.; Lee, H. B.; 
Shin, H. J. Org. Chem. 2008, 73, 8106.  
227 Wang, M.; Wang, B. M.; Shi, L.; Tu, Y. Q.; Fan, C.-A.; Wang, S. H.; Hu, X. D.; Zhang, S. Y. Chem. Commun. 2005, 
5580.  
228 (a) Romanov-Michailidis, F.; Guénée, L.; Alexakis, A. Angew. Chem. Int. Ed. 2013, 52, 9266. (b) Romanov-Michailidis, 
F.; Pupier, M.; Guénée, L.; Alexakis, A. Chem. Commun. 2014, 50, 13461. 
Scheme 4.6. Fluorinative semipinacol rearrangement (Tu, 2005).
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Scheme 4.7. Asymmetric Wagner-Meerwein transposition via CAPT (Alexakis, 2013).
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Previously, Gouverneur and coworkers accomplished the preparation of β-fluoro carboxylic 
acid derivatives through an electrophilic fluorodesilylation reaction in the presence of Selectfluor 
(Scheme 4.5c).229  
Recently reported methods explored selective C–H230 and C–C activation231 as a means to 
guide C(sp3) fluorination. In this sense, the groups of Shi, Yu, Ge and Xu recently reported a 
palladium-catalyzed anti-selective β-fluorination of valuable chiral α-amino acid derivatives by 
ligand-enabled C(sp3)–H activation (Scheme 4.5d).232 Mechanistic studies were consistent with direct 
C–F reductive elimination from a Pd(IV) fluoride intermediate.  
More recently, Leckta and coworkers disclosed a tandem ring-opening of conformationally 
strained cyclopropanols and successive site-selective β-fluorination towards the preparation of β-
fluoro ketones in moderate to good yields (Scheme 4.5e).233  This protocol, which relies on a 
photoinduced C–C bond activation, employs 1,2,4,5-tetracyanobenzene (TCB) as a photosensitizer, 
along with Selectfluor.  
Finally, the Grubbs group discloses the preparation of achiral β-fluoro aldehydes 4.16 by an 
anti-Markovnikov Wacker-type oxidation of allylic fluorides 4.15 (Scheme 4.5f & 4.8). 234  The 
observed regioselectivity is determined by the inductive withdrawing effects imparted by the fluoride.   
 
 
                                                       
229 Tredwell, M.; Tenza, K.; Pacheco, M. C.; Gouverneur, V. Org. Lett. 2005, 7, 4495.  
230 Selected examples: (a) Xia, J.-B; Ma, Y.; Chen, C. Org. Chem. Front. 2014, 1, 468. (b) Bloom, S.; Pitts, C. R.; 
Woltornist, R.; Griswold, A.; Holl, M. G.; Lectka, T. Org. Lett. 2013, 15, 1722. (c) Bloom, S.; Sharber, A.; Holl, M. G.; 
Knippel, J. L.; Lectka, T. J. Org. Chem. 2013, 78, 11082. Metal-free C(sp3)-H fluorinations: (d) Pitts, C. R.; Ling, B.; 
Woltornist, R.; Liu, R.; Lectka, T. J. Org. Chem. 2014, 79, 8895. (e) S. Bloom, J. L. Knippel, T. Lectka, Chem. Sci. 2014, 5, 
1175. (f) Halperin, S. D.; Fan, H.; Chang, S.; Martin, R. E.; Britton, R. Angew. Chem. Int. Ed. 2014, 53, 4690. (g) Kee, C. 
W.; Chin, K. F.; Wong, M. W.; Tan, C.-H. Chem. Commun. 2014, 50, 8211. (h) Bloom, S.; McCann, M.; Lectka, T. Org. 
Lett. 2014, 16, 6338. (i) Xia, J.-B.; Zhu, C.; Chen, C. J. Am. Chem. Soc. 2013, 135, 17494.  
231 (a) Bloom, S.; Bume, D. D.; Pitts, C. R.; Lectka, T. Chem. Eur. J. 2015, 21, 8060. (b) Ventre, S.; Petronijevic, F. R.; 
MacMillan, D. W. C. J. Am. Chem. Soc. 2015, 137, 5654.  
232 (a) Zhu, R.-Y.; Tanaka, K.; Li, G.-C.; He, J.; Fu, H.-Y.; Li, S.-H.; Yu, J.-Q. J. Am. Chem. Soc. 2015, 137, 7067. (b) 
Zhang, Q.; Yin, X.-S.; Chen, K.; Zhang, S.-Q.; Shi, B.-F. J. Am. Chem. Soc. 2015, 137, 8219. For other closely-related 
examples, see: (c) Zhu, Q.; Ji, D.; Liang, T.; Wang, X.; Xu, Y. Org. Lett. 2015, 17, 3798. (d) Miao, J.; Yang, K.; Kurek, M.; 
Ge, H. Org. Lett. 2015, 17, 3738.  
233 Bloom, S.; Bume, D. D.; Pitts, C. R.; Lectka, T. Chem. Eur. J. 2015, 21, 8060.	  
234 Chu, C. K.; Ziegler, D. T.; Carr, B.; Wickens, Z. K.; Grubbs, R. H. Angew. Chem. Int. Ed. 2016, 55, 8435.  
Scheme 4.8. Nitrite-modified Wacker oxidation (Grubbs, 2016).
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4.2. Enantioselective Pd-catalyzed β ,β-fluoroarylation reaction.  
 
On the basis of the limited reports of oxidative transition metal-catalyzed fluorinations and 
inspired by recent examples of palladium-catalyzed 1,1-difunctionalizations from Sanford, Sigman 
and Toste,235 we envisioned accessing β-fluorinated carbonyl derivatives via a single-step three-
component Heck arylation-oxidative fluorination cascade (Scheme 4.9).  
 
 
 
Our attempted catalytic cycle is outlined in Scheme 4.10.  
 
 
                                                       
235 (a) Kalyani, D.; Satterfield, A. D.; Sanford, M. S. J. Am. Chem. Soc. 2010, 132, 8419. (b) Kalyani, D.; Sanford, M. S. J. 
Am. Chem. Soc. 2008, 130, 2150. (c) Ref. 165: Saini, V.; Liao, L.; Wang, Q.; Jana, R.; Sigman, M. S. Org. Lett. 2013, 15, 
5008. (d) Ref. 194b: Saini, V.; Sigman, M. S. J. Am. Chem. Soc. 2012, 134, 11372. (e) Liao, L.; Jana, R.; Urkalan, K. B.; 
Sigman, M. S. J. Am. Chem. Soc. 2011, 133, 5784. (f) Ref. 201: Nelson, H. M.; Williams, B. D.; Miró, J. Toste, F. D. J. Am. 
Chem. Soc. 2015, 137, 3213. (g) He, Y.; Yang, Z.; Thornbury, R. T.; Toste, F. D. J. Am. Chem. Soc. 2015, 137, 12207.	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Starting from a suitable Pd(II) species, transmetalation with an aryl boronic acid and 
subsequent migratory insertion, would generate a β-arylated-α-Pd(II) intermediate B. Thereafter, 
sequential β-hydride elimination and reinsertion steps would yield a π-benzyl palladium complex C. 
Oxidation by an appropriate electrophilic fluorine source, [N-F], would give rise to a high-valent 
Pd(IV)-fluoride D, which is poised to undergo reductive elimination yielding the final β-
fluorocarbonyl derivative and completing the catalytic cycle.  
During the realization of this work, the Toste group published an enantioselective palladium-
catalyzed 1,1-fluoroarylation of unactivated allyl amines 4.18 (Scheme 4.11),235g showcasing the 
feasibility of the attempted 1,1-difunctionalization. As for the previously reported 1,2-fluoroarylation 
reaction (see Scheme 4.4),225 chiral bidentate diimine BOX-type ligands were used to render the 
process enantioselective. Once again, the presence of a directing group (in this case nosyl) was critical 
prompting insertion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4.11. 1,1-Fluoroarylation of allyl amines (Toste, 2015).
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4.3. Results and discussion.  
 
Under this scenario, we decided to test our hypothesis by examining the fluoroarylation of 
ethyl acrylate with 4-tolyl boronic acid as a model reaction. The optimization process is summarized 
in Table 4.1. Initially, the reaction was performed under similar conditions to those previously 
employed in the 1,2-fluoroarylation of styrenes.225 Thus, ethyl acrylate was treated with 2.0 equiv of 
the aryl boronic acid, 15 mol% of Pd(OAc)2, 15 mol% of 1,10-phenanthroline, and 4 mol% of 4-tert-
butylcatechol, in a 0.08M mixture DCM:H2O (10:1), using Selectfluor (2.0 equiv) as both the 
electrophilic fluorine source and the oxidant. However, after 20 hours, only trace amounts of the 
desired β-fluoroester 4.20 were detected, with the major product resulting from the competing Heck 
reaction (entry 1).  
 
 
 
Pleasingly, switching [N-F] source to NFSI had a dramatic effect, giving rise to the exclusive 
formation of 1,1-fluoroarylated product 4.20 in excellent yield (entry 2), with complete exclusion of 
Table 4.1. Optimization of reaction conditions.a
[N-F] (2.0 equiv), 4-Me-C6H4B(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol
F
EtO2CEtO2C
15 mol% Pd(OAc)2/1,10-phenanthroline
entry
 1
2
3
4
5
6
DCM/H2O (10:1) 0.08 M, 20-25 ºC, 20 h
a Conditions: all reactions were run on 0.055 mmol scale with respect to α,β-unsaturated 
system. b Yield determined by 19F NMR utilizing fluorobenzene as internal standard.
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95%
-
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-
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yieldb
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styrene formation.236 Notably, degassing of the system was necessary to avoid oxidation of the boronic 
acid coupling partner (entry 3). Moreover, the reaction did not proceed in the absence of water (entry 
4), which is potentially responsible for initiating transmetalation. Even though water may result in 
having a more active, tetracoordinated, negatively charged boronate [ArB(OR)2(OH)]- as the actual 
species undergoing transmetalation, mechanistic studies suggest that nucleophilic palladium hydroxo 
complexes are likely operative.237 Aryl boronic ester 4-Me–C6H4B(pin) was found inactive under these 
conditions. The presence of a bipyridine-type ligand is crucial to achieve the desired fluorinative 
reaction manifold (entry 5). Therefore, an N,N-ligated Pd(II) complex is most likely the catalytically 
active species. Likewise, the presence of a radical scavenger to prevent either alternative radical 
pathways involving the aryl boronic acid or polymerization of starting alkenes (entry 6), was 
critical.238 Remarkably, the product derived from the 1,2-fluoroarylation of ethyl acrylate was not 
observed. 
With these optimized conditions in hand, the scope of the β,β-fluoroarylation protocol was 
next evaluated (Table 4.2).  
 
 
                                                       
236 Outstandingly, this electrophilic fluorine source was inefficient in previously reported 1,2- and 1,1-fluoroarylation of 
alkenes reported by the Toste group: (a) Ref. 225: Talbot, E. P. A.; Fernandes, T. de A.; McKenna, J. M.; Toste, F. D. J. Am. 
Chem. Soc. 2014, 136, 4101. (b) Ref. 235g: He, Y.; Yang, Z.; Thornbury, R. T.; Toste, F. D. J. Am. Chem. Soc. 2015, 137, 
12207.  
237 (a) Carrow, B. P.; Hartwig, J. F. J. Am. Chem. Soc. 2011, 133, 2116. (b) Amatore, C.; Jutand, A.; Le Duc, G. Chem. Eur. 
J. 2011, 17, 2492. (c) Butters, M.; Harvey, J. N.; Jover, J.; Lennox, A. J. J.; Lloyd-Jones, G. C.; Murray, P. M. Angew. Chem. 
Int. Ed. 2010, 49, 5156.  
238 Martínez, C.; Muñiz, K. Angew. Chem. Int. Ed. 2012, 51, 7031.  
Table 4.2. Non-enantioselective substrate scope.a,b,c
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We were pleased to observe that, under optimized conditions, acrylic esters, amides, and 
ketones smoothly provided racemic β-fluoro derivatives 4.20-4.23 in good to excellent yields. 
Nevertheless, acrylic acid furnished benzyl fluoride 4.24 in diminished yields, despite increased 
equivalents of aryl boronic acid. Diminished yields obtained for methyl vinyl ketone (4.22) offers an 
interesting mechanistic insight into the reaction manifold. We hypothesized that this result was an 
indication of the likely role displayed by the chelating carbonyl group, prompting insertion, while 
backing up the stabilization of the palladium intermediate species. In agreement with this hypothesis, 
highly activated 4-methoxyphenyl vinyl ketone, afforded β-fluoroketone 4.23 in a satisfactory 84% 
yield. Moreover, a Weinreb amide underwent smooth β,β-fluoroarylation in 98% yield. This result, in 
addition to widening the ketone scope, opened access to aldehyde derivatives (4.26), and in turn, to 
over-reduced 3,3-fluoroaryl alcohols 4.37 (Scheme 4.12).  
 
 
ArB(OH)2 scope
a Conditions: all reactions were run in 0.11 mmol scale with respect to starting α,β-unsaturated system. b Yield de-
termined by 19F NMR utilizing fluorobenzene as internal standard. c Isolated yields in brackets. d Yield over two 
steps: (1) β,β-fluoroarylation of N-methoxy-N-methylacrylamide and (2) reduction of 4.25.
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Scheme 4.12. Weinreb amide derivables.
O
N
Me
OMe
NFSI (2.0 equiv), 4-TolB(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol
15 mol% Pd(OAc)2/1,10-phenanthroline
DCM/H2O (10:1) 0.08 M, 20-25 ºC, 20 h
4.25
DIBAL-H (1.1 equiv)
THF, -78 ºC, 0.5 h
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Furthermore, the use of a nitrile-substituted substrate provided γ-fluoro nitrile 4.27 in modest 
yields, however the nitrile moiety had to be placed at a more distant position. α-Substituted ethyl 
methacrylate provided the corresponding product 4.28 in good yield and modest diastereoselectivity, 
while β-substituents were not tolerated.  
Likewise, a range of aryl boronic acids was subjected to oxidative conditions. As shown in 
Table 4.2, this procedure was efficient with non-electronically-biased aryl boronic acids. β-Fluoro 
esters 4.29 and 4.30 were formed in 85% and 76% yields, respectively, indicating that steric hindrance 
did not significantly impact the reaction. Electron-rich 4-methoxyphenyl boronic acid gave trace 
amounts of the desired product, most likely because of the incompatibility of the anisole ring with 
strongly oxidizing species such as NFSI.239 The less activated 3-methoxyphenyl boronic acid afforded 
the desired product 4.32 in good yield. On the other hand, highly deactivated aryl boronic acids such 
as 4-trifluoromethyl phenyl boronic acid, failed to provide the desired β-fluoro carbonyl adducts, but 
formed the Heck coupled product instead. Presumably, electron-withdrawing substituents difficult 
oxidation of palladium species C (see Scheme 4.10). Likewise, the reaction was amenable to halogen 
substitution (4.33-4.36), leaving chlorine, bromine and iodine moieties intact for further 
transformations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                       
239 (a) Qian, D.; Zhang, J. Beilstein. J. Org. Chem. 2011, 7, 808. (b) Brenzovich, W. E., Jr.; Benitez, D.; Lackner, A. D.; 
Shunatona, H. P.; Tkatchouk, E.; Goddard, W. A., III; Toste, F. D. Angew. Chem. Int. Ed. 2010, 49, 5519. (c) Zhang, G.; 
Peng, Y.; Cui, L.; Zhang, L. Angew. Chem. Int. Ed. 2009, 48, 3112.  
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The regiochemistry of 1,1-difunctionalization was confirmed by two-dimensional NMR 
studies on substrate 4.25. A heteronuclear multiple bond correlation (HMBC) experiment showed a 
correlation between the methylene and carbonyl groups, but not with the CHF proton, confirming 1,1-
regiochemistry (Figure 4.1).  
 
 
 
Having provided proof-of-principle for the β,β-fluoroarylation reaction, the enantioselective 
variant was next examined using ethyl acrylate as a model substrate (Table 4.3). To this end, we 
undertook the evaluation of a range of different bidentate diimine chiral ligands, e.g. those indicated in 
Table 4.3, entries 1-4.240 Among them, BOX 3a was identified as the most encouraging ligand, 
affording 4.20 in 72:38 er and quantitative yield (entry 3). Unfortunately, attempts at increasing the er 
by cooling proved unfruitful (entry 5). We then proceeded to survey solvent effects. Switching to 
nonpolar solvents, such as toluene, resulted in the erosion of yield without increasing selectivity (entry 
6). Pleasingly, further examination led us to identify that coordinating solvents, such as EtOAc, EtOH, 
and acetone, are superior in terms of enantioselectivity (entries 7-9), providing the desired product 
4.20 in up to 96:4 er (entry 8). However, this improvement in selectivity was obtained at the expense 
of yield, as previously observed in the reported Heck-Matsuda arylation-Miyaura borylation cascade 
reaction.201 Attempts to increase yield by combining solvents, were unsuccessful (entry 10). Finally, 
acetone was the solvent of choice, providing a good compromise in terms of selectivity and yield 
(entry 9).  
                                                       
240 For further details on the optimization, see Experimental Section 4.5.2.  
Me
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Ph
4.25
Figure 4.1. HMBC of substrate 4.25.
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Notably, the major byproduct in the asymmetric reactions was the corresponding styrene, i.e. 
selected conditions resulted in significant termination via β-hydride elimination (Scheme 4.13a). 
Alternatively, styrene formation might be ascribed to either HF elimination on the final products 
(Scheme 4.13b)241 or C–OH reductive elimination and subsequent dehydration as a result of F/OH 
exchange on the metal center (Scheme 4.13c).  
 
                                                       
241 As it was mentioned above, this pathway was significant just for certain ketones under acidic conditions, via keto-enol 
tautomerism. 
 
 
Table 4.3. Optimization of enantioselective β,β-fluoroarylation.a
NFSI (2.0 equiv), 4-Me-C6H4B(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol
F
EtO2CEtO2C
15 mol% Pd(OAc)2/ligand
entry
 1
2
3
4
5
6 
7 
8 
9 
10
solvent 0.08 M, 20 h
a Conditions: all reactions were run on 0.055 mmol scale with respect to ethyl acrylate. b Yi-
eld determined by 19F NMR utilizing fluorobenzene as internal standard. c Enantiomeric ra-
tio determined by chiral phase HPLC.
PyrOX 1
BOX 2 
BOX 3a 
BOX 3b 
BOX 3a
BOX 3a 
BOX 3a 
BOX 3a 
BOX 3a 
BOX 3a
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Me
4.200.055 mmol
>99% 
39% 
>99%
>99% 
96% 
43% 
37% 
53% 
61% 
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yieldb
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DCM/H2O (10:1) 
DCM/H2O (10:1) 
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DCM/H2O (10:1) 
toluene/H2O (10:1) 
AcOEt/H2O (10:1) 
EtOH/H2O (10:1) 
acetone/H2O (10:1) 
acetone/DCM/H2O (6:3:1)
solvent
52:48 
62:38  
72:28 
68:32  
72:28 
78:22  
95:5 
96:4 
93:7 
91:9
erc
20-25 ºC 
20-25 ºC 
20-25 ºC 
20-25 ºC 
10 ºC 
20-25 ºC 
20-25 ºC 
20-25 ºC 
20-25 ºC 
20-25 ºC
temperature
N N
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BOX 3b (R = Ph)
Ar
F O
R Ar
F OH
R
-HF
Ar
O
R
	  	   	  
	  194 
 
 
Additionally, amides were also evaluated for the enantioselective transformation. In this case, 
a combination of PyrOX 1 ligand and iPrOH as solvent provided the best results.242  
With optimized conditions in hand, a range of boronic acids were evaluated (Table 4.4). To 
our delight, the desired β-fluoroesters and amides were obtained in synthetically useful yields and 
good enantiomeric ratios. As for the racemic reaction, this procedure was efficient with non-
electronically-biased aryl boronic acids. While steric effects did not have a deleterious effect on the 
efficiency of the process (4.29, 4.47), 3-substituted aryl boronic acids provided higher er. 3-
Methoxyphenyl boronic acid afforded the desired products 4.32 and 4.41 in comparably good yields 
and good er. Again, the reaction was amenable to the presence of halogens (4.33-4.35, 4.40). The 
protocol was even compatible with heteroaryl boronic acids, rendering product 4.48 in 46% yield and 
88:12 er. Notably, the ester group did not have a dramatic effect on the enantioselectivity (4.39), 
providing good levels of stereoselectivity even when more challenging steroid-derived acrylates (4.43) 
were used.  
Molecular complexity was also tolerated in the aryl coupling partner (4.44), showcasing that 
this chemistry may add to the repertoire of late-stage functionalization methods and even to the ready 
generation of fluoro-bioconjugates (4.45). Moreover, the protocol was applicable to primary (4.50), 
secondary (4.49), and tertiary amides (4.25). Notably, the stereochemical integrity of the products was 
preserved after several weeks of storage at room temperature. Furthermore, when this protocol was 
scaled up ten fold, the catalytic charge (5 mol%) and the amount of ArB(OH)2 (2.0 equiv) were 
reduced without affecting neither the yield nor er (4.20, 4.39). 
 
                                                       
242 For further details on the optimization, see Experimental Section 4.5.3.  
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4.39, 60% yield  (43%), 95:5 er 
(x10)e  66% yield  (55%), 94:6 er
Table 4.4. Enantioselective substrate scope.a,b,c,d
Ar
F
RO2C
F
EtO2C
4.20, 61% yield  (52%), 93:7 er 
(x10)e  69% yield  (53%), 93:7 er
a Conditions: all reactions were run in 0.11 mmol scale with respect to starting α,β-unsaturated system. b Yield determined by 19F 
NMR utilizing fluorobenzene as internal standard. c Isolated yields in brackets. d Enantiomeric ratio (er) determined by chiral phase 
HPLC. e Absolute configuration assigned by analogy to that of 4.46, which was determined to be (R) by single-crystal X-ray diffracti-
on. f 5 mol% Pd(OAc)2/BOX 3a. g Diastereomeric ratio (dr) determined by 19F NMR. h 0.04 M.
Me
NFSI (2.0 equiv), ArB(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol
RO2C
15 mol% Pd(OAc)2/BOX 3a
acetone/H2O (10:1) 0.08 M, 20-25 ºC, 20 h0.11 mmol
F
EtO2C
4.29, 61% yield  (54%), 92:8 er
Me
F
EtO2C
4.38, 66% yield  (47%), 95:5 er
Me
Me
F
EtO2C
4.33, 63% yield  (56%), 92:8 er
Me
F
F
EtO2C
4.34, 54% yield  (42%), 92:8 er
Cl
F
EtO2C
4.35, 55% yield  (49%), 93:7 er
F
EtO2C
4.32, 62% yield  (50%), 96:4 er
OMe
F
BnO2C
MeBr
N N
Me Me
O O
Me
Me
Me
Me
BOX 3a
(a)
4.43g 
70% yield , 11:1 dr in acetone 
55% yield , 20:1 dr in EtOAc
F
BnO2C
4.40, 61% yield  (52%), 95:5 er
F
BnO2C
4.41, 88% yield  (73%), 97:3 er
F
BnO2C
4.42, 59% yield  (41%), 93:7 er
CO2Me
F
R1O2C
Me
Cl OMe
F
BnO2C
4.44,g,h 70% yield , 13:1 dr
F
R1O2C
4.45,g,h 76% yield , 7:1 dr
Ar Ar MeH
Me
Me
Me
H
H
3(  )
O
H
H H
H
Me
Me
R1 = Ar =
Ar
F
F
4.25, 55% yield  (48%), 90:10 er
Me
NFSI (2.0 equiv), ArB(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol
15 mol% Pd(OAc)2/PyrOX 1
iPrOH/H2O (10:1) 0.08 M, 20-25 ºC, 20 h0.11 mmol
F
4.46, 56% yield  (41%), 92:8 er
F
4.47, 45% yield  (32%), 84:16 er
PyrOX 1
(b)
N N
O
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O
N
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O
N
R2
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O
N
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MeO
O
N
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MeO
O
N
Me
MeO
Me
F
4.48, 46% yield  (37%), 88:12 er
F
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F
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Finally, deuterium labeling experiments carried out with d8-labelled methyl methacrylate, 
corroborated the proposed 1,1-difunctionalization mechanism disclosed above, i.e. β-deuteride 
elimination and subsequent Pd-deuteride reinsertion (Scheme 4.14a). Additionally, the β-fluoride ester 
was not observed when the reaction conditions were examined with the Heck-type byproduct ethyl 
cinnamate, eliminating a pathway involving β-fluoride addition to the unsaturated ester (Scheme 
4.14b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4.14. Mechanistic experiments.
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4.4. Conclusions.  
 
In conclusion, we have disclosed a novel strategy to access β-fluoro-carbonyl derived systems 
via the mild catalytic and direct 1,1-difunctionalization of α,β-unsaturated systems (Scheme 4.15).243 
In agreement with previously reported transformations, the reaction is likely to proceed through the 
intermediacy of a high valent Pd(IV)-fluoride species in an oxidative Heck-type mechanism. The 
developed methodology establishes a general, modular, and step-economical approach that broadens 
the limited number of reported strategies for the still challenging enantioselective construction of 
C(sp3)–F bonds β to electron-withdrawing groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                       
243 Miró, J.; del Pozo, C.; Toste, F. D.; Fustero, S. Angew. Chem. Int. Ed. 2016, 55, 9045.  
Scheme 4.15. Heck arylation-oxidative fluorination.
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4.5. Experimental section.  
 
General remarks: Unless otherwise noted, reactions were carried out under argon atmosphere and all 
reagents were purchased from commercial suppliers and used without further purification. 4-
Methoxyphenyl vinyl ketone, Weinreb amide, cholesterol-derived acrylate and estrone-derived 
boronic acid were prepared according to procedures previously described in the literature.244 Non-
commercially available BOX ligands were prepared according to previously reported procedures.245 
The reactions were monitored with the aid of thin-layer chromatography (TLC) on 0.25 mm precoated 
silica gel plates. Visualization was carried out with UV light and aqueous potassium permanganate 
stain. Flash column chromatography was performed with the indicated solvents on silica gel 60 
(particle size 0.040-0.063 mm). Melting points were measured on Büchi B-540 apparatus. 1H, 13C and 
19F spectra were recorded on 300 MHz and 500 MHz Bruker spectrometers. Chemical shifts (δ) are 
given in ppm relative to the residual solvent signals (chloroform, 7.26 ppm for 1H NMR and 77.00 
ppm for 13C NMR). Coupling constants (J) are given in Hertz (Hz). Letters m, s, d, t and q stand for 
multiplet, singlet, doublet, triplet and quartet, respectively. Letters br indicate that the signal is broad. 
High-resolution mass spectra were carried out on an AB SCIEX TripleTOF™ 5600 LC/MS/MS 
system in ESI mode [Conditions: Ion source gas 1 (GC1): 35 psi; Ion source gas 2 (GC2): 35 psi; 
Curtain gas 1: 25 psi; Temperature: 450 ºC; Ion Spray Voltage (ISVF): 5500; Infusion positive mode] 
by the University of Valencia Mass Spectrometry Service. Enantiomeric ratios were determined with 
the aid of HPLC analysis with ChiralPak OD-H, ChiralPak IC, ChiralPak AD or Amylose-1 columns 
(25 cm x 0.46 cm).   
 
Note: It is worthy to note that, for both general procedures A and B, employed organic solvents, as 
well as water, were previously degassed using an argon stream for ca. 30 minutes under stirring.  
 
 
 
 
 
 
 
                                                       
244 (a) Hellmuth, T.; Frey, W.; Peters, R. Angew. Chem. Int. Ed. 2015, 54, 2788. (b) Commare, B.; Rigault, D.; Lemasson, I. 
A.; Deschamps, P.; Tomas, A.; Roussel, P.; Brabet, I.; Goudet, C.; Pin, J.-P.; Leroux, F. R.; Colobert, F.; Acher, F. C. Org. 
Biomol. Chem. 2015, 13, 1106. (c) Laskar, P.; Samanta, S.; Ghosh, S. K.; Dey, J. J. of Colloid and Interface Science, 2014, 
430, 305. (d) Baek, Y.; Kim, S.; Jeon, B.; Lee, P. H. Org. Lett. 2016, 18, 104.  
245 (a) Desimoni, G.; Faita, G.; Mella, M. Tetrahedron, 1996, 52, 13649. (b) Desimoni, G.; Faita, G.; Guala, M.; Pratelli, C. 
Tetrahedron Asymmetry, 2002, 13, 1651. (c) Cornejo, A.; Fraile, J. M.; García, J. I.; Gil, M. J.; Martínez-Merino, V.; 
Mayoral, J. A.; Pires, E.; Villalba, I. Synlett, 2005, 2321. (d) Ginotra, S. K.; Singh, V. K. Org. Biomol. Chem. 2007, 5, 3932.  
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4.5.1. General procedure A: Racemic three-component β ,β-fluoroarylation reaction.  
 
 
 
A 1 dram vial was charged of palladium catalyst (15 mol%), 1,10-phenanthroline (15 mol%) and 1/3 
of DCM. The headspace of the reaction vessel was sparged with Ar for ca. 10 seconds, and then vial 
was capped and the mixture was stirred for 15-20 min. A separate 1 dram vial was charged with aryl 
boronic acid (2.0 equiv) and NFSI (2.0 equiv). To the solid reagents, 2/3 of DCM were added; then, 4 
mol% of 4-tert-butylcatechol (stock solution), the corresponding alkene (0.11 mmol, 1.0 equiv) and 
H2O. The palladium complex was then transferred to the reaction mixture via syringe. Once again, the 
headspace of the reaction vessel was sparged with Ar for ca. 10 seconds, vial was capped and the 
mixture was vigorously stirred for 20 hours. After the reaction was complete, the mixture was diluted 
with DCM and filtered through a pad of Celite eluting with DCM. The organic phase was evaporated 
and yield was determined, firstly, by 19F-NMR. 246  Then, the crude was purified by column 
chromatography over silica gel using a mixture of hexanes/DCM/EtOAc as eluent to give the desired 
products.  
 
 
Ethyl 3-fluoro-3-(p-tolyl)propanoate. Following the general procedure A, 4.20 was obtained in 83% 
yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 1.27 (t, J = 6.0 Hz, 3H), 2.36 (s, 3H), 2.77 
(ddd, J = 33.0, 15.0, 6.0 Hz, 1H), 3.03 (ddd, J = 15.0, 12.0, 9.0 Hz, 1H), 4.19 (qd, J = 6.0, 3.0 Hz, 2H), 
5.88 (ddd, J = 45.0, 9.0, 3.0 Hz, 1H), 7.20 (d, J = 9.0 Hz, 2H), 7.27 (d, J = 9.0 Hz, 2H); 13C-NMR 
(CDCl3, 75.5 MHz): δ 14.1, 21.2, 42.4 (d, J = 27.2 Hz), 60.9, 90.6 (d, J = 171.4 Hz), 125.7 (d, J = 6.0 
Hz), 129.3, 135.7 (d, J = 19.6 Hz), 138.7 (d, J = 2.3 Hz), 169.7 (d, J = 5.3 Hz); 19F-NMR (CDCl3, 282 
MHz): δ -171.6 (ddd, J = 48.0, 33.0, 12.0 Hz); HRMS (ES) calc. for (M++Na) C12H15FNaO2: 
233.0948; found: 233.0944.  
 
                                                       
246 19F NMR yield: The crude reaction mixture was dissolved in CDCl3 and 0.25 equivalents of fluorobenzene were added to 
obtain the NMR yield. 	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N-benzyl-3-fluoro-3-(p-tolyl)propanamide. Following the general procedure A, 4.21 was obtained in 
80% yield as a white solid (mp = 113-115 ºC). 1H-NMR (CDCl3, 300 MHz): δ 2.37 (s, 3H), 2.71 (ddd, 
J = 33.0, 15.0, 3.0 Hz, 1H), 2.90 (dt, J = 15.0, 9.0 Hz, 1H), 4.45 (d, J = 6.0 Hz, 2H), 5.92 (ddd, J = 
45.0, 9.0, 6.0 Hz, 1H), 6.08 (br s, NH), 7.17-7.35 (m, 9H); 13C-NMR (CDCl3, 75.5 MHz): δ 21.2, 43.6, 
44.8 (d, J = 24.9 Hz), 91.4 (d, J = 170.6 Hz), 125.5 (d, J = 6.0 Hz), 127.5, 127.7, 128.6, 129.3, 135.8 
(d, J = 19.6 Hz), 137.8, 138.6 (d, J = 2.3 Hz), 168.8 (d, J = 3.0 Hz); 19F-NMR (CDCl3, 282 MHz): δ -
172.2 (ddd, J = 47.7, 33.0, 15.2 Hz); HRMS (ES) calc. for (M++1) C17H18NOF: 272.1445; found: 
272.1445.  
 
 
Following the general procedure A, 4.22 was obtained in 49% NMR yield. Attempts of 
chromatographic purification on silica gel lead majorly to elimination product. Alternatively, the crude 
reaction mixture was placed under inert atmosphere, redissolved in DCM/MeOH (1:1) and cooled to 0 
ºC. Solid NaBH4 (5.0 equiv) was added and the reaction was stirred vigorously for 2 hours at room 
temperature. Then, solvents were removed under reduced pressure. The crude reaction mixture was 
quenched with H2O and extracted into DCM. Combined organic extracts were dried with anhydrous 
Na2SO4, filtered through a pad of Celite and concentrated by rotary evaporation. 19F-NMR of the crude 
indicates dr prior to isolation. Alcohol 4.52 was isolated as an inseparable mixture of diastereoisomers 
(dr 1:0.6), besides over-reduced elimination product 4.53, by column chromatography on silica gel, 
using a mixture hexanes/DCM/EtOAc as eluent. 4.52 + 4.53: 1H-NMR (CDCl3, 300 MHz): δ 1.26 (d, 
J = 6.0 Hz, 3H), 1.28 (d, J = 9.0 Hz, 1.8H), 1.81-2.28 (m, 3+1.8H), 2.36 (s, 3+1.8H), 3.93-4.04 (m, 
1H), 4.10-4.21 (m, 0.6H), 5.62 (ddd, J = 48.0, 6.0, 3.0 Hz, 1H), 5.70 (ddd, J = 48.0, 9.0, 3.0 Hz, 0.6H), 
7.10 (m, 4+2.4H); 13C-NMR (CDCl3, 75.5 MHz): δ 21.0, 21.2, 23.6, 24.1, 31.7, 41.0, 45.9 (d, J = 21.9 
Hz), 46.4 (d, J = 23.4 Hz), 64.3 (d, J = 3.0 Hz), 66.0 (d, J = 4.5 Hz), 67.5, 91.7 (d, J = 168.4 Hz), 94.1 
(d, J = 167.6 Hz), 125.5 (d, J = 6.0 Hz), 125.7 (d, J = 6.8 Hz), 128.2, 129.1, 129.2, 129.2, 135.2, 136.7 
(d, J = 19.6 Hz), 137.2 (d, J = 20.4 Hz), 138.1 (d, J = 2.3 Hz), 138.4 (d, J = 2.3 Hz), 138.9; 19F-NMR 
(CDCl3, 282 MHz): δ -172.6 (ddd, J = 45.1, 31.0, 14.1 Hz, 1F), -176.6 (ddd, J = 47.9, 36.7, 14.1 Hz, 
0.6F); HRMS (ES) calc. for 4.22 (M+-F) C11H13O: 161.0961; found: 161.0955.  
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3-Fluoro-1-(4-methoxyphenyl)-3-(p-tolyl)propan-1-one. Following the general procedure A, 4.23 
was obtained in 61% yield as a yellowish oil. In this case, HF elimination on silica gel was not as fast 
and ketone 4.23 could be purified by column chromatography. 1H-NMR (CDCl3, 300 MHz): δ 2.36 (s, 
3H), 3.26 (ddd, J = 30.0, 18.0, 6.0 Hz, 1H), 3.76 (ddd, J = 18.0, 15.0, 6.0 Hz, 1H), 3.87 (s, 3H), 6.13 
(ddd, J = 48.0, 9.0, 6.0 Hz, 1H), 6.94 (d, J = 9.0 Hz, 2H), 7.21 (d, J = 9.0 Hz, 2H), 7.33 (d, J = 6.0 Hz, 
2H), 7.95 (d, J = 9.0 Hz, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 21.2, 45.5 (d, J = 26.4 Hz), 55.5, 90.5 
(d, J = 169.9 Hz), 113.8, 120.9, 123.0, 125.7 (d, J = 6.0 Hz), 129.3, 130.6, 138.5 (d, J = 2.3 Hz), 
163.8, 194.7 (d, J = 3.8 Hz); 19F-NMR (CDCl3, 282 MHz): δ -172.6 (ddd, J = 47.9, 31.0, 16.9 Hz); 
HRMS (ES) calc. for (M+-F) C17H17O2: 253.1223; found: 253.1228.  
 
 
3-Fluoro-N-methoxy-N-methyl-3-(p-tolyl)propanamide. Following the general procedure A, 4.25 
was obtained in 80% yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 2.36 (s, 3H), 2.76 (ddd, 
J = 33.0, 18.0, 6.0 Hz, 1H), 3.21 (s, 3H), 3.24-3.41 (m, 1H), 3.67 (s, 3H), 5.99 (ddd, J = 48.0, 9.0, 3.0 
Hz, 1H), 7.20 (d, J = 9.0 Hz, 2H), 7.30 (d, J = 9.0 Hz, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 21.2, 
32.1, 39.7 (d, J = 26.4 Hz), 61.4, 90.7 (d, J = 169.9 Hz), 125.7 (d, J = 6.0 Hz), 129.2, 136.4 (d, J = 
19.6 Hz), 138.5 (d, J = 2.3 Hz), 170.2 (d, J = 3.8 Hz); 19F-NMR (CDCl3, 282 MHz): δ -172.5 (ddd, J = 
45.2, 31.0, 11.3 Hz); HRMS (ES) calc. for (M++Na) C12H16FNNaO2: 248.1057; found: 248.1052.  
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Following the general procedure A, vinyl Weinreb amide was submitted to β,β-fluoroarylation 
protocol. Crude reaction mixture was filtered through a pad of silica gel to obtain Weinreb amide 4.25 
slightly contaminated. Aldehyde 4.26 was prepared from 4.25 by treatment of a solution of 4.25 in 
THF 0.1 M cooled at -78 ºC with 1.1 equiv of DIBAL-H for 0.5 h. After completion, reaction mixture 
was quenched with a 1.0 M HCl solution and extracted with EtOAc. Collected organic fractions were 
dried with anhydrous Na2SO4 and filtered. Attempts of chromatographic purification on silica gel lead 
majorly to elimination product. However, crude reaction mixture was pure enough for 
characterization. 3-Fluoro-3-(p-tolyl)propanal (4.26): 1H-NMR (CDCl3, 500 MHz): δ 2.37 (s, 3H), 
2.88 (dddd, J = 30.0, 20.0, 5.0, 5.0 Hz, 1H), 3.17 (ddd, J = 25.0, 15.0, 10.0 Hz, 1H), 5.97 (ddd, J = 
50.0, 10.0, 5.0 Hz, 1H), 7.21 (d, J = 10.0 Hz, 2H), 7.26 (d, J = 10.0 Hz, 2H), 9.84 (br s, 1H); 13C-NMR 
(CDCl3, 125.3 MHz): δ 21.2, 50.4 (d, J = 25.1 Hz), 89.1 (d, J = 170.4 Hz), 125.5 (d, J = 6.3 Hz), 
129.4, 135.5 (d, J = 20.0 Hz), 138.9 (d, J = 2.5 Hz), 198.6 (d, J = 3.8 Hz); 19F-NMR (CDCl3, 282 
MHz): δ -172.7 (ddd, J = 47.9, 31.0, 16.9 Hz); HRMS (ES) calc. for (M+-F) C10H11O: 147.0804; 
found: 147.0803. Alcohol 4.54 was obtained by reduction with 1.5 equivalents of NaBH4 in an 
equimolar mixture of DCM/MeOH 0.1M. After 0.5 h, solvents were removed under reduced pressure. 
Crude reaction mixture was treated with water and extracted with DCM. Collected organic fractions 
were washed with brine, then dried with anhydrous Na2SO4, filtered and distilled to remove solvents, 
rendering alcohol 4.54 pure enough for characterization. 3-Fluoro-3-(p-tolyl)propan-1-ol (4.54): 1H-
NMR (CDCl3, 500 MHz): δ 1.72 (br s, OH), 1.99-2.12 (m, 1H), 2.20-2.30 (m, 1H), 2.37 (s, 3H), 3.78-
3.82 (m, 1H), 3.85-3.90 (m, 1H), 5.65 (ddd, J = 50.0, 10.0, 5.0 Hz, 1H), 7.20 (d, J = 10.0 Hz, 2H), 
7.26 (d, J = 5.0 Hz, 2H); 13C-NMR (CDCl3, 125.3 MHz): δ 21.2, 39.2 (d, J = 22.6 Hz), 59.2 (d, J = 3.8 
Hz), 92.4 (d, J = 166.6 Hz), 125.5 (d, J = 6.3 Hz), 129.2, 136.9 (d, J = 20.0 Hz), 138.3 (d, J = 2.5 Hz); 
19F-NMR (CDCl3, 282 MHz): δ -175.8 (ddd, J = 47.9, 33.8, 16.9 Hz); HRMS (ES) calc. for (M+-F) 
C10H13O: 149.0961; found: 149.0961.  
 
15 mol% Pd(OAc)2/1,10-phenanthroline 
NFSI (2.0 equiv), 4-TolB(OH)2 (2.0 equiv) 
4 mol% 4-tBu-catechol 
DCM/H2O (10:1) 0.08 M
20-25 ºC, 20 h
N
O
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4-Fluoro-4-(p-tolyl)butanenitrile. Following the general procedure A, 4.27 was obtained in 36% 
yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 2.04-2.35 (m, 2H), 2.37 (s, 3H), 2.41-2.62 (m, 
2H), 5.54 (ddd, J = 48.0, 9.0, 6.0 Hz, 1H), 7.22 (s, 4H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.4 (d, J = 
5.3 Hz), 21.2, 32.8 (d, J = 25.7 Hz), 92.1 (d, J = 172.9 Hz), 118.8, 125.4 (d, J = 6.0 Hz), 129.4, 135.2 
(d, J = 19.6 Hz), 138.9; 19F-NMR (CDCl3, 282 MHz): δ -178.1 (ddd, J = 45.1, 31.0, 16.9 Hz); HRMS 
(ES) calc. for (M++Na) C11H12FNNa: 200.0846; found: 200.0848. 
 
 
Ethyl 3-fluoro-2-methyl-3-(p-tolyl)propanoate. Following the general procedure A, 4.28 was 
obtained in 69% yield as a yellowish oil. Isolated as an inseparable mixture of diastereoisomers (3:1 
dr). 1H-NMR (CDCl3, 300 MHz): δ 0.95 (d, J = 9.0 Hz, 3H), 1.07 (t, J = 6.0 Hz, 3/4H), 1.30 (t, J = 9.0 
Hz, 3H), 2.28 (s, 3/4H), 2.36-2.38 (m, 3+3/4H), 2.72 (dd, J = 12.0, 9.0 Hz, 1/4H), 2.99 (m, 1H), 4.05 
(q, J = 8.0 Hz, 1/2H), 4.23 (q, J = 7.0 Hz, 2H), 5.51 (dd, J = 45.0, 9.0 Hz, 1H), 5.55 (dd, J = 48.0, 9.0 
Hz, 1/4H), 6.92-7.04 (m, 1H), 7.16-7.31 (m, 4H); 13C-NMR (CDCl3, 75.5 MHz): δ 13.4 (d, J = 7.6 
Hz), 14.0, 14.2, 21.0, 21.2, 34.2 (d, J = 6.0 Hz), 46.3 (d, J = 25.7 Hz), 54.5 (d, J = 24.2 Hz), 60.7, 
60.9, 94.8 (d, J = 174.4 Hz), 95.6 (d, J = 172.9 Hz), 121.2, 126.8 (d, J = 6.0 Hz), 128.6, 129.0, 129.2, 
129.4, 129.9, 134.0 (d, J = 19.6 Hz), 134.6, 136.0, 139.0 (d, J = 3.0 Hz), 139.1 (d, J = 3.0 Hz), 172.5 
(d, J = 2.3 Hz), 173.9 (d, J = 2.3 Hz); 19F-NMR (CDCl3, 282 MHz): δ -166.8 (dd, J = 47.9, 8.5 Hz), -
168.4 (dd, J = 47.9, 11.3 Hz); HRMS (ES) calc. for (M++Na) C13H17FNaO2: 247.1105; found: 
247.1102.  
 
 
Ethyl 3-fluoro-3-(m-tolyl)propanoate. Following the general procedure A, 4.29 was obtained in 78% 
yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 1.27 (t, J = 6.0 Hz, 3H), 2.37 (s, 3H), 2.78 
(ddd, J = 33.0, 15.0, 3.0 Hz, 1H), 3.02 (ddd, J = 15.0, 12.0, 9.0 Hz, 1H), 4.20 (qd, J = 6.0, 3.0 Hz, 2H), 
5.89 (ddd, J = 48.0, 9.0, 6.0 Hz, 1H), 7.15-7.18 (m, 3H), 7.25-7.30 (m, 1H); 13C-NMR (CDCl3, 75.5 
MHz): δ 14.1, 21.4, 42.5 (d, J = 27.2 Hz), 60.9, 90.7 (d, J = 172.1 Hz), 122.7 (d, J = 6.8 Hz), 126.3 (d, 
J = 6.0 Hz), 128.5, 129.5 (d, J = 2.3 Hz), 138.4, 138.6 (d, J = 19.6 Hz), 169.7 (d, J = 5.3 Hz); 19F-
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NMR (CDCl3, 282 MHz): δ -173.3 (ddd, J = 45.1, 31.0, 11.3 Hz); HRMS (ES) calc. for (M++Na) 
C12H15FNaO2: 233.0948; found: 233.0944.  
 
 
Ethyl 3-fluoro-3-(o-tolyl)propanoate. Following the general procedure A, 4.30 was obtained in 61% 
yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 1.28 (t, J = 9.0 Hz, 3H), 2.38 (s, 3H), 2.76 
(ddd, J = 33.0, 15.0, 3.0 Hz, 1H), 2.99 (ddd, J = 18.0, 15.0, 12.0 Hz, 1H), 4.21 (qd, J = 9.0, 3.0 Hz, 
2H), 6.15 (ddd, J = 48.0, 9.0, 3.0 Hz, 1H), 7.16-7.28 (m, 3H), 7.38-7.44 (m, 1H); 13C-NMR (CDCl3, 
75.5 MHz): δ 14.1, 18.9, 41.4 (d, J = 27.9 Hz), 61.0, 88.1 (d, J = 171.4 Hz), 125.3 (d, J = 8.3 Hz), 
126.3, 128.6 (d, J = 2.3 Hz), 130.7, 134.6 (d, J = 4.5 Hz), 136.7 (d, J = 18.9 Hz), 169.8 (d, J = 3.8 Hz); 
19F-NMR (CDCl3, 282 MHz): δ -175.9 (ddd, J = 45.1, 33.8, 14.1 Hz); HRMS (ES) calc. for (M++Na) 
C12H15FNaO2: 233.0948; found: 233.0945. 
 
 
Ethyl 3-fluoro-3-phenylpropanoate. Following the general procedure A, 4.31 was obtained in 67% 
yield as a yellowish oil. 1H-NMR (CDCl3, 300 MHz): δ 1.27 (t, J = 6.0 Hz, 3H), 2.79 (ddd, J = 33.0, 
15.0, 6.0 Hz, 1H), 3.04 (ddd, J = 18.0, 15.0, 9.0 Hz, 1H), 4.20 (qd, J = 6.0, 3.0 Hz, 2H), 5.93 (ddd, J = 
48.0, 9.0, 6.0 Hz, 1H), 7.35-7.40 (m, 5H); 13C-NMR (CDCl3, 75.5 MHz): δ 14.1, 42.5 (d, J = 27.2 Hz), 
60.9, 90.6 (d, J = 172.1 Hz), 125.6 (d, J = 6.8 Hz), 128.6, 128.8 (d, J = 2.3 Hz), 138.7 (d, J = 19.6 Hz), 
169.6 (d, J = 5.3 Hz); 19F-NMR (CDCl3, 282 MHz): δ -173.6 (ddd, J = 47.9, 31.0, 14.1 Hz); HRMS 
(ES) calc. for (M++Na) C11H13FNaO2: 219.0780; found: 219.0784.  
 
 
Ethyl 3-fluoro-3-(3-methoxyphenyl)propanoate. Following the general procedure A, 4.32 was 
obtained in 56% yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 1.27 (t, J = 6.0 Hz, 3H), 2.78 
(ddd, J = 33.0, 18.0, 6.0 Hz, 1H), 3.01 (ddd, J = 15.0, 12.0, 9.0 Hz, 1H), 3.82 (s, 3H), 4.20 (qd, J = 
6.0, 3.0 Hz, 2H), 5.90 (ddd, J = 48.0, 9.0, 6.0 Hz, 1H), 6.87-6.95 (m, 3H), 7.27-7.32 (m, 1H); 13C-
NMR (CDCl3, 75.5 MHz): δ 14.1, 42.6 (d, J = 27.2 Hz), 55.3, 61.0, 90.5 (d, J = 172.9 Hz), 111.0 (d, J 
= 6.8 Hz), 114.3 (d, J = 2.3 Hz), 117.7 (d, J = 6.8 Hz), 129.7, 140.3 (d, J = 19.6 Hz), 159.8, 169.6 (d, J 
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= 4.5 Hz); 19F-NMR (CDCl3, 282 MHz): δ -174.2 (ddd, J = 45.1, 31.0, 11.3 Hz); HRMS (ES) calc. for 
(M++Na) C12H15FNaO3: 249.0897; found: 249.0895.  
 
 
Ethyl 3-fluoro-3-(4-fluoro-3-methylphenyl)propanoate. Following the general procedure A, 4.33 
was obtained in 54% yield as a yellowish oil. 1H-NMR (CDCl3, 300 MHz): δ 1.26 (t, J = 6.0 Hz, 3H), 
2.29 (d, J = 3.0 Hz, 3H), 2.76 (ddd, J = 30.0, 15.0, 3.0 Hz, 1H), 3.02 (ddd, J = 15.0, 15.0, 9.0 Hz, 1H), 
4.18 (qd, J = 6.0, 3.0 Hz, 2H), 5.85 (ddd, J = 45.0, 9.0, 3.0 Hz, 1H), 7.00 (7.5), 7.13-7.21 (m, 2H); 
13C-NMR (CDCl3, 75.5 MHz): δ 14.1, 14.6 (d, J = 3.0 Hz), 42.4 (d, J = 27.2 Hz), 61.0, 90.2 (172.1), 
115.2 (d, J = 23.4 Hz), 124.8 (dd, J = 8.3, 6.0 Hz), 125.3 (d, J = 18.1 Hz), 129.0 (t, J = 6.0 Hz), 134.1 
(dd, J = 19.6, 3.8 Hz), 161.4 (dd, J = 246.9, 3.0 Hz), 169.5 (d, J = 6.0 Hz); 19F-NMR (CDCl3, 282 
MHz): δ -117.5 (m, 1F), -171.0 (dddd, J = 45.1, 31.0, 11.3, 2.8 Hz, 1F); HRMS (ES) calc. for 
(M++Na) C12H14F2NaO2: 251.0854; found: 251.0851.  
 
 
Ethyl 3-(4-chlorophenyl)-3-fluoropropanoate. Following the general procedure A, 4.34 was 
obtained in 47% yield as a yellowish oil. 1H-NMR (CDCl3, 300 MHz): δ 1.26 (t, J = 6.0 Hz, 3H), 2.77 
(ddd, J = 30.0, 15.0, 6.0 Hz, 1H), 3.01 (ddd, J = 15.0, 15.0, 9.0 Hz, 1H), 4.18 (qd, J = 6.0, 3.0 Hz, 2H), 
5.89 (ddd, J = 45.0, 9.0, 3.0 Hz, 1H), 7.31 (d, J = 9.0 Hz, 2H), 7.37 (d, J = 9.0 Hz, 2H); 13C-NMR 
(CDCl3, 75.5 MHz): δ 14.1, 42.4 (d, J = 26.4 Hz), 61.1, 89.9 (d, J = 172.9 Hz), 127.0 (d, J = 6.0 Hz), 
128.9, 134.7 (d, J = 2.3 Hz), 137.2 (d, J = 19.6 Hz), 169.3 (d, J = 5.3 Hz); 19F-NMR (CDCl3, 282 
MHz): δ -174.0 (ddd, J = 45.1, 31.0, 14.1 Hz); HRMS (ES) calc. for (M++Na) C11H12ClFO2: 
253.0402; found: 253.0402.  
 
 
Ethyl 3-(4-bromophenyl)-3-fluoropropanoate. Following the general procedure A, 4.35 was 
obtained in 47% yield as a yellowish oil. 1H-NMR (CDCl3, 300 MHz): δ 1.26 (t, J = 6.0 Hz, 3H), 2.76 
(ddd, J = 30.0, 15.0, 3.0 Hz, 1H), 3.00 (ddd, J = 15.0, 12.0, 9.0 Hz, 1H), 4.18 (qd, J = 6.0, 3.0 Hz, 2H), 
5.88 (ddd, J = 48.0, 9.0, 6.0 Hz, 1H), 7.25 (d, J = 9.0 Hz, 2H), 7.52 (d, J = 9.0 Hz, 2H); 13C-NMR 
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(CDCl3, 75.5 MHz): δ 14.1, 42.3 (d, J = 27.2 Hz), 61.1, 90.0 (d, J = 173.7 Hz), 122.8 (d, J = 3.0 Hz), 
127.3 (d, J = 6.8 Hz), 131.8, 137.7 (d, J = 19.6 Hz), 169.3 (d, J = 5.3 Hz); 19F-NMR (CDCl3, 282 
MHz): δ -174.5 (ddd, J = 45.1, 31.0, 14.1 Hz); HRMS (ES) calc. for (M++Na) C11H12BrFNaO2: 
296.9897; found: 296.9903.  
 
 
3-Fluoro-3-(4-iodophenyl)-N-methoxy-N-methylpropanamide. Following the general procedure A, 
4.36 was obtained in 43% yield as a yellowish oil. 1H-NMR (CDCl3, 300 MHz): δ 2.76 (ddd, J = 30.0, 
15.0, 3.0 Hz, 1H), 3.14-3.32 (m, 1H), 3.20 (s, 3H), 3.66 (s, 3H), 5.97 (ddd, J = 48.0, 9.0, 6.0 Hz, 1H), 
7.15 (d, J = 9.0 Hz, 2H), 7.72 (d, J = 6.0 Hz, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 32.1, 39.7 (d, J = 
27.2 Hz), 61.4, 90.2 (d, J = 172.1 Hz), 94.2 (d, J = 3.0 Hz), 127.5 (d, J = 6.8 Hz), 137.7, 139.2 (d, J = 
20.4 Hz), 169.8; 19F-NMR (CDCl3, 282 MHz): δ -175.8 (ddd, J = 45.1, 31.0, 14.1 Hz); HRMS (ES) 
calc. for (M+-F) C13H11INO2: 317.9997; found: 317.9988.  
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4.5.2. Optimization of the enantioselective three-component β ,β-fluoroarylation reaction of ethyl 
acrylate. Summary data.  
 
 ·Catalyst screening  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
N
O
N Me
Me Me
N
O
Bn
O
NBn
Me Me
O
N N
O
Me
Me
Me
Me
Et Et
O
N N
O
Me
Me
Me
Me
Me Me
O
N N
O
Me Me
O
N N
O
Ph Ph
Me Me
O
N N
O
Me
Me
Me
MeMe Me
Me Me
O
N N
O
Ph
Ph Ph
Ph
O
N N
O
Ph
Ph Ph
Ph
Me Me
O
N N
O
Bn Bn
Me Me
O
N N
O
Me
Me
Me
Me
Me Me
O
N N
O
99% yield, 4% ee 39% yield, 24% ee 99% yield, 44% ee 99% yield, 43% ee
38% yield, <5% ee 99% yield, 16% ee 99% yield, 36% ee 93% yield, <10% ee
93% yield, -22% ee 99% yield, -12% ee 99% yield, -38% ee 54% yield, -54% ee
CO2Et
15 mol% Pd(OAc)2/Ln* 
NFSI (2.0 equiv), 4-TolB(OH)2 (4.0 equiv)
4 mol% 4-tBu-catechol 
DCM/H2O (10:1) 0.08 M
20-25 ºC, 20 h
F
EtO2C
Me
4.20
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·Solvent screening  
 
 
 
 
 
 
 
 
 
 
 
 
 
entry
 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
a Yield determined by 19F NMR utilizing fluorobenzene as internal 
standard. b Enantiomeric excess determined by chiral phase HPLC.
>99% 
96% 
97%
44%
43% 
42%
10%
18%
67%
-
37%
22%
31%
27%
47%
53%
35%
61%
62%
yielda
DCM 
DCM, 10ºC 
1,2-DCE 
CHCl3 
toluene 
benzene 
hexane 
MeCN 
MeNO2
DMF 
EtOAc 
Et2O 
THF 
dioxane 
MeOH 
EtOH 
iPrOH 
acetone 
acetone:DCM (2:1)
solvent
0.055 mmol
CO2Et
15 mol% Pd(OAc)2/BOX 3a 
NFSI (2.0 equiv), 4-TolB(OH)2 (4.0 equiv)
4 mol% 4-tBu-catechol 
solvent/H2O (10:1) 0.08 M
20-25 ºC, 20 h
F
EtO2C
Me
44% 
44%
38%
60%
56%
58%
nd
14%
65%
-
90%
73%
86%
84%
90%
92%
96%
86%
82%
eeb
4.20
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 ·Additives  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
entry
 1
2
3
4
5
6
7
8
9
10
11
a Yield determined by 19F NMR utilizing fluorobenzene as internal 
standard. b Enantiomeric excess determined by chiral phase HPLC.
64% 
43% 
55%
24%
61% 
40%
60%
58%
61%
62%
64%
yielda
benzoquinone (1.0 equiv) 
Cu(OAc)2 (1.0 equiv) 
Ag(OAc) (1.0 equiv) 
Ag(TFA) (1.0 equiv) 
AcOH (0.5 equiv) 
TFA (0.5 equiv) 
30 mol% (BnO)2PO2H 
30 mol% 4-tBu-dba 
30 mol% 4-MeO-dba 
30 mol% 4-F-dba 
30 mol% 3-CF3-dba
additive
0.055 mmol
CO2Et
15 mol% Pd(OAc)2/BOX 3a 
NFSI (2.0 equiv), 4-TolB(OH)2 (4.0 equiv)
4 mol% 4-tBu-catechol, additive 
acetone/H2O (10:1) 0.08 M
20-25 ºC, 20 h
F
EtO2C
Me
86% 
74%
82%
30%
84%
70%
86%
86%
86%
86%
84%
eeb
4.20
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4.5.3. Optimization of the enantioselective three-component β ,β-fluoroarylation reaction of vinyl 
Weinreb amide. Summary data.   
 
 ·Solvent screening  
 
 
 
 ·Catalyst screening  
 
 
entry
 1
2
3
4
5
a Yield determined by 19F NMR utilizing fluorobenzene as internal 
standard. b Enantiomeric excess determined by chiral phase HPLC.
83% 
99% 
69%
65%
45%
yielda
acetone 
DCM 
EtOAc 
THF 
EtOH
solvent
0.055 mmol
19% 
-24%
36%
44%
42%
eeb
15 mol% Pd(OAc)2/BOX 3a 
NFSI (2.0 equiv), 4-TolB(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol 
solvent/H2O (10:1) 0.08 M
20-25 ºC, 20 h
F
Me
O
N
Me
OMe
O
N
Me
MeO
4.25
N
O
N Me
Me Me
N
O
Bn
O
NBn
Me Me
O
N N
O
Me
Me
Me
Me
Me Me
O
N N
O
Me Me
O
N N
O
Ph Ph
Me Me
O
N N
O
Me
Me
Me
MeMe Me
Me Me
O
N N
O
Ph
Ph Ph
Ph
Me Me
O
N N
O
Bn Bn
Me Me
O
N N
O
Me
Me
Me
Me
Me Me
O
N N
O
16% yield, 62% ee 37% yield, 4% ee 65% yield, 44% ee
70% yield, 0% ee 58% yield, 10% ee 63% yield, 10% ee 63% yield, -40% ee
59% yield, 12% ee 68% yield, 6% ee 56% yield, -14% ee
15 mol% Pd(OAc)2/Ln* 
NFSI (2.0 equiv), 4-TolB(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol 
THF/H2O (10:1) 0.08 M
20-25 ºC, 20 h
F
Me
O
N
Me
OMe
O
N
Me
MeO
4.25
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 ·Solvent screening  
 
 
 
 
4.5.4. General procedure B: Enantioselective three-component β ,β-fluoroarylation reaction.  
 
 
 
A 1 dram vial was charged of palladium catalyst (15 mol%), chiral ligand (15 mol%) and 1/3 of 
organic solvent (acetone or iPrOH). The headspace of the reaction vessel was sparged with Ar for ca. 
10 seconds, and then vial was capped and the mixture was stirred for 15-20 min. A separate 1 dram 
vial was charged with aryl boronic acid (4.0 or 2.0 equiv) and NFSI (2.0 equiv). To the solid reagents, 
entry
 1
2
3
4
5
6
7
8
9
10
a Yield determined by 19F NMR utilizing fluorobenzene as internal 
standard. b Enantiomeric excess determined by chiral phase HPLC.
16% 
99% 
76% 
68% 
55% 
<5% 
19% 
54% 
66% 
59%
yielda
THF 
DCM 
acetone 
EtOAc 
EtOH 
Et2O 
MeCN 
MeOH 
iPrOH 
tBuOH
solvent
0.055 mmol
62% 
38%
70% 
68% 
78% 
nd 
32% 
74% 
80% 
78%
eeb
15 mol% Pd(OAc)2/PyrOX 1 
NFSI (2.0 equiv), 4-TolB(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol 
solvent/H2O (10:1) 0.08 M
20-25 ºC, 20 h
F
Me
O
N
Me
OMe
O
N
Me
MeO
4.25
15 mol% Pd(OAc)2/PyrOX 1 
NFSI (2.0 equiv), ArB(OH)2 (2.0 equiv)
4 mol% 4-tBu-catechol 
iPrOH/H2O (10:1) 0.08 M
20-25 ºC, 20 h
FO
N
R2
R1
O
N
R2
R1
CO2R
15 mol% Pd(OAc)2/BOX 3a 
NFSI (2.0 equiv), ArB(OH)2 (4.0 equiv)
4 mol% 4-tBu-catechol 
acetone/H2O (10:1) 0.08 M
20-25 ºC, 20 h
F
RO2C
Ar
Ar
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2/3 of organic solvent were added; then, 4 mol% of 4-tert-butylcatechol (from a stock solution), ethyl 
acrylate or vinyl Weinreb amide (0.11 mmol, 1.0 equiv) and H2O. The palladium complex was then 
transferred to the reaction mixture via syringe. Once again, the headspace of the reaction vessel was 
sparged with Ar for ca. 10 seconds, vial was capped and the mixture was vigorously stirred for 20 
hours. After the reaction was complete, the mixture was diluted with DCM and filtered through a pad 
of Celite eluting with DCM. The organic phase was evaporated and yield was determined, firstly, by 
19F NMR.247 Then, the crude was purified by column chromatography over silica gel using a mixture 
of hexanes/DCM/EtOAc as eluent to give the desired products. When necessary, preparative TLC was 
used for purification. Enantiomeric ratio (er) was determined by chiral phase HPLC using IC, AD, 
OD-H or Amylose-1 columns under indicated conditions.   
Note: When the reaction was scaled up to 1.1 mmol (x10), it was run in a sealed tube using 2.0 equiv 
of the corresponding aryl boronic acid and 5 mol% of the catalytic system Pd(OAc)/Ln*. The work-up 
was modified in this case. After removal of solvents, the crude reaction mixture was diluted in DCM 
(20 mL) and poured onto a separatory funnel. Then, water was added (20 mL). The organic phase was 
separated and dried over anhydrous Na2SO4. After removal of solvents, the crude reaction mixture was 
purified by flash column chromatography, rendering the corresponding fluorinated product slightly 
contaminated by the Heck byproduct. This mixture could be separated on a semi-preparative HPLC 
column.  
 
 
Ethyl (R)-3-fluoro-3-(p-tolyl)propanoate. Following the general procedure B, 4.20 was obtained in 
52% yield. HPLC (ChiralPak IC column) 98:2 (Hexane/iPrOH) 1.0 mL/min; Tmajor (8.9 min), Tminor 
(10.1 min); 93:7 er (87% ee).  
 
 
(R)-3-Fluoro-N-methoxy-N-methyl-3-(p-tolyl)propanamide. Following the general procedure B, 
4.25 was obtained in 48% yield. HPLC (ChiralPak IC column) 70:30 (Hexane/iPrOH) 1.0 mL/min; 
Tmajor (10.5 min), Tminor (11.7 min); 90:10 er (80% ee).  
 
                                                       
247	  19F NMR yield: The crude reaction mixture was dissolved in CDCl3 and 0.25 equivalents of fluorobenzene were added to 
obtain the NMR yield. 	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Ethyl (R)-3-fluoro-3-(m-tolyl)propanoate. Following the general procedure B, 4.29 was obtained in 
54% yield as a colourless oil. HPLC (ChiralPak ODH column) 98:2 (Hexane/iPrOH) 1.0 mL/min; 
Tmajor (8.0 min), Tminor (9.0 min); 92:8 er (84% ee).  
 
 
Ethyl (R)-3-(3,5-dimethylphenyl)-3-fluoropropanoate. Following the general procedure B, 4.38 was 
obtained in 47% yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 1.27 (t, J = 6.0 Hz, 3H), 2.33 
(s, 6H), 2.76 (ddd, J = 33.0, 18.0, 6.0 Hz, 1H), 3.01 (ddd, J = 15.0, 12.0, 9.0 Hz, 1H), 4.20 (qd, J = 
6.0, 3.0 Hz, 2H), 5.85 (ddd, J = 48.0, 9.0, 3.0 Hz, 1H), 6.98 (s, 3H); 13C-NMR (CDCl3, 75.5 MHz): δ 
14.1, 21.3, 42.5 (d, J = 27.2 Hz), 60.9, 90.8 (d, J = 172.1 Hz), 123.4 (d, J = 6.0 Hz), 130.4 (d, J = 2.3 
Hz), 138.3, 138.6 (d, J = 18.9 Hz), 169.8 (d, J = 5.3 Hz); 19F-NMR (CDCl3, 282 MHz): δ -173.0 (ddd, 
J = 47.9, 33.8, 14.1 Hz); HRMS (ES) calc. for (M++Na) C13H17FNaO2: 247.1105; found: 247.1106. 
HPLC (ChiralPak IC column) 99:1 (Hexane/iPrOH) 0.7 mL/min; Tmajor (16.5 min), Tminor (17.9 min); 
95:5 er (90% ee).  
 
 
Ethyl (R)-3-fluoro-3-(4-fluoro-3-methylphenyl)propanoate. Following the general procedure B, 
4.33 was obtained in 56% yield as a yellowish oil. HPLC (ChiralPak IC column) 99:1 (Hexane/iPrOH) 
0.7 mL/min; Tmajor (11.9 min), Tminor (13.0 min); 92:8 er (84% ee).  
 
 
Ethyl (R)-3-(4-chlorophenyl)-3-fluoropropanoate. Following the general procedure B, 4.34 was 
obtained in 42% yield as a yellowish oil. HPLC (ChiralPak IC column) 98:2 (Hexane/iPrOH) 1.0 
mL/min; Tmajor (7.2 min), Tminor (7.8 min); 92:8 er (84% ee).  
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Ethyl (R)-3-(4-bromophenyl)-3-fluoropropanoate. Following the general procedure B, 4.35 was 
obtained in 49% yield as a yellowish oil. HPLC (ChiralPak IC column) 98:2 (Hexane/iPrOH) 1.0 
mL/min; Tmajor (7.5 min), Tminor (8.1 min); 93:7 er (86% ee).  
 
 
Ethyl (R)-3-fluoro-3-(3-methoxyphenyl)propanoate. Following the general procedure B, 4.32 was 
obtained in 50% yield as a colourless oil. HPLC (ChiralPak IC column) 99:1 (Hexane/iPrOH) 0.7 
mL/min; Tmajor (29.4 min), Tminor (27.9 min); 4:96 er (-92% ee).  
 
 
Benzyl (R)-3-fluoro-3-(p-tolyl)propanoate. Following the general procedure B, 4.39 was obtained in 
43% yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 2.36 (s, 3H), 2.84 (ddd, J = 30.0, 15.0, 
3.0 Hz, 1H), 3.10 (ddd, J = 15.0, 12.0, 9.0 Hz, 1H), 5.17 (s, 2H), 5.90 (ddd, J = 45.0, 9.0, 3.0 Hz, 1H), 
7.18 (d, J = 6.0 Hz, 2H), 7.25 (d, J = 9.0 Hz, 2H), 7.30-7.40 (m, 5H); 13C-NMR (CDCl3, 125.3 MHz): 
δ 21.2, 42.4 (d, J = 27.6 Hz), 66.7, 90.5 (d, J = 171.7 Hz), 125.7 (d, J = 6.3 Hz), 128.2, 128.3, 128.6, 
129.3, 135.5, 135.5 (d, J = 18.8 Hz), 138.8 (d, J = 2.5 Hz), 169.5 (d, J = 5.0 Hz); 19F-NMR (CDCl3, 
282 MHz): δ -171.4 (ddd, J = 45.1, 31.0, 14.1 Hz); HRMS (ES) calc. for (M++NH4+) C17H21FNO2: 
290.1551; found: 290.1551. HPLC (ChiralPak IC column) 98:2 (Hexane/iPrOH) 1.0 mL/min; Tmajor 
(9.9 min), Tminor (11.0 min); 95:5 er (90% ee).  
 
 
Benzyl (R)-3-(3-chlorophenyl)-3-fluoropropanoate. Following the general procedure B, 4.40 was 
obtained in 52% yield as a colourless oil. 1H-NMR (CDCl3, 500 MHz): δ 2.84 (ddd, J = 30.0, 15.0, 5.0 
Hz, 1H), 3.07 (ddd, J = 15.0, 10.0, 5.0 Hz, 1H), 5.17 (s, 2H), 5.91 (ddd, J = 50.0, 10.0, 5.0 Hz, 1H), 
7.21-7.23 (m, 1H), 7.29-7.39 (m, 8H); 13C-NMR (CDCl3, 125.3 MHz): δ  42.3 (d, J = 27.6 Hz), 66.9, 
89.7 (d, J = 172.9 Hz), 123.7 (d, J = 6.3 Hz), 125.8 (d, J = 7.5 Hz), 128.3, 128.4, 128.6, 129.0 (d, J = 
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1.3 Hz), 130.0, 134.7, 135.4, 140.6 (d, J = 18.8 Hz), 169.1 (d, J = 5.0 Hz); 19F-NMR (CDCl3, 468.9 
MHz): δ  -175.2 (ddd, J = 46.9, 32.8, 14.1 Hz); HRMS (ES) calc. for (M++Na) C16H14ClFNaO2: 
315.0559; found: 315.0567. HPLC (ChiralPak IC column) 98:2 (Hexane/iPrOH) 1.0 mL/min; Tmajor 
(8.0 min), Tminor (8.5 min); 95:5 er (90% ee).  
 
 
Benzyl (R)-3-fluoro-3-(3-methoxyphenyl)propanoate. Following the general procedure B, 4.41 was 
obtained in 73% yield as a colourless oil. 1H-NMR (CDCl3, 500 MHz): δ 2.85 (ddd, J = 35.0, 15.0, 5.0 
Hz, 1H), 3.08 (ddd, J = 15.0, 10.0, 5.0 Hz, 1H), 3.81 (s, 3H), 5.18 (s, 2H), 5.92 (ddd, J = 50.0, 10.0, 
5.0 Hz, 1H), 6.87-6.93 (m, 3H), 7.27-7.39 (m, 6H); 13C-NMR (CDCl3, 125.3 MHz): δ 42.5 (d, J = 26.3 
Hz), 55.3, 66.8, 90.4 (d, J = 172.9 Hz), 111.0 (d, J = 7.5 Hz), 114.4 (d, J = 2.5 Hz), 117.7 (d, J = 6.3 
Hz), 128.2, 128.4, 128.6, 129.8, 135.5, 140.1 (d, J = 20.0 Hz), 159.8, 169.4 (d, J = 3.8 Hz); 19F-NMR 
(CDCl3, 468.9 MHz): δ -174.0 (ddd, J = 46.9, 32.8, 14.1 Hz); HRMS (ES) calc. for (M++Na) 
C17H17FNaO3: 311.1054; found: 311.1055. HPLC (ChiralPak AD column) 99:1 (Hexane/iPrOH) 0.5 
mL/min; Tmajor (31.2 min), Tminor (33.0 min); 97:3 er (94% ee).  
 
 
Methyl (R)-3-(3-(benzyloxy)-1-fluoro-3-oxopropyl)benzoate. Following the general procedure B, 
4.42 was obtained in 41% yield as a colourless oil. 1H-NMR (CDCl3, 500 MHz): δ 2.88 (ddd, J = 30.0, 
15.0, 5.0 Hz, 1H), 3.11 (ddd, J = 15.0, 10.0, 5.0 Hz, 1H), 3.93 (s, 3H), 5.17 (s, 2H), 5.98 (ddd, J = 
45.0, 10.0, 5.0 Hz, 1H), 7.31-7.38 (m, 5H), 7.46 (t, J = 7.5 Hz, 1H), 7.56 (d, J = 5.0 Hz, 1H), 8.03 (d, J 
= 10.0 Hz, 2H); 13C-NMR (CDCl3, 125.3 MHz): δ 42.3 (d, J = 26.3 Hz), 52.3, 66.9, 90.0 (d, J = 172.9 
Hz), 126.7 (d, J = 6.3 Hz), 128.3, 128.4, 128.6, 128.8, 130.0 (d, J = 1.3 Hz), 130.1 (d, J = 6.3 Hz), 
130.7, 135.4, 139.0 (d, J = 20.0 Hz), 166.5, 169.1 (d, J = 5.0 Hz); 19F-NMR (CDCl3, 468.9 MHz): δ -
174.8 (ddd, J = 46.9, 32.8, 14.1 Hz); HRMS (ES) calc. for (M++NH4+) C18H21FNO4: 334.1449; found: 
334.1455. HPLC (ChiralPak IC column) 98:2 (Hexane/iPrOH) 1.0 mL/min; Tmajor (35.2 min), Tminor 
(39.0 min); 93:7 er (86% ee).  
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(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12, 
13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl (R)-3-fluoro-3-(p-tolyl)propa-
noate. Following the general procedure B, 4.43 was obtained in 55% yield and 20:1 dr (when using 
EtOAc as solvent) as a white solid (mp 103-105 ºC). 1H-NMR (CDCl3, 500 MHz): δ 0.68 (s, 3H), 0.87 
(dd, J = 10.0, 5.0 Hz, 6H), 0.92 (d, J = 10.0 Hz, 3H), 0.94-1.20 (m, 11H), 1.02 (s, 3H), 1.22-1.42 (m, 
5H), 1.43-1.64 (m, 5H), 1.80-1.88 (m, 3H), 1.95-2.03 (m, 2H), 2.29-2.39 (m, 2H), 2.36 (s, 3H), 2.76 
(ddd, J = 30.0, 15.0, 5.0 Hz, 1H), 3.01 (ddd, J = 15.0, 10.0, 5.0 Hz, 1H), 4.63-4.70 (m, 1H), 5.38 (t, J 
= 5.0 Hz, 1H), 5.87 (ddd, J = 45.0, 10.0, 5.0 Hz, 1H), 7.19 (d, J = 10.0 Hz, 2H), 7.26 (d, J = 10.0 Hz, 
2H); 13C-NMR (CDCl3, 125.3 MHz): δ 11.9, 18.7, 19.3, 21.0, 21.2, 22.6, 22.8, 23.8, 24.3, 27.7, 28.0, 
28.2, 31.9, 31.9, 35.8, 36.2, 36.6, 36.9, 38.0, 39.5, 39.7, 42.3, 42.7 (d, J = 27.6 Hz), 50.0, 56.1, 56.7, 
74.6, 90.7 (d, J = 170.4 Hz), 122.8, 125.7 (d, J = 6.3 Hz), 129.3, 135.7 (d, J = 20.0 Hz), 138.7 (d, J = 
2.5 Hz), 139.5, 169.1 (d, J = 5.0 Hz); 19F-NMR (CDCl3, 468.9 MHz): δ -171.6, -171.6; HRMS (ES) 
calc. for (M++NH4+) C37H59FNO2: 568.4524; found: 568.4511.  
 
 
Benzyl (R)-3-fluoro-3-((8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-deca-hydro-
6H-cyclopenta[a]phenanthren-3-yl)propanoate. Following the general procedure B, 4.44 was 
obtained in 70% NMR yield and 13:1 dr. 1H-NMR (CDCl3, 500 MHz): δ 0.91 (s, 3H), 1.41-1.68 (m, 
6H), 1.96-2.19 (m, 4H), 2.28-2.32 (m, 1H), 2.41-2.45 (m, 1H), 2.51 (dd, J = 20.0, 10.0 Hz, 1H), 2.84 
(ddd, J = 30.0, 15.0, 5.0 Hz, 1H), 2.91 (dd, J = 5.0, 5.0 Hz, 2H), 3.09 (ddd, J = 20.0, 15.0, 10.0 Hz, 
1H), 5.17 (s, 2H), 5.88 (ddd, J = 45.0, 10.0, 5.0 Hz, 1H), 7.10 (s, 1H), 7.14 (d, J = 5.0 Hz, 1H), 7.34 
(m, 6H); 13C-NMR (CDCl3, 125.3 MHz): δ 13.8, 21.6, 25.7, 26.4, 29.4, 31.6, 35.8, 38.0, 42.3 (d, J = 
26.3 Hz), 44.4, 47.9, 50.5, 66.7, 90.5 (d, J = 170.4 Hz), 123.1 (d, J = 6.3 Hz), 125.7 (d, J = 2.5 Hz), 
126.4 (d, J = 8.8 Hz), 128.2, 128.3, 128.6, 135.5, 136.0 (d, J = 17.5 Hz), 136.9, 140.6, 169.5 (d, J = 
F
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5.0 Hz); 19F-NMR (CDCl3, 282 MHz): δ -171.4, -171.6; HRMS (ES) calc. for (M++NH4+) 
C28H35FNO3: 452.2595; found: 452.2595.  
 
 
(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12, 
13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl (R)-3-fluoro-3-((8R,9S,13S, 
14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta-[a]phenanthren-3-
yl)propanoate. Following the general procedure B, 4.45 was obtained in 76% NMR yield and 7:1 dr 
besides an inseparable impurity corresponding to the Heck byproduct. 1H-NMR (CDCl3, 300 MHz): δ 
0.68 (s, 3H), 0.87 (dd, J = 6.0, 3.0 Hz, 6H), 0.91 (s, 6H), 1.02 (s, 3H), 0.96-2.56 (m, 41H), 2.77 (ddd, J 
= 33.0, 15.0, 6.0 Hz, 1H), 2.93 (dd, J = 6.0, 3.0 Hz, 2H), 3.01 (ddd, J = 15.0, 12.0, 9.0 Hz, 1H), 4.61-
4.74 (m, 1H), 5.39 (dd, J = 12.0, 6.0 Hz, 1H), 5.85 (ddd, J = 48.0, 9.0, 3.0 Hz, 1H), 7.11 (s, 1H), 7.14 
(d, J = 9.0 Hz, 1H), 7.31 (d, J = 3.0 Hz, 1H); 13C-NMR (CDCl3, 125.3 MHz): δ 74.6, 90.6 (d, J = 
164.1 Hz), 169.1 (d, J = 5.0 Hz); 19F-NMR (CDCl3, 282 MHz): δ -171.8, -172.1; HRMS (ES) calc. for 
(M++NH4+) C48H73FNO3: 730.5569; found: 730.5548.  
 
 
(R)-3-Fluoro-N-methoxy-N-methyl-3-(naphthalen-2-yl)propanamide. Following the general 
procedure B, 4.46 was obtained in 41% yield as a white solid (mp 68-70 ºC). 1H-NMR (CDCl3, 300 
MHz): δ 2.88 (ddd, J = 30.0, 15.0, 3.0 Hz, 1H), 3.22 (s, 3H), 3.32-3.46 (m, 1H), 3.68 (s, 3H), 6.20 
(ddd, J = 45.0, 9.0, 3.0 Hz, 1H), 7.46-7.54 (m, 3H), 7.82-7.89 (m, 4H); 13C-NMR (CDCl3, 75.5 MHz): 
δ 32.1, 39.9 (d, J = 25.7 Hz), 61.4, 90.9 (d, J = 171.4 Hz), 123.1 (d, J = 5.3 Hz), 124.9 (d, J = 8.3 Hz), 
126.4, 126.4, 127.7, 128.1, 128.5, 133.0, 133.3 (d, J = 0.8 Hz), 136.8 (d, J = 19.6 Hz), 170.1; 19F-
NMR (CDCl3, 282 MHz): δ -174.3 (ddd, J = 45.1, 31.0, 14.1 Hz); HRMS (ES) calc. for (M+-F) 
C15H16NO2: 242.1176; found: 242.1165. HPLC (ChiralPak IC column) 75:25 (Hexane/iPrOH) 1.0 
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mL/min; Tmajor (12.6 min), Tminor (13.7 min); 92:8 er (86% ee). Absolute configuration was determined 
to be (R) by single-crystal X-ray diffraction (Figure 4.2).  
 
 
Figure 4.2. X-Ray ORTEP of compound (R)-4.46.  
 
 
 
(R)-3-Fluoro-N-methoxy-N-methyl-3-(o-tolyl)propanamide. Following the general procedure B, 
4.47 was obtained in 32% yield as a colourless oil. 1H-NMR (CDCl3, 300 MHz): δ 2.38 (s, 3H), 2.72 
(ddd, J = 36.0, 18.0, 3.0 Hz, 1H), 3.21-3.35 (m, 1H), 3.23 (s, 3H), 3.70 (s, 3H), 6.25 (ddd, J = 48.0, 
9.0, 3.0 Hz, 1H), 7.16-7.21 (m, 1H), 7.22-7.29 (m, 2H), 7.42-7.48 (m, 1H); 13C-NMR (CDCl3, 75.5 
MHz): δ 18.9, 32.1, 38.8 (d, J = 26.4 Hz), 61.4, 88.2 (d, J = 170.6 Hz), 125.2 (d, J = 8.3 Hz), 126.2, 
128.4 (d, J = 2.3 Hz), 130.6, 134.6 (d, J = 4.5 Hz), 137.5 (d, J = 18.1 Hz), 170.2; 19F-NMR (CDCl3, 
282 MHz): δ -176.5 (ddd, J = 47.9, 33.8, 14.1 Hz); HRMS (ES) calc. for (M++Na) C12H16FNNaO2: 
248.1057; found: 248.1052. HPLC (ChiralPak ODH column) 70:30 (Hexane/iPrOH) 1.0 mL/min; 
Tmajor (5.4 min), Tminor (5.9 min); 84:16 er (68% ee).  
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(R)-3-Fluoro-N-methoxy-N-methyl-3-(thiophen-3-yl)propanamide. Following the general 
procedure B, 4.48 was obtained in 37% yield as a colourless oil. 1H-NMR (CDCl3, 500 MHz): δ 2.84 
(ddd, J = 30.0, 15.0, 5.0 Hz, 1H), 3.22 (s, 3H), 3.29-3.36 (m, 1H), 3.69 (s, 3H), 6.10 (ddd, J = 45.0, 
10.0, 5.0 Hz, 1H), 7.12-7.14 (m, 1H), 7.33-7.35 (m, 2H); 13C-NMR (CDCl3, 75.5 MHz): δ 32.1, 39.0 
(d, J = 27.2 Hz), 61.4, 87.1 (d, J = 168.4 Hz), 122.5 (d, J = 8.3 Hz), 125.3 (d, J = 3.4 Hz), 126.5, 140.5 
(d, J = 21.9 Hz), 170.0; 19F-NMR (CDCl3, 282 MHz): δ -168.9 (ddd, J = 45.1, 31.0, 14.1 Hz); HRMS 
(ES) calc. for (M++Na) C9H12FNNaO2: 240.0465; found: 240.0458. HPLC (ChiralPak IC column) 
70:30 (Hexane/iPrOH) 1.0 mL/min; Tmajor (10.8 min), Tminor (11.6 min); 88:12 er (76% ee).  
 
 
(R)-N-benzyl-3-fluoro-3-(m-tolyl)propanamide. Following the general procedure B, 4.49 was 
obtained in 72% yield as a white solid (mp 84-86 ºC). 1H-NMR (CDCl3, 500 MHz): δ 2.36 (s, 3H), 
2.72 (ddd, J = 30.0, 15.0, 5.0 Hz, 1H), 2.88 (dt, J = 15.0, 10.0 Hz, 1H), 4.47 (t, J = 5.0 Hz, 2H), 5.93 
(ddd, J = 50.0, 10.0, 5.0 Hz, 1H), 5.96 (br s, NH), 7.14-7.17 (m, 3H), 7.21-7.23 (m, 2H), 7.25-7.34 (m, 
4H); 13C-NMR (CDCl3, 125.3 MHz): δ 21.4, 43.7, 44.9 (d, J = 25.1 Hz), 91.5 (d, J = 170.4 Hz), 122.4, 
122.5, 126.0, 126.1, 127.5, 127.7, 128.6, 128.7, 129.5, 129.5, 137.8, 138.4, 138.8 (d, J = 25.1 Hz), 
168.7 (d, J = 3.8 Hz); 19F-NMR (CDCl3, 282 MHz): δ -173.9 (ddd, J = 47.9, 33.8, 16.9 Hz); HRMS 
(ES) calc. for (M++H) C17H20FNO: 272.1445; found: 272.1446. HPLC (Lux® 5 mm Amylose-1 
column) 90:10 (Hexane/iPrOH) 1.0 mL/min; Tmajor (14.7 min), Tminor (12.9 min); 90:10 er (80% ee).  
 
 
(R)-3-Fluoro-3-(m-tolyl)propanamide. Following the general procedure B, 4.50 was obtained in 
51% yield as a colourless oil. 1H-NMR (CDCl3, 500 MHz): δ 2.37 (s, 3H), 2.70 (ddd, J = 35.0, 15.0, 
5.0 Hz, 1H), 2.91 (dt, J = 15.0, 10.0 Hz, 1H), 5.56 (br s, NH), 5.70 (br s, NH), 5.89 (ddd, J = 50.0, 
10.0, 5.0 Hz, 1H), 7.12-7.18 (m, 3H), 7.22-7.30 (m, 1H); 13C-NMR (CDCl3, 125.3 MHz): δ 21.4, 44.1 
(d, J = 25.1 Hz), 91.2 (d, J = 170.4 Hz), 122.4 (d, J = 6.3 Hz), 126.0 (d, J = 6.3 Hz), 128.6, 129.6 (d, J 
= 2.5 Hz), 138.5, 138.6 (d, J = 20.0 Hz), 171.1 (d, J = 2.5 Hz); 19F-NMR (CDCl3, 282 MHz): δ -174.1 
(ddd, J = 47.9, 33.8, 16.9 Hz); HRMS (ES) calc. for (M++H) C10H13FNO: 182.0964; found: 182.0965. 
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HPLC (ChiralPak ODH column) 95:5 (Hexane/iPrOH) 1.0 mL/min; Tmajor (35.7 min), Tminor (40.9 
min); 90:10 er (80% ee).  
 
 
4.5.5. Deuterium labeling experiments.  
 
 
 
The reaction was carried out following the general procedure A described above over commercially 
available d8-labeled methyl methacrylate. 100% deuterium migration from β to α-position bears out 
proposed 1,1-difunctionalization mechanism, i.e. β-deuteride elimination and subsequent Pd-deuteride 
reinsertion. Final β-fluoride carbonyl-derived systems would be rendered by oxidation and reductive 
elimination of the Pd(IV) intermediate D (Scheme 4.10). Compound 4.51 was isolated as a yellowish 
oil in 52% yield. Diastereomeric ratio (6:1) was determined by 19F NMR over the crude reaction 
mixture. 1H-NMR (CDCl3, 300 MHz): δ 2.32-2.39 (m, 3H), 6.90-7.30 (m, 4H); 13C-NMR (CDCl3, 
75.5 MHz): δ 20.8, 21.2, 121.2, 126.7 (d, J = 6.0 Hz), 128.4, 129.2, 129.9, 133.9 (d, J = 19.6 Hz), 
135.8 (d, J = 48.3 Hz), 139.0 (d, J = 3.0 Hz), 169.7, 174.3; 19F-NMR (CDCl3, 282 MHz): δ -167.5 (t, J 
= 7.1 Hz), -168.9 (br s); HRMS (ES) calc. for (M+-F) C12H7D8O2: 199.1569; found: 199.1565.  
 
 
4.5.6. HPLC data.  
 
  
retention time area 
8.9 min 93.4% 
10.1 min  6.6% 
OCD3
O
CD3
D
D
15 mol% Pd(OAc)2/1,10-phenanthroline 
NFSI (2.0 equiv), 4-TolB(OH)2 (2.0 equiv)   
4-tBu-catechol (4 mol%) 
DCM/H2O (10:1) 0.08 M
20-25 ºC, 20 h
Me
D CD3
OCD3
OD F
4.51
100% D migration
76% NMR yield 
(52% isolated yield) 
6:1 dr
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retention time area 
8.3 min 92.7% 
10.7 min  7.3% 
 
 
  
retention time area 
10.5 min 89.7% 
11.7 min  10.3% 
 
 
  
retention time area 
8.0 min 92.3% 
9.0 min  7.7% 
  8,640  51,56  
  9,653  48,44  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0 
Retention Time [min]
 0 
 20000 
 40000 
In
te
ns
ity
 [µ
V
]
MA791E-1 98.2 IC 1mL - CH14   9,307  92,70  
  10,707  7,30  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0 
Retention Time [min]
 0 
 200000 
 400000 
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ity
 [µ
V
]
MA860-1 98.2 IC 1mL - CH14
  10,467  49,60  
  11,640  50,40  
 6,0  7,0  8,0  9,0  10,0  11,0  12,0  13,0 
Retention Time [min]
 0 
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V
]
MA814C-1 70.30 1mL IC - CH13   10,480  89,65  
  11,720  10,35  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0  18,0  20,0  22,0 
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V
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MA832-1x4 70.30 1mL IC - CH13
  7,440  49,35  
  8,293  50,65  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0 
Retention Time [min]
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]
MA699-1x2 98.2 ODH 1mL - CH14   8,027  92,27  
  8,987  7,73  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0 
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retention time area 
16.5 min 94.8% 
17.9 min  5.2% 
 
 
  
retention time area 
11.9 min 92.3% 
13.0 min  7.7% 
 
 
  
retention time area 
7.2 min 92.3% 
7.8 min  7.7% 
  13,947  49,85  
  14,973  50,15  
 7,0  8,0  9,0  10,0  11,0  12,0  13,0  14,0  15,0  16,0  17,0  18,0 
Retention Time [min]
 0 
 500000 
 1000000 
In
te
ns
ity
 [µ
V
]
MA731-1 99.1 IC point7mL - CH14   16,520  94,81  
  17,947  5,19  
 0,0  5,0  10,0  15,0  20,0  25,0 
Retention Time [min]
 0 
 500000 
 1000000 
In
te
ns
ity
 [µ
V
]
MA802-1 99.1 IC point7mL - CH14
  11,640  49,48  
  12,707  50,52  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0  18,0 
Retention Time [min]
 0 
 500000 
 1000000 
In
te
ns
ity
 [µ
V
]
MA720-1 99.1 IC point7mL - CH14   11,933  92,31  
  13,040  7,69  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0  18,0 
Retention Time [min]
 0 
 200000 
 400000 
In
te
ns
ity
 [µ
V
]
MA805-1 99.1 IC point7mL - CH14
  7,027  49,65  
  7,507  50,35  
 0,0  1,0  2,0  3,0  4,0  5,0  6,0  7,0  8,0  9,0  10,0  11,0 
Retention Time [min]
 0 
 1000000 
 2000000 
In
te
ns
ity
 [µ
V
]
MA741-1 98.2 IC 1mL - CH14   7,173  91,70  
  7,760  8,30  
 0,0  1,0  2,0  3,0  4,0  5,0  6,0  7,0  8,0  9,0  10,0  11,0 
Retention Time [min]
 0 
 1000000 
 2000000 
In
te
ns
ity
 [µ
V
]
MA807-1 98.2 IC 1mL - CH14
F
EtO2C Me
Me
F
EtO2C
F
Me
F
EtO2C
Cl
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retention time area 
7.5 min 93.0% 
8.1 min  7.0% 
 
 
  
retention time area 
27.9 min 4.2% 
29.4 min  95.8% 
 
 
 
 
 
 
 
 
 
 
 
 
  7,253  49,92  
  7,773  50,08  
 6,5  7,0  7,5  8,0  8,5  9,0  9,5  10,0  10,5  11,0  11,5 
Retention Time [min]
 0 
 1000000 
 2000000 
In
te
ns
ity
 [µ
V
]
MA730-1 98.2 IC 1mL - CH14   7,520  92,98  
  8,147  7,02  
 0,0  1,0  2,0  3,0  4,0  5,0  6,0  7,0  8,0  9,0  10,0  11,0 
Retention Time [min]
 0 
 500000 
 1000000 
In
te
ns
ity
 [µ
V
]
MA806-1x2 98.2 IC 1mL - CH14
  27,240  49,99  
  29,080  50,01  
 22,0  24,0  26,0  28,0  30,0  32,0  34,0 
Retention Time [min]
 0 
 200000 
 400000 
In
te
ns
ity
 [µ
V
]
MA714-1 99.1 IC point7mL - CH14
  27,893  4,18  
  29,360  95,82  
 18,0  20,0  22,0  24,0  26,0  28,0  30,0  32,0  34,0 
Retention Time [min]
 0 
 200000 
 400000 
In
te
ns
ity
 [µ
V
]
MA804-1 99.1 IC point7mL - CH14
F
EtO2C
Br
F
EtO2C OMe
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retention time area 
9.9 min 94.5% 
11.0 min  5.5% 
 
 
 
  
retention time area 
8.0 min 94.9% 
8.5 min  5.1% 
 
 
 
  9,933  49,91  
  11,027  50,09  
 4,0  5,0  6,0  7,0  8,0  9,0  10,0  11,0  12,0  13,0  14,0 
Retention Time [min]
 0 
 500000 
 1000000 
In
te
ns
ity
 [µ
V
]
MA852-1 98.2 IC 1mL - CH14   9,920  94,47  
  11,000  5,53  
 4,0  5,0  6,0  7,0  8,0  9,0  10,0  11,0  12,0  13,0  14,0 
Retention Time [min]
 0 
 500000 
 1000000 
In
te
ns
ity
 [µ
V
]
MA853B-1 98.2 IC 1mL - CH14
  9,667  94,63  
  10,720  5,37  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0 
Retention Time [min]
 0 
 500000 
 1000000 
 1500000 
In
te
ns
ity
 [µ
V
]
MA854-1 98.2 IC 1mL-after 1month - CH14   10,000  93,88  
  11,133  6,12  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0 
Retention Time [min]
 0 
 200000 
 400000 
 600000 
 800000 
In
te
ns
ity
 [µ
V
]
MA855-1 98.2 IC 1mL - CH14
  7,947  50,05  
  8,453  49,95  
 0,0  1,0  2,0  3,0  4,0  5,0  6,0  7,0  8,0  9,0  10,0 
Retention Time [min]
 0 
 500000 
 1000000 
In
te
ns
ity
 [µ
V
]
MA856D-1 98.2 IC 1mL - CH14
  8,040  94,91  
  8,547  5,09  
 0,0  1,0  2,0  3,0  4,0  5,0  6,0  7,0  8,0  9,0  10,0 
Retention Time [min]
 0 
 500000 
 1000000 
In
te
ns
ity
 [µ
V
]
MA857D-1 98.2 IC 1mL - CH14
F
BnO2C
Me
F
BnO2C
Me
after 1 month
F
BnO2C
Me
x10
F
BnO2C Cl
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retention time area 
31.2 min 97.1% 
33.0 min  2.9% 
 
 
  
retention time area 
35.2 min 92.6% 
39.0 min  7.4% 
 
 
  
retention time area 
12.6 min 92.0% 
13.7 min  8.0% 
  33,707  49,74  
  36,227  50,26  
 0,0  5,0  10,0  15,0  20,0  25,0  30,0  35,0  40,0  45,0 
Retention Time [min]
 0 
 100000 
 200000 
In
te
ns
ity
 [µ
V
]
MA856C-1 99.1 AD point5mL - CH14
  31,173  97,12  
  33,027  2,88  
 0,0  5,0  10,0  15,0  20,0  25,0  30,0  35,0  40,0  45,0 
Retention Time [min]
 0 
 200000 
 400000 
In
te
ns
ity
 [µ
V
]
MA857C-1x2 99.1 AD point5mL - CH14
  35,600  47,91  
  39,240  52,09  
 18,0  20,0  22,0  24,0  26,0  28,0  30,0  32,0  34,0  36,0  38,0  40,0 
Retention Time [min]
 0 
 20000 
 40000 
 60000 
In
te
ns
ity
 [µ
V
]
MA858D-1 98.2 IC 1mL - CH10
  35,160  92,59  
  39,000  7,41  
 18,0  20,0  22,0  24,0  26,0  28,0  30,0  32,0  34,0  36,0  38,0  40,0 
Retention Time [min]
 0 
 100000 
 200000 
In
te
ns
ity
 [µ
V
]
MA868C-1 98.2 IC 1mL - CH10
  12,107  49,27  
  12,947  50,73  
 4,0  6,0  8,0  10,0  12,0  14,0  16,0 
Retention Time [min]
 0 
 1000000 
 2000000 
In
te
ns
ity
 [µ
V
]
MA813B-1  75.25 1mL IC - CH10   12,640  92,01  
  13,667  7,99  
 4,0  6,0  8,0  10,0  12,0  14,0  16,0 
Retention Time [min]
 0 
 500000 
 1000000 
 1500000 
In
te
ns
ity
 [µ
V
]
MA833-1x2  75.25 1mL IC - CH10
F
BnO2C OMe
F
BnO2C CO2Me
F
N
O
MeO
Me
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retention time area 
5.4 min 84.3% 
5.9 min  15.7% 
 
 
  
retention time area 
10.8 min 87.8% 
11.6 min  12.2% 
 
 
  
retention time area 
12.9 min 10.1% 
14.7 min  89.9% 
  5,227  49,21  
  5,747  50,79  
 0,0  1,0  2,0  3,0  4,0  5,0  6,0  7,0  8,0  9,0  10,0  11,0  12,0 
Retention Time [min]
 0 
 500000 
 1000000 
 1500000 
In
te
ns
ity
 [µ
V
]
MA823B-1 70.30 1mL ODH - CH13   5,360  84,33  
  5,933  15,67  
 0,0  1,0  2,0  3,0  4,0  5,0  6,0  7,0  8,0  9,0 
Retention Time [min]
 0 
 200000 
 400000 
In
te
ns
ity
 [µ
V
]
MA835A-1 70.30 1mL ODH - CH13
  10,560  50,23  
  11,387  49,77  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0 
Retention Time [min]
 0 
 50000 
 100000 
 150000 
In
te
ns
ity
 [µ
V
]
MA817A-1 70.30 1mL IC - CH14   10,760  87,77  
  11,613  12,23  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0 
Retention Time [min]
 0 
 50000 
 100000 
In
te
ns
ity
 [µ
V
]
MA834-1 70.30 1mL IC - CH14
  13,027  50,06  
  14,680  49,94  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0  18,0  20,0 
Retention Time [min]
 0 
 100000 
 200000 
 300000 
 400000 
In
te
ns
ity
 [µ
V
]
MA899C-1 90.10 AMY1 1mL - CH13
  12,867  10,10  
  14,653  89,90  
 0,0  2,0  4,0  6,0  8,0  10,0  12,0  14,0  16,0  18,0  20,0 
Retention Time [min]
 0 
 100000 
 200000 
 300000 
 400000 
In
te
ns
ity
 [µ
V
]
MA907-1 90.10 AMY1 1mL - CH13
F
N
O
MeO
Me
Me
F
N
O
MeO
Me S
F
BnHNOC Me
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retention time area 
35.7 min 90.4% 
40.9 min  9.6% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  35,813  49,22  
  40,373  50,78  
 0,0  5,0  10,0  15,0  20,0  25,0  30,0  35,0  40,0  45,0  50,0 
Retention Time [min]
 0 
 20000 
 40000 
 60000 
In
te
ns
ity
 [µ
V
]
MA903C-1 95.5 1mL ODH - CH13
  35,653  90,37  
  40,893  9,63  
 0,0  5,0  10,0  15,0  20,0  25,0  30,0  35,0  40,0  45,0  50,0 
Retention Time [min]
 0 
 50000 
In
te
ns
ity
 [µ
V
]
MA904C-1 95.5 1mL ODH - CH13
F
H2NOC Me
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